Sentence,class,file
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/fd/6f/bmjqir-3-u204759-w2219.PMC4645884.pdf
"London,  http://bma.org.uk/-/media/Files/PDFs/Practical%20advice%2 0at%20work/Contracts/safe%20handover%20s 2.",Non-OADS,/arxiv_data1/oa_pdf/c1/96/bmjqir-3-u203341-w1798.PMC4645885.pdf
Accessed via: http://office.microsoft.com/en-gb/word-help/ta bles-i-create-and-format-basic-tables-RZ001200716.aspxDeclaration of interests Nothing to declare.,Non-OADS,/arxiv_data1/oa_pdf/c1/96/bmjqir-3-u203341-w1798.PMC4645885.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/c1/96/bmjqir-3-u203341-w1798.PMC4645885.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/5c/af/bmjqir-4-u204075-w1773.PMC4645886.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/9c/40/bmjqir-3-u201157-w1124.PMC4645887.pdf
http://cks.nice.org.uk/red-eye 7.,Non-OADS,/arxiv_data1/oa_pdf/67/2a/bmjqir-3-u206617-w2852.PMC4645888.pdf
NICE guidelines Clinical Knowledge Summaries (last revised August 2012).Retrieved from  http://cks.nice.org.uk/conjunctivitis-infective 8.,Non-OADS,/arxiv_data1/oa_pdf/67/2a/bmjqir-3-u206617-w2852.PMC4645888.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/67/2a/bmjqir-3-u206617-w2852.PMC4645888.pdf
"Centers for Disease Control and Prevention (CDC) National Healthcare Safety Network (NHSN)(2015), Surgical site infection: 1-27 (http://www.cdc.gov/nhsn/PDFs/pscManual/9pscSSIcurrent.",Non-OADS,/arxiv_data1/oa_pdf/55/d3/bmjqir-4-u205401-w3279.PMC4645889.pdf
"Association for Professionals of Infection Control and Epidemiology (APIC) Guide (2010), Elimination of orthopaedic surgical site infections: 1-80 (http://www.apic.org/Resource_/EliminationGuideForm/34e0 3612-d1e6-4214-a76b-e532c6fc3898/File/APIC-Ortho- Guide.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/55/d3/bmjqir-4-u205401-w3279.PMC4645889.pdf
"Institute for Healthcare Improvement (IHI) (2012), Prevention of surgical site infection: 1-28 (http://www.ihi.org/resources/Pages/Tools/HowtoGuidePrev entSurgicalSiteInfection.aspx ).",Non-OADS,/arxiv_data1/oa_pdf/55/d3/bmjqir-4-u205401-w3279.PMC4645889.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/55/d3/bmjqir-4-u205401-w3279.PMC4645889.pdf
2012 [cited 2012 July 9]; Available from:  http://www.drfosterhealth.co.uk/quality- reports/trust.aspx?otype=2&id=9 .,Non-OADS,/arxiv_data1/oa_pdf/52/7a/bmjqir-3-u202922-w1358.PMC4645890.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/52/7a/bmjqir-3-u202922-w1358.PMC4645890.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/65/18/TOORTHJ-9-495.PMC4645891.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/cb/95/bmjqir-3-u204762-w2037.PMC4645892.pdf
Problem Suicide is one of the leading causes of death in the 20-34 year old age group (http://www.ons.gov.uk/ons/rel/vsob1/mortality-statistics--deaths-reg istered-in-england-and-wales--series-dr-/2012/info-causes-of- death.html ).,Non-OADS,/arxiv_data1/oa_pdf/4a/26/bmjqir-4-u207272-w2919.PMC4645893.pdf
"NICE provide guidelines on the initial management of self harm in A+E (https://www.nice.org.uk/guidance/cg16/resources/guidance- selfharm-pdf ), so the audit cycles were aimed at improving the compliance to the guidelines set out by NICE.",Non-OADS,/arxiv_data1/oa_pdf/4a/26/bmjqir-4-u207272-w2919.PMC4645893.pdf
(http://www.ons.gov.uk/ons/rel/vsob1/mortality-statistics--de aths-registered-in-england-and-wales--series-dr-/2012/info- causes-of-death.html ).,Non-OADS,/arxiv_data1/oa_pdf/4a/26/bmjqir-4-u207272-w2919.PMC4645893.pdf
(https://www.nice.org.uk/guidance/cg16/resources/guidance- selfharm-pdf ).,Non-OADS,/arxiv_data1/oa_pdf/4a/26/bmjqir-4-u207272-w2919.PMC4645893.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/4a/26/bmjqir-4-u207272-w2919.PMC4645893.pdf
"Dr Foster Hospital Guide (2011), Reducing mortality at nights and weekends, pg 19-22 (http://drfosterintelligence.co.uk/wp- content/uploads/2011/11/Hospital_Guide_2011.pdf ) 5.",Non-OADS,/arxiv_data1/oa_pdf/73/28/bmjqir-3-u203298-w1533.PMC4645894.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/73/28/bmjqir-3-u203298-w1533.PMC4645894.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f0/e3/TOORTHJ-9-480.PMC4645895.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/ 3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/18/bd/TOAIDJ-9-80.PMC4645897.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/ 3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b7/e3/TOAIDJ-9-96.PMC4645898.pdf
References 1. http://www.nhs.uk/conditions/Urinary-tract-infection- adults/Pages/Introduction.aspx 2.,Non-OADS,/arxiv_data1/oa_pdf/e8/1d/bmjqir-4-u208446-w3374.PMC4645900.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/e8/1d/bmjqir-4-u208446-w3374.PMC4645900.pdf
"Online article, accessed on 31 July 2014, available at http://www.nhs.uk/Conditions/vitamins- minerals/Pages/Vitamin-D.aspx 3.",Non-OADS,/arxiv_data1/oa_pdf/f9/1d/bmjqir-3-u203171-w1436.PMC4645901.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/f9/1d/bmjqir-3-u203171-w1436.PMC4645901.pdf
July 2012.  http://www.sign.ac.uk/guidelines/fulltext/88/index.html (accessed 20 January 2014).,Non-OADS,/arxiv_data1/oa_pdf/33/db/bmjqir-3-u203314-w1503.PMC4645902.pdf
"July 2012.  http://www.sign.ac.uk/pdf/sign88_algorithm_older.pdf (accessed 20 January 2014).Declaration of interests None declared Acknowledgements Dr Appu Suman, Consultant Stroke Medicine, and Dr Camilia Farris, Consultant Microbiologist.",Non-OADS,/arxiv_data1/oa_pdf/33/db/bmjqir-3-u203314-w1503.PMC4645902.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/33/db/bmjqir-3-u203314-w1503.PMC4645902.pdf
Available at http://www.cdc.gov/hicpac/SSI/002_SSI.html 5.,OADS,/arxiv_data1/oa_pdf/73/b3/bmjqir-4-u205509-w2980.PMC4645904.pdf
Available at:  http://www.cdc.gov/hicpac/SSI/table7-8-9-10-SSI.html 6.,OADS,/arxiv_data1/oa_pdf/73/b3/bmjqir-4-u205509-w2980.PMC4645904.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/73/b3/bmjqir-4-u205509-w2980.PMC4645904.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/d7/54/bmjqir-3-u203377-w1925.PMC4645905.pdf
"The Canadian Alliance for Monitoring Effectiveness and Safety of Antipsychotics in Children (CAMESA) Guidelines (2011) were chosen for this project due to their comprehensiveness, availability of a free excel monitoring template for each atypical antipsychotic based on CAMESA guidelines and accessibility (for more information on the CAMESA tool, see http://camesaguideline.org  for details and free tool).",Non-OADS,/arxiv_data1/oa_pdf/eb/dc/bmjqir-4-u208804-w3544.PMC4645906.pdf
2011.  http://www.amednews.com/article/20110711/profession/307 119948/4/ .,Non-OADS,/arxiv_data1/oa_pdf/eb/dc/bmjqir-4-u208804-w3544.PMC4645906.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/eb/dc/bmjqir-4-u208804-w3544.PMC4645906.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/80/36/bmjqir-4-u204560-w3221.PMC4645907.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/7b/4a/bmjqir-4-u203210-w1579.PMC4645908.pdf
RCGP Policy Paper March 2011.  http://www.rcgp.org.uk/policy/rcgp-policy-areas/~/media/File s/Policy/A-Z-policy/RCGP-Continuity-of-Care.ashx 2.,Non-OADS,/arxiv_data1/oa_pdf/bd/ae/bmjqir-3-u203324-w1511.PMC4645909.pdf
2010.  https://www.gov.uk/government/publications/the-operating- framework-for-the-nhs-in-england-2011-12 .,Non-OADS,/arxiv_data1/oa_pdf/bd/ae/bmjqir-3-u203324-w1511.PMC4645909.pdf
http://sdm.rightcare.nhs.uk/about/shared- decision-making/ .,Non-OADS,/arxiv_data1/oa_pdf/bd/ae/bmjqir-3-u203324-w1511.PMC4645909.pdf
The King’s Fund 2010.  http://www.kingsfund.org.uk/sites/files/kf/field/field_documen t/continuity-care-patient-experience-gp-inquiry-research- paper-mar11.pdf 13.,Non-OADS,/arxiv_data1/oa_pdf/bd/ae/bmjqir-3-u203324-w1511.PMC4645909.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/bd/ae/bmjqir-3-u203324-w1511.PMC4645909.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/17/b6/bmjqir-3-u204930-w2080.PMC4645910.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/2a/7a/bmjqir-3-u204152-w1807.PMC4645911.pdf
2011.  http://www.nice.org.uk/nicemedia/live/13489/54921/54921.p df 2.,Non-OADS,/arxiv_data1/oa_pdf/78/f7/bmjqir-3-u202991-w1956.PMC4645912.pdf
2010 http://www.nice.org.uk/nicemedia/pdf/CG92NICEGuidelineP DF.pdf 3.,Non-OADS,/arxiv_data1/oa_pdf/78/f7/bmjqir-3-u202991-w1956.PMC4645912.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/78/f7/bmjqir-3-u202991-w1956.PMC4645912.pdf
http://www.rcpsych.ac.uk/healthadvice/improvingphysicalan dmh/physicalhealthinadults.aspx  (accessed 31st December 2014).,Non-OADS,/arxiv_data1/oa_pdf/59/ca/bmjqir-4-u206294-w2558.PMC4645913.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/59/ca/bmjqir-4-u206294-w2558.PMC4645913.pdf
London:  http://www.midstaffspublicinquiry.com/sites/default/files/repo rt/Executive%20summary.pdf 3.,Non-OADS,/arxiv_data1/oa_pdf/af/a2/bmjqir-3-u202980-w1397.PMC4645914.pdf
"Ramanug R. https://www.fmlm.ac.uk/news-policy-and-opinion/policy/the-francis- report-a-trainee%E2%80%99s-perspective Declaration of interests Nothing to declare Powered by TCPDF (www.tcpdf.org)  Page 3 of 3 © 2014, Published by the BMJ Publishing Group Limited.",Non-OADS,/arxiv_data1/oa_pdf/af/a2/bmjqir-3-u202980-w1397.PMC4645914.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/af/a2/bmjqir-3-u202980-w1397.PMC4645914.pdf
Comptroller and Auditor General Special Report (2014) Managing Elective Day Surgery (downloaded 9/12/14 from  http://www.audgen.gov.ie/documents/vfmreports/83_Electiv eDaySurgery.pdf ) 2.,Non-OADS,/arxiv_data1/oa_pdf/da/51/bmjqir-4-u203452-w1552.PMC4645915.pdf
A systematic review of present innovations (downloaded on 9/12/14 from  http://www.sdo.nihr.ac.uk/files/project/29-finalreport.pdf ) 3.,Non-OADS,/arxiv_data1/oa_pdf/da/51/bmjqir-4-u203452-w1552.PMC4645915.pdf
9/12/14 from https://www.rcplondon.ac.uk/press-releases/ne w-toolkit-based-rcp-discharge-summary-record-launched ) Declaration of interests None declared Acknowledgements The authors would like to acknowledge: North Bristol NHS Trust and specifically the urology department at Southmead Hospital.,Non-OADS,/arxiv_data1/oa_pdf/da/51/bmjqir-4-u203452-w1552.PMC4645915.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/da/51/bmjqir-4-u203452-w1552.PMC4645915.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/0e/c1/bmjqir-3-u204923-w2078.PMC4645916.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/7c/c3/bmjqir-4-u207778-w3190.PMC4645917.pdf
"http://www.bliss.org.uk/wp-content/uploads/2014/05/Best-pr actice-bank-baby-diaries-a-tool-to-improve-communication- Croydon-University-Hosital2.pdf 8.Croydon University Hospital Care Quality Commission Report 2013. http://www.cqc.org.uk/sites/default/files/new_reports/AAAA0 782.pdf , Page 35 Declaration of interests None declared.Acknowledgements Sophie Bertaud, Samantha Nailor, and Grant Marais as well as all members of staff and parents involved in the project at Croydon University Hospital for their support.",Non-OADS,/arxiv_data1/oa_pdf/cc/fd/bmjqir-4-u203180-w3084.PMC4645918.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/cc/fd/bmjqir-4-u203180-w3084.PMC4645918.pdf
Available from:  http://www.gmc-uk.org/guidance/good_medical_practice/con tinuity_care.asp 2.,Non-OADS,/arxiv_data1/oa_pdf/1d/17/bmjqir-4-u206467-w2913.PMC4645919.pdf
Available from:  http://bma.org.uk/-/media/files/pdfs/practical%20advice%20 at%20work/contracts/safe%20handover%20safe%20patient s.pdf Declaration of interests Nothing to declare.,Non-OADS,/arxiv_data1/oa_pdf/1d/17/bmjqir-4-u206467-w2913.PMC4645919.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/1d/17/bmjqir-4-u206467-w2913.PMC4645919.pdf
Available from: https://www.ismp-canada.org/abx/ 2.,Non-OADS,/arxiv_data1/oa_pdf/44/a4/bmjqir-4-u200786-w2247.PMC4645920.pdf
Available from:  http://www.accreditation.ca/sites/default/files/rop- handbook-2014-en.pdf 3.,Non-OADS,/arxiv_data1/oa_pdf/44/a4/bmjqir-4-u200786-w2247.PMC4645920.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/44/a4/bmjqir-4-u200786-w2247.PMC4645920.pdf
"2011 May 16; Available from: URL: http://www.rcplondon.ac.uk/sites/default/files/documents/hos pital-admission-clerking-audit-tool_0.xls   Page 3 of 4 © 2014, Published by the BMJ Publishing Group Limited.",Non-OADS,/arxiv_data1/oa_pdf/e3/7f/bmjqir-3-u202917-w1357.PMC4645921.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/e3/7f/bmjqir-3-u202917-w1357.PMC4645921.pdf
Available from:  http://www.nice.org.uk/guidance/cg83 .,Non-OADS,/arxiv_data1/oa_pdf/33/45/bmjqir-4-u203938-w3268.PMC4645923.pdf
Available from:  http://www.safetyandquality.gov.au/wp- content/uploads/2012/01/clinhovrlitrev.pdf .,Non-OADS,/arxiv_data1/oa_pdf/33/45/bmjqir-4-u203938-w3268.PMC4645923.pdf
"Online first, available from:  http://journal.publications.chestnet.org/data/Journals/CHES T/932713/chest_147_2_317.pdf .",Non-OADS,/arxiv_data1/oa_pdf/33/45/bmjqir-4-u203938-w3268.PMC4645923.pdf
Available from:  http://www.nice.org.uk/guidance/cg50/resources/guidance- acutely-ill-patients-in-hospital-pdf .,Non-OADS,/arxiv_data1/oa_pdf/33/45/bmjqir-4-u203938-w3268.PMC4645923.pdf
Available from:  http://www.safetyandquality.gov.au/wp- content/uploads/2012/01/EDS-self-eval-toolkit-sept2011.pdf .,Non-OADS,/arxiv_data1/oa_pdf/33/45/bmjqir-4-u203938-w3268.PMC4645923.pdf
Available from:  https://www.cadth.ca/resources/rx-for- change/database/browse .,OADS,/arxiv_data1/oa_pdf/33/45/bmjqir-4-u203938-w3268.PMC4645923.pdf
Available from:  http://eprints.soton.ac.uk/300532/  Accessed: 02/02/15.,Non-OADS,/arxiv_data1/oa_pdf/33/45/bmjqir-4-u203938-w3268.PMC4645923.pdf
Available from:  http://www.ihi.org/resources/Pages/HowtoImprove/default.a spx.,Non-OADS,/arxiv_data1/oa_pdf/33/45/bmjqir-4-u203938-w3268.PMC4645923.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/33/45/bmjqir-4-u203938-w3268.PMC4645923.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/36/2f/TOORTHJ-9-450.PMC4645924.pdf
"Available at: http://www.rcseng.ac.uk/publications/docs/higher-risk- surgical-patient 4.Din N, Ghaderi S, O'Connell R, et al.",Non-OADS,/arxiv_data1/oa_pdf/58/82/bmjqir-3-u201797-w1958.PMC4645925.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/58/82/bmjqir-3-u201797-w1958.PMC4645925.pdf
http://www.scottishpatientsafetyprogramme.scot.nhs.uk/prog rammes/acute-adult  (accessed 17 Jul 2014).,Non-OADS,/arxiv_data1/oa_pdf/46/5f/bmjqir-4-u204775-w2440.PMC4645926.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/46/5f/bmjqir-4-u204775-w2440.PMC4645926.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/ 3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e8/2d/TOAIDJ-9-89.PMC4645927.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b5/4c/TOORTHJ-9-489.PMC4645928.pdf
"(Acces sedonline, http://www.hse.ie/eng/services/publications , 31Oct 2009).",Non-OADS,/arxiv_data1/oa_pdf/31/bb/bmjqir-4-u205599-w3015.PMC4645929.pdf
"The relationship of nursing workforce characteristics to patient outcomes, Online J Iss Nurs 2007; 12(3)  http://www.nursingworld.org/MainMenuCategories/ANAMark etplace/ANAPeriodicals/OJIN/TableofContents/Volume1220 07/No3Sept07/NursingWorkforceCharacteristics.aspx  Last accessed April 3rd 2011.",OADS,/arxiv_data1/oa_pdf/31/bb/bmjqir-4-u205599-w3015.PMC4645929.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/31/bb/bmjqir-4-u205599-w3015.PMC4645929.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/42/80/TOORTHJ-9-460.PMC4645930.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/30/80/bmjqir-3-u203864-w1691.PMC4645932.pdf
"London: The Health Foundation, 2011.  http://www.health.org.uk/publications/making-care-safer (last accessed 21st Septemer 2014).",Non-OADS,/arxiv_data1/oa_pdf/77/ed/bmjqir-3-u203261-w2538.PMC4645934.pdf
"Clinical teams’ experiences of implementing shared decision making as part of the MAGIC programme: Health Foundation, 2013.  http://www.health.org.uk/public/cms/75/76/313/4173/MAGIC %20evaluation.pdf?realName=hrsgE6.pdf  (last accessed 23rd September 2014).",Non-OADS,/arxiv_data1/oa_pdf/77/ed/bmjqir-3-u203261-w2538.PMC4645934.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/77/ed/bmjqir-3-u203261-w2538.PMC4645934.pdf
National Institute for Clinical Excellence Clinical Guideline 95: Chest pain of recent onset: Assessment and diagnosis of recent onset chest pain or discomfort of suspected cardiac origin  http://www.nice.org.uk/nicemedia/live/12947/47931/47931.p df 2010 accessed 23/11/12.,Non-OADS,/arxiv_data1/oa_pdf/59/07/bmjqir-3-u204753-w2003.PMC4645935.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/59/07/bmjqir-3-u204753-w2003.PMC4645935.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bc/3f/TOORTHJ-9-511.PMC4645936.pdf
Accessed at  http://www.midstaffspublicinquiry.com/sites/default/files/repo rt/Executive%20summary.pdf  on 28/8/14 at 20:28 2.,Non-OADS,/arxiv_data1/oa_pdf/44/ff/bmjqir-3-u206189-w2537.PMC4645937.pdf
http://www.england.nhs.uk/wp- content/uploads/2013/12/evidence-base.pdf 4.,Non-OADS,/arxiv_data1/oa_pdf/44/ff/bmjqir-3-u206189-w2537.PMC4645937.pdf
http://www.gmc-uk.org/Good_Medical_Practice_2012___Dr aft_for_consultation.pdf_45081179.pdf 7.,Non-OADS,/arxiv_data1/oa_pdf/44/ff/bmjqir-3-u206189-w2537.PMC4645937.pdf
http://www.rcplondon.ac.uk/sites/default/files/standards-for- the-clinical-structure-and-content-of-patient-records.pdf 8.,Non-OADS,/arxiv_data1/oa_pdf/44/ff/bmjqir-3-u206189-w2537.PMC4645937.pdf
http://www.rcseng.ac.uk/surgeons/surgical- standards/professionalism-surgery/good-surgical-practice 9.,Non-OADS,/arxiv_data1/oa_pdf/44/ff/bmjqir-3-u206189-w2537.PMC4645937.pdf
Accessed at http://www.rcplondon.ac.uk/sites/default/files/ward_rounds_i n_medicine.pdf 10.,Non-OADS,/arxiv_data1/oa_pdf/44/ff/bmjqir-3-u206189-w2537.PMC4645937.pdf
"http://bma.org.uk/-/media/files/pdfs/practical%20advice%20 at%20work/contracts/safe%20handover%20safe%20patient s.pdf   Page 3 of 4 © 2014, Published by the BMJ Publishing Group Limited.",Non-OADS,/arxiv_data1/oa_pdf/44/ff/bmjqir-3-u206189-w2537.PMC4645937.pdf
http://www.southampton.ac.uk/assets/imported/transforms/p eripheral-block/UsefulDownloads_Download/4762464A4BA D4178B69F79EDB183F8ED/The%20demise%20of%20the %20firm_Report_v2.pdf Declaration of interests No conflicts of interest to declare.,Non-OADS,/arxiv_data1/oa_pdf/44/ff/bmjqir-3-u206189-w2537.PMC4645937.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/44/ff/bmjqir-3-u206189-w2537.PMC4645937.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/ad/79/bmjqir-3-u204059-w2102.PMC4645938.pdf
Scottish Patient Safety Programme Available from:  http://www.scottishpatientsafetyprogramme.scot.nhs.uk/prog rammes/acute-adult  Accessed 7th January 2015.,Non-OADS,/arxiv_data1/oa_pdf/e0/e1/bmjqir-4-u207660-w3069.PMC4645939.pdf
2012; Available from:  http://www.sicsag.scot.nhs.uk/HAI/VAP-Prevention-Bundle- web.pdf  Accessed 7th January 2015.,Non-OADS,/arxiv_data1/oa_pdf/e0/e1/bmjqir-4-u207660-w3069.PMC4645939.pdf
Surveillance of NosocomialInfections in Intensive Care Units (2004) Protocol Version 6.1.: HELICS 2004; Version 6.1:[Available from:  http://www.ecdc.europa.eu/en/activities/surveillance/HAI/Do cuments/0409_IPSE_ICU_protocol.pdf  Accessed 7th January 2015.,Non-OADS,/arxiv_data1/oa_pdf/e0/e1/bmjqir-4-u207660-w3069.PMC4645939.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/e0/e1/bmjqir-4-u207660-w3069.PMC4645939.pdf
Available  http://www.ihi.org/resources/pages/tools/IHIGlobalTriggerTo olforMeasuringAEs.aspx 4.,OADS,/arxiv_data1/oa_pdf/4b/77/bmjqir-4-u202625-w3247.PMC4645940.pdf
Available  https://www.gov.uk/government/publications/review-of- liverpool-care-pathway-for-dying-patients 6.,Non-OADS,/arxiv_data1/oa_pdf/4b/77/bmjqir-4-u202625-w3247.PMC4645940.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/4b/77/bmjqir-4-u202625-w3247.PMC4645940.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/17/43/bmjqir-4-u208308-w3441.PMC4645941.pdf
2009.  http://www.nrls.npsa.nhs.uk/resources/?entryid45=62811 .,Non-OADS,/arxiv_data1/oa_pdf/93/35/bmjqir-3-u204031-w1815.PMC4645942.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/93/35/bmjqir-3-u204031-w1815.PMC4645942.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/74/5f/bmjqir-3-u203278-w1486.PMC4645943.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/a4/63/bmjqir-4-u208549-w3409.PMC4645944.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/1c/7a/bmjqir-3-u201797-w1992.PMC4645945.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/5a/96/bmjqir-4-u204509-w1983.PMC4645946.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/d9/a3/bmjqir-4-u206577-w2642.PMC4645947.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/ef/3c/bmjqir-4-u202580-w1592.PMC4645948.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/61/05/bmjqir-4-u207618-w3050.PMC4645949.pdf
[cited 2014 Sep 27] Available from:  http://www.nice.org.uk/guidance/cg103/chapter/introduction 2.,Non-OADS,/arxiv_data1/oa_pdf/c4/92/bmjqir-4-u206598-w2653.PMC4645950.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/c4/92/bmjqir-4-u206598-w2653.PMC4645950.pdf
January 2010. https://www.nice.org.uk/guidance/cg92 2.,Non-OADS,/arxiv_data1/oa_pdf/ce/01/bmjqir-4-u205852-w3226.PMC4645951.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/ce/01/bmjqir-4-u205852-w3226.PMC4645951.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a3/69/TOORTHJ-9-445.PMC4645952.pdf
Circ Heart Fail is available at http://circheartfailure.ahajournals.org DOI: 10.1161/CIRCHEARTFAILURE.114.002169Background—Whether the myocardium in nonischemic heart failure experiences oxygen limitation remains a long-standing  controversy.,Non-OADS,/arxiv_data1/oa_pdf/53/1a/hhf-8-1088.PMC4645953.pdf
"Similar to MDAMC cells, VacA treatment caused an increase in AGO2 in HeLa cells (see Fig., Supplemental Digital Content 1, http://links.lww.com/IBD/B48).",Non-OADS,/arxiv_data1/oa_pdf/ec/b1/ibd-21-2778.PMC4645954.pdf
"Details of studies excluded after full-text review are shown in the supplementary appendix (Supplementary Table 2, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/76/c0/aids-29-2465.PMC4645957.pdf
"The full assessment of risk of bias is shown in the supplementary appendix (Supplementary Table 3, http://links.lww.com/QAD/A767).",Non-OADS,/arxiv_data1/oa_pdf/76/c0/aids-29-2465.PMC4645957.pdf
"2, Tables S1 and S2, http://links.lww.com/QAD/ A764) of the spread of infection in an age-structured population was developed and tailored to the epidemic in Caio´from 1990.",Non-OADS,/arxiv_data1/oa_pdf/e6/5b/aids-29-2479.PMC4645958.pdf
"Net removal rates vary with age and HIV-2 infection status (T ext S3 and Table S2, http://links.lww.com/QAD/A764); further- more, they vary with time to account for changes in therapy and HIV-1 prevalence (Fig.",Non-OADS,/arxiv_data1/oa_pdf/e6/5b/aids-29-2479.PMC4645958.pdf
"The fact that partnerships are more likely to be made with high-risk individuals who in turn are more likely to be HIV-1 positive and therefore are also more likely to be receiving therapy isaccounted for (T ext S4, http://links.lww.com/QAD/ A764) [32,33].",Non-OADS,/arxiv_data1/oa_pdf/e6/5b/aids-29-2479.PMC4645958.pdf
"The model, formulated using difference equations (T ext S1, equations 1–4, http://links.lww.com/QAD/A764), was ﬁtted using maximum likelihood estimation (T ext S5, http://links.lww.com/QAD/A764) to the incidence and2482 AIDS 2015, Vol 29 No 18 Age15 1716Susceptible Infected Birth B S15,t Infection Removal Ageingγ15,t γ16,tλ15,t (1–γ15,t) λ16,t (1–γ16,t) 1–γ16,t γ17,tγ16,t γ17,tI16,t I17,t(1–λ15,t)(1–γ15,t) (1–λ16,t )(1–γ16,t) (1–λ17,t )(1–γ17,t)λ17,t (1–γ17,t)S16,t S17,tγ17,t ~~~~ Fig.",Non-OADS,/arxiv_data1/oa_pdf/e6/5b/aids-29-2479.PMC4645958.pdf
"A stochastic version (T ext S7, equations 19–22, http://links.lww.com/QAD/A764) was also formulated by allowing death and infection to be governed by probabilistic methods.",Non-OADS,/arxiv_data1/oa_pdf/e6/5b/aids-29-2479.PMC4645958.pdf
"Nevertheless, for simplicity, we model the apparent reduction in risk behaviour as a stepwise reduction, estimated to be a factor of 2.6 in the average numberof sexual partnerships per year applied across all age groups occurring in 1997 (Figure S2, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/e6/5b/aids-29-2479.PMC4645958.pdf
"This ﬁnding is not dependent upon the assumption of independence of incidence and prevalence data during model ﬁtting (T ext S6, http://links.lww.com/ QAD/A764).",Non-OADS,/arxiv_data1/oa_pdf/e6/5b/aids-29-2479.PMC4645958.pdf
"Estimations indicate that the effective reproductive number, deﬁned as the average number of secondary infections generated by one primary infection, declined from 0.9 between 1990 and 1997 to 0.4 between 1997 and 2007 (T ext S8, http://links.lww.com/QAD/ A764).",Non-OADS,/arxiv_data1/oa_pdf/e6/5b/aids-29-2479.PMC4645958.pdf
"The age difference between sexual partners is assumed to be less than 20 years for 81% of partnerships (T ext S4, http://links.lww.com/QAD/ A764) [23].",Non-OADS,/arxiv_data1/oa_pdf/e6/5b/aids-29-2479.PMC4645958.pdf
"Model predictions of the future epidemiologyof HIV-2 are the same when susceptibility to HIV-2 is independent of age and when its age-dependency optimizes the model ﬁt (Table S4, http://links.lww.com/ QAD/A764).",Non-OADS,/arxiv_data1/oa_pdf/e6/5b/aids-29-2479.PMC4645958.pdf
"Additional details about the model are provided in the supplementary text, http://links.lww.com/QAD/A764.",Non-OADS,/arxiv_data1/oa_pdf/e6/5b/aids-29-2479.PMC4645958.pdf
"The fraction of HIV-1, HIV-2 and dually infected individuals receiving therapy was assumed to remain ﬁxed beyond 2007 at levels estimated from clinical records from 2014 (Table S3, http://links.lww.com/QAD/A764).",OADS,/arxiv_data1/oa_pdf/e6/5b/aids-29-2479.PMC4645958.pdf
"Therapy rates are estimated from clinical records from 2014, not a population survey, and therefore may vary compared with our best estimates (Table S3, http://links.lww.com/QAD/A764; Fig.",Non-OADS,/arxiv_data1/oa_pdf/e6/5b/aids-29-2479.PMC4645958.pdf
"The sensitivity of our results to plausible increases or decreases in treatment rates and/or HIV-1 rates (Table S4, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/e6/5b/aids-29-2479.PMC4645958.pdf
"The optimal ﬁt under this assumption is therefore presented in the supplementary material (Figure S3, http://links.lww.com/QAD/A764).",Non-OADS,/arxiv_data1/oa_pdf/e6/5b/aids-29-2479.PMC4645958.pdf
"(Figure S4, http://links.lww.com/QAD/ A764).",Non-OADS,/arxiv_data1/oa_pdf/e6/5b/aids-29-2479.PMC4645958.pdf
This study was supported by Synageva BioPharma Corp. Clinical trial registration number: http://www.clinicaltrials.gov/ct2/show/NCT01528917.,Non-OADS,/arxiv_data1/oa_pdf/eb/80/jpga-61-619.PMC4645959.pdf
"LIPA mutation data were available in 19 patients (supplemental Table 1, http://links.lww.com/MPG/ A534 ).",OADS,/arxiv_data1/oa_pdf/eb/80/jpga-61-619.PMC4645959.pdf
"Biochemical Abnormalities The median age of first recorded elevated transaminase was 8.2 years (supplemental Table 2, http://links.lww.com/MPG/A535 ).",Non-OADS,/arxiv_data1/oa_pdf/eb/80/jpga-61-619.PMC4645959.pdf
"1, http://links.lww.com/MPG/A536 [values, by patient and LLM use, for {A}AST, {B} TG, and {C} HDL-C]).",Non-OADS,/arxiv_data1/oa_pdf/eb/80/jpga-61-619.PMC4645959.pdf
Available at: http://aidsinfo.nih.gov/content ﬁles/lvguidelines/AdultandAdolescentGL.,Non-OADS,/arxiv_data1/oa_pdf/80/23/qai-70-0515.PMC4645960.pdf
2015 [23/03/15]; http://www.ema.europa.eu/docs/en_GB/docu ment_library/EPAR_-_Summary_for_the_public/human/ 000368/WC500039044.pdf [Accessed 27 August 2015].,Non-OADS,/arxiv_data1/oa_pdf/5d/66/aids-29-2447.PMC4645961.pdf
"Highlights of prescribing information (Refer- ence ID: 3089639) 2011; http://www.accessdata.fda.gov/drug satfda_docs/label/2012/021251s042,021906s035lbl.pdf.",Non-OADS,/arxiv_data1/oa_pdf/5d/66/aids-29-2447.PMC4645961.pdf
"Sensitivity analyses were performed for patients who had between three and seven CD4þmeasurements ( n¼1571 and n¼903, respectively); the results as well as further detail on patient selection are shown in the Supple- mentary Material, http://links.lww.com/QAD/A766.",Non-OADS,/arxiv_data1/oa_pdf/77/a0/aids-29-2435.PMC4645962.pdf
"More speciﬁcally, for each individual, we ﬁtted a monotonic decreasing cubic regression spline to describe the decline of CD4þcell count as a function of time since seroconversion [17] (see Supplementary Material for detail, http://links.lww.com/QAD/A766).",Non-OADS,/arxiv_data1/oa_pdf/77/a0/aids-29-2435.PMC4645962.pdf
"peripheral blood plasma (see Supplementary Material for details, http://links.lww.com/QAD/A766).",Non-OADS,/arxiv_data1/oa_pdf/77/a0/aids-29-2435.PMC4645962.pdf
"We also examined the inﬂuence of retrospective inclusion of patients diagnosed before 1996 by comparing individuals recruited after 1996 to the whole study population (see Supplementary Material, http://links.lww.com/QAD/A766 for full details and results of sensitivity analyses).",Non-OADS,/arxiv_data1/oa_pdf/77/a0/aids-29-2435.PMC4645962.pdf
"The predicted times of transition were then compared with those directly derived by monotonic spline smoothing of the observed CD4þcell counts for each patient (seeSupplementary material for detail, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/77/a0/aids-29-2435.PMC4645962.pdf
"Across the cohort, SPVL varied over time (Figure S2, http://links.lww.com/QAD/A766) [18].",OADS,/arxiv_data1/oa_pdf/77/a0/aids-29-2435.PMC4645962.pdf
"Figure S3, http://links.lww.com/QAD/A766, shows the distribution of all individual viral load measurements throughout the set-point window, stratiﬁed by SPVL and CD4þcell count.",OADS,/arxiv_data1/oa_pdf/77/a0/aids-29-2435.PMC4645962.pdf
"These ﬁndings were relatively insensitive to the choice of smoothing method used (see Supplementary Material, http://links.lww.com/QAD/A766).",Non-OADS,/arxiv_data1/oa_pdf/77/a0/aids-29-2435.PMC4645962.pdf
"Patients were only included in the analysis if they had a minimum number (six) of CD4þcell counts so that smoothing could be reliably performed; the choice of minimum number of individual CD4þmeasurements used to estimate the smoothing model was also seen not to have an effect on the results (Supplementary Material, http://links.lww.com/QAD/A766).",Non-OADS,/arxiv_data1/oa_pdf/77/a0/aids-29-2435.PMC4645962.pdf
"Similarly, results were similar when considering only CD4þmeasurements prior to mono or dual ART initiation, or when considering only patients recruited after 1996 (Supple- mentary Material, http://links.lww.com/QAD/A766).",Non-OADS,/arxiv_data1/oa_pdf/77/a0/aids-29-2435.PMC4645962.pdf
"Substantial changes have been seen in population-level SPVL over time (Figure S2, http://links.lww.com/ QAD/A766), and similarly large differences can beobserved in the unstratiﬁed CD4þprogression rates between different time periods.",OADS,/arxiv_data1/oa_pdf/77/a0/aids-29-2435.PMC4645962.pdf
"Comparing MSM/ bisexual men to other HIV transmission routes (79% via heterosexual sex, but also including people who inject drugs and one haemophiliac), there was little difference in the rate of CD4þprogression, although results indicate that MSM/bisexual men may progress more quickly to death once they reach a CD4þcell count of 200 cells/ ml (Supplementary Material, http://links.lww.com/QAD/ A766).",Non-OADS,/arxiv_data1/oa_pdf/77/a0/aids-29-2435.PMC4645962.pdf
"No signiﬁcant difference was found in CD4þ progression between men and women, but there were very few women in the sample and hence only unstratiﬁed analysis was possible (Supplementary Material, http://links.lww.com/QAD/A766).",OADS,/arxiv_data1/oa_pdf/77/a0/aids-29-2435.PMC4645962.pdf
"This predictive model was able to broadly reproduce the true CD4þdynamics of the patients selected for validation, given their ﬁrst observed CD4þcategory (see Figure S6 and Supplementary Material for detail, http://links.lww.com/QAD/A766).2440 AIDS 2015, Vol 29 No 18",Non-OADS,/arxiv_data1/oa_pdf/77/a0/aids-29-2435.PMC4645962.pdf
"Our results suggest that if the patient’s SPVL is known, the frequency of CD4þmonitoring could be adapted to account for that, with a CD4þcell count test every 13–23, 6–12, 3–8 and 2–4 months for individuals with SPVL below 4.0, 4.0–4.5, 4.5–5.0 and at least 5.0 log10copies/ml, respectively (see Supplementary Material for detail, http://links.lww.com/QAD/A766).",Non-OADS,/arxiv_data1/oa_pdf/77/a0/aids-29-2435.PMC4645962.pdf
Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach; 2010. http://apps.who.int/iris/bit stream/10665/44379/1/9789241599764_eng.pdf [Accessed 1 September 2015] 3.,Non-OADS,/arxiv_data1/oa_pdf/77/a0/aids-29-2435.PMC4645962.pdf
"15. van Sighem A, Smit C, Gras L, Holman R, Stolte I, Prins M, de Wolf F. Monitoring of Human immunodeﬁciency virus (HIV) infection in the Netherlands 2011. http://www.hiv-monitoring.",Non-OADS,/arxiv_data1/oa_pdf/77/a0/aids-29-2435.PMC4645962.pdf
"Washington DC: Center for Food Safety and Applied Nutrition, Food and Drug Administration, Department of Health and Human Services; 1998. http://jn.nutrition.org/content/128/11/suppl/DC1 .",Non-OADS,/arxiv_data1/oa_pdf/a7/47/jpga-61-649.PMC4645963.pdf
"Competing risks model estimates of proportionof LTFU were of 8.10% (95% CI: 6.4% to 10.0%) at 6 months,12.96% (95% CI: 10.8% to 15.3%) at 12 months, and 19.35% (95% CI: 16.6% to 22.2%) at 24 months (see Figure S1, Supplemental Digital Content, http://links.lww.com/QAI/A721).",Non-OADS,/arxiv_data1/oa_pdf/ab/b1/qai-70-e160.PMC4645964.pdf
"In an additional sensitivity analysis including children transferred-in, signi ﬁ- cance of associations did not change, so transfer-in children were excluded from the main analysis (see Table S1, Supple- mental Digital Content, http://links.lww.com/QAI/A721).",Non-OADS,/arxiv_data1/oa_pdf/ab/b1/qai-70-e160.PMC4645964.pdf
"Active tracing reduced the risk of being LTFU at the end of the study period by 38% (AHR 0.62 and 95% CI: 0.42 to0.91, and P= 0.014) (see Table S2, Supplemental Digital Content, http://links.lww.com/QAI/A721).TABLE 2.",Non-OADS,/arxiv_data1/oa_pdf/ab/b1/qai-70-e160.PMC4645964.pdf
Available at: http://www.unaids.org/sites/default/ ﬁles/en/media/ unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS_Global_Report_2013_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ab/b1/qai-70-e160.PMC4645964.pdf
Available at: http://apps.who.int/iris/bitstream/10665/ 75186/1/9789241503945_eng.pdf?ua=1.,Non-OADS,/arxiv_data1/oa_pdf/ab/b1/qai-70-e160.PMC4645964.pdf
Available at: http://www.who.int/hiv/pub/ guidelines/HIVstaging150307.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ab/b1/qai-70-e160.PMC4645964.pdf
Available at: http://www.google.com/earth/download/ge/agree.html.,Non-OADS,/arxiv_data1/oa_pdf/ab/b1/qai-70-e160.PMC4645964.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b3/9c/TOORTHJ-9-463.PMC4645968.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ae/ab/TOORTHJ-9-475.PMC4645971.pdf
http://www.boa.ac.uk/BOAAhome.htm [Acc-essed 18th November 2003].,Non-OADS,/arxiv_data1/oa_pdf/ee/64/TOORTHJ-9-515.PMC4645972.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ee/64/TOORTHJ-9-515.PMC4645972.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b0/5f/tcrm-11-1697.PMC4646473.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 1697–1700Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1697Case Repo RTopen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S9580 5systemic spread of tuberculosis after surgery  for a splenic tuberculous abscess without  postoperational antituberculosis treatment:  a case report Dong Yan1,2 Cheng-Li Zhong1 Lan-Juan Li1,2 1state Key Laboratory for Diagnosis  and Treatment of Infectious Diseases,   The First affiliated Hospital, school  of Medicine, Zhejiang University,   2Collaborative Innovation Center  for Diagnosis and Treatment of  Infectious Diseases, Hangzhou,   people’s  Republic of ChinaAbstract:  Solitary splenic tuberculosis (TB) is rare, with less than ten cases ever being  reported.",Non-OADS,/arxiv_data1/oa_pdf/b0/5f/tcrm-11-1697.PMC4646473.pdf
"A large amount of suppuration and Correspondence: Lan-Juan Li state Key Laboratory for Diagnosis  and Treatment of Infectious Diseases,  The First Affiliated Hospital, School  of Medicine, Zhejiang University,  79 Qingchun Road, Hangzhou 310003,  people’s Republic of China Tel +86 139 065 124 210 email ljli@zju.edu.c n Journal name: Therapeutics and Clinical Risk Management Article Designation: Case report Y ear: 2015 Volume: 11 Running head verso: Y an et al Running head recto: Systemic spread of tuberculosis after surgery DOI: http://dx.doi.org/10.2147/TCRM.S95805",Non-OADS,/arxiv_data1/oa_pdf/b0/5f/tcrm-11-1697.PMC4646473.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/b0/5f/tcrm-11-1697.PMC4646473.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b0/5f/tcrm-11-1697.PMC4646473.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8b/f9/tcrm-11-1687.PMC4646474.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 1687–1696Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1687Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S9419 3evidence-based treatments for cluster headache Rubesh Gooriah Alina Buture Fayyaz Ahmed Department of Neurology, Hull Royal  infirmary, Kingston upon Hull, UKAbstract:  Cluster headache (CH), one of the most painful syndromes known to man, is managed  with acute and preventive medications.",Non-OADS,/arxiv_data1/oa_pdf/8b/f9/tcrm-11-1687.PMC4646474.pdf
"The three fundamental aspects of the condition are the Correspondence: Rubesh Gooriah Department of Neurology, Hull Royal  Infirmary, Anlaby Road, Hull HU3 2JZ, UK email rubesh@doctors.org.u k Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Gooriah et al Running head recto: Evidence-based treatments for cluster headache DOI: http://dx.doi.org/10.2147/TCRM.S94193",Non-OADS,/arxiv_data1/oa_pdf/8b/f9/tcrm-11-1687.PMC4646474.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/8b/f9/tcrm-11-1687.PMC4646474.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8b/f9/tcrm-11-1687.PMC4646474.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4e/b1/ceor-7-575.PMC4646475.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinicoEconomics and Outcomes Research 2015:7 575–581ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  575ORiginal REsEaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEOR.S8853 1Doctors commitment and long-term effectiveness  for cost containment policies: lesson learned from  biosimilar drugs Enrica Menditto1 Valentina Orlando1 silvia Coretti2 Daria Putignano1 Denise Fiorentino1 Matteo Ruggeri2  1CiRFF , Center of Pharmacoeconomics,   Federico ii University of naples,  naples, 2Postgraduate school   of health Economics and Management  (alTEMs), Università Cattolica del  sacro Cuore, school of Economics,  Rome, italy Correspondence: Valentina Orlando   CiRFF, Center of Pharmacoeconomics,   Federico ii University of naples,   Via D Montesano 49, 80131 naples, italy   Tel +39 081 678 657   Fax +39 081 678 658   Email valentina.orlando@unina.i tBackground:  Agency is a pervasive feature of the health care market, with doctors  acting  as agents for both patients and the health care system.",Non-OADS,/arxiv_data1/oa_pdf/4e/b1/ceor-7-575.PMC4646475.pdf
Available from: http://www.ema.europa.eu/docs/en_GB/ document_library/Scientific_guideline/2014/10/WC500176768.pdf .,Non-OADS,/arxiv_data1/oa_pdf/4e/b1/ceor-7-575.PMC4646475.pdf
Available at: http://www.agenziafarmaco.,Non-OADS,/arxiv_data1/oa_pdf/4e/b1/ceor-7-575.PMC4646475.pdf
"Available from: http://www.aslna3sud.it/regione/DECRETO_15_ DELIBERAZIONI_DEL_COMMISSARIO_AD_ACT A. Accessed  May 13, 2015.",Non-OADS,/arxiv_data1/oa_pdf/4e/b1/ceor-7-575.PMC4646475.pdf
"Available from: http://www.aslcaserta.it/portale/Portals/0/doc_ pub/2012/ATTIREGIONE/dca_44_Misure%20di%20controllo%20 spesa%20farmaceutica.pd f. Accessed May 13, 2015.",Non-OADS,/arxiv_data1/oa_pdf/4e/b1/ceor-7-575.PMC4646475.pdf
"Available from: http://www.aslcaserta.it/portale/Portals/0/doc_ pub/2012/ATTIREGIONE/34_Farmaci%20biosimilari.pd f. Accessed  May 13, 2015.",Non-OADS,/arxiv_data1/oa_pdf/4e/b1/ceor-7-575.PMC4646475.pdf
"Available from: http://www.arsan.campania.it/documents/10157/59773/ DCA_27_13.pd f. Accessed May 13, 2015.",Non-OADS,/arxiv_data1/oa_pdf/4e/b1/ceor-7-575.PMC4646475.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/4e/b1/ceor-7-575.PMC4646475.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4e/b1/ceor-7-575.PMC4646475.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cf/84/amep-6-609.PMC4646476.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pAdvances in Medical Education and Practice 2015:6 609–613Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  609OriginAl rEsEArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S9253 4Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/cf/84/amep-6-609.PMC4646476.pdf
"Or use: http://youtu.be/0lb5Rv8t85 sSubject preferences of first- and second-year  medical students for their future specialization at  chitwan Medical college and T eaching hospital,  Chitwan, Nepal – a questionnaire-based study rajesh K Jha1 Keshab r Paudel1 Dev K shah2 Ajit K sah1 sangharshila Basnet1 Phoolgen sah1 sandeep Adhikari1 1Department of Pharmacology,   2Department of Physiology, Chitwan  Medical college, Bharatpur, nepal correspondence: rajesh K Jha   Department of Pharmacology, Chitwan  Medical college, Bharatpur, nepal   Email rkjhadr@gmail.co mIntroduction:  The selection of a discipline for future specialization may be an important factor  for the medical students’ future career, and it is influenced by multiple factors.",Non-OADS,/arxiv_data1/oa_pdf/cf/84/amep-6-609.PMC4646476.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/cf/84/amep-6-609.PMC4646476.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cf/84/amep-6-609.PMC4646476.pdf
Available from: http://lori.academicdirect.org/conferences/ pdf/?user=lori&id=98.,Non-OADS,/arxiv_data1/oa_pdf/cf/84/amep-6-609.PMC4646476.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8e/ba/cmar-7-331.PMC4646477.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pCancer Management and Research 2015:7 331–344Cancer Management and Research Dove press submit your manuscript | www.dovepress.co m Dove press  331Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CMAR.S5195 5Rationale and development of image-guided  intensity-modulated radiotherapy post- prostatectomy: the present standard of care?,Non-OADS,/arxiv_data1/oa_pdf/8e/ba/cmar-7-331.PMC4646477.pdf
"Available from: http://globocan.iarc.f r. Accessed July  23, 2015.",Non-OADS,/arxiv_data1/oa_pdf/8e/ba/cmar-7-331.PMC4646477.pdf
"Cancer Management and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/cancer-management-and-research-journa lCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of  preventative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/8e/ba/cmar-7-331.PMC4646477.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8e/ba/cmar-7-331.PMC4646477.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/68/2e/ccide-7-115.PMC4646478.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical, Cosmetic and Investigational Dentistry 2015:7 115–124Clinical, Cosmetic and Investigational Dentistry Dove press submit your manuscript | www.dovepress.co m Dove press  115RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCIDE.S6346 6Piezosurgery in implant dentistry Stefan Stübinger1 Andres Stricker2 Britt-Isabelle Berg3,4 1Hightech Research Center of Cranio- maxillofacial Surgery, University  of Basel, Allschwil, Switzerland;   2Private Practice, Konstanz, Germany;   3Department of Cranio-maxillofacial  Surgery, University Hospital Basel,   Basel, Switzerland;  4Division of Oral  and Maxillofacial Radiology, Columbia  University Medical Center, New Y ork,   NY, USA Correspondence: Stefan Stübinger   Hightech Research Center of   Cranio-maxillofacial Surgery,   University of Basel,  14–16  Gewerbestrasse, Allschwil  4123,   Switzerland   email  stefan.stuebinger@unibas.c hAbstract:  Piezosurgery, or the use of piezoelectric devices, is being applied increasingly in oral and  maxillofacial surgery.",Non-OADS,/arxiv_data1/oa_pdf/68/2e/ccide-7-115.PMC4646478.pdf
"Clinical, Cosmetic and Investigational Dentistry Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dentistry-journa lClinical, Cosmetic and Investigational Dentistry is an international,  peer-reviewed, open access, online journal focusing on the latest clini - cal and experimental research in dentistry with specific emphasis on  cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/68/2e/ccide-7-115.PMC4646478.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/68/2e/ccide-7-115.PMC4646478.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/85/38/clep-7-441.PMC4646479.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Epidemiology 2015:7 441–448Clinical Epidemiology Dove press submit your manuscript | www.dovepress.co m Dove press  441ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S9220 9Validation of International Classification   of Diseases coding for bone metastases in  electronic health records using technology- enabled abstraction Alexander Liede1 Rohini K Hernandez1 Maayan Roth2 Geoffrey Calkins2 Katherine Larrabee2 Leo Nicacio2 1Center for Observational Research,   Amgen Inc., South San Francisco and  Thousand Oaks, CA,  2Flatiron Health,   New Y ork, NY, USA Correspondence: Alexander Liede   Amgen Inc., 1120 Veterans Boulevard,  South San Francisco, CA  94080, USA   Email aliede@amgen.co mObjective:  The accuracy of bone metastases diagnostic coding based on International  Classification of Diseases, ninth revision (ICD-9) is unknown for most large databases used for  epidemiologic research in the US.",Non-OADS,/arxiv_data1/oa_pdf/85/38/clep-7-441.PMC4646479.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica - tion of risk factors and screening procedures to develop optimal pre - ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/85/38/clep-7-441.PMC4646479.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/16/79/sar-6-141.PMC4646480.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pSubstance Abuse and Rehabilitation 2015:6 141–150Substance Abuse and Rehabilitation Dove press submit your manuscript | www.dovepress.co m Dove press  141ORiginAl ReSeARchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/SAR.S9330 4gang membership and marijuana use   among African American female adolescents   in north carolina Wendee M Wechsberg1–4 irene A Doherty1 Felicia A Browne1,5 Tracy l Kline1 Monique g carry6 Jerris l Raiford6 Jeffrey h herbst6 1Substance Abuse Treatment  evaluations and interventions  Research Program, RTi international,   Research Triangle Park, 2gillings  global School of Public health,   University of north carolina, chapel  hill, 3Psychology in the Public interest,   north carolina State University,   Raleigh,  4Psychiatry and Behavioral  Sciences, School of Medicine, Duke  University, Durham, nc, 5Department  of Social and Behavioral Sciences,   harvard School of Public health,   Boston, MA,  6Division of hiV/AiDS  Prevention, national center for hiV/ AiDS, Viral hepatitis, STD and TB  Prevention, US centers for Disease  control and Prevention, Atlanta,    gA, USA correspondence: Wendee M Wechsberg   Substance Abuse Treatment evaluations  and interventions Research Program,   RTi international,  3040 east cornwallis  Road, Research Triangle Park,   nc 27709-2194, USA   Fax +1 919 485 5555  email wmw@rti.or gAbstract:  The southeastern US sustains the highest high school dropout rates, and gangs persist  in underserved communities.",Non-OADS,/arxiv_data1/oa_pdf/16/79/sar-6-141.PMC4646480.pdf
"Substance Abuse and Rehabilitation Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/substance abuse-and-rehabilitation-journa lSubstance Abuse and Rehabilitation is an international, peer-reviewed,  open access journal publishing original research, case reports, editorials,  reviews and commentaries on all areas of addiction and substance abuse  and options for treatment and rehabilitation.",Non-OADS,/arxiv_data1/oa_pdf/16/79/sar-6-141.PMC4646480.pdf
Visit http://www.dovepress.com/testimonials.ph p  to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/16/79/sar-6-141.PMC4646480.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e7/bb/jpr-8-809.PMC4646582.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2015:8 809–818Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  809ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S8803 3effect of a perspective-taking intervention on the  consideration of pain assessment and treatment  decisions laura D Wandner1 calia a T orres2 emily J Bartley1 steven Z george3 Michael e Robinson1 1Department of clinical and health  Psychology, University of Florida,   gainesville, Fl, 2Department of  clinical Psychology, University of  alabama, T uscaloosa, al, 3Department  of Physical Therapy, University of  Florida, gainesville,    Fl, Usa correspondence: Michael e Robinson   University of Florida, 101 south newell  Drive, gainesville, Fl 32610-9165, Usa   T el +1 325 273 5220   Fax +1 352 273 6156   email merobin@ufl.ed uObjectives:  Pain is often poorly managed, highlighting the need to better understand and  treat patients’ pain.",Non-OADS,/arxiv_data1/oa_pdf/e7/bb/jpr-8-809.PMC4646582.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/e7/bb/jpr-8-809.PMC4646582.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e7/bb/jpr-8-809.PMC4646582.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8d/3f/ppa-9-1593.PMC4646583.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 1593–1601Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1593OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S8843 1The changes and factors associated with post- discharge self-care behaviors among chinese  patients with heart failure Xiaolin hu1 Xiuying hu1 Y onglin su2 Moying Qu3 Mary A Dolansky4 1Department of n ursing, 2Department  of rehabilitation Medicine,   3Department of cardiology, West  china hospital, sichuan University,   chengdu, sichuan, People’s republic  of china; 4Frances Payne Bolton  school of nursing, case Western  reserve University, cleveland,   Oh, UsABackground:  Self-care behavior is essential for achieving good outcomes among patients  with heart failure.",Non-OADS,/arxiv_data1/oa_pdf/8d/3f/ppa-9-1593.PMC4646583.pdf
"Keywords:  heart failure, patients, self-care behaviors, associated factors Introduction Heart failure (HF) is a group of complicated syndromes resulting in frequent  hospitalizations, high mortality rates, and reduced quality of life.1 In the People’s  Republic of China, over four million patients are afflicted with HF.2 The readmission  rate associated with HF has been as high as 58.4% in a year.3 In Western countries, HF readmissions are one of the primary causes of health care  spending.4 Approximately 23% to 31% of readmissions may have been prevented via  improved self-care, including improved medication adherence, early symptom recogni - tion, and timely responses to escalating symptoms.5 Improvements in self-care among correspondence: Yonglin su Department of rehabilitation Medicine,  West china hospital, sichuan University,  37 guo-xue-xiang street, chengdu,  sichuan 610041, People’s republic of china Tel +86 8 540 3401 Fax +86 8 540 3401 email daage@163.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Hu et al Running head recto: Factors related to self-care behaviors DOI: http://dx.doi.org/10.2147/PPA.S88431",Non-OADS,/arxiv_data1/oa_pdf/8d/3f/ppa-9-1593.PMC4646583.pdf
Available  from: http://www.cdst.gov.cn/.,OADS,/arxiv_data1/oa_pdf/8d/3f/ppa-9-1593.PMC4646583.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/8d/3f/ppa-9-1593.PMC4646583.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a3/a5/ijn-10-6975.PMC4646584.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 6975–6983International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6975PersPectIvesopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/IJN.S8938 5Amyloids in solid-state nuclear magnetic resonance:  potential causes of the usually low resolution Alba espargaró Maria Antònia Busquets Joan estelrich raimon sabate Department of Physical chemistry,   school of Pharmacy, Institute of  Nanoscience and Nanotechnology  (IN2UB), University of Barcelona,   Barcelona, spainAbstract:  Amyloids are non-crystalline and insoluble, which imply that the classical structural  biology tools, ie, X-ray crystallography and solution nuclear magnetic resonance (NMR), are  not suitable for their analysis.",Non-OADS,/arxiv_data1/oa_pdf/a3/a5/ijn-10-6975.PMC4646584.pdf
"Only the atomic correspondence: raimon sabate Department of Physical chemistry,  school of Pharmacy, Institute of  Nanoscience and Nanotechnology  (IN2UB), University of Barcelona, Avda  Joan XXIII, 27-31, Barcelona e-08028,  spain email rsabate@ub.ed u Journal name: International Journal of Nanomedicine Article Designation: Perspectives Y ear: 2015 Volume: 10 Running head verso: Espargaró et al Running head recto: Amyloids in ssNMR DOI: http://dx.doi.org/10.2147/IJN.S89385",Non-OADS,/arxiv_data1/oa_pdf/a3/a5/ijn-10-6975.PMC4646584.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/a3/a5/ijn-10-6975.PMC4646584.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a3/a5/ijn-10-6975.PMC4646584.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/57/c0/mder-8-473.PMC4646585.pdf
"Information on how to  request permission may be found at: http://www.dovepress.com/permissions.ph pMedical Devices: Evidence and Research 2015:8 473–484Medical Devices: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  473ORiginal REsEaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/MDER.S9101 9Evaluation of the impact of viscosity, injection  volume, and injection flow rate on subcutaneous  injection tolerance cecile Berteau1 Orchidée Filipe-santos1 Tao Wang2 Humberto E Rojas2 corinne granger1 Florence Schwarzenbach1 1Becton-Dickinson Medical  Pharmaceutical systems, le Pont de  claix, France; 2Eli lilly and company,   indianapolis, in, Usa correspondence: Florence  Schwarzenbach   Becton-Dickinson Medical Pharmaceutical  systems,  11, rue aristide Bergès,  F-38800 le Pont de claix, France   Tel +33 4 76 68 94 07   Email florence_schwarzenbach@europe.",Non-OADS,/arxiv_data1/oa_pdf/57/c0/mder-8-473.PMC4646585.pdf
"Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa lMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology,  research, and expert opinion supporting the use and application of  medical devices in the diagnosis, treatment and management of clini - cal conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/57/c0/mder-8-473.PMC4646585.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/57/15/ott-8-3315.PMC4646586.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3315–3322OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3315Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9129 2Concurrent radiotherapy with oral fluoropyrimidine  versus gemcitabine in locally advanced pancreatic  cancer: a systematic review and meta-analysis Y ong-Feng Yang1 Xiao-hui cao1 chao-en Bao1 Xin Wan2 1Department of radiation Oncology,   Third hospital of hebei Medical  University, shijiazhuang, People’s  republic of china; 2Department  of radiation Oncology, Fourth  hospital of hebei Medical  University,  shijiazhuang, People’s  republic of chinaBackground:  Gemcitabine (GEM) is the most widely utilized systemic agent in combination  with radiation therapy (RT) for treating locally advanced pancreatic cancer (LAPC) in the  concurrent setting.",Non-OADS,/arxiv_data1/oa_pdf/57/15/ott-8-3315.PMC4646586.pdf
"For  these patients, both chemotherapy alone and chemoradiotherapy (CRT) are regarded as  acceptable treatment options.2–4 However, randomized controlled trials that compared correspondence: Xin Wan Department of radiation Oncology,  Fourth hospital of hebei Medical  University, no 12 Jiankang road,  shijiazhuang, hebei Province, 050011,  People’s republic of china Tel +86 311 8609 5588 email wanxin20150606@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Y ang et al Running head recto: Oral FU versus GEM for LAPC DOI: http://dx.doi.org/10.2147/OTT.S91292",Non-OADS,/arxiv_data1/oa_pdf/57/15/ott-8-3315.PMC4646586.pdf
"Available from: http://www.ohri.ca/programs/clinical_epidemiology/ oxford.as p. Accessed August 22, 2014.",Non-OADS,/arxiv_data1/oa_pdf/57/15/ott-8-3315.PMC4646586.pdf
"Available from: http://www.nccn.org/ professionals/physician_gls/f_guidelines.asp#pancreati c. Accessed  October 10, 2014.",Non-OADS,/arxiv_data1/oa_pdf/57/15/ott-8-3315.PMC4646586.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/57/15/ott-8-3315.PMC4646586.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/57/15/ott-8-3315.PMC4646586.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a3/8f/mder-8-467.PMC4646587.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pMedical Devices: Evidence and Research 2015:8 467–472Medical Devices: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  467ORiginal REsEaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/MDER.S8376 8Validation of pressure gradient and peripheral  fractional flow reserve measured by a pressure  wire for diagnosis of iliofemoral artery disease  with intermediate stenosis naotaka Murata1 hideaki aihara2 Y oshimitsu soga1 Yusuke T omoi1 seiichi hiramori1 Y ohei Kobayashi1 Kei ichihashi1 Nobuhiro Tanaka3 1Department of Cardiology, Kokura  Memorial Hospital, Kitakyushu,   2Department of Cardiology, Tsukuba  Medical Center Hospital, Ibaraki,   3Department of Cardiology, Tokyo  Medical University, T okyo, Japan correspondence: naotaka Murata   Tokyo Medical University, Department  of Cardiology, 6-7-1 Nishishinnjuku,  Shinjuku-ku, Tokyo 160-0023, Japan   Tel +81 3 3342 6111   Fax +81 3 5381 6652   Email metallion2@yahoo.co.j pObjective:  To examine the pressure gradient and peripheral fractional flow reserve (pFFR)  measured by a pressure wire as indicators of hemodynamic significance in iliofemoral angio - graphic intermediate stenosis.",Non-OADS,/arxiv_data1/oa_pdf/a3/8f/mder-8-467.PMC4646587.pdf
"Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa lMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology,  research, and expert opinion supporting the use and application of  medical devices in the diagnosis, treatment and management of clini - cal conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/a3/8f/mder-8-467.PMC4646587.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/04/5b/ppa-9-1611.PMC4646588.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 1611–1622Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1611OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S9084 2Evaluating preferences for profiles of GLP-1  receptor agonists among injection-naïve type 2  diabetes patients in the UK heather l gelhorn1 Jiat-Ling Poon1 evan W Davies2 rosirene Paczkowski3 sarah e curtis3 Kristina S Boye3 1Outcomes research, evidera,   Bethesda, MD, UsA; 2Outcomes  research, evidera, london, UK;   3global Patient Outcomes and  Real World Evidence, Eli Lilly and  Company, Indianapolis, IN, USAObjective:  To use a discrete choice experiment (DCE) to evaluate preferences for the actual  treatment features and overall profiles of two injectable glucagon-like peptide-1 receptor agonists  (dulaglutide and liraglutide) among patients with type 2 diabetes mellitus (T2DM) in the UK.",Non-OADS,/arxiv_data1/oa_pdf/04/5b/ppa-9-1611.PMC4646588.pdf
"Patients may then progress to injectable  therapy, where treatment options include glucagon-like peptide-1 (GLP-1) receptor  agonist medications and insulin, if other medications fail to control blood glucose.2,3correspondence: heather l gelhorn  evidera, 7101 Wisconsin Avenue, suite  1400, Bethesda, MD 20814, UsA Tel +1 303 216 2274 Fax +1 303 271 3665 email heather.gelhorn@evidera.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Gelhorn et al Running head recto: UK patient preference for GLP-1 RAs in T2DM DOI: http://dx.doi.org/10.2147/PPA.S90842",Non-OADS,/arxiv_data1/oa_pdf/04/5b/ppa-9-1611.PMC4646588.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/04/5b/ppa-9-1611.PMC4646588.pdf
"Available from: http://support.sas.com/techsup/ technote/mr2010.pd f. Accessed April 13, 2015.",OADS,/arxiv_data1/oa_pdf/04/5b/ppa-9-1611.PMC4646588.pdf
Available from: http://www.mims.,Non-OADS,/arxiv_data1/oa_pdf/04/5b/ppa-9-1611.PMC4646588.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8a/c6/ppa-9-1603.PMC4646589.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 1603–1610Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1603OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S9094 2Physical activity in patients with heart failure:  barriers and motivations with special focus on sex  differences leonie Klompstra1 Tiny Jaarsma1 Anna strömberg2,3 1Department of social and Welfare  studies, Faculty of health sciences,   2Department of Medical and health  sciences, Division of nursing,   3Department of cardiology, linköping  University, linköping, swedenBackground:  Adherence to recommendations for physical activity is low in both male and  female patients with heart failure (HF).",Non-OADS,/arxiv_data1/oa_pdf/8a/c6/ppa-9-1603.PMC4646589.pdf
"Lower age positively correlates with physical activity as well as correspondence: leonie Klompstra Department of social and Welfare  studies, linköping University,  norrköping, 601 74 linköping, sweden Tel +46 11 363 629 Fax +46 11 125 448 email leonie.klompstra@liu.s e Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Klompstra et al Running head recto: Physical activity in patients with heart failure DOI: http://dx.doi.org/10.2147/PPA.S90942",Non-OADS,/arxiv_data1/oa_pdf/8a/c6/ppa-9-1603.PMC4646589.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/8a/c6/ppa-9-1603.PMC4646589.pdf
Available from: http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/8a/c6/ppa-9-1603.PMC4646589.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f6/45/ott-8-3305.PMC4646590.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3305–3313OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3305Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8284 5O-glcnacylation enhances the invasion of thyroid  anaplastic cancer cells partially by Pi3K/akt1  pathway Peng Zhang chunli Wang Tao Ma shengyi Y ou general surgery Department, general  hospital of Tianjin Medical University,   Tianjin, People’s republic of chinaBackground:  The PI3K family participates in multiple signaling pathways to regulate cellular  functions.",Non-OADS,/arxiv_data1/oa_pdf/f6/45/ott-8-3305.PMC4646590.pdf
"The lipid products produced by PI3K activation, PI(3,4)P2 and PI(3,4,5)P3 as  the second messengers, bind and activate the intracellular target proteins to form a correspondence: shengyi You general surgery Department,  general hospital of Tianjin  Medical University, Tianjin 300050,  People’s republic of china Tel +86 22 6036 3745 email yshengyi2000@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Zhang et al Running head recto: O-GlcNAcylation promotes invasion of thyroid anaplastic cancer cells DOI: http://dx.doi.org/10.2147/OTT.S82845",Non-OADS,/arxiv_data1/oa_pdf/f6/45/ott-8-3305.PMC4646590.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/f6/45/ott-8-3305.PMC4646590.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f6/45/ott-8-3305.PMC4646590.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e7/16/oajsm-6-343.PMC4646591.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOpen Access Journal of Sports Medicine 2015:6 343–352Open Access Journal of Sports Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  343Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S7132 6Optimal management of ulnar collateral ligament  injury in baseball pitchers elizabeth e Hibberd1 J Rodney Brown2 Joseph T Hoffer2 1Department of Health Science,    The University of Alabama,   T uscaloosa, AL, USA; 2Department  of intercollegiate Athletics, The  University of Alabama, T uscaloosa,    AL, USA Correspondence: elizabeth e Hibberd   Department of Health Science,  The University of Alabama,   483 Russell Hall, Box 870311,   Tuscaloosa, AL 35487-0311, USA   Tel +1 205 348 7320   email eehibberd@ches.ua.ed uAbstract:  The ulnar collateral ligament stabilizes the elbow joint from valgus stress associated  with the throwing motion.",Non-OADS,/arxiv_data1/oa_pdf/e7/16/oajsm-6-343.PMC4646591.pdf
"Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-journal-of-sports-medicine-journa lOpen Access Journal of Sports Medicine is an international,  peer-reviewed, open access journal publishing original research,  reports, reviews and commentaries on all areas of sports  medicine.",Non-OADS,/arxiv_data1/oa_pdf/e7/16/oajsm-6-343.PMC4646591.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e7/16/oajsm-6-343.PMC4646591.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/43/9c/jpr-8-807.PMC4646592.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/43/9c/jpr-8-807.PMC4646592.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/43/9c/jpr-8-807.PMC4646592.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f9/75/ndt-11-2875.PMC4646593.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 2875–2882Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2875OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S9279 5The ability of early changes in motivation to  predict later antidepressant treatment response Philip gorwood1,2 guillaume Vaiva3 emmanuelle corruble4 Pierre-Michel llorca5 Franck J Baylé1,2 Philippe courtet6 1centre hospitalier sainte- anne  (cMM e), Paris, France; 2centre of  Psychiatry and Neuroscience, iNserM  U894, University Paris-Descartes,   Paris, France; 3Pôle de Psychiatrie,   chr U de lille, hôpital Michel-Fontan,   Université lille-Nord de France, lille,   France; 4Psychiatry Department of  Bicêtre, University hospital, iNserM  U669, Paris Xi University, le Kremlin  Bicêtre, France; 5chU clermont- Ferrand, clermont Université,   Université d’auvergne, clermont- Ferrand, France; 6Department  of emergency Psychiatry, chU  Montpellier, Montpellier, FranceIntroduction:  Baseline values and early changes of emotional reactivity, cognitive speed,  psychomotor function, motivation, and sensory perception have not been studied to any extent  in unipolar depression, although they could help to characterize different dimensions of illness  that are harder to capture by clinicians, give new insights on how patients improve, and offer  new early clinical markers for later treatment response.",Non-OADS,/arxiv_data1/oa_pdf/f9/75/ndt-11-2875.PMC4646593.pdf
"These are manifested by decreased responsivity  to positive or rewarding stimuli and reduced approach-related behaviors.2,3 Recent  functional imaging studies have also indicated that depression is associated with correspondence: Philip gorwood centre hospitalier sainte-anne (cMMe),  100 rue de la santé, 75014 Paris, France Tel +33 1 45 65 86 39 Fax +33 1 45 65 89 43 email p.gorwood@ch-sainte-anne.f r Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Gorwood et al Running head recto: Predicting antidepressant treatment response DOI: http://dx.doi.org/10.2147/NDT.S92795",Non-OADS,/arxiv_data1/oa_pdf/f9/75/ndt-11-2875.PMC4646593.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/f9/75/ndt-11-2875.PMC4646593.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f9/75/ndt-11-2875.PMC4646593.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2b/9f/imcrj-8-291.PMC4646594.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Medical Case Reports Journal 2015:8 291–294International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  291Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IMCRJ.S9544 2Choroidal thickening and macular serous retinal  detachment in pregnancy-induced hypertension Ranko aoyagi takaaki Hayashi Hiroshi tsuneoka Department of ophthalmology,    the Jikei University school of  Medicine, tokyo, Japan Correspondence: takaaki Hayashi   Department of ophthalmology, the Jikei  University school of Medicine,   3-25-8 Nishi-shimbashi, Minato-ku,   tokyo  105-8461, Japan   tel +81 3 3433 1111 ext  3581  Fax +81 3 5378 8828  email taka@jikei.ac.j pObjective:  The purpose of this study was to report optical coherence tomography (OCT) and  angiographic findings in a patient with pregnancy-induced hypertension (PIH).",Non-OADS,/arxiv_data1/oa_pdf/2b/9f/imcrj-8-291.PMC4646594.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/2b/9f/imcrj-8-291.PMC4646594.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2b/9f/imcrj-8-291.PMC4646594.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e6/bd/opth-9-2103.PMC4646595.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 2103–2107Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2103Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S9133 9scleral buckling for primary rhegmatogenous  retinal detachment using noncontact wide-angle  viewing system with a cannula-based 25 g  chandelier endoilluminator hisanori imai1,2 Mizuki Tagami1 atsushi azumi1,2 1Department of Ophthalmology,   Kobe Kaisei hospital, 2Division of  Ophthalmology, Department of  Organ Therapeutics, Kobe University  graduate school of Medicine,   Kobe,  JapanPurpose:  The aim of this study is to report the result of scleral buckling (SB) using a  combination of a noncontact wide-angle viewing system and a cannula-based 25 G chandelier  endoilluminator.",Non-OADS,/arxiv_data1/oa_pdf/e6/bd/opth-9-2103.PMC4646595.pdf
"In this study, we report the result of the modified SB using a combination of a non - contact wide-angle viewing system (Resight®; Carl Zeiss Meditec AG, Jena, Germany) Correspondence: hisanori imai Division of Ophthalmology, Department  of Organ Therapeutics, Kobe University  graduate school of Medicine,  7-5-2 Kusunoki-cho, Chu ˉo ˉ  -ku,   Kobe 650-0017, Japan Tel +81 78 382 6048 Fax +81 78 382 6059 email hisimai@med.kobe-u.ac.j p Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Imai et al Running head recto: Scleral buckling with wide-angle viewing system DOI: http://dx.doi.org/10.2147/OPTH.S91339",Non-OADS,/arxiv_data1/oa_pdf/e6/bd/opth-9-2103.PMC4646595.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/e6/bd/opth-9-2103.PMC4646595.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e6/bd/opth-9-2103.PMC4646595.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/78/6e/ijn-10-6997.PMC4646596.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 6997–7018International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6997OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8659 2Specific detection of CD133-positive tumor  cells with iron oxide nanoparticles labeling  using noninvasive molecular magnetic  resonance imaging Ya-Wen Chen1,2 Gunn-Guang Liou3 Huay-Ben Pan4,5 Hui-Hwa Tseng5,6 Yu-Ting Hung4 Chen-Pin Chou4,5,7,8 1National Institute of cancer  research, National health research  Institutes, Miaoli, 2graduate Institute  of Basic Medical Science, China  Medical University, Taichung, 3Institute  of Molecular and genomic Medicine,   National health research Institutes,   Miaoli, 4Department of Radiology,   Kaohsiung Veterans general hospital,   Kaohsiung, 5school of Medicine,   National Yang-Ming University, Taipei,   6Department of Pathology, Kaohsiung  Veterans general hospital, Kaohsiung,   7Department of Medical Laboratory  Sciences and Biotechnology, Fooyin  University, Kaohsiung, 8school of  Medicine, National Defense Medical  center, Taipei, TaiwanBackground:  The use of ultrasmall superparamagnetic iron oxide (USPIO) nanoparticles to  visualize cells has been applied clinically, showing the potential for monitoring cells in vivo with  magnetic resonance imaging (MRI).",Non-OADS,/arxiv_data1/oa_pdf/78/6e/ijn-10-6997.PMC4646596.pdf
"Keywords:  MRI, USPIO, CD133, USPIO-CD133 Ab, molecular imaging Introduction Cancer stem cells (CSCs) have the ability to give rise to all cell types found in cancer  histology.1,2 CSCs are generally considered to be key contributors to tumor initiation,  maintenance, chemoresistance, radioresistance, recurrence, and metastasis.1,2 CD133  (AC133; human prominin-1), a well-studied stem cell marker, belongs to a family of  cell surface glycoproteins harboring five transmembrane domains and is expressed in  hematopoietic stem cells and a subset of putative neural stem/precursor cells in the  normal adult central nervous system.3–6 A characteristic feature of CD133 is its rapid Correspondence: Chen-Pin Chou Department of Radiology, Kaohsiung  Veterans General Hospital, 386,  Dazhong 1st Road, Zuoying District,  Kaohsiung 813, Taiwan Tel +886 7 342 2121 ext 6254 Fax +886 7 350 7581 email r2207759@ms19.hinet.ne t Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Chen et al Running head recto: Detection of CD133-positive tumor cells by MRI DOI: http://dx.doi.org/10.2147/IJN.S86592",Non-OADS,/arxiv_data1/oa_pdf/78/6e/ijn-10-6997.PMC4646596.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/78/6e/ijn-10-6997.PMC4646596.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/78/6e/ijn-10-6997.PMC4646596.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/17/ff/ijn-10-6955.PMC4646597.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 6955–6973International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6955OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8734 7The effects of hierarchical micro/nanosurfaces  decorated with TiO2 nanotubes on the bioactivity  of titanium implants in vitro and in vivo Xianglong Ding1 lei Zhou1 Jingxu Wang2 Qingxia Zhao3 Xi lin1 Yan gao1 shaobing li4 Jingyi Wu1 Mingdeng rong4 Zehong guo1 chunhua lai1 haibin lu4 Fang Jia1 1center of Oral Implantology,   guangdong Provincial stomatological  hospital, southern Medical University,   2Department of stomatology, The  First affiliated hospital of guangzhou  Medical University, 3Department  of stomatology, Nanfang hospital,   4Department of Periodontics and  Implantology, guangdong Provincial  stomatological hospital, southern  Medical University, guangzhou,   People’s republic of chinaAbstract:  In the present work, a hierarchical hybrid micro/nanostructured titanium surface  was obtained by sandblasting with large grit and acid etching (SLA), and nanotubes of different  diameters (30 nm, 50 nm, and 80 nm) were superimposed by anodization.",Non-OADS,/arxiv_data1/oa_pdf/17/ff/ijn-10-6955.PMC4646597.pdf
"The interactions between cells and nanotopog - raphies are of increasing interest, as nanostructures may be more efficient in promoting  desirable cell functions.12 Among the different approaches for producing nanotopogra - phies, titania nanotubes have attracted much attention since they can be fabricated easily correspondence: lei Zhou center of Oral Implantology, guangdong  Provincial stomatological hospital,  southern Medical University, 366 south  Jiang Nan road, hai Zhu District,  guangzhou 510280, People’s republic  of china  Tel +86 20 8423 3801 Fax +86 20 8443 3177 email zho668@263.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Ding et al Running head recto: Micro/nanosurfaces decorated with TiO2 nanotubes DOI: http://dx.doi.org/10.2147/IJN.S87347",Non-OADS,/arxiv_data1/oa_pdf/17/ff/ijn-10-6955.PMC4646597.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/17/ff/ijn-10-6955.PMC4646597.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/17/ff/ijn-10-6955.PMC4646597.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/20/7a/ndt-11-2865.PMC4646598.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 2865–2873Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2865OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S8896 8The impact of nonmotor symptoms on quality of  life in patients with Parkinson’s disease in Taiwan Weng-Ming liu1,2 ru-Jen lin1 rwei-ling Yu3 chun-hwei Tai1 chin-hsien lin1 ruey-Meei Wu1 1Department of Neurology, National  Taiwan University hospital, college of  Medicine, National Taiwan University,   Taipei, Taiwan; 2Department of  Neurology, Buddhist Tzu chi general  hospital, hualien, Taiwan; 3institute  of Behavioral Medicine, college  of Medicine, National cheng Kung  University, Tainan, TaiwanPurpose:  The nonmotor symptoms (NMS) of Parkinson’s disease (PD) are important factors  for quality of life (QoL).",Non-OADS,/arxiv_data1/oa_pdf/20/7a/ndt-11-2865.PMC4646598.pdf
"Demographic data regarding NMS in Taiwanese PD  patients remain unknown.correspondence: ruey-Meei Wu Department of Neurology, National  Taiwan University hospital, college of  Medicine, National Taiwan University,  7 chung shan south rd, Zhongzheng  District, Taipei city 10002, Taiwan Tel +886 2 2312 3456 extension 65337 Fax +886 2 22 341 8395 email robinwu@ntu.edu.t w Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Liu et al Running head recto: Nonmotor PD symptoms in Taiwan DOI: http://dx.doi.org/10.2147/NDT.S88968",Non-OADS,/arxiv_data1/oa_pdf/20/7a/ndt-11-2865.PMC4646598.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/20/7a/ndt-11-2865.PMC4646598.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/20/7a/ndt-11-2865.PMC4646598.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/da/67/opth-9-2109.PMC4646599.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 2109–2118Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2109Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S8044 5Current perspective of neuroprotection and  glaucoma Kailin Tian1,2 Shannon Shibata- Germanos1 Milena Pahlitzsch1 M Francesca Cordeiro1,3 1Glaucoma and Retinal  Neurodegeneration Research Group,   UCL institute of Ophthalmology,   London, UK; 2eye Centre, Renmin  Hospital of wuhan University, wuhan,   People’s Republic of China; 3western  eye Hospital, iCORG, imperial  College NHS Trust, London, UKAbstract:  Glaucoma is the second leading cause of blindness worldwide and is most notably  characterized by progressive optic nerve atrophy and advancing loss of retinal ganglion cells  (RGCs).",Non-OADS,/arxiv_data1/oa_pdf/da/67/opth-9-2109.PMC4646599.pdf
"In addition, primary open-angle glaucoma (POAG) can present with  high and low IOPs, with the latter termed “normal tension glaucoma” representing  40% of patients with POAG.5 Furthermore, there is increasing recognition that even Correspondence: M Francesca Cordeiro Glaucoma and Retinal  Neurodegeneration Research Group,  UCL institute of Ophthalmology, Bath  Street, London eC1v 9eL, UK Tel/fax +44 207 608 6939 email m.cordeiro@ucl.ac.u k Journal name: Clinical Ophthalmology Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Tian et al Running head recto: Perspective of neuroprotection and glaucoma DOI: http://dx.doi.org/10.2147/OPTH.S80445",Non-OADS,/arxiv_data1/oa_pdf/da/67/opth-9-2109.PMC4646599.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/da/67/opth-9-2109.PMC4646599.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/da/67/opth-9-2109.PMC4646599.pdf
"Available from: http://www.who.int/ blindness/causes/priority/en/index9.htm l. Accessed October 16,  2015.",Non-OADS,/arxiv_data1/oa_pdf/da/67/opth-9-2109.PMC4646599.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e4/98/ppa-9-1623.PMC4646600.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 1623–1630Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1623OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S9298 5Understanding patient preferences and willingness  to pay for hemophilia therapies shraddha s chaugule1 Joel W hay1 guy Y oung2 1Department of clinical Pharmacy,   Pharmaceutical economics and Policy,   University of southern california,   2hemostasis and Thrombosis center,   children’s hospital los Angeles,   University of southern california,   Keck school of Medicine, los Angeles,   cA, UsABackground:  Despite clearly improved clinical outcomes for prophylaxis compared to  on-demand therapy, on average only 56% of patients diagnosed with severe hemophilia receive  prophylactic factor replacement therapy in the US.",Non-OADS,/arxiv_data1/oa_pdf/e4/98/ppa-9-1623.PMC4646600.pdf
"Without properly functioning factors VIII and IX, patients are  vulnerable to serious bleeding episodes and associated degenerative joint disease as  well as other potential morbidities.2 There are two approaches for the treatment of  hemophilia: 1) on-demand therapy provided on an as-needed basis when bleeding  occurs and 2) prophylactic (preventative) factor replacement therapy (given three to correspondence: Joel W hay leonard schaeffer center for health  Policy and economics, University  of southern california, VPD 214-l,  los Angeles, cA 90089-3333, UsA Tel +1 818 338 5433 Fax +1 818 224 7567 email jhay@usc.ed u Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Chaugule et al Running head recto: Hemophilia therapy preferences and willingness to pay DOI: http://dx.doi.org/10.2147/PPA.S92985",Non-OADS,/arxiv_data1/oa_pdf/e4/98/ppa-9-1623.PMC4646600.pdf
"Available from: http://www.cdc.gov/ncbddd/ hemophilia/data.htm l. Accessed September 14, 2014.",OADS,/arxiv_data1/oa_pdf/e4/98/ppa-9-1623.PMC4646600.pdf
"Available from: http://www.cdc.gov/ ncbddd/blooddisorders/udc/documents/report-udcprogram_january2005- december-2009_jan-2014.pd f. Accessed September 14, 2014.",OADS,/arxiv_data1/oa_pdf/e4/98/ppa-9-1623.PMC4646600.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/e4/98/ppa-9-1623.PMC4646600.pdf
"16. http://c-path.org/wp-content/uploads/2013/09/PRO_Consortium_FDA_ PDUFA_V_PatientFocusedDD.pd f. Accessed July 5, 2015.",Non-OADS,/arxiv_data1/oa_pdf/e4/98/ppa-9-1623.PMC4646600.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/content/ full/1/6/e1400185/DC1 Fig.,Non-OADS,/arxiv_data1/oa_pdf/b1/74/1400185.PMC4646765.pdf
"The GBS approach produces a large fraction of missing geno- types, so most missing genotypes were imputed on the basis of nearest neighbor searches using Viterbi algorithm in TASSEL version 4.0 (MinorWindowViterbiImputationP lugin) (http://tassel.bitbucket.",OADS,/arxiv_data1/oa_pdf/3a/fe/1400218.PMC4646766.pdf
"We used NCEP reanalysis data to estimate interannual variability in precipitation (data provided by the National Oceanic & Atmospheric Administration/Office of Oceanic and Atmospheric Research/EarthSystem Research Laboratory Physical Sciences Division, http://esrl.noaa.gov/psd/) ( 66).",OADS,/arxiv_data1/oa_pdf/3a/fe/1400218.PMC4646766.pdf
"To determine when moisture permitted growing seasons, we follo w e dF o o da n dA g r i c u l t u r eO r g a n i - zation of the United Nations (FAO) criteria for rough growing seasondetermination for dryland crops (http://fao.org/nr/climpag/cropfor/ lgp_en.asp; http://www.fao.org/geonetwork/srv/en/metadata.show?",Non-OADS,/arxiv_data1/oa_pdf/3a/fe/1400218.PMC4646766.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/content/ full/1/6/e1400218/DC1 Fig.,Non-OADS,/arxiv_data1/oa_pdf/3a/fe/1400218.PMC4646766.pdf
"K. A. Dunne, C. J. Willmott, Global distribution of plant-extractable water capacity of soil (Dunne); http://daac.ornl.gov/SOILS/guides/DunneSoil.html.",Non-OADS,/arxiv_data1/oa_pdf/3a/fe/1400218.PMC4646766.pdf
"D. Bates, M. Maechler, B. M. Bolker, S. Walker, lme4: Linear mixed-effects models using Eigen and S4; http://cran.r-project.org/web/packages/lme4/index.html.",OADS,/arxiv_data1/oa_pdf/3a/fe/1400218.PMC4646766.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/content/ full/1/6/e1500021/DC1 DiscussionFig.,Non-OADS,/arxiv_data1/oa_pdf/81/66/1500021.PMC4646769.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/content/ full/1/6/e1500031/DC1Fig.,Non-OADS,/arxiv_data1/oa_pdf/6e/af/1500031.PMC4646770.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/6/e1500092/DC1Systematic PaleontologyTaphonomy and PreservationCladistic Analysis Table S1.,Non-OADS,/arxiv_data1/oa_pdf/43/ae/1500092.PMC4646772.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/6/e1500093/DC1Fig.,Non-OADS,/arxiv_data1/oa_pdf/07/3d/1500093.PMC4646773.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/6/e1500094/DC1TextFig.,Non-OADS,/arxiv_data1/oa_pdf/4e/f3/1500094.PMC4646774.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/6/e1500101/DC1Materials and MethodsFig.,Non-OADS,/arxiv_data1/oa_pdf/a2/dc/1500101.PMC4646775.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/content/ full/1/6/e1500105/DC1Fig.,Non-OADS,/arxiv_data1/oa_pdf/c3/fa/1500105.PMC4646776.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/6/e1500107/DC1 Fig.,Non-OADS,/arxiv_data1/oa_pdf/6c/90/1500107.PMC4646777.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/6/e1500112/DC1 Materials and MethodsFig.,Non-OADS,/arxiv_data1/oa_pdf/5f/58/1500112.PMC4646778.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/6/e1500157/DC1 Fig.,Non-OADS,/arxiv_data1/oa_pdf/a9/ec/1500157.PMC4646780.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/6/e1500165/DC1Fig.,Non-OADS,/arxiv_data1/oa_pdf/1f/ba/1500165.PMC4646781.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/content/ full/1/6/e1500168/DC1 Fig.,Non-OADS,/arxiv_data1/oa_pdf/48/37/1500168.PMC4646782.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/6/e1500188/DC1 Fig.,Non-OADS,/arxiv_data1/oa_pdf/63/bc/1500188.PMC4646783.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/6/e1500222/DC1TextFig.,Non-OADS,/arxiv_data1/oa_pdf/d8/30/1500222.PMC4646786.pdf
"Other defense marker genes, Os12g36830 and Os06g37224 , were identified in RNAseq experiments as up-regulated genes after elf18 treatment of rice leaves expressing EFR::XA21::GFP (60) (http://genome.jgi.doe.gov/pages/dynamicOrganismDownload.",Non-OADS,/arxiv_data1/oa_pdf/98/7b/1500245.PMC4646787.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/6/e1500245/DC1 Fig.,Non-OADS,/arxiv_data1/oa_pdf/98/7b/1500245.PMC4646787.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/6/e1500558/DC1Fig.,Non-OADS,/arxiv_data1/oa_pdf/ba/a8/1500558.PMC4646789.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/9/e1500206/DC1Fig.,Non-OADS,/arxiv_data1/oa_pdf/21/ea/1500206.PMC4646791.pdf
Data and materials availability: Underpinning data can be obtained from http://risweb.st-andrews.ac.uk/portal/.,Non-OADS,/arxiv_data1/oa_pdf/21/ea/1500206.PMC4646791.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/9/e1500228/DC1 Fig.,Non-OADS,/arxiv_data1/oa_pdf/c2/e0/1500228.PMC4646792.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/9/e1500291/DC1Data File S1.,Non-OADS,/arxiv_data1/oa_pdf/ca/f1/1500291.PMC4646793.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/9/e1500199/DC1Fig.,Non-OADS,/arxiv_data1/oa_pdf/7d/42/1500299.PMC4646794.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/9/e1500360/DC1Details on microstructural observationsFig.,Non-OADS,/arxiv_data1/oa_pdf/7b/b6/1500360.PMC4646795.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/9/e1500379/DC1 Materials and MethodsFig.,Non-OADS,/arxiv_data1/oa_pdf/90/5c/1500379.PMC4646796.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/9/e1500396/DC1 TextFig.,Non-OADS,/arxiv_data1/oa_pdf/ce/10/1500396.PMC4646797.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/9/e1500401/DC1Fig.,Non-OADS,/arxiv_data1/oa_pdf/4f/fc/1500401.PMC4646798.pdf
R package version 1.1-8 (2015); http://cran.r-project.org/package=lme4.,Non-OADS,/arxiv_data1/oa_pdf/4f/fc/1500401.PMC4646798.pdf
R package version 2.0-3 (2015); http://cran.r-project.org/package=AICcmodavg.,Non-OADS,/arxiv_data1/oa_pdf/4f/fc/1500401.PMC4646798.pdf
Data and materials availability: Data avail- able at the Dryad Digital Repository (http://dx.doi.org/10.5061/dryad.n7t76).,OADS,/arxiv_data1/oa_pdf/4f/fc/1500401.PMC4646798.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/9/e1500415/DC1Fig.,Non-OADS,/arxiv_data1/oa_pdf/6c/08/1500415.PMC4646799.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/9/e1500425/DC1 Materials and Methods Fig.,Non-OADS,/arxiv_data1/oa_pdf/e1/07/1500425.PMC4646800.pdf
"Because MED12 methylationoccurs on R1862 and R1912, we searched the COSMIC database (http://cancer.sanger.ac.uk/cancergenome/projects/cosmic/) for muta- tions at these sites and found that R1862 is mutated in a lung carcino- ma, and a somatic, homozygous mutation at R1912 was found in amelanoma patient who was resistant to a combined RAF/MEK (mitogen- activated protein kinase kinase) inhibitor treatment ( 21).",Non-OADS,/arxiv_data1/oa_pdf/91/db/1500463.PMC4646802.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/9/e1500463/DC1 Fig.,Non-OADS,/arxiv_data1/oa_pdf/91/db/1500463.PMC4646802.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/9/e1500468/DC1 Fig.,Non-OADS,/arxiv_data1/oa_pdf/4f/4c/1500468.PMC4646803.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/9/e1500469/DC1 Table S1.,Non-OADS,/arxiv_data1/oa_pdf/26/77/1500469.PMC4646804.pdf
"A complete description of this methodology can be found in (37), and the FAST software used for analysis is available for downloading on our Web site (http://spudlab.stanford.edu/FAST.html).RESEARCH ARTICLE Nag et al .",OADS,/arxiv_data1/oa_pdf/ef/1b/1500511.PMC4646805.pdf
"A Gaussian function was then fit to this distribution to obtain a mean and variance of the bootstrapped means, and we report this mean as the intrinsicforce generated by a single myosin molecule.SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/9/e1500511/DC1Fig.",Non-OADS,/arxiv_data1/oa_pdf/ef/1b/1500511.PMC4646805.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/9/e1500531/DC1 Pearson correlation of environmental parametersFig.,Non-OADS,/arxiv_data1/oa_pdf/11/d4/1500531.PMC4646806.pdf
R package version 2.0-10. http://CRAN.R-project.org/package=vegan (2013).,Non-OADS,/arxiv_data1/oa_pdf/11/d4/1500531.PMC4646806.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/9/e1500605/DC1Fig.,Non-OADS,/arxiv_data1/oa_pdf/4f/f2/1500605.PMC4646808.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/9/e1500608/DC1 Fig.,Non-OADS,/arxiv_data1/oa_pdf/8c/b7/1500608.PMC4646810.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/9/e1500613/DC1Fig.,Non-OADS,/arxiv_data1/oa_pdf/73/b5/1500613.PMC4646811.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/9/e1500633/DC1 WGA and glycoprotein interactions in a live cellFig.,Non-OADS,/arxiv_data1/oa_pdf/da/24/1500633.PMC4646812.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/9/e1500639/DC1Fig.,Non-OADS,/arxiv_data1/oa_pdf/e9/16/1500639.PMC4646813.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/9/e1500640/DC1§ S1.,Non-OADS,/arxiv_data1/oa_pdf/42/1b/1500640.PMC4646814.pdf
Data and materials availability: Reanalysis data from the European Centre for Medium Range Weather Forecasts was downloaded from http://apps.ecmwf.int/datasets/.Global Precipitation Climatology Project data were downloaded from the National ClimaticData Center Web site (http://ncdc.noaa.gov).,OADS,/arxiv_data1/oa_pdf/d6/01/1500646.PMC4646815.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/9/e1500656/DC1General informationGeneral procedureTable S1.,Non-OADS,/arxiv_data1/oa_pdf/5b/3c/1500656.PMC4646816.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/9/e1500661/DC1Section 1.,Non-OADS,/arxiv_data1/oa_pdf/0f/9e/1500661.PMC4646817.pdf
"68A,1 0 5–111 (1964).20. https://en.m.wikipedia.org/wiki/Ionic_radius 21.",OADS,/arxiv_data1/oa_pdf/b2/19/1500669.PMC4646818.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/9/e1500675/DC1Table S1.,Non-OADS,/arxiv_data1/oa_pdf/9a/5f/1500675.PMC4646819.pdf
Data and materials availability: All raw data can be obtained from the JGI Gold Database (http://gold.jgi.doe.,OADS,/arxiv_data1/oa_pdf/9a/5f/1500675.PMC4646819.pdf
"We then juxtapose the paleoclimate information with climate simulations conducted as part of the recent Coupled Model Intercomparison Project 5 (CMIP5, http://cmip-pcmdi.llnl.gov/cmip5/)and discuss the implications for future prediction of regional aridity.",Non-OADS,/arxiv_data1/oa_pdf/e6/a1/1500682.PMC4646820.pdf
"Climate model experiments We use output from the CMIP5 modeling experiments, publicly avail- able online at the Earth System Grid : http://pcmdi9.llnl.gov/.",Non-OADS,/arxiv_data1/oa_pdf/e6/a1/1500682.PMC4646820.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/9/e1500682/DC1Materials and MethodsTable S1.,Non-OADS,/arxiv_data1/oa_pdf/e6/a1/1500682.PMC4646820.pdf
Competing interests: The authors declare that they have no competing interests.Data and materials availability: Data associated with this research are available at the National Oceanic and Atmospheric Administration (NOAA) Na tional Climatic Data Center: https://www.ncdc.,Non-OADS,/arxiv_data1/oa_pdf/e6/a1/1500682.PMC4646820.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/9/e1500692/DC1 Hall effect measurement Fig.,Non-OADS,/arxiv_data1/oa_pdf/7a/ac/1500692.PMC4646822.pdf
Data and materials availability: Data underpinning this publication can be accessed at http://dx.doi.org/10.17630/7a88d794-d747-4aa2-a099-9335c5b702ec.,Non-OADS,/arxiv_data1/oa_pdf/7a/ac/1500692.PMC4646822.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/9/e1500701/DC1Methods: Device fabricationMaterials: Peel strength and adhesionFig.,Non-OADS,/arxiv_data1/oa_pdf/e5/e0/1500701.PMC4646823.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/9/e1500707/DC1Experimental considerations: 3D electrostatic simulationsPM qubit activation/deactivation Fig.,Non-OADS,/arxiv_data1/oa_pdf/86/d5/1500707.PMC4646824.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/9/e1500738/DC1Vibrational spectroscopic imaging of live C. elegans Fig.,Non-OADS,/arxiv_data1/oa_pdf/dc/98/1500738.PMC4646825.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/9/e1500761/DC1 TextFig.,Non-OADS,/arxiv_data1/oa_pdf/6b/49/1500761.PMC4646827.pdf
"S. J. Lancaster, http://cssp.chemspider.com/Article.aspx?id=215.",Non-OADS,/arxiv_data1/oa_pdf/6b/49/1500761.PMC4646827.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/9/e1500781/DC1Fig.,Non-OADS,/arxiv_data1/oa_pdf/13/b4/1500781.PMC4646828.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/9/e1500825/DC1Movie S1.,Non-OADS,/arxiv_data1/oa_pdf/7b/83/1500825.PMC4646829.pdf
"JETP 52, 129 – 131 (1980), http://www.jetp.ac.ru/cgi-bin/dn/e_052_01_0129.pdf (accessed 14 October 2015).",Non-OADS,/arxiv_data1/oa_pdf/7b/83/1500825.PMC4646829.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/9/e1500852/DC1Supplementary TextMorphology and morphometry of impact basinsMaps of impact basinsMultiring basins Peak-ring basins and other sizeable lunar impacts Basins without measurable rings that are identifed by GRAIL Bouguer gravity anomalyFig.,Non-OADS,/arxiv_data1/oa_pdf/ce/81/1500852.PMC4646831.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/9/e1500857/DC1Section I.,Non-OADS,/arxiv_data1/oa_pdf/f3/ed/1500857.PMC4646832.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/9/e1500863/DC1 Table S1.,Non-OADS,/arxiv_data1/oa_pdf/fa/33/1500863.PMC4646833.pdf
Data and materials availability: The spectral data set is available at the CDS via anonymous ftp to http://cdsarc.u-strasbg.fr (ftp://130.79.128.5).,OADS,/arxiv_data1/oa_pdf/fa/33/1500863.PMC4646833.pdf
"For GSEA, the HG_U133_Plus_2.0 chip annota- tion file downloaded from ftp://ftp.br oad.mit.edu//pub/g sea/annotations/ was used to annotate the Affymetrix probe sets and to remove dupli- cate probe sets for a given gene symbol.",OADS,/arxiv_data1/oa_pdf/78/f1/1500973.PMC4646834.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/9/e1500973/DC1Fig.,Non-OADS,/arxiv_data1/oa_pdf/78/f1/1500973.PMC4646834.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/9/e1501188/DC1 Fig.,Non-OADS,/arxiv_data1/oa_pdf/cc/85/1501188.PMC4646835.pdf
"- J .H s i e h ,G .C u i ,D .R .R o e ,D .H .M a t h e w s ,M. G. Seetin, R. Salomon-Ferrer, C. Sagui, V. Babin, T. Luchko, S. Gusarov, A. Kovalenko, P. A. Kollman,AMBER 12 (2012); http://ambermd.org/.",Non-OADS,/arxiv_data1/oa_pdf/cc/85/1501188.PMC4646835.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/f9/07/iranjradiol-12-04-19273.PMC4647118.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.,Non-OADS,/arxiv_data1/oa_pdf/c4/74/JCIS-5-57.PMC4647119.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.,Non-OADS,/arxiv_data1/oa_pdf/7c/45/JCIS-5-56.PMC4647125.pdf
Available on: “http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/7c/45/JCIS-5-56.PMC4647125.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.,Non-OADS,/arxiv_data1/oa_pdf/50/d7/JCIS-5-58.PMC4647127.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.,Non-OADS,/arxiv_data1/oa_pdf/c7/a2/JCIS-5-59.PMC4647135.pdf
Available from http://www.who.int/ chp/knowledge/publications/adherence_ introduction.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a2/60/227.PMC4647169.pdf
Available from  http://diabetes.org/diabetes-basics/statistics.,Non-OADS,/arxiv_data1/oa_pdf/2c/9d/258.PMC4647171.pdf
Available from http://packageinserts.bms.com/pi/pi_bydureon.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1e/1e/283.PMC4647172.pdf
Available from http://www.fda.gov/Drugs/ GuidanceComplianceRegulatoryInformation/Surveillance/ AdverseDrugEffects/default.htm.,Non-OADS,/arxiv_data1/oa_pdf/1e/1e/283.PMC4647172.pdf
Available from http://www.who.int/mediacentre/factsheets/fs312/en.,Non-OADS,/arxiv_data1/oa_pdf/d5/1e/252.PMC4647176.pdf
http://rer.aera.net  698 Benefits and Pitfalls of Multimedia and  Interactive Features in Technology-Enhanced  Storybooks: A Meta-Analysis Zsofia K. Takacs Elise K. Swart Adriana G. Bus Leiden University A meta-analysis was conducted on the effects of technology-enhanced sto- ries for young children’ s literacy development when compared to listening to stories in more traditional settings like storybook reading.,Non-OADS,/arxiv_data1/oa_pdf/e9/ea/10.3102_0034654314566989.PMC4647204.pdf
"Retrieved from http://www.joanganzcooneycenter.org/wp-content/uploads/2012/07/jgcc_ebooks_ quickreport.pdf Choat, E., & Griffin, H. (1986).",Non-OADS,/arxiv_data1/oa_pdf/e9/ea/10.3102_0034654314566989.PMC4647204.pdf
Retrieved from http://www.joangan-zcooneycenter.org/wp-content/uploads/2012/12/GLR_TechnologyGuide_final.,Non-OADS,/arxiv_data1/oa_pdf/e9/ea/10.3102_0034654314566989.PMC4647204.pdf
Retrieved from http://eric.ed.,Non-OADS,/arxiv_data1/oa_pdf/e9/ea/10.3102_0034654314566989.PMC4647204.pdf
Retrieved from http://www.j-e-r-o.com/index.php/jero/article/ viewFile/66/54,Non-OADS,/arxiv_data1/oa_pdf/e9/ea/10.3102_0034654314566989.PMC4647204.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/3.0/ www.bjcancer.com 1835,Non-OADS,/arxiv_data1/oa_pdf/ec/c8/bjc2014614a.PMC4647227.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/3.0/ www.bjcancer.com 1841,Non-OADS,/arxiv_data1/oa_pdf/fd/85/bjc2015106a.PMC4647228.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/3.0/ 1842 www.bjcancer.com,Non-OADS,/arxiv_data1/oa_pdf/fd/85/bjc2015106a.PMC4647228.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/3.0/ *Correspondence: Dr J-K Hu; E-mail: hujkwch@126.com 4This author co-first senior author.,Non-OADS,/arxiv_data1/oa_pdf/34/81/bjc2015161a.PMC4647229.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/3.0/ 1844 www.bjcancer.com,Non-OADS,/arxiv_data1/oa_pdf/34/81/bjc2015161a.PMC4647229.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/3.0/ 1842 www.bjcancer.com,Non-OADS,/arxiv_data1/oa_pdf/f8/8d/bjc2015155a.PMC4647230.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/3.0/ www.bjcancer.com 1843,Non-OADS,/arxiv_data1/oa_pdf/f8/8d/bjc2015155a.PMC4647230.pdf
"Breast cancer is the most common cause of cancer mortality in women worldwide (GLOBOCAN 2012, http://globocan.iarc.fr/ Pages/fact_sheets_population.aspx).",Non-OADS,/arxiv_data1/oa_pdf/cf/17/bjc2015143a.PMC4647231.pdf
The miRNA-specific forward primers sequenceswere designed based on the miRNA sequences obtained from the miRBase database (release 20; http://mirbase.org/).,OADS,/arxiv_data1/oa_pdf/cf/17/bjc2015143a.PMC4647231.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Cell-free miRNA and triple-negative breast cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.143 1759,Non-OADS,/arxiv_data1/oa_pdf/cf/17/bjc2015143a.PMC4647231.pdf
"Array data was analysed with the software Chipster (an open source project, http://chipster.csc.fi/) and the P-value was set to 0.05 allowing for false discovery rate correction.",OADS,/arxiv_data1/oa_pdf/92/e3/bjc2015150a.PMC4647232.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)miRNA-424 marker of field cancerisation in tongue SCC BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.150 1765,Non-OADS,/arxiv_data1/oa_pdf/92/e3/bjc2015150a.PMC4647232.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/3.0/ 1838 www.bjcancer.com,Non-OADS,/arxiv_data1/oa_pdf/44/63/bjc2015130a.PMC4647233.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/3.0/ www.bjcancer.com 1839,Non-OADS,/arxiv_data1/oa_pdf/44/63/bjc2015130a.PMC4647233.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/3.0/ www.bjcancer.com 1843,Non-OADS,/arxiv_data1/oa_pdf/a3/62/bjc2015105a.PMC4647234.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/3.0/ *Correspondence: Dr J-K Hu; E-mail: hujkwch@126.com 4This author co-first senior author.,Non-OADS,/arxiv_data1/oa_pdf/a3/62/bjc2015105a.PMC4647234.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/3.0/ 1844 www.bjcancer.com,Non-OADS,/arxiv_data1/oa_pdf/a3/62/bjc2015105a.PMC4647234.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/3.0/ *Correspondence: Dr RJQ McNally; E-mail: Richard.mcnally@ncl.ac.uk Published online 20 November 2014 &2015 Cancer Research UK.,Non-OADS,/arxiv_data1/oa_pdf/5d/e4/bjc2014582a.PMC4647235.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/3.0/ www.bjcancer.com 1837,Non-OADS,/arxiv_data1/oa_pdf/5d/e4/bjc2014582a.PMC4647235.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/3.0/ *Correspondence: &2015 Cancer Research UK.,Non-OADS,/arxiv_data1/oa_pdf/d0/bb/bjc2014583a.PMC4647236.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/3.0/ 1840 www.bjcancer.com,Non-OADS,/arxiv_data1/oa_pdf/d0/bb/bjc2014583a.PMC4647236.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Tertiary lymphoid organs in pancreatic cancer 1790 www.bjcancer.com | DOI:10.1038/bjc.2015.145,Non-OADS,/arxiv_data1/oa_pdf/ac/88/bjc2015145a.PMC4647237.pdf
"Comorbidity was classified according to the Adult Comorbidity Evaluation 27 (ACE-27) index calculator (http://oto2.wustl.edu/ clinepi/calc.html) that divides comorbidity into three categories: mild, moderate and severe.",Non-OADS,/arxiv_data1/oa_pdf/6d/c3/bjc2015139a.PMC4647238.pdf
Available at https://www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=36872 accessed 22 January 2015.,Non-OADS,/arxiv_data1/oa_pdf/d1/26/bjc2015147a.PMC4647239.pdf
Available at https://www.cancercare.on.ca/common/pages/ UserFile.aspx?fileId=288834 accessed 22 January 2015.,Non-OADS,/arxiv_data1/oa_pdf/d1/26/bjc2015147a.PMC4647239.pdf
Available at https://www.cancercare.on.ca/ common/pages/userfile.aspx?fileId=13032 accessed 22 January 2015.,Non-OADS,/arxiv_data1/oa_pdf/d1/26/bjc2015147a.PMC4647239.pdf
Available at https://www.cancercare.on.ca/ common/pages accessed 17 September 2013.,Non-OADS,/arxiv_data1/oa_pdf/d1/26/bjc2015147a.PMC4647239.pdf
Available at https://www.cancercare.on.ca/common/ pages/UserFile.aspx?fileId=64068 accessed 22 January 2015.,Non-OADS,/arxiv_data1/oa_pdf/d1/26/bjc2015147a.PMC4647239.pdf
Available at http://www.csqi.on.ca/ ptjourney/diagnosis/dap_patient_exp/ accessed 22 January 2015.,Non-OADS,/arxiv_data1/oa_pdf/d1/26/bjc2015147a.PMC4647239.pdf
Available at https://fr.cancercare.on.ca/common/pages/UserFile.aspx?fileId=47303 accessed 22 January 2015.,Non-OADS,/arxiv_data1/oa_pdf/d1/26/bjc2015147a.PMC4647239.pdf
Available at https://outside.ices.on.ca/Data%20Holdings/Health%20Services/ohip/Variables/feecode.html accessed 11 November 2013.,Non-OADS,/arxiv_data1/oa_pdf/d1/26/bjc2015147a.PMC4647239.pdf
Available at https://www.oma.org/Resources/Documents/2008RIO-FullTechnicalPaper.pdf accessed 22 January 2015.,Non-OADS,/arxiv_data1/oa_pdf/d1/26/bjc2015147a.PMC4647239.pdf
Available athttp://www.torontohealthprofiles.ca/onmarg/userguide_data/ON-Marg_user_guide_1.0_FINAL_MAY2012.pdf accessed 22 January 2015.,Non-OADS,/arxiv_data1/oa_pdf/d1/26/bjc2015147a.PMC4647239.pdf
Available athttp://www.cancercare.on.ca accessed 17 September 2013.,Non-OADS,/arxiv_data1/oa_pdf/d1/26/bjc2015147a.PMC4647239.pdf
Available at http://www.phac-aspc.gc.ca/publicat/2007/gmbspp-ldsppdcs/pdf/gmbspp-ldsppdcs_e.pdf accessed 22January 2015.,Non-OADS,/arxiv_data1/oa_pdf/d1/26/bjc2015147a.PMC4647239.pdf
"International Agency for Research on Cancer: Lyon, France, Availablefrom http://globocan.iarc.fr.",Non-OADS,/arxiv_data1/oa_pdf/6d/e1/bjc2015140a.PMC4647240.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/3.0/ www.bjcancer.com 1833,Non-OADS,/arxiv_data1/oa_pdf/e7/ce/bjc2014571a.PMC4647241.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/3.0/ *Correspondence: Dr CK Tai; E-mail: Chehkuan.tai@gmail.com 4These authors contributed equally to this work.,Non-OADS,/arxiv_data1/oa_pdf/e7/ce/bjc2014571a.PMC4647241.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/3.0/ 1834 www.bjcancer.com,Non-OADS,/arxiv_data1/oa_pdf/e7/ce/bjc2014571a.PMC4647241.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/3.0/ 1836 www.bjcancer.com,Non-OADS,/arxiv_data1/oa_pdf/23/5c/bjc2014613a.PMC4647242.pdf
"All of the statistical analyses were performed with R2.11.1 (http://www.r-project.org), and a Po0.05 indicated statistical significance.",OADS,/arxiv_data1/oa_pdf/fd/47/bjc2015141a.PMC4647243.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/3.0/ *Correspondence: Dr CK Tai; E-mail: Chehkuan.tai@gmail.com 4These authors contributed equally to this work.,Non-OADS,/arxiv_data1/oa_pdf/79/23/bjc2014559a.PMC4647244.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/3.0/ 1834 www.bjcancer.com,Non-OADS,/arxiv_data1/oa_pdf/79/23/bjc2014559a.PMC4647244.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/3.0/ *Correspondence: &2015 Cancer Research UK.,Non-OADS,/arxiv_data1/oa_pdf/b1/96/bjc2014584a.PMC4647246.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/3.0/ 1840 www.bjcancer.com,Non-OADS,/arxiv_data1/oa_pdf/b1/96/bjc2014584a.PMC4647246.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/3.0/ www.bjcancer.com 1841,Non-OADS,/arxiv_data1/oa_pdf/b1/96/bjc2014584a.PMC4647246.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/3.0/ 1838 www.bjcancer.com,Non-OADS,/arxiv_data1/oa_pdf/df/43/bjc2014663a.PMC4647247.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)stomach cancer and asbestos BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.599 1815,Non-OADS,/arxiv_data1/oa_pdf/8f/27/bjc2014599a.PMC4647249.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)IL-8 in FKBP51-induced melanoma pathogenesis BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.154 1781,Non-OADS,/arxiv_data1/oa_pdf/6a/cc/bjc2015154a.PMC4647250.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/3.0/ www.bjcancer.com 1839,Non-OADS,/arxiv_data1/oa_pdf/f0/04/bjc2015131a.PMC4647252.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/3.0/ *Correspondence: &2015 Cancer Research UK.,Non-OADS,/arxiv_data1/oa_pdf/f0/04/bjc2015131a.PMC4647252.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/3.0/ 1840 www.bjcancer.com,Non-OADS,/arxiv_data1/oa_pdf/f0/04/bjc2015131a.PMC4647252.pdf
Available at http://www.ssi.dk/~/media/Indhold/DK%20-%20dansk/Sundhedsdata%20og%20it/NSF/Registre/Cancerregisteret/Det%20moderniserede%20Cancerregister%20%20metode%20og%20kvalitet.ashx.,Non-OADS,/arxiv_data1/oa_pdf/53/a8/bjc2015136a.PMC4647253.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Herpes zoster and cancer mortality 1826 www.bjcancer.com | DOI:10.1038/bjc.2015.136,Non-OADS,/arxiv_data1/oa_pdf/53/a8/bjc2015136a.PMC4647253.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/3.0/ 1836 www.bjcancer.com,Non-OADS,/arxiv_data1/oa_pdf/82/31/bjc2014581a.PMC4647254.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/3.0/ *Correspondence: Dr RJQ McNally; E-mail: Richard.mcnally@ncl.ac.uk Published online 20 November 2014 &2015 Cancer Research UK.,Non-OADS,/arxiv_data1/oa_pdf/82/31/bjc2014581a.PMC4647254.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/3.0/ www.bjcancer.com 1837,Non-OADS,/arxiv_data1/oa_pdf/82/31/bjc2014581a.PMC4647254.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/3.0/ www.bjcancer.com 1833,Non-OADS,/arxiv_data1/oa_pdf/7f/95/bjc2014570a.PMC4647256.pdf
Available at http://www.bbc.co.uk/news/health-25274287 (accessed 23 September2014).,Non-OADS,/arxiv_data1/oa_pdf/d1/25/bjc2015110a.PMC4647257.pdf
Available at http://www.ncin.org.uk/cancer_information_tools/profiles/gp_profiles (accessed 23 September 2014).,Non-OADS,/arxiv_data1/oa_pdf/d1/25/bjc2015110a.PMC4647257.pdf
Available at http://www.ncin.org.uk/publications/routes_(accessed23 September 2014).,Non-OADS,/arxiv_data1/oa_pdf/d1/25/bjc2015110a.PMC4647257.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER GP performance in referral for suspected cancer 1798 www.bjcancer.com | DOI:10.1038/bjc.2015.110,Non-OADS,/arxiv_data1/oa_pdf/d1/25/bjc2015110a.PMC4647257.pdf
"After six months it is available under a Creative Commons License (Attribution– Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0/).Correspondence to George Miller: george.miller@nyumc.org Abbreviations used: CAF, cancer-associated fibroblast; DAMP, damage-associated  molecular pattern; HMGB1, high-mobility group protein B1; KrasG12D-PDEC, Kras- transformed pancreatic ductal epithelial cells; MDSC, myeloid-derived suppressor  cell; OIS, oncogene-induced senescence; PAMP, pathogen-associated molecular  pattern; PDAC, pancreatic ductal adenocarcinoma; PSC, pancreatic stellate cell; TLR,  Toll-like receptor; TME, tumor microenvironment.The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
http://dx.doi.org/10.1002/pros.22597 American Cancer Society.,Non-OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"http://dx.doi.org/10.1038/nrgastro.2012.111 Bera, A., S. Zhao, L. Cao, P .J.",OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"http://dx.doi.org/10.1371/journal.pone.0082282 Butts, C., N. Murray, A. Maksymiuk, G. Goss, E. Marshall, D. Soulières, Y .",Non-OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"http://dx.doi.org/10.1200/JCO.2005.13.011 Caldwell, M.E., G.M.",OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"http://dx.doi.org/10.1038/onc.2011.350 Chatterjee, S., L. Crozet, D. Damotte, K. Iribarren, C. Schramm, M. Alifano, A.  Lupo, J. Cherfils-Vicini, J. Goc, S. Katsahian, et al.",Non-OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
http://dx.doi.org/10.1158/0008-5472.CAN-13-2698,Non-OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"http://dx.doi.org/10.1016/j.intimp.2007.05.016 Connolly, M.K., J. Mallen-St Clair, A.S. Bedrosian, A. Malhotra, V .",OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"http://dx.doi.org/10.1189/jlb.0909607 Deer, E.L., J. González-Hernández, J.D.",Non-OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"http://dx.doi.org/10.1097/MPA.0b013e3181c15963 El Andaloussi, A., A.M. Sonabend, Y .",Non-OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"http://dx.doi.org/10.1002/glia.20401 Erez, N., M. Truitt, P .",OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"http://dx.doi.org/10.1016/j.ccr.2009.12.041 Fukata, M., and M.T.",OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"http://dx.doi.org/10.1038/sj.onc.1210908 Fukata, M., A. Chen, A.S. Vamadevan, J. Cohen, K. Breglio, S. Krishnareddy,  D. Hsu, R. Xu, N. Harpaz, A.J.",Non-OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
http://dx.doi.org/10.1053/j.,Non-OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"http://dx.doi.org/10.1016/j.ccr.2011.03.002 Gabitass, R.F ., N.E.",OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"http://dx.doi.org/10.1007/s00262-011-1028-0 Greten, F .R., C.K.",Non-OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"http://dx.doi.org/10.1053/gast.2002.37075 Guerra, C., A.J.",Non-OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"http://dx.doi.org/10.1016/j.ccr.2007.01.012 Gukovsky, I., N. Li, J. T odoric, A. Gukovskaya, and M. Karin.",OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"http://dx.doi.org/10.1053/j.gastro.2013.02.007 Hemmi, H., O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, H. Sanjo, M. Matsumoto,  K. Hoshino, H. Wagner, K. Takeda, and S. Akira.",OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"http://dx.doi.org/10.1038/35047123 Hingorani, S.R., E.F .",Non-OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"http://dx.doi.org/10.1016/S1535-6108(03)00309-XHingorani, S.R., L. Wang, A.S. Multani, C. Combs, T.B.",OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"http://dx.doi.org/10.1016/j.ccr.2005.04.023 Hirata, Y ., H. Kurobe, M. Higashida, D. Fukuda, M. Shimabukuro, K. Tanaka,  Y .",OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"http://dx.doi.org/10.1016/j.atherosclerosis.2013.09.010 Ho-Pun-Cheung, A., C. Bascoul-Mollevi, E. Assenat, F .",OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"10:31. http://dx.doi.org/10.1186/1471-2199-10-31 Hruban, R.H., N.V .",Non-OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"http://dx.doi.org/10.1097/00000478-200105000-00003 Huang, H., J. Daniluk, Y .",OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"http://dx.doi.org/10.1038/onc.2012.619 Ibrahim, J., A.H. Nguyen, A. Rehman, A. Ochi, M. Jamal, C.S.",Non-OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"http://dx.doi.org/10.1053/j.gastro.2012.06.003 Kanzler, H., F .J.",OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"http://dx.doi.org/10.1038/nm1589 Lesina, M., M.U.",OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"http://dx.doi.org/10.1016/j.ccr.2011.03.009 Levina, V ., B.M.",OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"http://dx.doi.org/10.1158/1078-0432.CCR-08-2024 Li, S., A.L.",OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"http://dx.doi.org/10.1371/journal.pone.0018498 Masamune, A., K. Kikuta, T. Watanabe, K. Satoh, A. Satoh, and T. Shimosegawa.",OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"http://dx.doi.org/10.1007/s00535-008-2162-0 Mehner, C., E. Miller, D. Khauv, A. Nassar, A.L.",Non-OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"http://dx.doi.org/10.1158/1541-7786.MCR-13-0557-T Mohrin, M., E. Bourke, D. Alexander, M.R.",Non-OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"http://dx.doi.org/10.1016/j.stem.2010.06.014 Murdoch, C., M. Muthana, S.B.",OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"http://dx.doi.org/10.1038/nrc2444 Ochi, A., C.S.",OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
http://dx.doi.org/10.1172/JCI63606,Non-OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"http://dx.doi.org/10.1084/jem.20111706 Pylayeva-Gupta, Y ., K.E.",OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"http://dx.doi.org/10.1016/j.ccr.2012.04.024 Ray, A., K. Chakraborty, and P .",OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"3:52. http://dx.doi.org/10.3389/ fcimb.2013.00052 Salaun, B., I. Coste, M.C.",OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"http://dx.doi.org/10.4049/jimmunol.176.8.4894 Schlecker, E., A. Stojanovic, C. Eisen, C. Quack, C.S.",OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"http://dx.doi.org/10.1053/j.gastro.2004.03.058 Sfondrini, L., A. Rossini, D. Besusso, A. Merlo, E. Tagliabue, S. Mènard, and  A. Balsari.",Non-OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"http://dx.doi.org/10.4049/jimmunol.176.11.6624 Spaner, D.E., and A. Masellis.",OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"http://dx.doi.org/10.1158/1940-6207.CAPR-10-0251 Takeda, K., and S. Akira.",OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"http://dx.doi.org/10.1002/0471142735.im1412s77 Takeuchi, O., and S. Akira.",OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"http://dx.doi.org/10.1016/j.cell.2010.01.022 Tan, M.C., P .S.",OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"http://dx.doi.org/10.4049/jimmunol.182.3.1746 Tuomela, J., J. Sandholm, M. Kaakinen, A. Patel, J.H.",OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"http://dx.doi.org/10.2337/db11-1297 Vonlaufen, A., S. Joshi, C. Qu, P .A.",OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-07-2477 Vonlaufen, A., P .A.",Non-OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"http://dx.doi.org/10.1074/jbc.M305698200 Yadav, D., and A.B.",OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"http://dx.doi.org/10.1053/j.gastro.2013.01.068 Yanai, H., T. Ban, and T. Taniguchi.",OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"http://dx.doi.org/10.1016/j.it.2012.10.005 Zambirinis, C.P ., S. Pushalkar, D. Saxena, and G. Miller.",OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"http://dx.doi.org/10.1097/PPO.0000000000000045 Zheng, L., J. Xue, E.M. Jaffee, and A. Habtezion.",OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
"http://dx.doi.org/10.1053/j.gastro.2012.12.042 Zhu, F ., P .",OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/48/cc/JEM_20142162.PMC4647258.pdf
This article is distributed under the terms of an Attribution–Noncommercial–Share  Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/ terms).,Non-OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"After six months it is available under a Creative Commons License (Attribution–Noncommercial– Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).Correspondence to Dean Tantin: dean.tantin@path.utah.edu; or Matthew A. Wil - liams: matthew.williams@path.utah.edu A. Shalek's present address is Dept.",Non-OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
Online supplemental material is available at http://www.jem.org/cgi/content/full/jem.20150363/DC1.,Non-OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.4049/jimmunol.1002042 Beaulieu, A.M., C.L.",Non-OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.1038/ni.2876 Bert, A.G., J. Burrows, A. Hawwari, M.A.",Non-OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.4049/jimmunol.165.10.5646 Brunner, C., A. Sindrilaru, I. Girkontaite, K.D.",Non-OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.1038/sj.emboj.7601742 Casellas, R., M. Jankovic, G. Meyer, A. Gazumyan, Y .",Non-OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.1016/S0092-8674(02)00911-X Collier, S.P ., P .L.",OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.4049/jimmunol.1200774 Cron, R.Q., B. Zhou, M.W .",OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.1038/sj.gene.6363811Cui, W ., Y .",OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"171:5727– 5735. http://dx.doi.org/10.4049/jimmunol.171.11.5727 Darrah, P .A., D.T.",Non-OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.1038/ nm1592 Duncliffe, K.N., A.G. Bert, M.A.",OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.1016/S1074-7613(00)80424-0 Falkner, F .G., and H.G.",OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.1038/310071a0 Fletcher, C., N. Heintz, and R.G.",OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.1016/0092-8674(87)90100-0 Garrity, P .A., D. Chen, E.V .",OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.1128/MCB.14.3.2159 Gomez, J.A., O.L.",Non-OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.1016/j.cell.2013.01.015 Hammarlund, E., M.W .",OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.1038/nm917 Hess Michelini, R., A.L.",OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.1084/jem.20130392 Hori, N., H. Nakano, T. Takeuchi, H. Kato, S. Hamaguchi, M. Oshimura,  and K. Sato.",OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.1074/jbc.M202280200 Huffaker, T.B., R. Hu, M.C.",OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.1016/j.celrep.2012.10.025 Hussain, S.F ., C.F .",OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.4049/ jimmunol.168.4.1557 Ichii, H., A. Sakamoto, M. Hatano, S. Okada, H. T oyama, S. Taki, M. Arima,  Y .",OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
http://dx.doi.org/10.1093/intimm/dxm007,Non-OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.1126/science.1257530 Intlekofer, A.M., N. Takemoto, C. Kao, A. Banerjee, F .",OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.1084/jem.20070841 Jin, T., and H. Li.",OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.1074/jbc.M008277200 Joshi, N.S., W .",Non-OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.1016/j.immuni.2007.07.010 Kallies, A., A. Xin, G.T.",OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.1016/j.immuni.2009.06.021 Kang, J., M. Gemberling, M. Nakamura, F .G.",OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.1101/gad.1750709 Kaushansky, K., S.G. Shoemaker, C.A.",Non-OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.1093/hmg/ ddp411 Kim, L.K., E. Esplugues, C.E.",Non-OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.1016/j.molcel.2014.02.004 Kim, U., X.F .",OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.1038/383542a0 Lee, P .P ., D.R.",OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.1016/S0092-8674(85)80021-0 McLean, C.Y ., D. Bristor, M. Hiller, S.L.",OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.4049/ jimmunol.0904089 Mollo, S.B., A.J.",OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.4049/jimmunol.1302033 Mueller, K., J. Quandt, R.B.",OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.1038/sj.emboj.7601012 Oxenius, A., M.F .",OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.1002/ (SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.0.CO;2-O Penix, L., W .M.",OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.1084/jem.178.5.1483 Pepper, M., A.J.",Non-OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.1016/j.immuni.2011.09.009 Pfeuffer, I., S. Klein-Hessling, A. Heinfling, S. Chuvpilo, C. Escher, T. Brabletz,  B. Hentsch, H. Schwarzenbach, P .",OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.1093/emboj/17.17.5066 Quinlan, A.R., and I.M.",OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.1016/j.molcel.2011.04.011 Rutishauser, R.L., G.A.",OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.1016/j.immuni.2009.05.014 Sauter, P ., and P .",OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.1038/383538a0 Sebastiano, V ., M. Dalvai, L. Gentile, K. Schubart, J. Sutter, G.M.",Non-OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
http://dx.doi.org/10.1242/dev.047027,Non-OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.1074/jbc.M110.174045 Shakya, A., C. Callister, A. Goren, N. Y osef, N. Garg, V .",Non-OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.1128/MCB.01105-14 Sive, H.L., N. Heintz, and R.G.",OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.1128/MCB.6.10.3329 Tantin, D., C. Schild-Poulter, V .",OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-05-2399 Tantin, D., W .P .",Non-OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.3791/50064 Ullman, K.S., W .M.",Non-OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.1126/science.1683003 Vigneau, S., P .S.",OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.1128/JVI.77.10.5632-5638.2003 Wang, V .E.H., T. Schmidt, J. Chen, P .A.",OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.1128/MCB.24.3.1022-1032.2004 Whitmire, J.K., M.S.",OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.1038/nature04790 Williams, M.A., E.V .",OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.1016/j.immuni.2008.02.014 Wirth, T., L. Staudt, and D. Baltimore.",OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.1038/329174a0 Wu, G.D., E.J.",OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.1074/ jbc.272.4.2396 Yamane, K., C. T oumazou, Y .",Non-OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.1016/j.cell.2006.03.027 Y oon, H.S., C.D.",OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.4049/jimmunol.1103371 Y osef, N., A.K.",Non-OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.1038/nature11981 Zens, K.D., and D.L.",Non-OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"http://dx.doi.org/10.1128/MCB.00788-06 Zwilling, S., A. Dieckmann, P .",Non-OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
http://dx.doi.org/10.1126/science.277.5323.221,Non-OADS,/arxiv_data1/oa_pdf/cb/b8/JEM_20150363.PMC4647264.pdf
"More than 150 pathogenic mutations in PSEN1   have been reported so far (http://www.molgen.ua.ac.be/ ADMutations); and notably, the vast majority are missense  substitutions distributed throughout the primary structure  of PSEN1.",Non-OADS,/arxiv_data1/oa_pdf/f1/7c/JEM_20150892.PMC4647268.pdf
This article is distributed under the terms of an Attribution–Noncommercial–Share  Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/ terms).,Non-OADS,/arxiv_data1/oa_pdf/f1/7c/JEM_20150892.PMC4647268.pdf
"After six months it is available under a Creative Commons License (Attribution–Noncommercial– Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).*M.",Non-OADS,/arxiv_data1/oa_pdf/f1/7c/JEM_20150892.PMC4647268.pdf
"http://dx.doi.org/10.1523/JNE  UROSCI.4742-11.2012 Bergmans, B.A., and B.",OADS,/arxiv_data1/oa_pdf/f1/7c/JEM_20150892.PMC4647268.pdf
"http://dx.doi.org/10.1016/S1474-4422(09)70332-1 Campion, D., C. Dumanchin, D. Hannequin, B. Dubois, S. Belliard, M. Puel,  C. Thomas-Anterion, A. Michon, C. Martin, F .",Non-OADS,/arxiv_data1/oa_pdf/f1/7c/JEM_20150892.PMC4647268.pdf
"http://dx.doi.org/10.1086/302553 Chávez-Gutiérrez, L., A. T olia, E. Maes, T. Li, P .C.",OADS,/arxiv_data1/oa_pdf/f1/7c/JEM_20150892.PMC4647268.pdf
"http://dx.doi.org/10.1074/jbc.M803040200 Chávez-Gutiérrez, L., L. Bammens, I. Benilova, A. Vandersteen, M. Benurwar,  M. Borgers, S. Lismont, L. Zhou, S. Van Cleynenbreugel, H. Esselmann, et al.. 2012.",Non-OADS,/arxiv_data1/oa_pdf/f1/7c/JEM_20150892.PMC4647268.pdf
"http://dx.doi.org/10.1038/emboj.2012.79 Crump, C.J., B.A.",OADS,/arxiv_data1/oa_pdf/f1/7c/JEM_20150892.PMC4647268.pdf
"http://dx.doi.org/10.1021/cn200098p De Strooper, B.",Non-OADS,/arxiv_data1/oa_pdf/f1/7c/JEM_20150892.PMC4647268.pdf
"http://dx.doi.org/10.1016/S0896-6273(03)00205-8 De Strooper, B.",OADS,/arxiv_data1/oa_pdf/f1/7c/JEM_20150892.PMC4647268.pdf
http://dx.doi.org/10.1038/ sj.embor.7400897,Non-OADS,/arxiv_data1/oa_pdf/f1/7c/JEM_20150892.PMC4647268.pdf
"http://dx.doi.org/10.1038/34910 Edland, S.D., and D.R.",OADS,/arxiv_data1/oa_pdf/f1/7c/JEM_20150892.PMC4647268.pdf
"http://dx.doi.org/10.1038/ nm.2495 Fernandez, M.A., J.A.",OADS,/arxiv_data1/oa_pdf/f1/7c/JEM_20150892.PMC4647268.pdf
"http://dx.doi.org/10.1074/jbc.M114.581165 Hata, S., S. Fujishige, Y .",OADS,/arxiv_data1/oa_pdf/f1/7c/JEM_20150892.PMC4647268.pdf
"http://dx.doi.org/10.1002/ana.22343 Hata, S., M. Taniguchi, Y .",OADS,/arxiv_data1/oa_pdf/f1/7c/JEM_20150892.PMC4647268.pdf
"7:16. http://dx.doi.org/10.1186/1750-1326-7-16 Heilig, E.A., U. Gutti, T. Tai, J. Shen, and R.J. Kelleher III.",Non-OADS,/arxiv_data1/oa_pdf/f1/7c/JEM_20150892.PMC4647268.pdf
"http://dx.doi.org/10.1523/JNE UROSCI.0954-13.2013 Herreman, A., L. Serneels, W .",Non-OADS,/arxiv_data1/oa_pdf/f1/7c/JEM_20150892.PMC4647268.pdf
"http://dx.doi.org/10.1038/35017105 Jurisch-Yaksi, N., R. Sannerud, and W .",Non-OADS,/arxiv_data1/oa_pdf/f1/7c/JEM_20150892.PMC4647268.pdf
"http://dx.doi.org/10.1016/j.bbamem.2013.04.016 Kakuda, N., M. Shoji, H. Arai, K. Furukawa, T. Ikeuchi, K. Akazawa, M.  Takami, H. Hatsuta, S. Murayama, Y .",OADS,/arxiv_data1/oa_pdf/f1/7c/JEM_20150892.PMC4647268.pdf
"http://dx.doi.org/10.1002/emmm.201200214 Kim, J., L. Onstead, S. Randle, R. Price, L. Smithson, C. Zwizinski, D.W .",Non-OADS,/arxiv_data1/oa_pdf/f1/7c/JEM_20150892.PMC4647268.pdf
"http://dx.doi.org/10.1523/JNE UROSCI.4849-06.2007 Kosik, K.S., C. Muñoz, L. Lopez, M.L.",Non-OADS,/arxiv_data1/oa_pdf/f1/7c/JEM_20150892.PMC4647268.pdf
"http://dx.doi.org/10.1212/WNL.0000000000001130 Kuperstein, I., K. Broersen, I. Benilova, J. Rozenski, W .",Non-OADS,/arxiv_data1/oa_pdf/f1/7c/JEM_20150892.PMC4647268.pdf
"http://dx.doi.org/10.1038/emboj.2010.211 Matsumura, N., M. Takami, M. Okochi, S. Wada-Kakuda, H. Fujiwara, S.  Tagami, S. Funamoto, Y .",OADS,/arxiv_data1/oa_pdf/f1/7c/JEM_20150892.PMC4647268.pdf
"http://dx.doi.org/10.1074/jbc.M113.510131 Mawuenyega, K.G., W .",Non-OADS,/arxiv_data1/oa_pdf/f1/7c/JEM_20150892.PMC4647268.pdf
"330:1774. http://dx.doi.org/10.1126/science.1197623Moore, S., L.D.",OADS,/arxiv_data1/oa_pdf/f1/7c/JEM_20150892.PMC4647268.pdf
"http://dx.doi.org/10.1016/j.celrep.2015.03.068 Pera, M., D. Alcolea, R. Sánchez-Valle, C. Guardia-Laguarta, M. Colom- Cadena, N. Badiola, M. Suárez-Calvet, A. Lladó, A.A. Barrera-Ocampo, D. Sepulveda-Falla, et al.. 2013.",Non-OADS,/arxiv_data1/oa_pdf/f1/7c/JEM_20150892.PMC4647268.pdf
"http://dx.doi.org/10.1007/ s00401-012-1062-9 Pink, A.E., M.A.",Non-OADS,/arxiv_data1/oa_pdf/f1/7c/JEM_20150892.PMC4647268.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/7c/JEM_20150892.PMC4647268.pdf
"http://dx.doi.org/10.1523/JNE UROSCI.1575-04.2005 Quintero-Monzon, O., M.M.",Non-OADS,/arxiv_data1/oa_pdf/f1/7c/JEM_20150892.PMC4647268.pdf
"http://dx.doi.org/10.1021/bi2007146 Saito, T., T. Suemoto, N. Brouwers, K. Sleegers, S. Funamoto, N. Mihira, Y .",OADS,/arxiv_data1/oa_pdf/f1/7c/JEM_20150892.PMC4647268.pdf
"http://dx.doi.org/10.1038/nn.2858 Takami, M., Y .",OADS,/arxiv_data1/oa_pdf/f1/7c/JEM_20150892.PMC4647268.pdf
"http://dx.doi.org/10.1523/JNE UROSCI.2362-09.2009 Takeo, K., S. Tanimura, T. Shinoda, S. Osawa, I.K.",OADS,/arxiv_data1/oa_pdf/f1/7c/JEM_20150892.PMC4647268.pdf
"http://dx.doi.org/10.1016/j.cell.2005.02.008 Velter, A.I., F .P .",OADS,/arxiv_data1/oa_pdf/f1/7c/JEM_20150892.PMC4647268.pdf
"http://dx.doi.org/10.1016/j.bmcl.2014.10.024 Wahrle, S., P .",OADS,/arxiv_data1/oa_pdf/f1/7c/JEM_20150892.PMC4647268.pdf
"http://dx.doi.org/10.1006/ nbdi.2001.0470 Wang, R., B. Wang, W .",OADS,/arxiv_data1/oa_pdf/f1/7c/JEM_20150892.PMC4647268.pdf
http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/f1/7c/JEM_20150892.PMC4647268.pdf
http://dx.doi.org/10.1038/19077,Non-OADS,/arxiv_data1/oa_pdf/f1/7c/JEM_20150892.PMC4647268.pdf
"http://dx.doi.org/10.1016/j.neuron.2015.02.010Yagishita, S., M. Morishima-Kawashima, S. Ishiura, and Y .",OADS,/arxiv_data1/oa_pdf/f1/7c/JEM_20150892.PMC4647268.pdf
http://dx.doi.org/10.1074/jbc.M707103200,Non-OADS,/arxiv_data1/oa_pdf/f1/7c/JEM_20150892.PMC4647268.pdf
Available  at: http://dx.doi.org/10.3402/meo.v19.24930.,Non-OADS,/arxiv_data1/oa_pdf/d4/1a/10.1177_1747016115586759.PMC4647303.pdf
Available at: http://www.biomedcentral.com/1472–6939/12/5.,Non-OADS,/arxiv_data1/oa_pdf/d4/1a/10.1177_1747016115586759.PMC4647303.pdf
Available at: http://www.espa.ac.uk (accessed 14 July 2014).,Non-OADS,/arxiv_data1/oa_pdf/d4/1a/10.1177_1747016115586759.PMC4647303.pdf
Available at: http://dx.doi.org/10.1080/13645579.2014.924169 (accessed 22 July 2014).,Non-OADS,/arxiv_data1/oa_pdf/d4/1a/10.1177_1747016115586759.PMC4647303.pdf
Available at: http://findarticles.com/p/articles/mi_qa3800/is_200710/ai_n21137685 (accessed 13 November 2011).,Non-OADS,/arxiv_data1/oa_pdf/d4/1a/10.1177_1747016115586759.PMC4647303.pdf
Available at: http://www.niehs.nih.gov/research/resources/bioethics/whatis/ (accessed 19 July 2014).,Non-OADS,/arxiv_data1/oa_pdf/d4/1a/10.1177_1747016115586759.PMC4647303.pdf
"PRC2 interacts with DNA methyltransferases 1Present address: EMBL Australia and the Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, MonashUniversity, Clayton, Victoria 3800, Australia Corresponding authors: chen.davidovich@monash.edu, thomas.cech@ colorado.edu Article and publication date are online at http:/ /www.rnajournal.org/cgi/doi/ 10.1261/rna.053918.115.© 2015 Davidovich and Cech This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).",Non-OADS,/arxiv_data1/oa_pdf/60/12/2007.PMC4647455.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommer-cial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.REVIEW RNA 21:2007 –2022; Published by Cold Spring Harbor Laboratory Press for the RNA Society 2007",Non-OADS,/arxiv_data1/oa_pdf/60/12/2007.PMC4647455.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.053058.115.© 2015 Dobson et al.,OADS,/arxiv_data1/oa_pdf/42/80/2023.PMC4647456.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/42/80/2023.PMC4647456.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.LETTER TO THE EDITOR RNA 21:2023 –2029; Published by Cold Spring Harbor Laboratory Press for the RNA Society 2023",Non-OADS,/arxiv_data1/oa_pdf/42/80/2023.PMC4647456.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.053207.115.© 2015 Lopez-Orozco et al.,OADS,/arxiv_data1/oa_pdf/d7/87/2030.PMC4647457.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/d7/87/2030.PMC4647457.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommer-cial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.REPORT 2030 RNA 21:2030 –2038; Published by Cold Spring Harbor Laboratory Press for the RNA Society",Non-OADS,/arxiv_data1/oa_pdf/d7/87/2030.PMC4647457.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.052969.115.© 2015 Cole et al.,OADS,/arxiv_data1/oa_pdf/78/d6/2053.PMC4647460.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/78/d6/2053.PMC4647460.pdf
DATA DEPOSITION The raw sequence reads supporting the results of this article areavailable in the NCBI SRA repository under accession numberSRP059357 (alias PRJNA285906) at http://www.ncbi.nlm.nih.gov/ Traces/sra/sra.cgi?study=SRP059357.,OADS,/arxiv_data1/oa_pdf/78/d6/2053.PMC4647460.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.054221.115.© 2015 Gu et al.,OADS,/arxiv_data1/oa_pdf/db/5a/2067.PMC4647461.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/db/5a/2067.PMC4647461.pdf
The data set can be accessedat the following link: http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=apwnwimmvnupfkr&acc=GSE67493.,OADS,/arxiv_data1/oa_pdf/db/5a/2067.PMC4647461.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.052340.115.© 2015 Huang et al.,OADS,/arxiv_data1/oa_pdf/eb/d3/2088.PMC4647463.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/eb/d3/2088.PMC4647463.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/eb/d3/2088.PMC4647463.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.053637.115.© 2015 Zagalak et al.,OADS,/arxiv_data1/oa_pdf/8d/13/2132.PMC4647466.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/8d/13/2132.PMC4647466.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.METHOD 2132 RNA 21:2132 –2142; Published by Cold Spring Harbor Laboratory Press for the RNA Society",Non-OADS,/arxiv_data1/oa_pdf/8d/13/2132.PMC4647466.pdf
Amplificationproducts were purified and sequenced on an Illumina HiSeq2000.Sequencing data were demultiplexed and analyzed using the Galaxyweb server (https://usegalaxy.org/).,OADS,/arxiv_data1/oa_pdf/8d/13/2132.PMC4647466.pdf
Raw data areaccessible online (http://www.genomespace.org/) with file name:“BSSE_QGF_20638_CAGATC_random_siRND3AS.fastq.gz ”.,OADS,/arxiv_data1/oa_pdf/8d/13/2132.PMC4647466.pdf
After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution- NonCommercial-Share Alike 4.0 Unported License Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Increasing incidence of HPV-positive BSCCs 134 www.bjcancer.com | DOI:10.1038/bjc.2015.198,Non-OADS,/arxiv_data1/oa_pdf/1c/1f/bjc2015198a.PMC4647522.pdf
After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution- NonCommercial-Share Alike 4.0 Unported License Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)p16 and pleural mesothelioma BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.187 75,Non-OADS,/arxiv_data1/oa_pdf/4e/70/bjc2015187a.PMC4647524.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Cancer survival in South Asians in England BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.182 181",Non-OADS,/arxiv_data1/oa_pdf/9a/05/bjc2015182a.PMC4647525.pdf
"The International Head and Neck Cancer Epidemiology (INHANCE) consortium (Hashibe et al , 2007; Conway et al , 2009; http://www.inhance.utah.edu, last accessed 15 March 2015) was established in 2004 to elucidate the aetiology of head and neck cancers (HNCs) through pooled analyses of individual-level data on HNCs on a large scale.",Non-OADS,/arxiv_data1/oa_pdf/fe/68/bjc2015149a.PMC4647526.pdf
URL http://CRAN.R-project.org/package=lme4R packageversion 0.999375-42.,Non-OADS,/arxiv_data1/oa_pdf/fe/68/bjc2015149a.PMC4647526.pdf
Available from http://www.bda-ieo.it.,Non-OADS,/arxiv_data1/oa_pdf/fe/68/bjc2015149a.PMC4647526.pdf
Available from http://www.R-project.org.,Non-OADS,/arxiv_data1/oa_pdf/fe/68/bjc2015149a.PMC4647526.pdf
Available from http://www.ars.usda.gov/ba/bhnrc/ndl.,Non-OADS,/arxiv_data1/oa_pdf/fe/68/bjc2015149a.PMC4647526.pdf
Available from http://www.stats.ox.ac.uk/pub/MASS4.,Non-OADS,/arxiv_data1/oa_pdf/fe/68/bjc2015149a.PMC4647526.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Vitamin E and head and neck cancer 192 www.bjcancer.com | DOI:10.1038/bjc.2015.149,Non-OADS,/arxiv_data1/oa_pdf/fe/68/bjc2015149a.PMC4647526.pdf
"Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER TH-302, VEGF-A inhibition and radiation for sarcomas 56 www.bjcancer.com | DOI:10.1038/bjc.2015.186",Non-OADS,/arxiv_data1/oa_pdf/f1/35/bjc2015186a.PMC4647529.pdf
"Office of National Statistics (2011) National Population Projections, 2010-Based Statistical Bulletin http://www.ons.gov.uk/ons/dcp171778_235886.pdf (accessed 9 April 2014).",Non-OADS,/arxiv_data1/oa_pdf/b6/cd/bjc201576a.PMC4647530.pdf
Office of National Statistics (2014a) Annual mid-year population estimates for England http://www.ons.gov.uk/ (accessed 25 March 2014).,Non-OADS,/arxiv_data1/oa_pdf/b6/cd/bjc201576a.PMC4647530.pdf
"Office of National Statistics (2014b) England, National Life Tables, 1980-82 to 2010-12 http://www.ons.gov.uk/ons/publications/re-reference-tables.html?edition=tcm%3A77-352834 (accessed 9 April 2014).",Non-OADS,/arxiv_data1/oa_pdf/b6/cd/bjc201576a.PMC4647530.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Flexible sigmoidocsopy and CRC screening in England BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.76 149,Non-OADS,/arxiv_data1/oa_pdf/b6/cd/bjc201576a.PMC4647530.pdf
"Primer sequences for RPS18 mRNA detection were designed using Primer 3 (http://frodo.wi.mit.edu) (forward: 50-GCGGCGGAAA ATAGCCTTTG-30, reverse: 50-GATCACACGTTCCACCTCAT C-30, amplicon size: 139, efficiency: 99%) (Life Technologies, Gent, Belgium).",OADS,/arxiv_data1/oa_pdf/af/cd/bjc2015194a.PMC4647532.pdf
"In order to determine a cutoff point and to categorise patients into two OS groups, we used the Cutoff Finder software available on http://molpath.charite.de/cutoff (Budczies et al , 2012) to optimise cutoff calculation as the point with the most significant (log-rank test) split based on survival variable.",OADS,/arxiv_data1/oa_pdf/af/cd/bjc2015194a.PMC4647532.pdf
After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution- NonCommercial-Share Alike 4.0 Unported License Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER miR-320e as novel biomarker in colorectal cancer 90 www.bjcancer.com | DOI:10.1038/bjc.2015.168,Non-OADS,/arxiv_data1/oa_pdf/ae/00/bjc2015168a.PMC4647533.pdf
"11 [Internet]International Agency for Research on Cancer: Lyon, France,Available at http://globocan.iarc.fr (last accessed on 10 June 2014).",Non-OADS,/arxiv_data1/oa_pdf/0c/b2/bjc2015178a.PMC4647534.pdf
Available at http://www.epicentro.iss.it/passi/rapporto2012/diabete.asp(last accessed 15 April 2014).,Non-OADS,/arxiv_data1/oa_pdf/0c/b2/bjc2015178a.PMC4647534.pdf
After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution- NonCommercial-Share Alike 4.0 Unported License Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)MYC-driven aggressive neuroblastoma BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.188 63,Non-OADS,/arxiv_data1/oa_pdf/52/0f/bjc2015188a.PMC4647535.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Prognostic biomarkers in oesophageal adenocarcinoma 118 www.bjcancer.com | DOI:10.1038/bjc.2015.179",Non-OADS,/arxiv_data1/oa_pdf/5a/f0/bjc2015179a.PMC4647536.pdf
"BMJ Publishing Group Ltd. Leuven E, Sianesi B (2013) PSMATCH2: Stata module to perform full Mahalanobis and propensity score matching, common support graphing,and covariate imbalance testing: version 4.0.5, http://ideas.repec.org/c/boc/bocode/s432001.html.",Non-OADS,/arxiv_data1/oa_pdf/03/d7/bjc2015152a.PMC4647537.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Classification of ampullary carcinomas 68 www.bjcancer.com | DOI:10.1038/bjc.2015.172,Non-OADS,/arxiv_data1/oa_pdf/60/01/bjc2015172a.PMC4647538.pdf
After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution- NonCommercial-Share Alike 4.0 Unported License Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Plasma miRNAs as prognostic radiotherapy markers 82 www.bjcancer.com | DOI:10.1038/bjc.2015.111,Non-OADS,/arxiv_data1/oa_pdf/12/b3/bjc2015111a.PMC4647540.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Biomarkers of bevacizumab benefit in colorectal cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.209 45,Non-OADS,/arxiv_data1/oa_pdf/0f/db/bjc2015209a.PMC4647541.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Survival after neoadjuvant chemotherapy 36 www.bjcancer.com | DOI:10.1038/bjc.2015.174",Non-OADS,/arxiv_data1/oa_pdf/9e/bc/bjc2015174a.PMC4647542.pdf
Available at http://karmastudy.org/sources/(last accessed on 30 November 2014).,Non-OADS,/arxiv_data1/oa_pdf/e1/f0/bjc2015185a.PMC4647543.pdf
Available at http://www.livsmedelsverket.se/livsmedelsdatabasen (last accessed 30 November2014).,Non-OADS,/arxiv_data1/oa_pdf/e1/f0/bjc2015185a.PMC4647543.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Alcohol consumption and mammographic density BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.185 165",Non-OADS,/arxiv_data1/oa_pdf/e1/f0/bjc2015185a.PMC4647543.pdf
After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution- NonCommercial-Share Alike 4.0 Unported License Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Leukocyte mtDNA content and glioma prognosis 106 www.bjcancer.com | DOI:10.1038/bjc.2015.184,Non-OADS,/arxiv_data1/oa_pdf/cd/0a/bjc2015184a.PMC4647544.pdf
Available at http://www.crd.york.ac.uk/CRDWeb/ AboutNHSEED.asp (last accessed 14 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/01/7e/bjc2015167a.PMC4647547.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Cost-effectiveness of NSCLC awareness campaigns BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.167 141",Non-OADS,/arxiv_data1/oa_pdf/01/7e/bjc2015167a.PMC4647547.pdf
Article and publication date are online at http://www.genesdev.org/cgi/doi/10.1101/gad.269498.115.© 2015 Stern et al.,Non-OADS,/arxiv_data1/oa_pdf/a3/a6/2219.PMC4647555.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publi-cation date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/a3/a6/2219.PMC4647555.pdf
Expression of [Keywords : differentiation; epidermis; transcription] Corresponding author: khavari@stanford.edu Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.267708.,Non-OADS,/arxiv_data1/oa_pdf/78/ff/2225.PMC4647556.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue pub-lication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/78/ff/2225.PMC4647556.pdf
Article and publication date areonline at http://www.genesdev.org/cgi/doi/10.1101/gad.267930.115.© 2015 Brien et al.,Non-OADS,/arxiv_data1/oa_pdf/ff/3c/2231.PMC4647557.pdf
"This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).After six months, it is available under a Creative Commons License(Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/ff/3c/2231.PMC4647557.pdf
"Work in the Bracken laboratory is supported by ScienceFoundation Ireland (SFI) under the Principal Investigator Career Advancement Award (SFI PICA SFI/10/IN.1/B3002), the Health Research Board under the Health Research Awards 2010 (HRA_-POR/2010/124), the Irish Research Council, St. Vincent ’s Foundation, the Irish Cancer Society Collaborative Cancer Re- search Centre, and BREAST-PREDICT grant CCRC13GAL (http://www.breastpredict.com).",Non-OADS,/arxiv_data1/oa_pdf/ff/3c/2231.PMC4647557.pdf
Corresponding author: lou.zhenkun@mayo.eduArticle is online at http://www.genesdev.org/cgi/doi/10.1101/gad.268128.115.© 2015 Kim et al.,Non-OADS,/arxiv_data1/oa_pdf/cf/03/2244.PMC4647558.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publi-cation date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/cf/03/2244.PMC4647558.pdf
"Aftersix months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/cf/03/2244.PMC4647558.pdf
"We analyzed these 2534 genes using IPA 8.5 soft- ware (Ingenuity Systems, http://www.ingenuity.com) to identify biological function in lung adenocarcinoma potentially modifiedbyWSB1 expression level.",Non-OADS,/arxiv_data1/oa_pdf/cf/03/2244.PMC4647558.pdf
Cancer data collection and processing We retrieved several cancer data sets from Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo; GDS3966 [Xu et al.,OADS,/arxiv_data1/oa_pdf/cf/03/2244.PMC4647558.pdf
We defined the relationship between WSB1 gene levels and the metastasis-free survival in human breast cancer and human colon cancer patient data sets using the PROGgene Web site (http://watson.compbio.iupui.edu/chirayu/proggene/database/?,OADS,/arxiv_data1/oa_pdf/cf/03/2244.PMC4647558.pdf
Article and publication date areonline at http://www.genesdev.org/cgi/doi/10.1101/gad.271908.115.© 2015 Sienski et al.,Non-OADS,/arxiv_data1/oa_pdf/85/e3/2258.PMC4647559.pdf
"This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).After six months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/85/e3/2258.PMC4647559.pdf
"2013), do not affect the initial re-cruitment of RNAP to promoters but instead regulatethe transition from the closed to the open complex, Corresponding author: laub@mit.edu Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.270660.115.© 2015 Haakonsen et al.",Non-OADS,/arxiv_data1/oa_pdf/5e/4b/2272.PMC4647560.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/5e/4b/2272.PMC4647560.pdf
"After six months, it is available under a Creative Commons Li-cense (Attribution-NonCommercial 4.0 International), as described athttp://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/5e/4b/2272.PMC4647560.pdf
Corresponding author: henry_levin@nih.gov Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.267609.115.© 2015 Singh et al.,Non-OADS,/arxiv_data1/oa_pdf/d5/d1/2287.PMC4647561.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/d5/d1/2287.PMC4647561.pdf
"After six months, it is available under a Creative Commons Li-cense (Attribution-NonCommercial 4.0 International), as described athttp://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/d5/d1/2287.PMC4647561.pdf
"To help determine which of the proteins identified in the LEDGF/p75 and LEDGF/p52 data sets are involvedin mRNA processing, the proteins were cross-referencedagainst the Spliceosome Database (http://spliceosomedb.ucsc.edu), which identified a large number of splicing fac-tors (Table 2).",OADS,/arxiv_data1/oa_pdf/d5/d1/2287.PMC4647561.pdf
Corresponding author: don_rio@berkeley.eduArticle is online at http://www.genesdev.org/cgi/doi/10.1101/gad.268847.115.© 2015 Horan et al.,Non-OADS,/arxiv_data1/oa_pdf/12/78/2298.PMC4647562.pdf
"This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).After six months, it is available under a Creative Commons License(Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/12/78/2298.PMC4647562.pdf
"The PCR primers were designed by using the SnapDragon program, which is designed to minimize the off- target effects and is available at the Drosophila RNAi Screening Center Web site (http://www.flyrnai.org).",Non-OADS,/arxiv_data1/oa_pdf/12/78/2298.PMC4647562.pdf
"Corresponding authors: brad.cairns@hci.utah.edu, eguccione@imcb.a-star.edu.sg, hammou@med.umich.eduArticle is online at http://www.genesdev.org/cgi/doi/10.1101/gad.261925.115.© 2015 Hammoud et al.",Non-OADS,/arxiv_data1/oa_pdf/db/fa/2312.PMC4647563.pdf
"This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).After six months, it is available under a Creative Commons License (Attri-bution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/db/fa/2312.PMC4647563.pdf
"Briefly, Fastq files from BisSeq libraries were aligned to the mm9 mouse genome assembly using No- voalign (Novocraft, Inc.) and analyzed using the USEQ package (http://useq.sourceforge.net).",OADS,/arxiv_data1/oa_pdf/db/fa/2312.PMC4647563.pdf
ChIP-seq libraries were aligned us- ing Bowtie (http://bowtie-bio.sourceforge.net).,OADS,/arxiv_data1/oa_pdf/db/fa/2312.PMC4647563.pdf
RNA-seq align-ments were done using TopHat version 2.0.9 (http://tophat.cbcb .umd.edu).,OADS,/arxiv_data1/oa_pdf/db/fa/2312.PMC4647563.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/Licenses/ by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not alter ed, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/b9/a0/terg-58-543.PMC4647650.pdf
"4, 543–547, http://dx.doi.org/10.1080/00140139.2014.1001445",Non-OADS,/arxiv_data1/oa_pdf/b9/a0/terg-58-543.PMC4647650.pdf
“Striving for Safety: Communicating and Deciding in Sociotechnical Systems.” http://dx.doi.org/10.1080/00140139.2015.1015621 .Y.,Non-OADS,/arxiv_data1/oa_pdf/b9/a0/terg-58-543.PMC4647650.pdf
“Modeling and Simulation of Complex Sociotechnical Systems: Envisioning and Analyzing Work Environments.” http://dx.doi.org/10.1080/00140139.2015.1008586 .,Non-OADS,/arxiv_data1/oa_pdf/b9/a0/terg-58-543.PMC4647650.pdf
“Sociotechnical Attributes of Safe and Unsafe Systems.” http://dx.doi.org/10.1080/00140139.2015.1009175 .,Non-OADS,/arxiv_data1/oa_pdf/b9/a0/terg-58-543.PMC4647650.pdf
“Deﬁning the Methodological Challenges and Opportunities for an Effective Science of Sociotechnical Systems and Safety.” http://dx.doi.org/10.1080/00140139.2015.1015622 .Ergonomics 547,Non-OADS,/arxiv_data1/oa_pdf/b9/a0/terg-58-543.PMC4647650.pdf
After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution- NonCommercial-Share Alike 4.0 Unported License Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Angiogenesis factors in head and neck cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.251 659,Non-OADS,/arxiv_data1/oa_pdf/b6/78/bjc2015251a.PMC4647678.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Lynch syndrome target gene mutational pattern 692 www.bjcancer.com | DOI:10.1038/bjc.2015.281,Non-OADS,/arxiv_data1/oa_pdf/fa/93/bjc2015281a.PMC4647680.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Effects of GADD34 on colorectal cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.263 679,Non-OADS,/arxiv_data1/oa_pdf/94/de/bjc2015263a.PMC4647681.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Axl is a therapeutic target in RCC BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.237 625,Non-OADS,/arxiv_data1/oa_pdf/e8/dd/bjc2015237a.PMC4647683.pdf
"To identify the target of miR-345, we performed in silico analysis using the algorithms Target Scan (http://www.targetscan.org) and miRanda (http://www.microrna.org), and identified BCL2 ,a n important molecule of the anti-apoptotic gene family, as putative target of miR-345.",OADS,/arxiv_data1/oa_pdf/f0/a2/bjc2015252a.PMC4647684.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER miR-345 induces apoptosis in pancreatic cancer 668 www.bjcancer.com | DOI:10.1038/bjc.2015.252,Non-OADS,/arxiv_data1/oa_pdf/f0/a2/bjc2015252a.PMC4647684.pdf
After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution- NonCommercial-Share Alike 4.0 Unported License Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Hypoxia-regulated miRNAs and miR-145 644 www.bjcancer.com | DOI:10.1038/bjc.2015.203,Non-OADS,/arxiv_data1/oa_pdf/5d/12/bjc2015203a.PMC4647685.pdf
Giessen: LEA Medizintechnik GmbH http://www.lea.de/eng/ indexe.html.,Non-OADS,/arxiv_data1/oa_pdf/13/5f/bjc2015246a.PMC4647687.pdf
"miRNA target prediction was performed using eight different prediction algorithms on the miRWalk website (http://www.umm.uni-heidelberg.de/apps/zmf/ mirwalk/; Lewis et al, 2005; Dweep et al, 2011).",OADS,/arxiv_data1/oa_pdf/c4/68/bjc2015262a.PMC4647689.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)miR-542-5p regulates DNA repair and Notch pathways BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.262 615,Non-OADS,/arxiv_data1/oa_pdf/c4/68/bjc2015262a.PMC4647689.pdf
"The protocol is published (Hurt et al, 2011) and a copy of full protocol can be accessed at: http://clinicaltrials.gov/ct2/ show/NCT00509561?term=SCOPE1&rank=2.",OADS,/arxiv_data1/oa_pdf/ec/b1/bjc2015258a.PMC4647690.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Patien-reported outcomes in the SCOPE-1 Trial 610 www.bjcancer.com | DOI:10.1038/bjc.2015.258,Non-OADS,/arxiv_data1/oa_pdf/ec/b1/bjc2015258a.PMC4647690.pdf
"Secondary end points included: ORR determined by ultrasound and mammo- graphy at 6 months based on RECIST Criteria; rate of breast- conserving surgery at 6 months; pathological response using the Sataloff classification (Sataloff et al , 1995); and safety profile examination using common terminology criteria for adverse events (CTCAE, version 3.0, DCTD, NCI, NIH; http://ctep.cancer.gov).",Non-OADS,/arxiv_data1/oa_pdf/5a/06/bjc2015247a.PMC4647692.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Neoadjuvant anastrozole vsfulvestrant 594 www.bjcancer.com | DOI:10.1038/bjc.2015.247",Non-OADS,/arxiv_data1/oa_pdf/5a/06/bjc2015247a.PMC4647692.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribu-tion License ( http://creativecommons.org/licenses/by/3.0 ), which permits unre- stricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/65/63/uasa-110-742.PMC4647694.pdf
"REFERENCES An, H.-Z., Huang, D., Yao, Q., and Zhang, C.-H. (2008), “Step- wise Searching for Feature Variables in High-dimensional Linear Re- gression,” unpublished manuscript, available at http://stats.lse.ac.uk/ q.yao/qyao.links/paper/ahyz08.pdf .",Non-OADS,/arxiv_data1/oa_pdf/65/63/uasa-110-742.PMC4647694.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.Critical Public Health , 2015 Vol.",Non-OADS,/arxiv_data1/oa_pdf/b7/68/ccph-25-410.PMC4647852.pdf
"4, 410 –426, http://dx.doi.org/10.1080/09581596.2015.1019835",Non-OADS,/arxiv_data1/oa_pdf/b7/68/ccph-25-410.PMC4647852.pdf
"Retrieved from http://www.ohtn.on.ca/Documents/Research/B-Adam-OHTN-Criminalization- 2012.pdf Adam, B., Husbands, W., Murray, J., & Maxwell, J.",OADS,/arxiv_data1/oa_pdf/b7/68/ccph-25-410.PMC4647852.pdf
"Retrieved from http://www.bhiva.org/documents/Guidelines/ HIV%20Transmission/HIVTransmission.pdf Bauman, Z.",Non-OADS,/arxiv_data1/oa_pdf/b7/68/ccph-25-410.PMC4647852.pdf
"Retrieved from http://www.aidsmap.com/resources/living-with-hiv/HIV-and-the-law/page/1254871/ Bernard, E., Geretti, A.-M., van Damme, A., Azad, Y., & Weait, M. (2007).",Non-OADS,/arxiv_data1/oa_pdf/b7/68/ccph-25-410.PMC4647852.pdf
"Retrieved from http://papers.ssrn.com/sol3/papers.cfm?abstract_id=977274 Cameron, S., & Reynolds, L. (2010).",OADS,/arxiv_data1/oa_pdf/b7/68/ccph-25-410.PMC4647852.pdf
"Retrieved from http://www.cps.gov.uk/legal/h_to_k/intentional_or_reck less_sexual_transmission_of_infection_guidance/ Dodds, C., Bourne, A., & Weait, M. (2009).",OADS,/arxiv_data1/oa_pdf/b7/68/ccph-25-410.PMC4647852.pdf
"Retrieved from http://sigmaresearch.org.uk/projects/policy/project55/ Dodds, C., Weatherburn, P., Bourne, A., Hammond, G., Weait, M., Hickson, F., …Jessup, K. (2009).",Non-OADS,/arxiv_data1/oa_pdf/b7/68/ccph-25-410.PMC4647852.pdf
"Retrieved from http://www.sigmaresearch.org.uk/ go.php?/reports/report2009a/ Flowers, P., Duncan, B., & Frankis, J.",OADS,/arxiv_data1/oa_pdf/b7/68/ccph-25-410.PMC4647852.pdf
"Retrieved from http://www.scielo.cl/pdf/abioeth/v9n2/Salud%20P%FAblica.pdf?ori gin=publicationDetail#page=10 Green, G., & Sobo, E. J.",Non-OADS,/arxiv_data1/oa_pdf/b7/68/ccph-25-410.PMC4647852.pdf
"Retrieved from http://www.scielo.cl/pdf/abioeth/v9n2/Salud%20P%FAblica.pdf?origin=publica tionDetail#page=10 Klitzman, R., & Bayer, R. (2003).",Non-OADS,/arxiv_data1/oa_pdf/b7/68/ccph-25-410.PMC4647852.pdf
"Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/1140452410.1097/00126334-200105010-00013 Mykhalovskiy, E. (2011).",OADS,/arxiv_data1/oa_pdf/b7/68/ccph-25-410.PMC4647852.pdf
"Retrieved from http://www.catie.ca/pdf/Brochures/HIV-non-disclosure-criminal-law.pdf O’Byrne P., & Gagnon M. (2012).",Non-OADS,/arxiv_data1/oa_pdf/b7/68/ccph-25-410.PMC4647852.pdf
"Retrieved from http://www.oa.uottawa.ca/journals/aporia/ articles/2012_04/v4i2.pdf O’Neill, O.",Non-OADS,/arxiv_data1/oa_pdf/b7/68/ccph-25-410.PMC4647852.pdf
"Retrieved from http://www.bhiva.org/Reckless-HIV-Transmission-2013.aspx Sanders, C. (2015).",Non-OADS,/arxiv_data1/oa_pdf/b7/68/ccph-25-410.PMC4647852.pdf
"Retrieved from http://www.unaids.org/en/media/unaids/contentassets/documents/document/2013/05/ 20130530_Guidance_Ending_Criminalisation.pdf Weait, M. (2005a, October).",Non-OADS,/arxiv_data1/oa_pdf/b7/68/ccph-25-410.PMC4647852.pdf
"Retrieved from http://www.academia.edu/151802/Weait_M._2005_Knowl edge_Autonomy_and_Consent_R_v_Konzani_Criminal_Law_Review_October_763-772 Weait, M. (2005b).",Non-OADS,/arxiv_data1/oa_pdf/b7/68/ccph-25-410.PMC4647852.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Multi-modal hormone-like cancer therapy for NF1 BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.345 1167",Non-OADS,/arxiv_data1/oa_pdf/c2/fa/bjc2015345a.PMC4647869.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Automated prognostic pattern detection in lymphoma BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.291 1205,Non-OADS,/arxiv_data1/oa_pdf/32/8a/bjc2015291a.PMC4647874.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER TERT promoter mutations in phyllodes tumors 1248 www.bjcancer.com | DOI:10.1038/bjc.2015.326,Non-OADS,/arxiv_data1/oa_pdf/e4/5e/bjc2015326a.PMC4647876.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Serum NMR metabolomics of metastatic renal cell carcinoma BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.322 1157,Non-OADS,/arxiv_data1/oa_pdf/50/59/bjc2015322a.PMC4647878.pdf
"To investigate the relation between S100A9 expression and ER, PgR, Her2 (ERBB2) and EGFR expression in primary breast cancers in more detail, we next used a publicly available data site (R2: microarray analysis and visualisation platform http://r2.amc.nl; Tumour breast EXPO-351)with gene expression profiles of 351 primary breast cancers.",OADS,/arxiv_data1/oa_pdf/3f/58/bjc2015346a.PMC4647879.pdf
"This correlation was found irrespective of the localisation of S100A9 (cytoplasmic, nuclear, membrane) in the malignant cells and was supported by a strong inverse correlation of the genes in a gene expression profile analysis made of 351 breast tumours (R2: microarray analysis and visualisation platform (http://r2.amc.nl; Tumour breast EXPO- 351).",OADS,/arxiv_data1/oa_pdf/3f/58/bjc2015346a.PMC4647879.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)S100A9 in human breast cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.346 1243",Non-OADS,/arxiv_data1/oa_pdf/3f/58/bjc2015346a.PMC4647879.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)HIF2 ainduces CSC-like properties via CXCR4 in RCC BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.338 1185,Non-OADS,/arxiv_data1/oa_pdf/42/05/bjc2015338a.PMC4647880.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)PTEN status in circulating tumour cells BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.332 1233",Non-OADS,/arxiv_data1/oa_pdf/85/fa/bjc2015332a.PMC4647881.pdf
Supportin ginformation forthisarticle isavailable ontheWWW under http://dx.doi.org/ 10.1002/ani e.201506432 .,Non-OADS,/arxiv_data1/oa_pdf/d2/8e/anie0054-14066.PMC4648026.pdf
Suppor ting informat ionforthisarticle isavailable ontheWWW under http://dx.doi.org /10.1002/anie.,Non-OADS,/arxiv_data1/oa_pdf/72/80/anie0052-5028.PMC4648027.pdf
"[a]Dr.H.A.Reeve ,Prof.K.A.Vincent Depar tment ofChem istry,University ofOxfor d Inorganic Chemi stryLabor atory Sout hParks Road ,Oxford,OX1 3QR (UK) E-mail :kylie.v incent@ chem.o x.ac.uk [b]Dr.L.Lauterbach, Dr.O.Lenz Institute ofChem istry,Technis cheUniversit (o22wtBerlin Strasse des17.Juni 135,1062 3Berlin (Germ any) Supp orting informa tionforthisarticleisavailab leontheWWW under http://dx.doi.o rg/10.1002/cc tc.2015 0076 6.",Non-OADS,/arxiv_data1/oa_pdf/41/e6/cctc0007-3480.PMC4648031.pdf
"[*]Dr.S.Su(o1w1rez-Pan tiga, K.Colas,Dr.A.Mendoza Department ofOrganic Chemist ryandBerzelii EXSELENT Centerfor Porous Materia ls,Stockholm Universi ty Arrhenius Laboratory ,10691 Stockholm (Sweden) E-mail :abraham.m endoza@su .se Homepag e:http://www .organ.su.se/ am/ Dr.M.J.Johansson Innovative Medicines, Cardiova scular andMetabolic Diseases, Medicinal Chemistry ,AstraZen ecaR&D Peppared sleden 1,43183 Mçlnd al(Sweden) Supportin ginformation andORCID(s )from theauthor(s) forthis article areavailable ontheWWW under http://dx.doi.org/ 10.1002/ anie.201505 608.",Non-OADS,/arxiv_data1/oa_pdf/35/3d/anie0054-14094.PMC4648034.pdf
"Textural properties indicate thatmilling causes[*]Dr.E.Aneggi, Dr.V.Rico-Perez, Prof. C.deLeitenbu rg, Prof. S.Maschio, Prof. A.Trovare lli Department ofChemist ry,Physics, andEnvironmen t Universit yofUdine ViadelCotonificio 108, IT-33100 Udine (Italy) E-mail :trovarelli@ uniud.it Dr.L.Soler,Prof.J.Llorca Institut deT(o;zzcnique sEnerg(o;zztiq uesand Centre forResearch inNanoengi neering Universit atPolit(o;zzcnica deCatalunya Diagonal 647, 08028 Barcelona (Spain) E-mail :jordi.llorca@u pc.edu Supportin ginformation andORCID(s )from theauthor(s) forthis article areavailable ontheWWW under http://dx.doi.org/ 10.1002/ anie.201507 839.",Non-OADS,/arxiv_data1/oa_pdf/34/ea/anie0054-14040.PMC4648039.pdf
"[*]J.A.Buonomo, Dr.C.C.Aldrich Department ofMedicin alChemist ry,Universi tyofMinnesota 308Harvard St.SE,Minneapolis ,MN55455 (USA) E-mail :aldri015@um n.edu Supportin ginformation forthisarticle isavailable ontheWWW under http://dx.doi.org/ 10.1002/ani e.201506263 .",Non-OADS,/arxiv_data1/oa_pdf/00/85/anie0054-13041.PMC4648044.pdf
"Lee, Dr.G.Hahne, Dr.T.N.Grossma nn Technical Universi tyDortmund Department ofChemist ryandChemical Biology Otto-Hah n-Strasse 6,44227 Dortmund (Germany) Dr.T.N.Grossmann VUUniversi tyAmsterda m Department ofChemist ry&Pharmaceut icalSciences DeBoelelaan 1083, 1081 HV,Amsterda m(TheNetherla nds) Supportin ginformation forthisarticle isavailable ontheWWW under http://dx.doi.org/ 10.1002/ani e.201506338 .",Non-OADS,/arxiv_data1/oa_pdf/4d/0d/anie0054-13796.PMC4648047.pdf
"micoli@gsk.c om Q.-Y.Hu,A.Usera, Z.Robinso n,M.Allan, A.Singh, H.Imase, J.Cobb,H.Zhai, D.Quinn, M.Lei Novartis Institutes forBioMedica lResearch 100Technology Square, Cambridg e,MA02139 (USA) E-mail :qiying.hu@n ovartis.com R.Adamo GSK, ViaFiorentina 1,53100 Siena (Italy) C.A.MacLennan Jenner Institute, Nuffield Department ofMedicin e Universit yofOxford OldRoad Campus Research Building, Roosevelt Drive Oxford, OX3 7DQ (UK) Supportin ginformation forthisarticle isavailable ontheWWW under http://dx.doi.org/ 10.1002/ani e.201506112 .",Non-OADS,/arxiv_data1/oa_pdf/74/55/anie0054-13198.PMC4648054.pdf
"Annual mean concentrations of nitrogen oxides (NO x) and particulate matter with an aerodynamic diameter of less than 10 micrograms (PM 10) were calculated using a wind model and a Gaussian air quality dispersionmodel, both part of the Airviro Air Quality Management System (SMHI,Norrköping, Sweden; http://airviro.smhi.se).",OADS,/arxiv_data1/oa_pdf/55/ac/jes201522a.PMC4648059.pdf
"Therefore, a street canyon contribution was calculated using the SMHI-Airviro street canyon model (http://airviro.smhi.se).",OADS,/arxiv_data1/oa_pdf/55/ac/jes201522a.PMC4648059.pdf
Available from http://slb.nu/slb/rapporter/pdf8/lvf1998_006.pdf.,Non-OADS,/arxiv_data1/oa_pdf/55/ac/jes201522a.PMC4648059.pdf
[cited 2015 Jan 23] Available from http://slb.nu/slb/rapporter/pdf8/lvf2007_002.pdf.,OADS,/arxiv_data1/oa_pdf/55/ac/jes201522a.PMC4648059.pdf
"IVL Swedish Environmental Research Institute Ltd.[Internet]: Sweden, 2010 [cited2015 Jan 23] Available from http://www.ivl.se/webdav/ ﬁles/B-rapporter/B1830.",Non-OADS,/arxiv_data1/oa_pdf/55/ac/jes201522a.PMC4648059.pdf
1999: 41[cited 2015 Jan 23] 1401-9612 Available from http://www.ivl.se/webdav/ ﬁles/B- rapporter/B1830.pdf.,Non-OADS,/arxiv_data1/oa_pdf/55/ac/jes201522a.PMC4648059.pdf
[cited 2015 Jan 23] Available from http://slb.nu/slb/rapporter/pdf8/lvf2006_012.pdf.,OADS,/arxiv_data1/oa_pdf/55/ac/jes201522a.PMC4648059.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on the Journal of Exposure Science and Environmental Epidemiology website (http:// www.nature.com/jes)Trafﬁc-related air pollution exposure and stroke Korek et al 523 © 2015 Nature America, Inc. Journal of Exposure Science and Environmental Epidemiology (2015), 517 –523",Non-OADS,/arxiv_data1/oa_pdf/55/ac/jes201522a.PMC4648059.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/dc/fb/aps20159a.PMC4648113.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/0e/90/aps201529a.PMC4648116.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/71/79/ijem-13-04-23091.PMC4648126.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/fc/f5/ijem-13-04-27995.PMC4648127.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/ff/b6/ijem-13-04-27528.PMC4648128.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/40/64/ijem-13-04-25465.PMC4648129.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f7/40/ieu166.PMC4648153.pdf
"Published by Oxford University Press on behalf of CINP.International Journal of Neuropsychopharmacology, 2015, 1–9 doi:10.1093/ijnp/pyv038 Research Article 1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9d/9d/pyv038.PMC4648154.pdf
"Published by Oxford University Press on behalf of CINP.International Journal of Neuropsychopharmacology, 2015, 1–12 doi:10.1093/ijnp/pyv046 Research Article 1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/08/88/pyv046.PMC4648155.pdf
Heart and respira-tion rates were continuously monitored using the PC-VetGard (TM) system (http://www.vmedtech.com/wireless_monitor.htm).,OADS,/arxiv_data1/oa_pdf/67/b3/pyv036.PMC4648157.pdf
"Published by Oxford University Press on behalf of CINP.International Journal of Neuropsychopharmacology, 2015, 1–3 doi:10.1093/ijnp/pyv050 Focus Paper 1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/21/68/pyv050.PMC4648158.pdf
Available at: http://dx.doi.org/10.1016/j.euroneuro.2015.02.007.,OADS,/arxiv_data1/oa_pdf/21/68/pyv050.PMC4648158.pdf
Int J Neuropsychopharmacol:1–9 Available at: http://ijnp.oxford- journals.org/cgi/doi/10.1093/ijnp/pyv013.,Non-OADS,/arxiv_data1/oa_pdf/21/68/pyv050.PMC4648158.pdf
"Data Processing Data were preprocessed and analyzed using the Statistical Parametric Mapping (SPM8, Wellcome Department of Cognitive Neurology) VBM8 toolbox (http://dbm.neuro.uni-jena.de/vbm) implemented in MatlabR2013 (MathWorksInc.).",OADS,/arxiv_data1/oa_pdf/81/d6/pyv061.PMC4648161.pdf
"years of cigarette use, age of cigarette use onset, cigarettes per day, pack years, and nicotine dependence), gray matter volume within each significant cluster was extracted for each participant using the MarsBaR tool in SPM (http://marsbar.sourceforge.net/) and exported to IBM SPSS Statistics 19.0.",OADS,/arxiv_data1/oa_pdf/81/d6/pyv061.PMC4648161.pdf
"NEWMEDS was established by the Innovative Medicines Initiative, which is a public/private undertaking between the European Union and the European Federation of Pharmaceutical Industries and Associations to find new methods of developing drugs for schiz-ophrenia and depression (http://www.newmeds-europe.com/index.php).",Non-OADS,/arxiv_data1/oa_pdf/0b/ce/pyv042.PMC4648162.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/c2/31/aps201573a.PMC4648174.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/c2/64/aps201592a.PMC4648179.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/7e/57/aps201541a.PMC4648180.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1e/c8/iev054.PMC4648181.pdf
(http://purl.oclc.org/estimates).,Non-OADS,/arxiv_data1/oa_pdf/1e/c8/iev054.PMC4648181.pdf
(http://www.zmuc.dk/entoweb/sarco-web/sarcweb/Intro/Intro.htm).,Non-OADS,/arxiv_data1/oa_pdf/1e/c8/iev054.PMC4648181.pdf
Clinical Trial Registration—URL: http://www.chictr.trc.com.cn.,Non-OADS,/arxiv_data1/oa_pdf/b3/d0/hcv-8-e002837.PMC4648183.pdf
"Key Words: arterial pressure ◼ denervation ◼ hemodynamics ◼ familial primary pulmonary hypertension   ◼ pulmonary artery Circ Cardiovasc Interv is available at http://circinterventions.ahajournals.org DOI: 10.1161/CIRCINTERVENTIONS.115.002837Received May 26, 2015; accepted October 5, 2015.",Non-OADS,/arxiv_data1/oa_pdf/b3/d0/hcv-8-e002837.PMC4648183.pdf
Clinical Trial Registration—URL: http://www.clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/50/93/hci-8-e003644.PMC4648185.pdf
"Circ Cardiovasc Imaging is available at http://circimaging.ahajournals.org DOI: 10.1161/CIRCIMAGING.115.003644Received January 15, 2015; accepted September 30, 2015.From the Department of Clinical Science, University of Bergen, Bergen, Norway (E.G., M.T.L.",Non-OADS,/arxiv_data1/oa_pdf/50/93/hci-8-e003644.PMC4648185.pdf
"Direct	URL	citations	 appear	in	the	printed	text	and	are	provided	in	the	HTML	and	PDF	versions	 of	this	article	on	the	journal’s	website	(http://journals.lww.com/ccmjournal).Supported,	in	part,	by	a	research	grant	from	ARARD,	Aubagne,	France.Dr.",Non-OADS,/arxiv_data1/oa_pdf/27/45/ccm-43-2570.PMC4648187.pdf
"For the detailed inclusion and exclusion criteria, see the supplemental data  (Supplemental Digital Content 1, http://links.lww.com/CCM/ B420).",Non-OADS,/arxiv_data1/oa_pdf/27/45/ccm-43-2570.PMC4648187.pdf
"Respiratory settings were modified according to the PEEP/ Fio2 table of the ARDS Net protocol (supplemental data,  Supplemental Digital Content 1, http://links.lww.com/CCM/B420).",Non-OADS,/arxiv_data1/oa_pdf/27/45/ccm-43-2570.PMC4648187.pdf
"Pump blood flow and effluent flow management  are described in the supplemental data (Supplemental Digital Content 1, http://links.lww.com/CCM/B420).",Non-OADS,/arxiv_data1/oa_pdf/27/45/ccm-43-2570.PMC4648187.pdf
"S1,  Supplemental Digital Content 2, http://links.lww.com/CCM/ B421, which illustrates the correlation between the inlet partial pressure of C o2 [PCO2 inlet] and the difference between the  inlet and the outlet PCO2 [Delta PCO2]).",Non-OADS,/arxiv_data1/oa_pdf/27/45/ccm-43-2570.PMC4648187.pdf
"S2, Supplemental Digital Content 3,   http://links.lww.com/CCM/B422, which illustrates the time  Figure 4.",Non-OADS,/arxiv_data1/oa_pdf/27/45/ccm-43-2570.PMC4648187.pdf
"S1, Supplemental Digital Content 2, http://links.lww.com/CCM/ B421).",Non-OADS,/arxiv_data1/oa_pdf/27/45/ccm-43-2570.PMC4648187.pdf
"http://informahealthcare.com/tam ISSN: 1368-5538 (print), 1473-0790 (electronic) Aging Male, 2015; 18(1): 5–15 !2015 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/5b/6a/dagm18_5.PMC4648196.pdf
"Although the clinical significance of hypogonadism in adult men is becoming increasingly recognized, the extent ofits prevalence in the general population is underappreciated.A large number of men with hypogonadism remain undiag-nosed and untreated [5].This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License(http://creativecommons.org/licenses/by-nc-nd/4.0/), which permitsnon-commercial re-use, distribution, and reproduction in any medium,provided the original work is properly cited, and is not altered,transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/5b/6a/dagm18_5.PMC4648196.pdf
Available from:http://www.uroweb.org/gls/pdf/16_Male_Hypogonadism_LR%20II.pdf [last accessed 8 Dec 2014].,Non-OADS,/arxiv_data1/oa_pdf/5b/6a/dagm18_5.PMC4648196.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/14/1e/cvv231.PMC4648199.pdf
"OECD recommendation on the governance of clinical trials, http://www.oecd.org/sti/sci-tech/oecdre commendationonthegovernanceofclinicaltrials.htm (2012, accessed 9 April 2015).",Non-OADS,/arxiv_data1/oa_pdf/63/2f/10.1177_1740774515591983.PMC4648234.pdf
"The plan for growth, https://www.gov.uk/ government/uploads/system/uploads/attachment_data/ file/31584/2011budget_growth.pdf (2011, accessed 9 April 2015).",Non-OADS,/arxiv_data1/oa_pdf/63/2f/10.1177_1740774515591983.PMC4648234.pdf
"Regulation (EU) No 536/2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC, http://ec.europa.eu/health/files/ eudralex/vol-1/reg_2014_536/reg_2014_536_en.pdf (2014, accessed 9 April 2015).",Non-OADS,/arxiv_data1/oa_pdf/63/2f/10.1177_1740774515591983.PMC4648234.pdf
"Federal act on research involving human beings (Human Research Act, HRA), http://www.bag.admin.ch/themen/ medizin/00701/00702/07558/index.html?lang=de (2011, accessed 9 April 2015).",Non-OADS,/arxiv_data1/oa_pdf/63/2f/10.1177_1740774515591983.PMC4648234.pdf
"810.305), http://www.admin.ch/ch/e/rs/810_305/ (2014, accessed 9 April 2015).",Non-OADS,/arxiv_data1/oa_pdf/63/2f/10.1177_1740774515591983.PMC4648234.pdf
"SR 810.301 Ordinance on human research with exception of clinical trials (Human Research Ordinance, HRO), http://www.admin.ch/ch/e/rs/810_301/a12.html (2014, accessed 9 April 2015).",Non-OADS,/arxiv_data1/oa_pdf/63/2f/10.1177_1740774515591983.PMC4648234.pdf
"Schaffung eines Bundesgesetzes betreffend medizinische Forschung am Menschen, http://www.par- lament.ch/d/suche/seiten/geschaefte.aspx?-gesch_id=19983543 (1998, accessed 9 April 2015).",Non-OADS,/arxiv_data1/oa_pdf/63/2f/10.1177_1740774515591983.PMC4648234.pdf
"Federal constitution of the Swiss confederation of 18 April 1999, http://www.ad min.ch/ch/e/rs/c101.html (1999, accessed 9 April 2015).25.",Non-OADS,/arxiv_data1/oa_pdf/63/2f/10.1177_1740774515591983.PMC4648234.pdf
"Verordnung u ¨ber klinische Versuche (Humanforschungsverordnung 1, HFV 1), http://www.bag.admin.ch/themen/medizin/00701/00702/12310/index.html?lang=de (2012, accessed 9 April 2015).",Non-OADS,/arxiv_data1/oa_pdf/63/2f/10.1177_1740774515591983.PMC4648234.pdf
"Ordinance on clinical trials in human research (Clinical Trials Ordinance, ClinO),http://www.admin.ch/opc/de/classified-compilation/81.html (2013, accessed 9 April 2015).",Non-OADS,/arxiv_data1/oa_pdf/63/2f/10.1177_1740774515591983.PMC4648234.pdf
"Ordinance on human research with the exception of clinical trials (Human ResearchOrdinance, HRO), http://www.admin.ch/opc/de/classi-fied-compilation/81.html (2013, accessed 9 April 2015).",Non-OADS,/arxiv_data1/oa_pdf/63/2f/10.1177_1740774515591983.PMC4648234.pdf
"of Medical Physics, Velindre Cancer Centre, Cardiff, UK w  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/5a/0e/nihms-658621.PMC4648243.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.radonc.2014.10.001 .",OADS,/arxiv_data1/oa_pdf/5a/0e/nihms-658621.PMC4648243.pdf
2014. https://www.cdisc.org/cdisc-share 10.,Non-OADS,/arxiv_data1/oa_pdf/5a/0e/nihms-658621.PMC4648243.pdf
https://www.europa.eu/rapid/ press-release_MEMO-14-60_en.htm 11.,Non-OADS,/arxiv_data1/oa_pdf/5a/0e/nihms-658621.PMC4648243.pdf
2014. https://www.ihe.net 13.,Non-OADS,/arxiv_data1/oa_pdf/5a/0e/nihms-658621.PMC4648243.pdf
"2014. https://bridgmodel.nci.nih.gov 15. de Montjoie, J.",Non-OADS,/arxiv_data1/oa_pdf/5a/0e/nihms-658621.PMC4648243.pdf
CDISC;  2009. https://www.cdisc.org 16.,Non-OADS,/arxiv_data1/oa_pdf/5a/0e/nihms-658621.PMC4648243.pdf
2014. https://www.hl7.org 17.,Non-OADS,/arxiv_data1/oa_pdf/5a/0e/nihms-658621.PMC4648243.pdf
2014. https://www.wellcome.ac.uk/About-us/Policy/Spotlight-issues/ Personal-information/Data-protection-legislation/index.htm 19.,Non-OADS,/arxiv_data1/oa_pdf/5a/0e/nihms-658621.PMC4648243.pdf
2014. https://wiki.nci.nih.gov/display/CRF/CRF +Harmonization+and+StandardizationSkripcak et al.,OADS,/arxiv_data1/oa_pdf/5a/0e/nihms-658621.PMC4648243.pdf
Sci Am.Available at: http://www.scientiﬁcamerican.com/article/can-we-con-trol-our-thoughts/.,Non-OADS,/arxiv_data1/oa_pdf/5e/7f/HIPO-25-1073.PMC4648295.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/TNF receptor activation by antibodies H Wajant 1741 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/93/c3/cdd2015109a.PMC4648319.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)Idh1 protects from LPS-induced oxidative stress M Itsumi et al 1845 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/21/3b/cdd201538a.PMC4648331.pdf
"Rev Sci Instrum 41, 909–916, doi:doi:http://dx.doi.org/ 10.1063/1.1684724 (1970).30.",Non-OADS,/arxiv_data1/oa_pdf/40/fc/srep07639.PMC4648344.pdf
"The webpage http://www.aibn.uq.edu.au/aibn-izon outlines an agreement between Izon, M.T.",Non-OADS,/arxiv_data1/oa_pdf/40/fc/srep07639.PMC4648344.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7639 | DOI: 10.1038/srep07639 7",Non-OADS,/arxiv_data1/oa_pdf/40/fc/srep07639.PMC4648344.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/16/f6/srep07695.PMC4648347.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/94/3f/srep07707.PMC4648349.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e6/7e/srep07777.PMC4648378.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/11/fe/srep07716.PMC4648379.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7716 | DOI: 10.1038/srep07716 9",Non-OADS,/arxiv_data1/oa_pdf/11/fe/srep07716.PMC4648379.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/7f/eb/srep07742.PMC4648380.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/A promising target for the treatment of gliomas C-H Fan et al 8 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/38/de/cddis2013388a.PMC4648381.pdf
The algorithm is based on the Toolbox of Frederico D’Almeida (see http://www.mathworks.com/matlabcentral/ fileexchange/3710-nonlinear-diffusiontoolbox).,Non-OADS,/arxiv_data1/oa_pdf/6e/20/srep07842.PMC4648386.pdf
Leica LCS Lite and Image J by W. Rasband (developed at the U.S.National Institutes of Health and available at http://rsbweb.nih.gov/ij/) were used for image processing.,OADS,/arxiv_data1/oa_pdf/6e/20/srep07842.PMC4648386.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/6e/20/srep07842.PMC4648386.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7842 | DOI: 10.1038/srep07842 12",Non-OADS,/arxiv_data1/oa_pdf/6e/20/srep07842.PMC4648386.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/de/8e/srep07980.PMC4648387.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7980 | DOI: 10.1038/srep07980 9",Non-OADS,/arxiv_data1/oa_pdf/de/8e/srep07980.PMC4648387.pdf
"Lancet Oncol 6, 279–286, doi:http://dx.doi.org/10.1016/S1470-2045(05)70102-9 (2005).",Non-OADS,/arxiv_data1/oa_pdf/69/6f/srep08065.PMC4648436.pdf
"http://meeting.ascopubs.org/cgi/content/abstract/27/15S/4053 [Accessed July 25, 2013].",Non-OADS,/arxiv_data1/oa_pdf/69/6f/srep08065.PMC4648436.pdf
"http://ovidsp.ovid.com/ovidweb.cgi?T 5JS&PAGE 5reference&D 5 emed9&NEWS 5N&AN570259052 [Accessed July 25, 2013].",Non-OADS,/arxiv_data1/oa_pdf/69/6f/srep08065.PMC4648436.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/69/6f/srep08065.PMC4648436.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8065 | DOI: 10.1038/srep08065 9",Non-OADS,/arxiv_data1/oa_pdf/69/6f/srep08065.PMC4648436.pdf
"The tool and genome wide predictions are available at http://www.isical.ac.in/ ,bioinfo_miu/MBStar30.htm.",OADS,/arxiv_data1/oa_pdf/a3/49/srep08004.PMC4648438.pdf
(2010) Available at: http://starbase.sysu.edu.cn/download.,Non-OADS,/arxiv_data1/oa_pdf/a3/49/srep08004.PMC4648438.pdf
Available at: http://www.targetscan.org/cgi-bin/targetscan/data_download.,OADS,/arxiv_data1/oa_pdf/a3/49/srep08004.PMC4648438.pdf
(2006) Available at: http://www.mirbase.org.,Non-OADS,/arxiv_data1/oa_pdf/a3/49/srep08004.PMC4648438.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a3/49/srep08004.PMC4648438.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Table 1 |Proportion of trigonal (B3) and tetrahedral (B4) boron in Lithothamnion glaciale with ( 1) and without (-) epithelium L. glaciale B3 (%) B4 (%) (a)1epithelium 30.3 64.3 (62.7 17.0) 64.3 (b) - epithelium 27.7 64.6 (66.5 15.8) 64.6www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8175 | DOI: 10.1038/srep08175 3",Non-OADS,/arxiv_data1/oa_pdf/2f/e4/srep08175.PMC4648444.pdf
The DNA sequences were analysed as previously reported 61and compared with the GenBank nucleotide data library using Blast software at the National Centre of Biotechnology Information website (http://www.ncbi.nlm.nih.gov/Blast.cgi).,OADS,/arxiv_data1/oa_pdf/76/c2/srep08161.PMC4648445.pdf
The nucleotide sequences of the type strains were retrieved from the Ribosomal Database Project (RDP - http://rdp.cme.msu.edu/).,OADS,/arxiv_data1/oa_pdf/76/c2/srep08161.PMC4648445.pdf
Accession Numbers .The 16S rRNA gene sequences obtained were deposited in the GenBank nucleotide database under accession numbers from KF040971 to KF040996and from KF057947 to KF057960 (http://www.ncbi.nlm.nih.gov/Blast.cgi).,OADS,/arxiv_data1/oa_pdf/76/c2/srep08161.PMC4648445.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8161 | DOI: 10.1038/srep08161 13",Non-OADS,/arxiv_data1/oa_pdf/76/c2/srep08161.PMC4648445.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8242 | DOI: 10.1038/srep08242 7",Non-OADS,/arxiv_data1/oa_pdf/f2/74/srep08242.PMC4648446.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.Annals of Botany 115: 1177–1190, 2015 doi:10.1093/aob/mcv040, available online at www.aob.oxfordjournals.org",Non-OADS,/arxiv_data1/oa_pdf/f6/58/mcv040.PMC4648456.pdf
http://CRAN.R-project.org/package ¼leaps.,Non-OADS,/arxiv_data1/oa_pdf/f6/58/mcv040.PMC4648456.pdf
"As in otherinternational series, in our survey, men were more affected thanFreely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/15/06/tre-05-295-6516-1.PMC4648473.pdf
"Mov Disord 1995;10: 440–443, doi: http://dx.doi.org/10.1002/mds.870100406.",OADS,/arxiv_data1/oa_pdf/15/06/tre-05-295-6516-1.PMC4648473.pdf
"Mov Disord 2001;16:778–779, doi: http://dx.doi.",OADS,/arxiv_data1/oa_pdf/15/06/tre-05-295-6516-1.PMC4648473.pdf
"Rev Bras Reumatol 2007;47,188–196, doi: http://dx.doi.org/10.1590/S0482-50042007000300008.",Non-OADS,/arxiv_data1/oa_pdf/15/06/tre-05-295-6516-1.PMC4648473.pdf
"Rev Bras Sau ´de Ocup Sa ˜o Paulo 2010;35:33–40., doi: http://dx.doi.org/10.1590/S0303-76572010000100005 11.Gatto E, Chade A, Persi G, et al.",Non-OADS,/arxiv_data1/oa_pdf/15/06/tre-05-295-6516-1.PMC4648473.pdf
"Eur J Neurol 2009;16:864–869, doi: http://dx.doi.org/10.1111/j.",Non-OADS,/arxiv_data1/oa_pdf/15/06/tre-05-295-6516-1.PMC4648473.pdf
Musicians dystonia Latin America Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/15/06/tre-05-295-6516-1.PMC4648473.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ea/ff/ott-8-3323.PMC4648593.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3323–3328OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3323Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9244 3Incidence and clinical significance of ESR1  mutations in heavily pretreated metastatic  breast cancer patients Jiaxin niu1 grant andres1 Kim Kramer2 Madappa n Kundranda3 ricardo h alvarez4 eiko Klimant5 ankur r Parikh5 Bradford Tan6 edgar D staren7 Maurie Markman8 1Department of Medical Oncology,   Western regional Medical center at  Cancer Treatment Centers of America  (CTCA), Goodyear, AZ, USA; 2cTca   Medicine and Science, Zion, IL, USA;   3Department of Medical Oncology,   Banner MD Anderson Cancer Center,   Gilbert, AZ, USA; 4Department of  Medical Oncology, Southeastern  Regional Medical Center at CTCA,   Newnan, GA, USA; 5Department of  Medical Oncology, Eastern Regional  Medical Center at CTCA, Philadelphia,   PA, USA; 6Department of Pathology,   Midwestern regional Medical center  at CTCA, Zion, IL, USA; 7advanced  Individual Medicine, Phoenix, AZ,   USA; 8CTCA Medicine and Science,   Philadelphia, PA, USABackground:  ESR1  mutation has recently emerged as one of the important mechanisms involved  in endocrine resistance.",Non-OADS,/arxiv_data1/oa_pdf/ea/ff/ott-8-3323.PMC4648593.pdf
"Unlike tamoxifen working through correspondence: Jiaxin niu Department of Medical Oncology,  Western regional Medical center at  Cancer Treatment Centers of America,  14200 West Celebrate Life Way,  Goodyear, AZ 85338, USA Tel +1 623 207 3329 Fax +1 623 321 1528 email jasonniu1@gmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Niu et al Running head recto: ESR1  mutations and breast cancer DOI: http://dx.doi.org/10.2147/OTT.S92443",Non-OADS,/arxiv_data1/oa_pdf/ea/ff/ott-8-3323.PMC4648593.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ea/ff/ott-8-3323.PMC4648593.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/ff/ott-8-3323.PMC4648593.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/26/96/ijn-10-6985.PMC4648594.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 6985–6996International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6985OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9233 6hypericin-bearing magnetic iron oxide  nanoparticles for selective drug delivery in  photodynamic therapy harald Unterweger1 Daniel subatzus1 rainer Tietze1 christina Janko1 Marina Poettler1 alfons stiegelschmitt2 Matthias schuster3 caroline Maake4 aldo r Boccaccini5 christoph alexiou1 1eNT Department, section of  experimental Oncology and  Nanomedicine (seON), else Kröner- Fresenius-stiftung Professorship,   University hospital erlangen;   2Institute of glass and ceramics,   Department of Materials science and  engineering, University erlangen- Nuremberg, 3Materials for electronics  and energy T echnology, Department  of Materials science and engineering,   University erlangen-Nürnberg,   erlangen, germany; 4Institute of  anatomy, University of Zurich,   Winterthurerstr, Zurich, switzerland;   5Institute of Biomaterials, Department  of Materials science and engineering,   University erlangen-Nuremberg,   erlangen, germanyAbstract:  Combining the concept of magnetic drug targeting and photodynamic therapy is a  promising approach for the treatment of cancer.",Non-OADS,/arxiv_data1/oa_pdf/26/96/ijn-10-6985.PMC4648594.pdf
"Magnetic particles that are commonly used for MDT are super - paramagnetic iron oxide nanoparticles (SPIONs), including magnetite (Fe3O4), correspondence: christoph alexiou eNT-Department, section of  experimental Oncology and  Nanomedicine, hNO Klinik, else  Kröner-Fresenius-stiftung Professorship,  University hospital erlangen, Waldstraße  1 1, 91054 erlangen, germany Tel +49 9131 8534769 Fax +49 9131 8534808 email c.alexiou@web.d e Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Unterweger et al Running head recto: Hypericin-bearing SPIONs for targeted drug delivery DOI: http://dx.doi.org/10.2147/IJN.S92336",Non-OADS,/arxiv_data1/oa_pdf/26/96/ijn-10-6985.PMC4648594.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/26/96/ijn-10-6985.PMC4648594.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/26/96/ijn-10-6985.PMC4648594.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0e/7e/copd-10-2423.PMC4648595.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 2423–2430International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2423ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S9117 6The one repetition maximum test and the sit- to-stand test in the assessment of a specific  pulmonary rehabilitation program on peripheral  muscle strength in COPD patients Andrea Zanini1,2 Marina Aiello3 Francesca Cherubino1 Elisabetta Zampogna1 Andrea Azzola4 Alfredo Chetta3 Antonio Spanevello1,5 1Division of Pneumology, IRCCS  Rehabilitation Institute of Tradate,   Salvatore Maugeri Foundation,   Tradate, Italy; 2Division of Internal and  Respiratory Medicine, Malcantonese  Hospital, Giuseppe Rossi Foundation,   Castelrotto, Switzerland; 3Respiratory  Disease and Lung Function Unit,   Department of Clinical and  Experimental Medicine, University of  Parma, Padiglione Rasori, Parma, Italy;   4Division of Pneumology, Department  of Internal Medicine, Ospedale Civico,   Lugano, Switzerland; 5Department of  Clinical and Experimental Medicine,   University of Insubria, Varese, ItalyBackground:  Individuals with COPD may present reduced peripheral muscle strength, leading  to impaired mobility.",Non-OADS,/arxiv_data1/oa_pdf/0e/7e/copd-10-2423.PMC4648595.pdf
"Keywords:  sit-to-stand test, strength training, COPD Introduction Muscle weakness and peripheral muscle dysfunction are highly prevalent comorbidities  of chronic obstructive pulmonary disease (COPD), contributing to exercise intolerance  and symptom intensity.1,2 Pulmonary rehabilitation (PR) has a well-established role in  the management of COPD patients with peripheral muscle dysfunction.3 Evidence-based  guidelines for PR recommend that the exercise component of the program includes endur - ance and strength training of the lower limbs.4 Strength training has a greater potential to  improve muscle mass and strength than with endurance training.5,6 In addition, strength  training also induces less dyspnea during the exercise period, making this strategy better  performed by patients with moderate-to-severe COPD, than with aerobic training.7Correspondence: Andrea Zanini Divisione di Medicina Interna a Indirizzo  Pneumologico, Ospedale Malcantonese,  Fondazione Giuseppe Rossi, 6980  Castelrotto, Switzerland Tel +41 91 611 3700 Fax +41 91 611 3701 Email azanini67@gmail.co m Journal name: International Journal of COPD Article Designation: ORIGINAL RESEARCH Y ear: 2015 Volume: 10 Running head verso: Zanini et al Running head recto: Sit-to-stand peripheral muscle strength in COPD DOI: http://dx.doi.org/10.2147/COPD.S91176",Non-OADS,/arxiv_data1/oa_pdf/0e/7e/copd-10-2423.PMC4648595.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/0e/7e/copd-10-2423.PMC4648595.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0e/7e/copd-10-2423.PMC4648595.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0e/03/dddt-9-6067.PMC4648596.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 6067–6073Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6067Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9490 1a single-arm Phase ii validation study of preventing  oxaliplatin-induced hypersensitivity reactions by  dexamethasone: the aVOiD trial Y oichiro Y oshida1 Keiji hirata2 hiroshi Matsuoka3 shigeyoshi iwamoto4 Masahito Kotaka5 hideto Fujita6 naoya aisu1 seiichiro hoshino1 Takeo Kosaka6 Kotaro Maeda3 Fumiaki Kiyomi7 Yuichi Yamashita1 1Department of gastroenterological  surgery, Fukuoka University  Faculty of Medicine, Fukuoka, Japan;   2Department of surgery, Fukuoka  sanno hospital, Fukuoka, Japan;   3Department of surgery, Fujita  health University school of Medicine,   T oyoake, Japan; 4Department of  surgery, Kansai Medical University  hirakata hospital, Osaka, Japan;   5gastrointestinal cancer center, sano  hospital, Kobe, Japan; 6Department  of surgical Oncology, Kanazawa  Medical University, Uchinada, Japan;   7academia, industry and government  collaborative research institute  of Translational Medicine for life  innovation, Fukuoka University,   Fukuoka, JapanBackground:  Patients with colorectal cancer treated with oxaliplatin are at risk of  hypersensitivity reactions, with the incidence estimated to be 12%–20%.",Non-OADS,/arxiv_data1/oa_pdf/0e/03/dddt-9-6067.PMC4648596.pdf
"However, both these regimens require  the implantation of a central venous (CV) access port and treatment is occasionally  interrupted by complications associated with the CV port, such as infection, thrombosis,  and pinch-off syndrome.7 With the recent development of capecitabine plus oxaliplatin correspondence: Yoichiro Yoshida Department of gastroenterological  surgery, Fukuoka University Faculty of  Medicine, 7-45-1 nanakuma, Jonan-ku,  Fukuoka 814-0180, Japan Tel +81 92 801 1011 Fax +81 92 863 9759 email yy4160@yahoo.co.j p Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Y oshida et al Running head recto: The AVOID trial DOI: http://dx.doi.org/10.2147/DDDT.S94901",Non-OADS,/arxiv_data1/oa_pdf/0e/03/dddt-9-6067.PMC4648596.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/0e/03/dddt-9-6067.PMC4648596.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0e/03/dddt-9-6067.PMC4648596.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/48/bc/cmar-7-345.PMC4648597.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pCancer Management and Research 2015:7 345–356Cancer Management and Research Dove press submit your manuscript | www.dovepress.co m Dove press  345Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CMAR.S7277 5Clinical utility of RapidArcTM radiotherapy  technology erminia infusino Department of Radiotherapy, Campus  Bio-Medico University Hospital,   Rome, italy Correspondence: erminia infusino   Department of Radiotherapy, Campus  Bio-Medico University Hospital, via  Alvaro del Portillo,200, 00128 Rome italy   email e.infusino@unicampus.i tAbstract:  RapidArcTM is a radiation technique that delivers highly conformal dose distribu - tions through the complete rotation (360°) and speed variation of the linear accelerator gantry.",Non-OADS,/arxiv_data1/oa_pdf/48/bc/cmar-7-345.PMC4648597.pdf
"Cancer Management and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/cancer-management-and-research-journa lCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of  preventative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/48/bc/cmar-7-345.PMC4648597.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/48/bc/cmar-7-345.PMC4648597.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/88/95/copd-10-2459.PMC4648598.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 2459–2467International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2459OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8967 2C  OPD in Taiwan: a national epidemiology survey shih-lung Cheng,1,2 Ming- Cheng Chan,3 Chin-Chou  Wang,4 Ching-hsiung lin,5  hao-Chien Wang,6 Jeng-Yuan  hsu,3 liang-Wen hang,7,8  Chee-Jen Chang,9 Diahn-Warng  Perng,10,* Chong-Jen Yu6,* On behalf of the Taiwan  COPD Consortium 1Department of Internal Medicine, Far  eastern Memorial hospital, new Taipei  City, 2Department of Chemical engineering  and Materials science, Yuan Ze University,  Chung-li City, Taoyuan County, 3Department  of Internal Medicine, Taichung Veterans  general hospital, Taichung, 4Division of  Pulmonary and Critical Care Medicine,  Kaohsiung Chang gung Memorial hospital,  Kaohsiung, 5Division of Chest Medicine,  Changhua Christian hospital, Changhua  City, Changhua County, 6Department of  Internal Medicine, national Taiwan University  hospital, Taipei, 7Department of Pulmonary  and Critical Care Medicine, sleep Medicine  Center, China Medical University hospital,  8Department of respiratory Therapy, College  of health Care, China Medical University,  Taichung, 9Biostatistical Center for Clinical  research, Chang gung Memorial hospital,  linkou Branch, guishan T ownship, Taoyuan  County, 10Department of Chest Medicine,  Taipei Veterans general hospital, Taipei,  Taiwan, republic of China *These authors contributed equally to this  workObjectives:  To determine the prevalence of COPD in Taiwan and to document the disease  characteristics and associated risk factors.",Non-OADS,/arxiv_data1/oa_pdf/88/95/copd-10-2459.PMC4648598.pdf
"Keywords:  Asia, COPD, epidemiology, health care utilization, risk factors Introduction COPD is a leading and increasingly important cause of morbidity and mortality  worldwide that is projected to become the third leading cause of death by 2020.1,2 COPD  also incurs substantial psychological and social burdens as a result of cumulative  exposure to risk factors and population aging, as well as extra direct and indirect  medical expenditures that impose a substantial economic burden.3,4 As a major public  health problem, precise and informative epidemiological data about COPD are needed;  however, reported prevalence estimates vary widely due to differing definitions and  methodologies.3 The Asia-Pacific region bears the highest burden of COPD in terms of deaths,  years spent living with disability, and years of life lost; however, the prevalence Correspondence: Chong-Jen Yu Department of Internal Medicine, national  Taiwan University hospital, 7 Chung-shan  south road, Taipei 100, Taiwan,   republic of China Tel +886 2 2312 3456 ext 2905 Fax +886 2 2358 2867 email jefferycjyu@ntu.edu.t w Diahn-Warng Perng Department of Chest Medicine, Taipei Veterans  general hospital, 201, section 2, shipai road,  Taipei 112, Taiwan, republic of China Tel +886 2 2871 2121 ext 2078 email dwperng@vghtpe.gov.t wJournal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Cheng et al Running head recto: Prevalence of COPD in Taiwan DOI: http://dx.doi.org/10.2147/COPD.S89672",Non-OADS,/arxiv_data1/oa_pdf/88/95/copd-10-2459.PMC4648598.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/88/95/copd-10-2459.PMC4648598.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/88/95/copd-10-2459.PMC4648598.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/71/67/ijn-10-7019.PMC4648599.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 7019–7030International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  7019OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9447 9Phytofabrication of bioinduced silver nanoparticles  for biomedical applications Nabeel ahmad1 sharad Bhatnagar1 syed salman ali2 rajiv Dutta3 1school of Biotechnology, 2school  of Pharmaceutical sciences, IFTM  University, lodhipur rajput,   Moradabad, Uttar Pradesh, India;   3Institute of Bio-science and  Technology, shri ramswaroop  Memorial University, Barabanki,   Uttar Pradesh, IndiaAbstract:  Synthesis of nanomaterials holds infinite possibilities as nanotechnology is  revolutionizing the field of medicine by its myriad applications.",Non-OADS,/arxiv_data1/oa_pdf/71/67/ijn-10-7019.PMC4648599.pdf
"correspondence: rajiv Dutta Institute of Bio-science and Technology,  shri ramswaroop Memorial University,  Village-hadauri, Post-Tindola, lucknow  Deva road, Barabanki 225003,  Uttar Pradesh, India Tel +91 98 3923 6821 email director.sbt@gmail.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Ahmad et al Running head recto: Phytofabrication of bioinduced silver nanoparticles DOI: http://dx.doi.org/10.2147/IJN.S94479",Non-OADS,/arxiv_data1/oa_pdf/71/67/ijn-10-7019.PMC4648599.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/71/67/ijn-10-7019.PMC4648599.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/71/67/ijn-10-7019.PMC4648599.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/80/30/ceg-8-293.PMC4648600.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical and Experimental Gastroenterology 2015:8 293–302Clinical and Experimental Gastroenterology Dove press submit your manuscript | www.dovepress.co m Dove press  293REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEG.S5724 8Optimal management of steroid-dependent  ulcerative colitis Hafiz M waqas Khan1 Faisal Mehmood1 Nabeel Khan2 1Department of Medicine, King  Edward Medical University,   Lahore, Pakistan; 2Section of  Gastroenterology, University of  Pennsylvania Perelman School of  Medicine, Philadelphia vA Medical  Center, Philadelphia, PA, USA Correspondence: Nabeel Khan   Section of Gastroenterology, University  of Pennsylvania Perelman School of  Medicine, Philadelphia vA Medical   Center, 3900 woodland Ave,  Philadelphia, PA 19104, USA   Email nabeelk@mail.med.upenn.ed uAbstract:  Ulcerative colitis (UC) is a chronic inflammatory condition that is variable in both  extent and severity of disease as well as response to therapy.",Non-OADS,/arxiv_data1/oa_pdf/80/30/ceg-8-293.PMC4648600.pdf
"Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-and-experimental-gastroenterology-journa lClinical and Experimental Gastroenterology is an international, peer- reviewed, open access journal, publishing all aspects of gastroenterology  in the clinic and laboratory, including: Pathology, pathophysiology  of gastrointestinal disease; Investigation and treatment of gastointes - tinal disease; Pharmacology of drugs used in the alimentary tract; Immunology/genetics/genomics related to gastrointestinal disease.",Non-OADS,/arxiv_data1/oa_pdf/80/30/ceg-8-293.PMC4648600.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/80/30/ceg-8-293.PMC4648600.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0d/8c/copd-10-2469.PMC4648601.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 2469–2478International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2469OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S9033 0The utility of inflammatory markers to predict  readmissions and mortality in COPD cases with  or without eosinophilia Dildar Duman Emine Aksoy Meltem Coban agca Nagihan Durmus Kocak Ipek Ozmen Ulku Aka Akturk sinem gungor Fatma Merve T epetam selma aydogan eroglu Selahattin Oztas Zuhal Karakurt sureyyapasa Chest Diseases and  Thoracic surgery T eaching hospital,   Istanbul, T urkeyBackground:  COPD exacerbations requiring hospitalization increase morbidity and mortality.",Non-OADS,/arxiv_data1/oa_pdf/0d/8c/copd-10-2469.PMC4648601.pdf
"It is esti - mated that COPD will become the third leading cause of death worldwide by 2020, up  from the sixth leading cause of death in 1990.1 The disease is characterized by acute  exacerbations that often require hospitalization.2 Exacerbation is the main issue affect - ing morbidity and mortality.3 COPD mortality rates range from 15% to 54% and are  higher in patients who are hospitalized due to acute exacerbations.4 Different factors  correlate with mortality associated with COPD exacerbation.2,5Correspondence: Dildar Duman sureyyapasa Chest Diseases and Thoracic  surgery Teaching and research hospital,  Basibuyuk Mahallesi-Maltepe 34854,  Istanbul, Turkey Tel +90 505 522 1124 email dildaryetis@yahoo.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Duman et al Running head recto: COPD exacerbation by peripheral eosinophil DOI: http://dx.doi.org/10.2147/COPD.S90330",Non-OADS,/arxiv_data1/oa_pdf/0d/8c/copd-10-2469.PMC4648601.pdf
"Available from: http://www.goldcopd.or g.  Accessed October 5, 2015.",Non-OADS,/arxiv_data1/oa_pdf/0d/8c/copd-10-2469.PMC4648601.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/0d/8c/copd-10-2469.PMC4648601.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0d/8c/copd-10-2469.PMC4648601.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4a/cb/ndt-11-2883.PMC4648602.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 2883–2885Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2883Shor T repor Topen access to scientific and medical research open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S9443 0Memantine for the treatment of frontotemporal  dementia: a meta-analysis Taro Kishi Shinji Matsunaga Nakao Iwata Department of psychiatry, Fujita  health University School of Medicine,   T oyoake, JapanBackground:  There is no conclusive evidence supporting the efficacy of memantine in  frontotemporal dementia (FTD).",Non-OADS,/arxiv_data1/oa_pdf/4a/cb/ndt-11-2883.PMC4648602.pdf
"Methods This meta-analysis was performed according to the Preferred Reporting Items for  Systematic Reviews and Meta-Analyses guidelines.6Correspondence: Taro Kishi Department of psychiatry, Fujita health  University School of Medicine, 1-98  Dengakugakubo, Kutsukakecho Toyoake,  Aichi 470-1192, Japan Tel +81 562 93 9250 Fax +81 562 93 1831 email tarok@fujita-hu.ac.j p Journal name: Neuropsychiatric Disease and Treatment Article Designation: Short Report Y ear: 2015 Volume: 11 Running head verso: Kishi et al Running head recto: Memantine for frontotemporal dementia DOI: http://dx.doi.org/10.2147/NDT.S94430",Non-OADS,/arxiv_data1/oa_pdf/4a/cb/ndt-11-2883.PMC4648602.pdf
"Two authors (TK and SM)  independently extracted, checked, and entered the data into  Review Manager (Version 5.3 for Windows, Cochrane Col - laboration, London, UK, http://tech.cochrane.org/Revma n).",OADS,/arxiv_data1/oa_pdf/4a/cb/ndt-11-2883.PMC4648602.pdf
"The Cochrane risk of bias criteria (Cochrane Col - laboration, http://www.cochrane.org /) was used to perform methodological quality control.",OADS,/arxiv_data1/oa_pdf/4a/cb/ndt-11-2883.PMC4648602.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/4a/cb/ndt-11-2883.PMC4648602.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4a/cb/ndt-11-2883.PMC4648602.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e6/c4/ijn-10-7031.PMC4648603.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 7031–7044International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  7031OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9034 3effect of micro-nano-hybrid structured  hydroxyapatite bioceramics on osteogenic and  cementogenic differentiation of human periodontal  ligament stem cell via Wnt signaling pathway lixia Mao,1,* Jiaqiang liu,1,*  Jinglei Zhao,1 Jiang chang,2  lunguo Xia,1 lingyong  Jiang,1 Xiuhui Wang,2   Kaili lin,2,3 Bing Fang1 1center of craniofacial Orthodontics,   Department of Oral and cranio- maxillofacial science, Top Priority  clinical Medical center of shanghai  Municipal commission of health  and Family Planning, Ninth People’s  hospital affiliated to shanghai  Jiao Tong University, school of  Medicine, shanghai Jiao T ong  University, 2state Key laboratory  of high Performance ceramics and  superfine Microstructure, shanghai  Institute of ceramics, chinese  academy of sciences, 3shanghai  engineering research center of Tooth  restoration and regeneration, school  of stomatology, T ongji University,   shanghai, People’s republic of china *These authors contributed equally  to this workAbstract:  The surface structure of bioceramic scaffolds is crucial for its bioactivity and  osteoinductive ability, and in recent years, human periodontal ligament stem cells have been  certified to possess high osteogenic and cementogenic differential ability.",Non-OADS,/arxiv_data1/oa_pdf/e6/c4/ijn-10-7031.PMC4648603.pdf
"Moreover, the formation of new bone and cementum with  supportive periodontal ligament is the ultimate objective for periodontal tissue  regeneration, but current regeneration therapies are incapable of achieving this in  a predictable way.3,4correspondence: Kaili lin shanghai engineering research center  of Tooth restoration and regeneration,  school of stomatology, Tongji University,  399 Middle Yanchang road, shanghai 200072,  People’s republic of china email lklecnu@aliyun.co m Bing Fang center of craniofacial Orthodontics,  Department of Oral and cranio-maxillofacial  science, Top Priority clinical Medical center  of shanghai Municipal commission of health  and Family Planning, Ninth People’s hospital  Affiliated to Shanghai Jiao Tong University,  school of Medicine, shanghai Jiao Tong  University, 639 Zhizaoju road, shanghai  200011, People’s republic of china email fangbing@sjtu.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Mao et al Running head recto: Effect of micro-nano-hybrid structured hydroxyapatite bioceramics DOI: http://dx.doi.org/10.2147/IJN.S90343",Non-OADS,/arxiv_data1/oa_pdf/e6/c4/ijn-10-7031.PMC4648603.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/e6/c4/ijn-10-7031.PMC4648603.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e6/c4/ijn-10-7031.PMC4648603.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/85/90/ijn-10-7045.PMC4648604.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 7045–7056International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  7045OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9243 6Intracellular targeted co-delivery of shMDr1  and gefitinib with chitosan nanoparticles for  overcoming multidrug resistance Xiwei Yu1,* guang Yang2,* Yijie shi1 chang su3 Ming liu1 Bo Feng1 liang Zhao1 1school of Pharmacy, liaoning  Medical University, Jinzhou, People’s  Republic of China; 2Department of  Oncology, BenQ Medical center,   Nanjing Medical University, Nanjing,   People’s Republic of China; 3school of  Veterinary Medicine, liaoning Medical  University, Jinzhou, People’s Republic  of china *These authors contributed equally  to this workAbstract:  Nowadays, multidrug resistance and side effects of drugs limit the effectiveness of  chemotherapies in clinics.",Non-OADS,/arxiv_data1/oa_pdf/85/90/ijn-10-7045.PMC4648604.pdf
"Some potential treatments such as the  application of MDR reversal agents, immune treatments, cytokines, gene therapy, and correspondence: liang Zhao school of Pharmacy, liaoning Medical  University, Number 40, Section 3,  songpo road, linghe District, Jinzhou  121000, People’s Republic of China Tel/fax +86 416 467 3439 email liangzhao79@163.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Yu et al Running head recto: shMDR1 and gefitinib with chitosan NPs for MDR DOI: http://dx.doi.org/10.2147/IJN.S92436",Non-OADS,/arxiv_data1/oa_pdf/85/90/ijn-10-7045.PMC4648604.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/85/90/ijn-10-7045.PMC4648604.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/85/90/ijn-10-7045.PMC4648604.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0c/e9/copd-10-2451.PMC4648605.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 2451–2457International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2451PersPeCtIvesopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/COPD.S8769 6COPD: it is time to change!,Non-OADS,/arxiv_data1/oa_pdf/0c/e9/copd-10-2451.PMC4648605.pdf
"It must be acknowledged, however, that COPD is recognized in the definition  as an obstructive functional defect associated with a chronic immune inflammatory Correspondence: Laura Pini   respiratory Medicine Unit, Department  of experimental and Clinical sciences,  University of Brescia, Brescia, Italy email laura.pini@unibs.i t Journal name: International Journal of COPD Article Designation: Perspectives Y ear: 2015 Volume: 10 Running head verso: Tantucci and Pini Running head recto: COPD: it is time to change DOI: http://dx.doi.org/10.2147/COPD.S87696",Non-OADS,/arxiv_data1/oa_pdf/0c/e9/copd-10-2451.PMC4648605.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/0c/e9/copd-10-2451.PMC4648605.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0c/e9/copd-10-2451.PMC4648605.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f8/b3/ott-8-3337.PMC4648606.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3337–3348OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3337Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9116 6hormone receptor status predicts the clinical  outcome of human epidermal growth factor  2-positive metastatic breast cancer patients  receiving trastuzumab therapy: a multicenter  retrospective study Yunchao Wang1 Tao sun2 Donggui Wan3 lijun sheng4 Wei li5 huayun Zhu6 Yanping li1 Janice lu1,7 1Department of Breast cancer, Beijing  shijitan hospital, capital Medical  University, Beijing, 2Department of  Oncology, liaoning cancer hospital  and institute, shenyang, 3Department  of Oncology, china-Japan Friendship  hospital, Beijing, 4Department of  Oncology, shandong cancer hospital,  Jinan, 5Department of Oncology, the  First Affiliated Hospital of Nanjing  Medical University, 6Department of  Oncology, Jiangsu cancer hospital of  nanjing Medical University, nanjing,  People’s republic of china; 7Division  of hematology and Oncology, David  geffen school of Medicine, University of  california, los angeles, ca, UsaObjectives:  Trastuzumab, a humanized monoclonal antibody that binds human epidermal  growth factor receptor 2 (HER2), dramatically improves the clinical outcomes of HER2- positive breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/f8/b3/ott-8-3337.PMC4648606.pdf
"Keywords:  HER2-positive, metastatic breast cancer, hormone receptor status Background Human epidermal growth factor receptor type 2 (HER2) is overexpressed in ~15%–20%  of invasive breast cancers and predicts a poor prognosis prior to the era of HER2- targeted therapy.1–5 Trastuzumab, a humanized monoclonal antibody that binds HER2,  dramatically improves the clinical outcomes of HER2-positive breast cancer.6–11 correspondence: Yanping li; Janice lu Department of Breast cancer, Beijing  shijitan hospital, capital Medical  University, 10 Tieyi road, haidian  District, Beijing 100038, People’s republic  of china Tel +86 153 0137 8638;   +86 186 1819 5136 email lyp671202@sina.c n;   mjlu@mednet.ucla.ed u Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Wang et al Running head recto: Hormone receptor status predicts trastuzumab efficacy DOI: http://dx.doi.org/10.2147/OTT.S91166",Non-OADS,/arxiv_data1/oa_pdf/f8/b3/ott-8-3337.PMC4648606.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/f8/b3/ott-8-3337.PMC4648606.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f8/b3/ott-8-3337.PMC4648606.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3f/70/ott-8-3329.PMC4648607.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3329–3336OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3329Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8924 1cetuximab could be more effective without prior  bevacizumab treatment in metastatic colorectal  cancer patients Yasuyoshi sato satoshi Matsusaka Mitsukuni suenaga eiji shinozaki nobuyuki Mizunuma Department of gastroenterology,   cancer institute hospital, Japanese  Foundation for cancer research,   T okyo, JapanBackground:  Cetuximab and bevacizumab reportedly improve the survival of patients with  metastatic colorectal cancer (mCRC), but their most effective sequence of administration is  unknown.",Non-OADS,/arxiv_data1/oa_pdf/3f/70/ott-8-3329.PMC4648607.pdf
"The median PFS was 10.9 months with correspondence: satoshi Matsusaka Department of gastroenterology, cancer  institute hospital, Japanese Foundation  for cancer research, 3-8-31 ariake,  Koto-ku, Tokyo 135-8550, Japan Tel +81 3 3520 0111 Fax +81 3 3520 0141 email satoshi.matsusaka@jfcr.or.j p Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Sato et al Running head recto: Cetuximab could be more effective without prior bevacizumab in mCRC DOI: http://dx.doi.org/10.2147/OTT.S89241",Non-OADS,/arxiv_data1/oa_pdf/3f/70/ott-8-3329.PMC4648607.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/3f/70/ott-8-3329.PMC4648607.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3f/70/ott-8-3329.PMC4648607.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f6/e8/copd-10-2431.PMC4648608.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 2431–2438International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2431MethODO lOgyopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/COPD.S9337 5the eFFeCt trial: evaluating exacerbations,  biomarkers, and safety outcomes with two dose  levels of fluticasone propionate/formoterol  in COPD Alberto Papi1 Paul W Jones2 Prashant S Dalvi3 Kirsten McAulay4 tammy McIver5 Sanjeeva Dissanayake3 1Department of Internal and  CardioRespiratory Medicine,   Research Centre on Asthma and  COPD, University of Ferrara, Ferrara,   Italy; 2Institute for Infection and  Immunity, St george’s, University  of london, london, UK; 3Medical  Science – Respiratory, 4Medical  Operations, 5Data Management and  Statistics, Mundipharma Research ltd,   Cambridge, UKAbstract:  Inhaled corticosteroid/long-acting β2-agonist combination therapy is recommended  in chronic obstructive pulmonary disease (COPD) patients at high risk of exacerbations.",Non-OADS,/arxiv_data1/oa_pdf/f6/e8/copd-10-2431.PMC4648608.pdf
"The present study evaluates the efficacy and Correspondence: Alberto Papi Department of Internal and  CardioRespiratory Medicine, Research  Centre on Asthma and COPD, University  of Ferrara, Via Savonarola 9, 44121  Ferrara, Italy tel +39 0532 236 908 Fax +39 0532 210 297 email ppa@unife.i t Journal name: International Journal of COPD Article Designation: Methodology Y ear: 2015 Volume: 10 Running head verso: Papi et al Running head recto: Fluticasone propionate/formoterol in COPD DOI: http://dx.doi.org/10.2147/COPD.S93375",Non-OADS,/arxiv_data1/oa_pdf/f6/e8/copd-10-2431.PMC4648608.pdf
"Available from: http://www.ema.europa.eu/docs/en_GB/document_ library/Scientific_guideline/2015/05/WC500186840.pd f. Accessed  July 16, 2015.",Non-OADS,/arxiv_data1/oa_pdf/f6/e8/copd-10-2431.PMC4648608.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/f6/e8/copd-10-2431.PMC4648608.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f6/e8/copd-10-2431.PMC4648608.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/29/bb/ijwh-7-889.PMC4648618.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2015:7 889–899International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  889RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S6237 2A critical appraisal of the misoprostol removable,  controlled-release vaginal delivery system of labor  induction Charlotte Patte1 Philippe Deruelle1,2 1Lille University Hospital, Jeanne  De Flandre Maternity, 2UPReS eA  4489, environnement périnatal  et santé, Faculté de médecine Henri  Warembourg, Université Lille 2, Lille,   FranceBackground:  Induction of labor is a major issue in pregnancy management.",Non-OADS,/arxiv_data1/oa_pdf/29/bb/ijwh-7-889.PMC4648618.pdf
"Induction of  labor is proposed postterm or for pathological obstetrical situations such as gestational  diabetes, gestational hypertension, preeclampsia, or fetal pathologies like intrauterine  growth retardation or laparoschisis.Correspondence: Philippe Deruelle Pôle femme mère nouveau-né, Maternité  Jeanne de Flandre, CHRU de Lille, 1 rue  eugène Avinée, 59037 Lille cedex, France Tel +33 3 2044 6307 Fax +33 3 2044 6311 email philippe.deruelle@univ-lille2.f r Journal name: International Journal of Women’s Health Article Designation: Review Y ear: 2015 Volume: 7 Running head verso: Patte and Deruelle Running head recto: Misoprostol vaginal insert DOI: http://dx.doi.org/10.2147/IJWH.S62372",Non-OADS,/arxiv_data1/oa_pdf/29/bb/ijwh-7-889.PMC4648618.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/29/bb/ijwh-7-889.PMC4648618.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/29/bb/ijwh-7-889.PMC4648618.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/da/71/jpr-8-819.PMC4648619.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2015:8 819–827Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  819ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S8750 1sleep is associated with task-negative brain activity  in fibromyalgia participants with comorbid chronic  insomnia Karlyn e Vatthauer1 Jason g craggs1 Michael e Robinson1 Roland staud2 Richard B Berry2 William M Perlstein1 christina s Mccrae1 1Department of clinical and health  Psychology, University of Florida,   gainesville, Fl, Usa; 2Department  of Medicine, University of Florida,   gainesville, Fl, Usa correspondence: christina s Mccrae   Department of health Psychology, school  of health Professions, University of  Missouri, One hospital Drive, Dc116 88,  columbia, MO 65212, Usa   T el +1 573 882 1561   Fax +1 573 884 1889   email mccraec@health.missouri.ed uAbstract:  Patients with chronic pain exhibit altered default mode network (DMN) activity.",Non-OADS,/arxiv_data1/oa_pdf/da/71/jpr-8-819.PMC4648619.pdf
"Functional data analysis Data were analyzed with Brain V oyager (BVQX, Version  2.3-Brain Innovation; Maastricht, the Netherlands [ http:// brainvoyager.co m]) and a MATLAB_r2011b (MathWorks  Inc., Natick, MA, USA) toolbox called NeuroElf (created  by Jochen Weber; Columbia University, New Y ork, NY,  USA [ http://www.neuroelf.ne t]).",OADS,/arxiv_data1/oa_pdf/da/71/jpr-8-819.PMC4648619.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/da/71/jpr-8-819.PMC4648619.pdf
Visit  http://www.dovepress.com/testimonials.php to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/da/71/jpr-8-819.PMC4648619.pdf
"http://itech.dickinson.edu/ chemistry/?p =408 Requena L, Requena C, Sanchez M et al.",OADS,/arxiv_data1/oa_pdf/49/0d/jid2015322a.PMC4648631.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/LA u et al.",Non-OADS,/arxiv_data1/oa_pdf/49/0d/jid2015322a.PMC4648631.pdf
http://dx.doi.org/10.1016/S0968-0004 (00)01609-1 .,OADS,/arxiv_data1/oa_pdf/96/ff/zmb4222.PMC4648825.pdf
http://dx.doi.org/10.1016/j.bbamcr.2008.06.013 .,OADS,/arxiv_data1/oa_pdf/96/ff/zmb4222.PMC4648825.pdf
http://dx.doi.org/10.1083/jcb.200811099 .,Non-OADS,/arxiv_data1/oa_pdf/96/ff/zmb4222.PMC4648825.pdf
EMBOJ30:4356 – 4370. http://dx.doi.org/10.1038/emboj.2011.379 .,Non-OADS,/arxiv_data1/oa_pdf/96/ff/zmb4222.PMC4648825.pdf
http://dx.doi.org/10.1083/jcb.201107053 .,Non-OADS,/arxiv_data1/oa_pdf/96/ff/zmb4222.PMC4648825.pdf
http://dx.doi.org/10.1016/j.devcel.2011.08.026 .,OADS,/arxiv_data1/oa_pdf/96/ff/zmb4222.PMC4648825.pdf
http://dx.doi.org/10.1091/mbc.E11-09-0774 .,Non-OADS,/arxiv_data1/oa_pdf/96/ff/zmb4222.PMC4648825.pdf
http://dx.doi.org/10 .1083/jcb.201401006 .,Non-OADS,/arxiv_data1/oa_pdf/96/ff/zmb4222.PMC4648825.pdf
http://dx.doi.org/10 .1074/jbc.M110.171975 .,Non-OADS,/arxiv_data1/oa_pdf/96/ff/zmb4222.PMC4648825.pdf
http://dx.doi.org/10.7554/eLife.06265 .,Non-OADS,/arxiv_data1/oa_pdf/96/ff/zmb4222.PMC4648825.pdf
http://dx.doi.org/10 .1371/journal.pone.0120213 .,Non-OADS,/arxiv_data1/oa_pdf/96/ff/zmb4222.PMC4648825.pdf
http://dx.doi.org/10.1002/jcp.22177 .,Non-OADS,/arxiv_data1/oa_pdf/96/ff/zmb4222.PMC4648825.pdf
http://dx.doi.org/10.1091/mbc .E12-04-0295 .,Non-OADS,/arxiv_data1/oa_pdf/96/ff/zmb4222.PMC4648825.pdf
http://dx.doi.org /10.1128/MCB.06388-11 .,Non-OADS,/arxiv_data1/oa_pdf/96/ff/zmb4222.PMC4648825.pdf
http://dx.doi.org/10.1016/j.tcb.2012.01.004 .,OADS,/arxiv_data1/oa_pdf/96/ff/zmb4222.PMC4648825.pdf
http://dx.doi.org/10.1016/j.jmb.2012.05.004 .,OADS,/arxiv_data1/oa_pdf/96/ff/zmb4222.PMC4648825.pdf
http://dx.doi.org/10.1146 /annurev.biochem.76.052705.163409 .,OADS,/arxiv_data1/oa_pdf/96/ff/zmb4222.PMC4648825.pdf
Cell138:628 – 644. http://dx.doi.org/10.1016/j.cell.2009.08.005 .,OADS,/arxiv_data1/oa_pdf/96/ff/zmb4222.PMC4648825.pdf
Nat Rev Mol Cell Biol11:655– 667. http://dx.doi.org/10.1038/nrm2959 .,OADS,/arxiv_data1/oa_pdf/96/ff/zmb4222.PMC4648825.pdf
http://dx.doi.org/10.1016/j.febslet.2014.05.028 .,OADS,/arxiv_data1/oa_pdf/96/ff/zmb4222.PMC4648825.pdf
http://dx.doi.org/10.1089/ars .2009.3063 .,Non-OADS,/arxiv_data1/oa_pdf/96/ff/zmb4222.PMC4648825.pdf
http://dx.doi.org/10.1016/j .bbamcr.2012.04.014 .,OADS,/arxiv_data1/oa_pdf/96/ff/zmb4222.PMC4648825.pdf
http://dx.doi.org/10.1038/nsmb.1553 .,Non-OADS,/arxiv_data1/oa_pdf/96/ff/zmb4222.PMC4648825.pdf
http://dx.doi.org/10.1089/ars.2010.3157 .,Non-OADS,/arxiv_data1/oa_pdf/96/ff/zmb4222.PMC4648825.pdf
J Biol Chem 287: 4426 – 4433. http://dx.doi.org/10.1074/jbc.R111.270678 .,OADS,/arxiv_data1/oa_pdf/96/ff/zmb4222.PMC4648825.pdf
Trends Biochem Sci 29:1– 4. http://dx.doi.org/10.1016/j.tibs.2003.11.003 .,OADS,/arxiv_data1/oa_pdf/96/ff/zmb4222.PMC4648825.pdf
http://dx.doi.org /10.1016/j.jmb.2009.08.041 .,OADS,/arxiv_data1/oa_pdf/96/ff/zmb4222.PMC4648825.pdf
Proc Natl Acad Sc iUSA 108:4811– 4816. http://dx.doi .org/10.1073/pnas.1014542108 .,Non-OADS,/arxiv_data1/oa_pdf/96/ff/zmb4222.PMC4648825.pdf
http://dx.doi.org/10.1091/mbc.E12-05-0358 .,Non-OADS,/arxiv_data1/oa_pdf/96/ff/zmb4222.PMC4648825.pdf
http://dx.doi.org/10.1074/jbc .M112.387696 .,Non-OADS,/arxiv_data1/oa_pdf/96/ff/zmb4222.PMC4648825.pdf
http://dx.doi.org/10.1016/j.jmb.2005.08.064 .,OADS,/arxiv_data1/oa_pdf/96/ff/zmb4222.PMC4648825.pdf
http://dx.doi.org/10.1385/1-59259 -958-3:033 .,Non-OADS,/arxiv_data1/oa_pdf/96/ff/zmb4222.PMC4648825.pdf
CellDeath Differ 14:616 – 624. http://dx.doi.org/10.1038/sj.cdd.4402035 .,OADS,/arxiv_data1/oa_pdf/96/ff/zmb4222.PMC4648825.pdf
http://dx.doi.org/10.1091 /mbc.E08-11-1108 .,Non-OADS,/arxiv_data1/oa_pdf/96/ff/zmb4222.PMC4648825.pdf
Methods Enzymol 350:3– 41. http://dx.doi.org/10.1016/S0076-6879(02)50954-X .,OADS,/arxiv_data1/oa_pdf/96/ff/zmb4222.PMC4648825.pdf
EMBO J 31:4348 – 4358. http://dx.doi.org/10.1038/emboj .2012.263 .,OADS,/arxiv_data1/oa_pdf/96/ff/zmb4222.PMC4648825.pdf
Dev Cell 28: 30 – 42. http://dx.doi.org/10.1016/j.devcel.2013.11.007 .,OADS,/arxiv_data1/oa_pdf/96/ff/zmb4222.PMC4648825.pdf
Cell 154:596 – 608. http://dx.doi.org/10.1016/j .cell.2013.06.033 .,OADS,/arxiv_data1/oa_pdf/96/ff/zmb4222.PMC4648825.pdf
Cell 120: 817– 829. http://dx.doi.org/10.1016/j.cell.2005.01.011 .,OADS,/arxiv_data1/oa_pdf/96/ff/zmb4222.PMC4648825.pdf
http://dx.doi.org/10.1111/tra .12030 .,Non-OADS,/arxiv_data1/oa_pdf/96/ff/zmb4222.PMC4648825.pdf
http://dx.doi.org/10.1016/j.cmet.2015.04.007 .,OADS,/arxiv_data1/oa_pdf/96/ff/zmb4222.PMC4648825.pdf
http://dx.doi .org/10.7554/eLife.07739 .,Non-OADS,/arxiv_data1/oa_pdf/96/ff/zmb4222.PMC4648825.pdf
http://dx.doi.org/10.1074/jbc.M115.645069 .,Non-OADS,/arxiv_data1/oa_pdf/96/ff/zmb4222.PMC4648825.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/02/c2/main.PMC4648993.pdf
The language of publication of eligible studies was restricted to English.Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/jboJournal of Bone Oncology http://dx.doi.org/10.1016/j.jbo.2015.09.001 2212-1374/ &2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/02/c2/main.PMC4648993.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/02/c2/main.PMC4648993.pdf
AllContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/jboJournal of Bone Oncology http://dx.doi.org/10.1016/j.jbo.2015.09.003 2212-1374/ &2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5c/6f/main.PMC4648994.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5c/6f/main.PMC4648994.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/53/72/main.PMC4648995.pdf
"As PET technology spread all around the world in 1990's, 18F –Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/jboJournal of Bone Oncology http://dx.doi.org/10.1016/j.jbo.2015.08.002 2212-1374/ &2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/53/72/main.PMC4648995.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/53/72/main.PMC4648995.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/08/main.PMC4648996.pdf
"Similarly, in breast cancer patients with bone me- tastases ( N¼42), zoledronic acid signi ﬁcantly reduced basal VEGFContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/jboJournal of Bone Oncology http://dx.doi.org/10.1016/j.jbo.2015.08.001 2212-1374/ &2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/c1/08/main.PMC4648996.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/08/main.PMC4648996.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0c/ba/main.PMC4648997.pdf
"Implementation of contemporary treatment protocols, incorporat- ing adjuvant chemotherapy, have resulted in an improvement in theprognosis of patients diagnosed with osteosarcoma over the pastContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/jboJournal of Bone Oncology http://dx.doi.org/10.1016/j.jbo.2015.09.002 2212-1374/ &2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/0c/ba/main.PMC4648997.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: ALP, alkaline phosphatase; AUC, area under curve; CI, con ﬁdence interval; CT, computed tomography; DLR, diagnostic likelihood ratio; ESMO, Eur-opean Society of Medical Oncology; FDG-PET, 18F- ﬂuorodeoxy-D-glucose positron emission tomography; LDH, lactate dehydrogenase; MRI, magnetic resonance imaging; OR, odds ratio; ROC, Receiver operating characteristic; SD, standard de- viation; SEER, Surveilance, Epidemiology and End Results nCorrespondence to: Department of Orthopaedic Surgery, Greys Hospital, Private Bag X9001, Pietermaritzburg 3200, South Africa.",Non-OADS,/arxiv_data1/oa_pdf/0c/ba/main.PMC4648997.pdf
"Menendez, A meta-analysis of osteosarcoma outcomes in themodern medical era, Sarcoma 2012 (2012) 10. http://dx.doi.org/10.1155/2012/704872 (Article ID 704872).",Non-OADS,/arxiv_data1/oa_pdf/0c/ba/main.PMC4648997.pdf
"Oncol.140 (2014) 1644, http://dx.doi.org/10.1007/s00432-014-1644-0 .",Non-OADS,/arxiv_data1/oa_pdf/0c/ba/main.PMC4648997.pdf
"Vries,2Hans Clevers,2Alain de Bruin,4,6 Jan Rothuizen,1Louis C. Penning,1and Baukje A. Schotanus1,* 1Department of Clinical Sciences of Companion Animals, Faculty of Veterinary Medicine, Utrecht University, Utrecht, 3584 CM, the Netherlands 2Hubrecht Institute and University Medical Centre, Utrecht, 3584 CT, the Netherlands 3Centre for Cellular Imaging (CCI), Department of Biochemistry and Cell Biology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, 3584 CL, the Netherlands 4Department of Pathobiology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, 3584 CL, the Netherlands 5Department of Chemistry, University of California, Berkeley, Berkeley, CA 94720-1460, USA 6Department of Pediatrics, Division of Molecular Genetics, University Medical Center Groningen, University of Groningen, Groningen, 9713 AV, the Netherlands 7Present address: Wellcome Trust/Cancer Research UK Gurdon Institute, Wellcome Trust/MRC Stem Cell Institute, and Department of Physiology, Development, and Neuroscience, University of Cambridge, Tennis Court Road, Cambridge CB2 1QN, UK*Correspondence: b.a.schotanus@uu.nl http://dx.doi.org/10.1016/j.stemcr.2015.09.002 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/10/89/main.PMC4649105.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, three ﬁgures, and two tables and can be found withthis article online at http://dx.doi.org/10.1016/j.stemcr.2015.09.",OADS,/arxiv_data1/oa_pdf/10/89/main.PMC4649105.pdf
"Stem Cell Reports Resource Vascular Platform to Deﬁne Hematopoietic Stem Cell Factors and Enhance Regenerative Hematopoiesis Michael G. Poulos,1,2,3Michael J.P. Crowley,1,2,3Michael C. Gutkin,1,2,3Pradeep Ramalingam,1,2,3 William Schachterle,1,2,3Jean-Leon Thomas,4,5,6,7Olivier Elemento,8and Jason M. Butler1,2,3,* 1Department of Genetic Medicine, Weill Cornell Medical College, New York, NY 10065, USA 2Department of Surgery, Weill Cornell Medical College, New York, NY, 10065 USA 3Ansary Stem Cell Institute, Department of Medicine, Weill Cornell Medical College, New York, NY 10065, USA 4Yale Stem Cell Center, Department of Neurology, Yale University School of Medicine, New Haven, CT 06510, USA 5Universite ´Pierre and Marie Curie–Paris 6, 75013 Paris, France 6INSERM/CNRS U-1127/UMR-7225, 75013 Paris, France 7APHP, Groupe Hospitalier Pitie ´-Salpe `trie`re, 75013 Paris, France 8HRH Prince Alwaleed Bin Talal Bin Abdulaziz Al-Saud Institute for Computational Biomedicine, Weill Cornell Medical College, New York, NY 10065, USA *Correspondence: jmb2009@med.cornell.edu http://dx.doi.org/10.1016/j.stemcr.2015.08.018 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/29/6a/main.PMC4649106.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, seven ﬁgures, and two tables and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.",OADS,/arxiv_data1/oa_pdf/29/6a/main.PMC4649106.pdf
"Stem Cell Reports Report Distinct Processes and T ranscriptional T argets Underlie CDX2 Requirements in Intestinal Stem Cells and Differentiated Villus Cells Adrianna K. San Roman,1,2Alessio Tovaglieri,3David T. Breault,3,4and Ramesh A. Shivdasani1,5,* 1Department of Medical Oncology and Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA 2Program in Biological and Biomedical Sciences, Harvard Medical School, Boston, MA 02215, USA 3Division of Endocrinology, Boston Children’s Hospital, Boston, MA 02115, USA 4Department of Pediatrics, Harvard Medical School, Boston, MA 02215, USA 5Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02215, USA *Correspondence: ramesh_shivdasani@dfci.harvard.edu http://dx.doi.org/10.1016/j.stemcr.2015.09.006 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/64/9c/main.PMC4649135.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, three ﬁgures, and one table and can be found with thisarticle online at http://dx.doi.org/10.1016/j.stemcr.2015.09.006 .",OADS,/arxiv_data1/oa_pdf/64/9c/main.PMC4649135.pdf
http://dx.doi.org/10.1016/j.stemcr.2015.09.004 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3b/b8/main.PMC4649136.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, four ﬁgures, and ﬁve tables and can be found withthis article online at http://dx.doi.org/10.1016/j.stemcr.2015.09.",OADS,/arxiv_data1/oa_pdf/3b/b8/main.PMC4649136.pdf
http://dx.doi.org/10.1016/j.stemcr.2015.09.007 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/94/a6/main.PMC4649137.pdf
ACCESSION NUMBERS The accession number for the microarray data reported in this pa- per is GEO GSE57593 ( http://www.ncbi.nlm.nih.gov/geo/ ).,Non-OADS,/arxiv_data1/oa_pdf/94/a6/main.PMC4649137.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, four ﬁgures, and two tables and can be found withthis article online at http://dx.doi.org/10.1016/j.stemcr.2015.09.",OADS,/arxiv_data1/oa_pdf/94/a6/main.PMC4649137.pdf
"Published online January 12, 2015.http://dx.doi.org/10.1038/onc.2014.424.",Non-OADS,/arxiv_data1/oa_pdf/94/a6/main.PMC4649137.pdf
http://dx.doi.org/10.1016/j.stemcr.2015.09.005 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8f/6e/main.PMC4649138.pdf
"SUPPLEMENTAL INFORMATION Supplemental information includes Supplemental Experi- mental Procedures, four ﬁgures, and two tables and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.",Non-OADS,/arxiv_data1/oa_pdf/8f/6e/main.PMC4649138.pdf
Supplemental material for this article may be found at http://dx.doi.org/10.1128 /AAC.01816-15 .,Non-OADS,/arxiv_data1/oa_pdf/a0/93/zac7290.PMC4649164.pdf
http://dx.doi.org/10.3390/md10071476 .,Non-OADS,/arxiv_data1/oa_pdf/a0/93/zac7290.PMC4649164.pdf
http://dx.doi.org/10.1128 /JVI.02675-10 .,Non-OADS,/arxiv_data1/oa_pdf/a0/93/zac7290.PMC4649164.pdf
http://dx.doi.org/10.1128/AAC .01407-13 .,Non-OADS,/arxiv_data1/oa_pdf/a0/93/zac7290.PMC4649164.pdf
http://dx.doi.org/10.1371/journal.pone.0022635 .,Non-OADS,/arxiv_data1/oa_pdf/a0/93/zac7290.PMC4649164.pdf
J Virol 87:6257– 6269. http://dx.doi.org/10.1128/JVI.00012-13 .,Non-OADS,/arxiv_data1/oa_pdf/a0/93/zac7290.PMC4649164.pdf
http://dx.doi.org/10.1371/journal.pone.0064449 .,Non-OADS,/arxiv_data1/oa_pdf/a0/93/zac7290.PMC4649164.pdf
http://dx.doi.org/10.1371/journal.ppat.0020069 .,Non-OADS,/arxiv_data1/oa_pdf/a0/93/zac7290.PMC4649164.pdf
http://dx.doi.org/10.1371/journal.pone .0094547 .,Non-OADS,/arxiv_data1/oa_pdf/a0/93/zac7290.PMC4649164.pdf
NatMed 13:857– 861. http://dx.doi.org/10.1038/nm1598 .,OADS,/arxiv_data1/oa_pdf/a0/93/zac7290.PMC4649164.pdf
http://dx.doi.org/10.1016/j.antiviral .2014.05.018 .,OADS,/arxiv_data1/oa_pdf/a0/93/zac7290.PMC4649164.pdf
http://dx.doi.org/10.1371/journal.pone.0014831 .,Non-OADS,/arxiv_data1/oa_pdf/a0/93/zac7290.PMC4649164.pdf
http://dx.doi.org/10.1016/j .contraception.2010.04.019 .,OADS,/arxiv_data1/oa_pdf/a0/93/zac7290.PMC4649164.pdf
http://dx.doi.org/10.1089/jwh.2009.1362 .,Non-OADS,/arxiv_data1/oa_pdf/a0/93/zac7290.PMC4649164.pdf
http://dx.doi.org/10 .1016/S0140-6736(08)61842-5 .,OADS,/arxiv_data1/oa_pdf/a0/93/zac7290.PMC4649164.pdf
Antivir Ther 16:1219 – 1226. http://dx.doi.org/10.3851/IMP1890 .,Non-OADS,/arxiv_data1/oa_pdf/a0/93/zac7290.PMC4649164.pdf
http://dx.doi.org/10.1097/00007435 -199810000-00010 .,Non-OADS,/arxiv_data1/oa_pdf/a0/93/zac7290.PMC4649164.pdf
http://dx.doi.org/10 .1016/S0166-3542(99)00038-8 .,OADS,/arxiv_data1/oa_pdf/a0/93/zac7290.PMC4649164.pdf
http://dx.doi.org/10.1128/AAC.05461-11 .,Non-OADS,/arxiv_data1/oa_pdf/a0/93/zac7290.PMC4649164.pdf
In vitro and in vivo characterization of a potential universal placebo designed for use in vaginal microbicide clinical trials.AIDS Res Hum Retroviruses 21:845– 853. http://dx.doi.org/10.1089/aid .2005.21.845 .,Non-OADS,/arxiv_data1/oa_pdf/a0/93/zac7290.PMC4649164.pdf
http://dx.doi.org/10.1089/aid .2010.0252 .,Non-OADS,/arxiv_data1/oa_pdf/a0/93/zac7290.PMC4649164.pdf
http://dx.doi.org /10.1099/0022-1317-83-9-2247 .,Non-OADS,/arxiv_data1/oa_pdf/a0/93/zac7290.PMC4649164.pdf
http://dx.doi.org/10.1006/viro.1999.0157 .,OADS,/arxiv_data1/oa_pdf/a0/93/zac7290.PMC4649164.pdf
http://dx.doi.org/10.1021/ja4038406 .,Non-OADS,/arxiv_data1/oa_pdf/a0/93/zac7290.PMC4649164.pdf
J Virol 87:6062– 6072. http://dx.doi.org/10.1128/JVI.00330-13 .,Non-OADS,/arxiv_data1/oa_pdf/a0/93/zac7290.PMC4649164.pdf
http://dx.doi.org/10.1016/j.virol.2013.10.034 .,OADS,/arxiv_data1/oa_pdf/a0/93/zac7290.PMC4649164.pdf
http://dx.doi.org/10.1128/JVI .02322-09 .,Non-OADS,/arxiv_data1/oa_pdf/a0/93/zac7290.PMC4649164.pdf
Antimicrob Agents Chemother 57:3976 – 3989. http://dx.doi.org/10.1128/AAC.00332-13 .Levendosky et al.,OADS,/arxiv_data1/oa_pdf/a0/93/zac7290.PMC4649164.pdf
Nat Rev Micro-biol7:845– 855. http://dx.doi.org/10.1038/nrmicro2236 .,OADS,/arxiv_data1/oa_pdf/cc/a7/zac7786.PMC4649170.pdf
http://dx.doi.org/10.1111/imr.12252 .,Non-OADS,/arxiv_data1/oa_pdf/cc/a7/zac7786.PMC4649170.pdf
Microbiology 156: 81– 87. http://dx.doi.org/10.1099/mic.0 .033084-0 .,Non-OADS,/arxiv_data1/oa_pdf/cc/a7/zac7786.PMC4649170.pdf
Mol Microbiol 43:717– 731. http://dx.doi.org/10.1046/j.1365-2958.2002.02779.x .,OADS,/arxiv_data1/oa_pdf/cc/a7/zac7786.PMC4649170.pdf
Antimicrob Agents Che- mother 49:4778 – 4780. http://dx.doi.org/10.1128/AAC.49.11.4778-4780 .2005 .,Non-OADS,/arxiv_data1/oa_pdf/cc/a7/zac7786.PMC4649170.pdf
http://dx.doi.org/10.1128/AAC.02202-12 .,Non-OADS,/arxiv_data1/oa_pdf/cc/a7/zac7786.PMC4649170.pdf
http://dx.doi.org/10.1128 /AAC.00250-06 .,Non-OADS,/arxiv_data1/oa_pdf/cc/a7/zac7786.PMC4649170.pdf
http://dx.doi.org/ 10.1128/AAC.49.5.2008-2014 .2005 .,OADS,/arxiv_data1/oa_pdf/cc/a7/zac7786.PMC4649170.pdf
http://dx.doi.org/10.1084/jem.88.1.99 .,Non-OADS,/arxiv_data1/oa_pdf/cc/a7/zac7786.PMC4649170.pdf
Eur J Clin Microbiol Infect Dis 10:240 – 248. http://dx.doi.org/10.1007/BF01966996 .,Non-OADS,/arxiv_data1/oa_pdf/cc/a7/zac7786.PMC4649170.pdf
http://dx.doi.org/10 .1128/AAC.00019-09 .,Non-OADS,/arxiv_data1/oa_pdf/cc/a7/zac7786.PMC4649170.pdf
http://dx.doi.org/10.1128 /AAC.8.3.251 .,Non-OADS,/arxiv_data1/oa_pdf/cc/a7/zac7786.PMC4649170.pdf
Antimicrob Agents Chemother 56:6048 – 6050. http://dx.doi.org/10.1128/AAC.00754-12 .,Non-OADS,/arxiv_data1/oa_pdf/cc/a7/zac7786.PMC4649170.pdf
http://dx.doi .org/10.1128/AAC.01617-06 .,Non-OADS,/arxiv_data1/oa_pdf/cc/a7/zac7786.PMC4649170.pdf
"Mol Microbiol61:810 – 825. http://dx.doi.org/10.1111/j.1365-2958.2006.05275.x .24.Long Q, Du Q, Fu T, Drlica K, Zhao X, Xie J.",OADS,/arxiv_data1/oa_pdf/cc/a7/zac7786.PMC4649170.pdf
J Antimicrob Chemother70:639 – 642. http://dx.doi.org/10.1093/jac/dku463 .,OADS,/arxiv_data1/oa_pdf/cc/a7/zac7786.PMC4649170.pdf
http://dx.doi.org/10.1093/jac/dkp486 .,Non-OADS,/arxiv_data1/oa_pdf/cc/a7/zac7786.PMC4649170.pdf
Curr Top Med Chem 9:981– 998. http://dx.doi.org/10.2174/156802609789630947 .,Non-OADS,/arxiv_data1/oa_pdf/cc/a7/zac7786.PMC4649170.pdf
Annu Rev Pharmacol Toxicol 55:313– 332. http://dx.doi.org/10.1146/annurev-pharmtox-010814-124712 .,Non-OADS,/arxiv_data1/oa_pdf/cc/a7/zac7786.PMC4649170.pdf
http://dx.doi.org/10.1128/AAC.50.1.362-364.2006 .,Non-OADS,/arxiv_data1/oa_pdf/cc/a7/zac7786.PMC4649170.pdf
http://dx.doi.org/10.1128/AAC.48.8.3175-3178.2004 .,Non-OADS,/arxiv_data1/oa_pdf/cc/a7/zac7786.PMC4649170.pdf
Antimicrob Agents Chemother 49:4775– 4777. http://dx.doi.org/10.1128/AAC.49.11.4775-4777.2005 .,Non-OADS,/arxiv_data1/oa_pdf/cc/a7/zac7786.PMC4649170.pdf
Alleles and sequence types (STs) were analyzed and determined via theMLST database ( http://efaecium.mlst.net/ ).,OADS,/arxiv_data1/oa_pdf/28/ee/zac7795.PMC4649207.pdf
"Clusters of related STs were grouped into clonal complexes (CCs) using the eBURSTprogram, version 3 ( http://efaecium.mlst.net/eburst/ ).",OADS,/arxiv_data1/oa_pdf/28/ee/zac7795.PMC4649207.pdf
http://dx.doi.org/10.1056/NEJM198807213190307 .,Non-OADS,/arxiv_data1/oa_pdf/28/ee/zac7795.PMC4649207.pdf
http://dx.doi.org/10.1093/jac/dks469 .,Non-OADS,/arxiv_data1/oa_pdf/28/ee/zac7795.PMC4649207.pdf
http://dx.doi.org/10.4065/81.4.529 .,Non-OADS,/arxiv_data1/oa_pdf/28/ee/zac7795.PMC4649207.pdf
Antimicrob Agents Chemother 54: 4643– 4647. http://dx.doi.org/10.1128/AAC.01710-09 .,Non-OADS,/arxiv_data1/oa_pdf/28/ee/zac7795.PMC4649207.pdf
J Clin Microbiol 49:4297– 4298. http://dx.doi.org/10.1128/JCM .05524-11 .,OADS,/arxiv_data1/oa_pdf/28/ee/zac7795.PMC4649207.pdf
J Clin Microbiol 42:4473– 4479. http://dx.doi.org /10.1128/JCM.42.10.4473-4479.2004 .,OADS,/arxiv_data1/oa_pdf/28/ee/zac7795.PMC4649207.pdf
http://dx.doi.org/10.1099/jmm.0.077701-0 .,Non-OADS,/arxiv_data1/oa_pdf/28/ee/zac7795.PMC4649207.pdf
http://dx.doi.org/10 .1128/JCM.40.6.1963-1971.2002 .,OADS,/arxiv_data1/oa_pdf/28/ee/zac7795.PMC4649207.pdf
http://dx.doi.org/10.1007/s10096-013-2029-z .,Non-OADS,/arxiv_data1/oa_pdf/28/ee/zac7795.PMC4649207.pdf
http://dx.doi.org/10.1007/s10096-011-1412-x .,Non-OADS,/arxiv_data1/oa_pdf/28/ee/zac7795.PMC4649207.pdf
Microb Drug Resist 17:59 – 65. http://dx.doi.org/10.1089/mdr.2010.0091 .,Non-OADS,/arxiv_data1/oa_pdf/28/ee/zac7795.PMC4649207.pdf
http://dx.doi.org/10 .1007/s10096-011-1306-y .,Non-OADS,/arxiv_data1/oa_pdf/28/ee/zac7795.PMC4649207.pdf
http://dx.doi.org/10.3201/eid1305.061421 .Chen et al.,OADS,/arxiv_data1/oa_pdf/28/ee/zac7795.PMC4649207.pdf
"Address correspondence to David J. Kelvin, dkelvin@jidc.org.Supplemental material for this article may be found at http://dx.doi.org/10.1128 /AAC.01885-15 .",Non-OADS,/arxiv_data1/oa_pdf/94/04/zac7255.PMC4649212.pdf
http://dx.doi.org/10.3855/jidc.3675 .,Non-OADS,/arxiv_data1/oa_pdf/94/04/zac7255.PMC4649212.pdf
http://dx.doi.org /10.1056/NEJMoa1305584 .,OADS,/arxiv_data1/oa_pdf/94/04/zac7255.PMC4649212.pdf
Lancet 381:1621. http://dx.doi.org/10 .1016/S0140-6736(13)60943-5 .,Non-OADS,/arxiv_data1/oa_pdf/94/04/zac7255.PMC4649212.pdf
http://dx.doi.org/10 .1093/cid/ciu105 .,OADS,/arxiv_data1/oa_pdf/94/04/zac7255.PMC4649212.pdf
http://dx.doi.org/10.1126/science.1239844 .,Non-OADS,/arxiv_data1/oa_pdf/94/04/zac7255.PMC4649212.pdf
http://dx.doi.org/10.1016/S0140 -6736(13)61209-X .,OADS,/arxiv_data1/oa_pdf/94/04/zac7255.PMC4649212.pdf
Nat Commun 4:2854. http://dx.doi.org/10.1038/ncomms3854 .,OADS,/arxiv_data1/oa_pdf/94/04/zac7255.PMC4649212.pdf
JMicrobiol Immunol Infect 2015: S1684 –1182(15)00772-0. http://dx.doi .org/10.1016/j.jmii.2015.06.004 .,OADS,/arxiv_data1/oa_pdf/94/04/zac7255.PMC4649212.pdf
http://dx.doi.org/10 .1056/NEJMoa1304617 .,OADS,/arxiv_data1/oa_pdf/94/04/zac7255.PMC4649212.pdf
http://dx.doi.org/10.1038/emi .2013.30 .,Non-OADS,/arxiv_data1/oa_pdf/94/04/zac7255.PMC4649212.pdf
http://dx.doi.org/10.1093/infdis/jit554 .,OADS,/arxiv_data1/oa_pdf/94/04/zac7255.PMC4649212.pdf
http://dx.doi.org/10.3851/IMP2672 .,Non-OADS,/arxiv_data1/oa_pdf/94/04/zac7255.PMC4649212.pdf
http://dx.doi.org/10.1056/NEJMp0910479 .,Non-OADS,/arxiv_data1/oa_pdf/94/04/zac7255.PMC4649212.pdf
http://dx.doi.org/10.1093/cid/cir001 .,OADS,/arxiv_data1/oa_pdf/94/04/zac7255.PMC4649212.pdf
http://dx.doi.org/10.1128/AAC.01718-10 .,Non-OADS,/arxiv_data1/oa_pdf/94/04/zac7255.PMC4649212.pdf
J InfectChemother 18:858 – 864. http://dx.doi.org/10.1007/s10156-012-0428-1 .,OADS,/arxiv_data1/oa_pdf/94/04/zac7255.PMC4649212.pdf
http://dx.doi.org/10.1016/S0140-6736(13)61125-3 .,OADS,/arxiv_data1/oa_pdf/94/04/zac7255.PMC4649212.pdf
BMC Infect Dis 15:109. http://dx.doi.org/10 .1186/s12879-015-0829-8 .,Non-OADS,/arxiv_data1/oa_pdf/94/04/zac7255.PMC4649212.pdf
http://dx.doi.org/10.1056 /NEJMoa1304459 .,OADS,/arxiv_data1/oa_pdf/94/04/zac7255.PMC4649212.pdf
http://dx.doi.org/10.1371/journal.pone.0046605 .,Non-OADS,/arxiv_data1/oa_pdf/94/04/zac7255.PMC4649212.pdf
http://dx.doi.org/10.1038 /nature12391 .,Non-OADS,/arxiv_data1/oa_pdf/94/04/zac7255.PMC4649212.pdf
http://dx.doi.org/10.1128/mBio .00362-13 .,Non-OADS,/arxiv_data1/oa_pdf/94/04/zac7255.PMC4649212.pdf
http://dx.doi.org/10.1099/vir.0.061721-0 .,Non-OADS,/arxiv_data1/oa_pdf/94/04/zac7255.PMC4649212.pdf
J Infect Dis 210:435– 440. http://dx.doi.org/10 .1093/infdis/jiu105 .,OADS,/arxiv_data1/oa_pdf/94/04/zac7255.PMC4649212.pdf
AntivirTher http://dx.doi.org/10.3851/IMP2874 .,Non-OADS,/arxiv_data1/oa_pdf/94/04/zac7255.PMC4649212.pdf
http://dx.doi.org/10.1016/j.antiviral .2011.06.010 .,OADS,/arxiv_data1/oa_pdf/94/04/zac7255.PMC4649212.pdf
http://dx.doi.org/10 .1086/591851 .,Non-OADS,/arxiv_data1/oa_pdf/94/04/zac7255.PMC4649212.pdf
Antimi- crob Agents Chemother 56:4375– 4380. http://dx.doi.org/10.1128/AAC .00753-12 .,Non-OADS,/arxiv_data1/oa_pdf/94/04/zac7255.PMC4649212.pdf
Antiviral Res 69:39 – 45. http://dx.doi.org/10.1016/j.antiviral .2005.10.002 .,OADS,/arxiv_data1/oa_pdf/94/04/zac7255.PMC4649212.pdf
http://dx.doi.org/10.1111/crj.12140 .,Non-OADS,/arxiv_data1/oa_pdf/94/04/zac7255.PMC4649212.pdf
http://dx.doi .org/10.1016/S0140-6736(13)61207-6 .,OADS,/arxiv_data1/oa_pdf/94/04/zac7255.PMC4649212.pdf
http://dx.doi.org /10.1056/NEJMopv0910738 .,Non-OADS,/arxiv_data1/oa_pdf/94/04/zac7255.PMC4649212.pdf
http://dx.doi.org/10 .1073/pnas.0900096106 .,Non-OADS,/arxiv_data1/oa_pdf/94/04/zac7255.PMC4649212.pdf
Pediatr Emerg Care 21:437– 439. http://dx.doi.org /10.1097/01.pec.0000169434.98819.05 .,Non-OADS,/arxiv_data1/oa_pdf/94/04/zac7255.PMC4649212.pdf
http://dx.doi.org/10.1111/j.1440 -1819.1997.tb02580.x .,Non-OADS,/arxiv_data1/oa_pdf/94/04/zac7255.PMC4649212.pdf
http://dx.doi.org/10.1016/j.virusres.2004.02.016 .,OADS,/arxiv_data1/oa_pdf/94/04/zac7255.PMC4649212.pdf
http://dx.doi.org/10.1016/j.virol.2007.12.029 .,OADS,/arxiv_data1/oa_pdf/94/04/zac7255.PMC4649212.pdf
http://dx.doi.org/10.1371/journal.pntd.0000774 .,Non-OADS,/arxiv_data1/oa_pdf/3f/58/zac7411.PMC4649222.pdf
Antimicrob Agents Chemother 48:4075– 4083. http://dx.doi.org/10.1128/AAC.48.11 .4075-4083.2004 .,Non-OADS,/arxiv_data1/oa_pdf/3f/58/zac7411.PMC4649222.pdf
http://dx.doi.org/10.1128/CMR.00008-09 .,Non-OADS,/arxiv_data1/oa_pdf/3f/58/zac7411.PMC4649222.pdf
http://dx.doi.org/10.1016/0140-6736 (93)92568-E .,OADS,/arxiv_data1/oa_pdf/3f/58/zac7411.PMC4649222.pdf
Trans R Soc Trop Med Hyg 87:687. http://dx.doi.org/10.1016 /0035-9203(93)90294-Z .,OADS,/arxiv_data1/oa_pdf/3f/58/zac7411.PMC4649222.pdf
http://dx.doi.org/10 .1016/0035-9203(95)90556-1 .,OADS,/arxiv_data1/oa_pdf/3f/58/zac7411.PMC4649222.pdf
Trans R Soc TropMed Hyg 89:656 – 657. http://dx.doi.org/10.1016/0035-9203(95)90432-8 .,OADS,/arxiv_data1/oa_pdf/3f/58/zac7411.PMC4649222.pdf
Trans R Soc Trop Med Hyg 94:327. http://dx.doi.org /10.1016/S0035-9203(00)90344-4 .,OADS,/arxiv_data1/oa_pdf/3f/58/zac7411.PMC4649222.pdf
J Travel Med 3:124. http://dx.doi.org/10 .1111/j.1708-8305.1996.tb00719.x .,Non-OADS,/arxiv_data1/oa_pdf/3f/58/zac7411.PMC4649222.pdf
Trop Med Int Health 7:858 – 864. http://dx.doi.org/10.1046/j.1365-3156.2002.00948.x .,OADS,/arxiv_data1/oa_pdf/3f/58/zac7411.PMC4649222.pdf
http://dx.doi.org/10.1016/S0035-9203(01)90023-9 .,OADS,/arxiv_data1/oa_pdf/3f/58/zac7411.PMC4649222.pdf
"Abstr Int Colloq ITM/NIMPE,p 71. http://www.itg.be/internet/colloq2007/abstracts.pdf .",OADS,/arxiv_data1/oa_pdf/3f/58/zac7411.PMC4649222.pdf
http://static1.1.sqspcdn.com /static/f/471029/25390280/1409624888740/National /H11001Strategy /H11001for/H11001 Malaria /H11001Control /H11001and/H11001Elimination /H110012012-2015.pdf?token /H11005 3BLd15GIHwidLPtf6Nl9xL1wf7o%3D .,Non-OADS,/arxiv_data1/oa_pdf/3f/58/zac7411.PMC4649222.pdf
http://www.who.int/malaria/ publications/atoz/update-artemisinin- resistance-jan2014/en/ .,Non-OADS,/arxiv_data1/oa_pdf/3f/58/zac7411.PMC4649222.pdf
"World malaria report, p 162. http://www.who.int/malaria /publications/country-proﬁles/proﬁle_vnm_en.pdf .",Non-OADS,/arxiv_data1/oa_pdf/3f/58/zac7411.PMC4649222.pdf
http://dx.doi .org/10.1111/j.1365-3156.2004.01310.x .,Non-OADS,/arxiv_data1/oa_pdf/3f/58/zac7411.PMC4649222.pdf
http://dx.doi.org/10.4269/ajtmh.2012.12-0047 .,Non-OADS,/arxiv_data1/oa_pdf/3f/58/zac7411.PMC4649222.pdf
http://www.impe-qn.org.vn/impe-qn/vn/portal/InfoDetail.jsp?area /H1100558 &cat/H110051066&ID /H110051322 .,OADS,/arxiv_data1/oa_pdf/3f/58/zac7411.PMC4649222.pdf
Epidemi- ology of forest malaria in Central Vietnam: the hidden parasite reservoir.Malaria J 14:86. http://dx.doi.org/10.1186/s12936-015-0601-y .,Non-OADS,/arxiv_data1/oa_pdf/3f/58/zac7411.PMC4649222.pdf
http://www.hemocue- .com/en/hemocue-point-of-care-products/anemia-screening-and-hemoglobin/hb-301-system .,Non-OADS,/arxiv_data1/oa_pdf/3f/58/zac7411.PMC4649222.pdf
http://dx.doi.org/10.1016/j.jpba.2011.03.001 .,OADS,/arxiv_data1/oa_pdf/3f/58/zac7411.PMC4649222.pdf
http://www.who.int/nutrition /publications/en/ida_assessment_prevention_control.pdf .,Non-OADS,/arxiv_data1/oa_pdf/3f/58/zac7411.PMC4649222.pdf
http://dx.doi.org/10.1016/0035 -9203(92)90531-G .,OADS,/arxiv_data1/oa_pdf/3f/58/zac7411.PMC4649222.pdf
http://dx.doi .org/10.1016/S1473-3099(14)70855-2 .,OADS,/arxiv_data1/oa_pdf/3f/58/zac7411.PMC4649222.pdf
http://dx.doi.org/10.1093/infdis /169.4.932 .,Non-OADS,/arxiv_data1/oa_pdf/3f/58/zac7411.PMC4649222.pdf
http://dx.doi.org/10 .1093/infdis/171.6.1678 .,Non-OADS,/arxiv_data1/oa_pdf/3f/58/zac7411.PMC4649222.pdf
MalariaJ9:373. http://dx.doi.org/10.1186/1475-2875-9-373 .,Non-OADS,/arxiv_data1/oa_pdf/3f/58/zac7411.PMC4649222.pdf
Malaria J 9:23. http://dx.doi .org/10.1186/1475-2875-9-23 .,Non-OADS,/arxiv_data1/oa_pdf/3f/58/zac7411.PMC4649222.pdf
http://dx.doi.org/10.1086/512241 .,OADS,/arxiv_data1/oa_pdf/3f/58/zac7411.PMC4649222.pdf
Malaria J 12:209. http://dx.doi.org/10 .1186/1475-2875-12-209 .,Non-OADS,/arxiv_data1/oa_pdf/3f/58/zac7411.PMC4649222.pdf
http://dx.doi.org/10 .1371/journal.pmed.1001575 .,Non-OADS,/arxiv_data1/oa_pdf/3f/58/zac7411.PMC4649222.pdf
http://dx.doi.org/10.1182/blood-2006-05-018697 .,Non-OADS,/arxiv_data1/oa_pdf/3f/58/zac7411.PMC4649222.pdf
http://dx.doi.org/10.1111/j.1365-3156.2007 .01821.x .,Non-OADS,/arxiv_data1/oa_pdf/3f/58/zac7411.PMC4649222.pdf
http://dx.doi.org/10.1128 /AAC.01135-09 .,Non-OADS,/arxiv_data1/oa_pdf/3f/58/zac7411.PMC4649222.pdf
Drug Safety 27:25– 61. http://dx.doi.org/10.2165/00002018-200427010-00003 .,Non-OADS,/arxiv_data1/oa_pdf/3f/58/zac7411.PMC4649222.pdf
Hum Mutat 19:185. http://dx.doi.org/10.1002/humu.9010 .,Non-OADS,/arxiv_data1/oa_pdf/3f/58/zac7411.PMC4649222.pdf
Malaria J 8:152. http://dx.doi.org/10.1186/1475-2875-8-152 .,Non-OADS,/arxiv_data1/oa_pdf/3f/58/zac7411.PMC4649222.pdf
Malaria J 10:339. http://dx.doi.org/10.1186 /1475-2875-10-339 .Conﬁrmed P. vivax CQ Resistance in Central Vietnam December 2015 Volume 59 Number 12 aac.asm.org 7419 Antimicrobial Agents and Chemotherapy,Non-OADS,/arxiv_data1/oa_pdf/3f/58/zac7411.PMC4649222.pdf
"Address correspondence to Maiken Cavling Arendrup, maca@ssi.dk.Supplemental material for this article may be found at http://dx.doi.org/10.1128 /AAC.01919-15 .",Non-OADS,/arxiv_data1/oa_pdf/71/dc/zac7735.PMC4649229.pdf
"All isolates underwent conﬁrmatory molecular species identiﬁcation by internaltranscribed spacer (ITS) DNA sequencing using the universal fungalprimers (ITS1, TCGTAGGTGAACCTGCGG, and ITS4, TCCTCCGCTTATTGATATGC [ 10]) and the online pairwise sequence alignment tool available through the webpage for Centraalbureau voor Schimmelcul-tures ( http://www.cbs.knaw.nl/collections/BioloMICSSequences.aspx ).",OADS,/arxiv_data1/oa_pdf/71/dc/zac7735.PMC4649229.pdf
Clin Infect Dis http://dx.doi.org/10 .1093/cid/civ571 .,OADS,/arxiv_data1/oa_pdf/71/dc/zac7735.PMC4649229.pdf
http://dx.doi.org/10.1111/1469 -0691.12371 .,Non-OADS,/arxiv_data1/oa_pdf/71/dc/zac7735.PMC4649229.pdf
http://dx.doi.org/10.3324/haematol.2012.065110 .,Non-OADS,/arxiv_data1/oa_pdf/71/dc/zac7735.PMC4649229.pdf
http://dx.doi.org /10.1128/AAC.01530-08 .In Vitro Activity of Isavuconazole against Mucorales December 2015 Volume 59 Number 12 aac.asm.org 7741 Antimicrobial Agents and Chemotherapy,Non-OADS,/arxiv_data1/oa_pdf/71/dc/zac7735.PMC4649229.pdf
Mycopathologia 170:291– 313. http://dx.doi.org/10.1007/s11046-010-9324-3 .,Non-OADS,/arxiv_data1/oa_pdf/71/dc/zac7735.PMC4649229.pdf
Antimicrob Agents Che-mother 59:666 – 668. http://dx.doi.org/10.1128/AAC.04055-14 .,Non-OADS,/arxiv_data1/oa_pdf/71/dc/zac7735.PMC4649229.pdf
http://dx.doi.org/10.1128/AAC.01512-07 .,Non-OADS,/arxiv_data1/oa_pdf/71/dc/zac7735.PMC4649229.pdf
Proc Natl Acad Sc iUSA 109:6241– 6246. http://dx.doi.org/10.1073 /pnas.1117018109 .,OADS,/arxiv_data1/oa_pdf/71/dc/zac7735.PMC4649229.pdf
http://dx.doi.org/10.1128/AAC.01111-13 .,Non-OADS,/arxiv_data1/oa_pdf/71/dc/zac7735.PMC4649229.pdf
http://dx.doi.org /10.1111/j.1469-0691.2012.03880.x .,Non-OADS,/arxiv_data1/oa_pdf/71/dc/zac7735.PMC4649229.pdf
http://dx.doi.org/10.1016/j.drup.2014.01.001 .,OADS,/arxiv_data1/oa_pdf/71/dc/zac7735.PMC4649229.pdf
http://dx.doi.org/10.1111/j.1469-0691.2012.03890.x .,Non-OADS,/arxiv_data1/oa_pdf/71/dc/zac7735.PMC4649229.pdf
http://dx.doi.org/10.1111/1469-0691.12148 .,Non-OADS,/arxiv_data1/oa_pdf/71/dc/zac7735.PMC4649229.pdf
http://dx.doi.org /10.1128/AAC.00686-11 .,Non-OADS,/arxiv_data1/oa_pdf/71/dc/zac7735.PMC4649229.pdf
http://dx.doi.org/10.1128/JCM .00536-10 .,Non-OADS,/arxiv_data1/oa_pdf/71/dc/zac7735.PMC4649229.pdf
Antimicrob Agents Chemother 50:658 – 666. http://dx.doi.org /10.1128/AAC.50.2.658-666.2006 .,Non-OADS,/arxiv_data1/oa_pdf/71/dc/zac7735.PMC4649229.pdf
Antimicrob Agents Chemother 58:5758 – 5765. http://dx.doi.org/10.1128/AAC.03050-14 .,Non-OADS,/arxiv_data1/oa_pdf/71/dc/zac7735.PMC4649229.pdf
http://dx.doi.org/10.1128/AAC.02686-13 .,Non-OADS,/arxiv_data1/oa_pdf/71/dc/zac7735.PMC4649229.pdf
http://dx.doi.org/10.1128 /AAC.00702-11 .,Non-OADS,/arxiv_data1/oa_pdf/71/dc/zac7735.PMC4649229.pdf
Population pharmacokinetic analysis of vori- conazole and anidulafungin in adult patients with invasive aspergillosis.Antimicrob Agents Chemother 58:4718 – 4726. http://dx.doi.org/10.1128 /AAC.02808-13 .,Non-OADS,/arxiv_data1/oa_pdf/71/dc/zac7735.PMC4649229.pdf
http://dx.doi.org/10.1093 /jac/dkt229 .,Non-OADS,/arxiv_data1/oa_pdf/71/dc/zac7735.PMC4649229.pdf
http://dx.doi.org/10.1097/FTD.0000000000000163 .,Non-OADS,/arxiv_data1/oa_pdf/71/dc/zac7735.PMC4649229.pdf
http://dx.doi.org/10.1111/j.1469-0691 .2011.03644.x .,Non-OADS,/arxiv_data1/oa_pdf/71/dc/zac7735.PMC4649229.pdf
http://dx.doi.org /10.1128/AAC.00636-13 .,Non-OADS,/arxiv_data1/oa_pdf/71/dc/zac7735.PMC4649229.pdf
Infection42:429 – 432. http://dx.doi.org/10.1007/s15010-013-0552-6 .,Non-OADS,/arxiv_data1/oa_pdf/71/dc/zac7735.PMC4649229.pdf
http://dx.doi .org/10.1128/AAC.02301-13 .,Non-OADS,/arxiv_data1/oa_pdf/71/dc/zac7735.PMC4649229.pdf
http://dx.doi.org/10.1179/joc.2009 .21.3.272 .Arendrup et al.,OADS,/arxiv_data1/oa_pdf/71/dc/zac7735.PMC4649229.pdf
Annu Rev Biochem 77:701– 726. http://dx.doi.org/10.1146/annurev.biochem.75.103004 .142532 .,Non-OADS,/arxiv_data1/oa_pdf/92/3d/zac7458.PMC4649251.pdf
http://dx.doi.org/10.1128 /CMR.15.2.194-222.2002 .,Non-OADS,/arxiv_data1/oa_pdf/92/3d/zac7458.PMC4649251.pdf
http://dx.doi .org/10.1111/2049-632X.12033 .,Non-OADS,/arxiv_data1/oa_pdf/92/3d/zac7458.PMC4649251.pdf
"http://dx.doi.org/10.1111/j.1462-5822.2012.01832.x .7.Dasenbrook EC, Checkley W, Merlo CA, Konstan MW, Lechtzin N, Boyle MP.",OADS,/arxiv_data1/oa_pdf/92/3d/zac7458.PMC4649251.pdf
http://dx.doi.org/10.1001/jama.2010.791 .,Non-OADS,/arxiv_data1/oa_pdf/92/3d/zac7458.PMC4649251.pdf
Am J Respir Crit Care Med 178:814 – 821. http://dx.doi.org/10.1164/rccm.200802-327OC .,Non-OADS,/arxiv_data1/oa_pdf/92/3d/zac7458.PMC4649251.pdf
http://dx.doi.org/10.1101 /cshperspect.a009738 .,Non-OADS,/arxiv_data1/oa_pdf/92/3d/zac7458.PMC4649251.pdf
http://dx.doi.org/10.1513/AnnalsATS.201306 -159MG .,Non-OADS,/arxiv_data1/oa_pdf/92/3d/zac7458.PMC4649251.pdf
J Bac- teriol 188:8079 – 8086. http://dx.doi.org/10.1128/JB.00858-06 .,OADS,/arxiv_data1/oa_pdf/92/3d/zac7458.PMC4649251.pdf
BMC Microbiol 10:33. http://dx.doi.org/10.1186/1471-2180 -10-33 .,Non-OADS,/arxiv_data1/oa_pdf/92/3d/zac7458.PMC4649251.pdf
Appl Environ Microbiol 75:6910 – 6912. http://dx.doi.org/10.1128/AEM.01211-09 .,OADS,/arxiv_data1/oa_pdf/92/3d/zac7458.PMC4649251.pdf
http://dx.doi .org/10.1073/pnas.0606756104 .,Non-OADS,/arxiv_data1/oa_pdf/92/3d/zac7458.PMC4649251.pdf
http://dx.doi.org/10.1038/nrmicro1384 .,OADS,/arxiv_data1/oa_pdf/92/3d/zac7458.PMC4649251.pdf
http://dx.doi .org/10.1517/14656561003724747 .,Non-OADS,/arxiv_data1/oa_pdf/92/3d/zac7458.PMC4649251.pdf
http://dx.doi.org/10.1016/j.jcf.2012 .12.003 .,OADS,/arxiv_data1/oa_pdf/92/3d/zac7458.PMC4649251.pdf
http://dx.doi.org/10.3390 /ijms10083400 .,OADS,/arxiv_data1/oa_pdf/92/3d/zac7458.PMC4649251.pdf
http://dx.doi.org/10.1094/MPMI.2000.13 .12.1301 .,OADS,/arxiv_data1/oa_pdf/92/3d/zac7458.PMC4649251.pdf
http://dx.doi.org/10.1021/jf3003027 .,Non-OADS,/arxiv_data1/oa_pdf/92/3d/zac7458.PMC4649251.pdf
http://dx.doi.org/10.1093/jac/dkr510 .,Non-OADS,/arxiv_data1/oa_pdf/92/3d/zac7458.PMC4649251.pdf
http://dx.doi.org/10.1128/AAC.01468-10 .,Non-OADS,/arxiv_data1/oa_pdf/92/3d/zac7458.PMC4649251.pdf
http://dx.doi.org/10 .1126/science.1106753 .,Non-OADS,/arxiv_data1/oa_pdf/92/3d/zac7458.PMC4649251.pdf
http://dx.doi.org/10 .1038/ja.2013.86 .,Non-OADS,/arxiv_data1/oa_pdf/92/3d/zac7458.PMC4649251.pdf
http://dx.doi.org/10.1126 /science.7604262 .,Non-OADS,/arxiv_data1/oa_pdf/92/3d/zac7458.PMC4649251.pdf
http://dx.doi.org/10 .1099/mic.0.022764-0 .,Non-OADS,/arxiv_data1/oa_pdf/92/3d/zac7458.PMC4649251.pdf
http://dx.doi.org/10.1073 /pnas.0511100103 .,Non-OADS,/arxiv_data1/oa_pdf/92/3d/zac7458.PMC4649251.pdf
Mol Biosyst 4:882– 888. http://dx.doi.org/10.1039/b803796p .,OADS,/arxiv_data1/oa_pdf/92/3d/zac7458.PMC4649251.pdf
Am JRespir Crit Care Med 187: 680 – 689. http://dx.doi.org/10.1164/rccm .201207-1160OE .,Non-OADS,/arxiv_data1/oa_pdf/92/3d/zac7458.PMC4649251.pdf
http://dx.doi.org/10.1183/09059180.00006512 .,Non-OADS,/arxiv_data1/oa_pdf/92/3d/zac7458.PMC4649251.pdf
http://dx.doi.org/10.1007/s00417-009-1061-2 .,Non-OADS,/arxiv_data1/oa_pdf/92/3d/zac7458.PMC4649251.pdf
http://dx.doi.org/10.1086/515238 .,Non-OADS,/arxiv_data1/oa_pdf/92/3d/zac7458.PMC4649251.pdf
Eur J Med Chem 80:605– 620. http://dx.doi.org /10.1016/j.ejmech.2013.11.019 .,OADS,/arxiv_data1/oa_pdf/92/3d/zac7458.PMC4649251.pdf
http://dx.doi.org/10.1111/j .1574-695X.2002.tb00553.x .,Non-OADS,/arxiv_data1/oa_pdf/92/3d/zac7458.PMC4649251.pdf
J ClinMicrobiol 41:4424 – 4427. http://dx.doi.org/10.1128/JCM.41.9.4424-4427 .2003 .,OADS,/arxiv_data1/oa_pdf/92/3d/zac7458.PMC4649251.pdf
Eur Respir J http://dx.doi.org/10.1183/09031936.00225214 .,Non-OADS,/arxiv_data1/oa_pdf/92/3d/zac7458.PMC4649251.pdf
http://www.accessdata.fda.gov/drugsatfda_docs/label /2014/050753s016lbl.pdf .Boulanger et al.,Non-OADS,/arxiv_data1/oa_pdf/92/3d/zac7458.PMC4649251.pdf
"Goldberg,1,2,3Jacqueline Caesar,2,3Ashley Park,2Shawn Sedgh,2Gilana Finogenov,2 Eliezer Masliah,4Joy Davis,2,3and Mathew Blurton-Jones1,2,3,* 1Department of Neurobiology and Behavior, University of California, Irvine, Irvine, CA 92697, USA 2Sue & Bill Gross Stem Cell Research Center, University of California, Irvine, Irvine, CA 92697, USA 3Institute for Memory Impairments and Neurological Disorders, University of California, Irvine, Irvine, CA 92697, USA 4Department of Pathology and Medicine, University of California, San Diego, San Diego, CA 92093, USA *Correspondence: mblurton@uci.edu http://dx.doi.org/10.1016/j.stemcr.2015.09.008 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/4e/00/main.PMC4649255.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures and Figures S1–S4 and can be found with this article on-line at http://dx.doi.org/10.1016/j.stemcr.2015.09.008 .,OADS,/arxiv_data1/oa_pdf/4e/00/main.PMC4649255.pdf
"), njing@sibcb.ac.cn (N.J.) http://dx.doi.org/10.1016/j.stemcr.2015.09.010 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/c2/6e/main.PMC4649256.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, six ﬁgures, and two tables and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2015.09.010 .",OADS,/arxiv_data1/oa_pdf/c2/6e/main.PMC4649256.pdf
"Stem Cell Reports Article Progressive Chromatin Condensation and H3K9 Methylation Regulate the Differentiation of Embryonic and Hematopoietic Stem Cells Fernando Ugarte,1Rebekah Sousae,1Bertrand Cinquin,2,3Eric W. Martin,1Jana Krietsch,1Gabriela Sanchez,1 Margaux Inman,1Herman Tsang,1Matthew Warr,4Emmanuelle Passegue ´,4Carolyn A. Larabell,2,3 and E. Camilla Forsberg1,* 1Institute for the Biology of Stem Cells, Department of Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA 95064, USA 2National Center for X-ray Tomography, UCSF, San Francisco, CA 94143, USA 3Physical Biosciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA 4The Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, Medicine Department, Hem/Onc Division, University of California, San Francisco, San Francisco, CA 94143, USA *Correspondence: cforsber@soe.ucsc.edu http://dx.doi.org/10.1016/j.stemcr.2015.09.009 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/43/b0/main.PMC4649257.pdf
"The intersect of differentially regulated genes was assessed by php coding, and the p value calculated by hypergeometric test ( http://nemates.org/MA/progs/overlap_stats.html ).",OADS,/arxiv_data1/oa_pdf/43/b0/main.PMC4649257.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, ﬁve ﬁgures, two tables, and three movies and can be found with this article online at http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/43/b0/main.PMC4649257.pdf
"Stem Cell Reports Article Enhancer Analysis Unveils Genetic Interactions between TLX and SOX2 in Neural Stem Cells and In Vivo Reprogramming Mohammed M. Islam,1,4Derek K. Smith,1,2Wenze Niu,1,2Sanhua Fang,1,5Nida Iqbal,1Guoqiang Sun,3 Yanhong Shi,3and Chun-Li Zhang1,2,* 1Department of Molecular Biology 2Hamon Center for Regenerative Science and Medicine University of Texas Southwestern Medical Center, 6000 Harry Hines Boulevard, Dallas, TX 75390, USA 3Department of Neurosciences, Cancer Center, Beckman Research Institute of City of Hope, 1500 E. Duarte Road, Duarte, CA 91010, USA 4Present address: College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia 5Present address: Core Facilities of Zhejiang University Institute of Neuroscience, 866 Yuhangtang Road, Hangzhou 310058, China *Correspondence: chun-li.zhang@utsouthwestern.edu http://dx.doi.org/10.1016/j.stemcr.2015.09.015 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/47/26/main.PMC4649261.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes one ﬁgure and three tablesand can be found with this article online at http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/47/26/main.PMC4649261.pdf
"Stem Cell Reports Article Dynamics of Lgr6+Progenitor Cells in the Hair Follicle, Sebaceous Gland, and Interfollicular Epidermis Anja Fu ¨llgrabe,1Simon Joost,1Alexandra Are,1Tina Jacob,1Unnikrishnan Sivan,1Andrea Haegebarth,2,7 Sten Linnarsson,3Benjamin D. Simons,4,5,6Hans Clevers,2Rune Toftga ˚rd,1and Maria Kasper1,* 1Karolinska Institutet, Department of Biosciences and Nutrition and Center for Innovative Medicine, Novum, 141 83 Huddinge, Sweden 2Hubrecht Institute–KNAW (Royal Netherlands Academy of Arts and Sciences) and University Medical Center Utrecht, Uppsalalaan 8, 3584 Utrecht, the Netherlands 3Karolinska Institutet, Department of Medical Biochemistry and Biophysics, Scheeles va ¨g 2, 171 77 Stockholm, Sweden 4The Wellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, Tennis Court Road, Cambridge CB2 1QN, UK 5Cavendish Laboratory, Department of Physics, J. J. Thomson Avenue, University of Cambridge, Cambridge CB3 0HE, UK 6Wellcome Trust-Medical Research Council Stem Cell Institute, University of Cambridge, Cambridge CB2 1QR, UK 7Present address: Bayer Pharma AG, 13353 Berlin, Germany *Correspondence: maria.kasper@ki.se http://dx.doi.org/10.1016/j.stemcr.2015.09.013 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/19/80/main.PMC4649262.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, four ﬁgures, and four tables and can be foundwith this article online at http://dx.doi.org/10.1016/j.stemcr.",OADS,/arxiv_data1/oa_pdf/19/80/main.PMC4649262.pdf
http://dx.doi.org/10.1016/j.stemcr.2015.09.014 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/56/a7/main.PMC4649264.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, two ﬁgures, and one table and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.",Non-OADS,/arxiv_data1/oa_pdf/56/a7/main.PMC4649264.pdf
"Chan,1,3,4Liza J. Raggatt,1,2 Kiarash Khosrotehrani,1,5and Nicholas M. Fisk1,6 1UQ Centre for Clinical Research, The University of Queensland, Herston, QLD 4029, Australia 2Mater Research Institute, The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia 3Department of Reproductive Medicine, KK Women’s and Children’s Hospital, Singapore 229899, Singapore 4Experimental Fetal Medicine Group, Department of Obstetrics and Gynaecology, National University of Singapore, Singapore 119228, Singapore 5UQ Diamantina Institute, The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia 6Royal Brisbane and Women’s Hospital, Centre for Advanced Prenatal Care, Herston, QLD 4029, Australia *Correspondence: susan.millard@mater.uq.edu.au http://dx.doi.org/10.1016/j.stemcr.2015.09.017 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/99/36/main.PMC4649292.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures and one ﬁgure and can be found with this article online athttp://dx.doi.org/10.1016/j.stemcr.2015.09.017 .,Non-OADS,/arxiv_data1/oa_pdf/99/36/main.PMC4649292.pdf
"Published online June 8, 2015. http://dx.doi.org/10.1002/ jbmr.2567.",OADS,/arxiv_data1/oa_pdf/99/36/main.PMC4649292.pdf
http://dx.doi.org/10.1016/j.stemcr.2015.09.016 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/84/c9/main.PMC4649293.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, two ﬁgures, and ﬁve tables and can be foundwith this article online at http://dx.doi.org/10.1016/j.stemcr.",Non-OADS,/arxiv_data1/oa_pdf/84/c9/main.PMC4649293.pdf
"Stem Cell Reports Article Atypical PKC-iota Controls Stem Cell Expansion via Regulation of the Notch Pathway In Kyoung Mah,1Rachel Soloff,2,3Stephen M. Hedrick,2and Francesca V. Mariani1,* 1Broad CIRM Center for Regenerative Medicine and Stem Cell Research, Keck School of Medicine, University of Southern California, 1425 San Pablo St., Los Angeles, CA 90033, USA 2Department of Biological Sciences, University of California, San Diego, La Jolla, CA 92093, USA 3Present address: Kyowa Hakko Kirin California, Inc., 9420 Athena Circle, La Jolla, CA 92037, USA *Correspondence: fmariani@usc.edu http://dx.doi.org/10.1016/j.stemcr.2015.09.021 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/9b/0d/main.PMC4649379.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, six ﬁgures, and two tables and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.",OADS,/arxiv_data1/oa_pdf/9b/0d/main.PMC4649379.pdf
"Oostendorp1,* 13rd Department of Internal Medicine, Klinikum Rechts der Isar der Technischen Universita ¨tM u¨nchen, 81675 Munich, Germany 2Helmholtz Zentrum Mu ¨nchen, Institute of Bioinformatics and Systems Biology, 85764 Neuherberg, Germany 3Institute of Medical Microbiology, Immunology, and Hygiene, Technische Universita ¨tM u¨nchen, 81675 Munich, Germany 4Clinic for Radiooncology and Radiation Therapy, Klinikums Rechts der Isar der Technischen Universita ¨tM u¨nchen, 81675 Munich, Germany 5German Consortium for Translational Research (DKTK), Partner Site Technical University Munich, 81675 Munich, Germany 6Genome-Oriented Bioinformatics, Technische Universita ¨tM u¨nchen, Weihenstephan, 85354 Freising, Germany 7Co-ﬁrst author *Correspondence: robert.oostendorp@tum.de http://dx.doi.org/10.1016/j.stemcr.2015.09.018 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/07/bc/main.PMC4649380.pdf
"Finally, clustering was performed using STEM ( http://www.sb.cs.cmu.edu/stem )(Ernst and Bar-Jo- seph, 2006 ).",OADS,/arxiv_data1/oa_pdf/07/bc/main.PMC4649380.pdf
"Candidate Gene Prioritization To ﬁnd candidate genes, we ﬁrst used the ToppGene candi- date gene prioritization algorithm ( http://toppgene.cchmc.org ) (Chen et al., 2009 ).",OADS,/arxiv_data1/oa_pdf/07/bc/main.PMC4649380.pdf
"Further interactions within CTGF ﬁrstneighbors were retrieved from the Pathway Commons database ( http://www.pathwaycommons.org )(Cerami et al., 2011 ) integrating several different protein-protein interaction resources.",OADS,/arxiv_data1/oa_pdf/07/bc/main.PMC4649380.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, six ﬁgures, and eight tables and can be foundwith this article online at http://dx.doi.org/10.1016/j.stemcr.",OADS,/arxiv_data1/oa_pdf/07/bc/main.PMC4649380.pdf
http://dx.doi.org/10.1016/j.stemcr.2015.09.019 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/34/ed/main.PMC4649382.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experi-mental Procedures, four ﬁgures, and six movies and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.",Non-OADS,/arxiv_data1/oa_pdf/34/ed/main.PMC4649382.pdf
"Stem Cell Reports Resource Cloning-free CRISPR Mandana Arbab,1,2Sharanya Srinivasan,3,4Tatsunori Hashimoto,4Niels Geijsen,1,2 and Richard I. Sherwood1,3,* 1Hubrecht Institute and UMC Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands 2Department of Clinical Sciences of Companion Animals, Faculty of Veterinary Medicine at Utrecht University, Yalelaan 108, 3583 CM Utrecht, the Netherlands 3Division of Genetics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115, USA 4Computer Science and Artiﬁcial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA 02142, USA *Correspondence: rsherwood@partners.org http://dx.doi.org/10.1016/j.stemcr.2015.09.022 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/9f/2d/main.PMC4649464.pdf
We chose the minimal overlap such that the overlapping region was estimated to have a Tm >65 /C14C using the NEB Tm calculator (http://tmcalculator.neb.com/#!/ ).,Non-OADS,/arxiv_data1/oa_pdf/9f/2d/main.PMC4649464.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, two ﬁgures, and one table and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2015.09.",OADS,/arxiv_data1/oa_pdf/9f/2d/main.PMC4649464.pdf
"Toview a copy of this license, visit http://creativecommons.org/licenses/ by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Innate CD8þT Cells are involved in thymic atrophy B Liu et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/73/a7/cddis2014323a.PMC4649502.pdf
The specific sequence used for CDKN2D silencing was selected from the WI siRNA SelectionProgram (http://sirna.wi.mit.edu/).,OADS,/arxiv_data1/oa_pdf/53/7c/cddis2014388a.PMC4649503.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)DPERK controls apoptosis and tissue homeostasis Y Demay et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/8c/13/cddis2014403a.PMC4649510.pdf
"To view a copy of thislicense, visit http://creativecommo ns.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)PPAR- δand - γinhibit HMGB1 release via SIRT1 JS Hwang et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/e5/63/cddis2014406a.PMC4649513.pdf
org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)TRAF1 mediates hepatic injury X-F Zhang et al 17 Cell Death and Disease,Non-OADS,/arxiv_data1/oa_pdf/65/dc/cddis2014411a.PMC4649517.pdf
Available from: http://envis.frlht.org/ junclist.php?txtbtname=&gesp=63|Aegle+marmelos+%28L.%29+CORREA +EX.+SCHULTZ.,OADS,/arxiv_data1/oa_pdf/e6/b4/AYU-35-344.PMC4649562.pdf
World Allergy Organization; 2011.  e‑book Available from: http://www.worldallergy.org/publications/wao_ white_book.pdf 5.,Non-OADS,/arxiv_data1/oa_pdf/c8/ec/AYU-35-261.PMC4649564.pdf
Available from:  http://www.tinyurl.com/5r62bu7.,Non-OADS,/arxiv_data1/oa_pdf/bd/fb/AYU-35-237.PMC4649566.pdf
Available from: http://www.ntn.org.,Non-OADS,/arxiv_data1/oa_pdf/bd/fb/AYU-35-237.PMC4649566.pdf
Available from: http://www.jortho.,Non-OADS,/arxiv_data1/oa_pdf/5a/9e/AYU-35-270.PMC4649569.pdf
Available  from: http://www.servedeva.org/documents/msbaghel.pdf/.,Non-OADS,/arxiv_data1/oa_pdf/96/f7/AYU-35-243.PMC4649571.pdf
Available from: http://www.ayushportal.ap.nic.in/.,Non-OADS,/arxiv_data1/oa_pdf/96/f7/AYU-35-243.PMC4649571.pdf
Available from: http://www.dharaonline.org/Forms/ Home.aspx.,Non-OADS,/arxiv_data1/oa_pdf/96/f7/AYU-35-243.PMC4649571.pdf
Available from: http://www.ccimindia.org/curriculum_ayurveda.html.,Non-OADS,/arxiv_data1/oa_pdf/96/f7/AYU-35-243.PMC4649571.pdf
Available from:  http://www.cpinfo.org/facts/.,Non-OADS,/arxiv_data1/oa_pdf/14/68/AYU-35-294.PMC4649573.pdf
Available from: http://www.aafp.org/afp/20001001/1565.html.,Non-OADS,/arxiv_data1/oa_pdf/72/e0/AYU-35-252.PMC4649575.pdf
Available from: http://www.donaldepstein.com/pdf/ newlongitudinal.pdf [Last accessed on 2010 Dec. 20].,Non-OADS,/arxiv_data1/oa_pdf/72/e0/AYU-35-252.PMC4649575.pdf
Available from:  http://www.clinicalgeriatrics.com/articles/Anemia‑Elderly .,Non-OADS,/arxiv_data1/oa_pdf/72/e0/AYU-35-252.PMC4649575.pdf
Available from: http://www.goshala.com/Articles/2011/Jun/Urinebenefits.,Non-OADS,/arxiv_data1/oa_pdf/72/e0/AYU-35-252.PMC4649575.pdf
Available  from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3383946.,Non-OADS,/arxiv_data1/oa_pdf/e4/89/AYU-35-231.PMC4649578.pdf
Available from: http://www.stemcells.nih.gov/info/basics/ pages/basics1.aspx.,Non-OADS,/arxiv_data1/oa_pdf/e4/89/AYU-35-231.PMC4649578.pdf
"[Last accessed on 2013  April 01] Available from: http://www.newindianexpress.com/states/kerala/ article539215.ece., 22.",Non-OADS,/arxiv_data1/oa_pdf/e4/89/AYU-35-231.PMC4649578.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7a/10/rjv146.PMC4649610.pdf
" Case Rep Ga stroenterol  2015;9:335 –340  DOI: 10.1159/000441383   Published online: October 21, 2015  © 2015 The Author(s)   Published  by S. Karger AG, Basel   1662‒0631/15/0093‒0335$39.50/0   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/49/5b/crg-0009-0335.PMC4649708.pdf
" Case Rep Ophthalmol  2015;6:361 –365  DOI: 10.1159/000441616   Published online: October 30, 2015  © 2015 The Author(s)   Published  by S. Karger AG, Basel   1663‒2699/15/0063‒0361$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/7c/96/cop-0006-0361.PMC4649709.pdf
" Case Rep Ophthalmol 2015;6:366 –372  DOI: 10.1159/000441615   Published online: October 30, 2015  © 2015 The Author(s)   Published by S. Karger AG, Basel   1663‒2699/15/0063‒0366$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/7c/ad/cop-0006-0366.PMC4649710.pdf
" Case Rep Gastroenterol 2015;9:347 –352  DOI: 10.1159/000441382   Published online: October 24, 2015  © 2015 The Author(s)   Published by S. Karger AG, Basel   1662‒0631/15/0093‒0347$39.50/0   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/78/72/crg-0009-0347.PMC4649712.pdf
" Case Rep Ophthalmol 2015;6:356 –360  DOI: 10.1159/000441121   Published online: October 14, 2015  © 2015 The Author(s)   Published by S. Karger AG, Basel   1663‒2699/15/0063‒0356$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/ce/f4/cop-0006-0356.PMC4649713.pdf
" Case Rep Ophthalmol  2015;6:351 –355  DOI: 10.1159/000440994   Published online: October 14, 2015  © 2015 The Author(s)   Published  by S. Karger AG, Basel   1663‒2699/15/0063‒0351$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/4b/16/cop-0006-0351.PMC4649714.pdf
"2013.  http://jdc.jefferson.edu/phsrs/12/  (accessed April 30, 2015 ).",OADS,/arxiv_data1/oa_pdf/4b/16/cop-0006-0351.PMC4649714.pdf
" Case Rep Gastroenterol 2015;9:327 –334  DOI: 10.1159/000441381   Published online: October 21, 2015  © 2015 The Author(s)   Published by S. Karger AG, Basel   1662‒0631/15/0093‒0327$39.50/0   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/Ope nAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/82/5a/crg-0009-0327.PMC4649715.pdf
"Among U.S. adults included in the T1D [type 1 diabetes] Exchange Registry (https://t1dexchange.org/pages/clinic-registry), only approximately 20% are reaching their glycated hemoglobin (HbA1c) targets.",Non-OADS,/arxiv_data1/oa_pdf/11/b9/dia.2015.0325.PMC4649720.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.DIABETES TECHNOLOGY & THERAPEUTICS Volume 17, Number 11, 2015 DOI: 10.1089/dia.2015.0325 832",Non-OADS,/arxiv_data1/oa_pdf/11/b9/dia.2015.0325.PMC4649720.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.JOURNAL OF WOMEN’S HEALTH Volume 24, Number 11, 2015DOI: 10.1089/jwh.2014.5127 899",Non-OADS,/arxiv_data1/oa_pdf/fe/f0/jwh.2014.5127.PMC4649722.pdf
"Available at: http://seer.cancer.gov/statfacts/html/ corp.html Accessed September 29, 2014.",Non-OADS,/arxiv_data1/oa_pdf/fe/f0/jwh.2014.5127.PMC4649722.pdf
"Available at: http://seer.cancer.gov/statfacts/html/ ovary.html Accessed September 29, 2014.",Non-OADS,/arxiv_data1/oa_pdf/fe/f0/jwh.2014.5127.PMC4649722.pdf
"Available at: http://seer.cancer.gov/statfacts/html/vulva.html Accessed September 29, 2014.",Non-OADS,/arxiv_data1/oa_pdf/fe/f0/jwh.2014.5127.PMC4649722.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.DIABETES TECHNOLOGY & THERAPEUTICS Volume 17, Number 11, 2015 DOI: 10.1089/dia.2014.0378 787",Non-OADS,/arxiv_data1/oa_pdf/32/02/dia.2014.0378.PMC4649725.pdf
" Case Rep Oncol 2015;8:447 –450  DOI: 10.1159/0004 41414   Published online: October 22, 2015  © 2015 The Author(s)   Published by S. Karger AG, Basel   1662‒6575/15/0083‒0447$39.50/0   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/ba/82/cro-0008-0447.PMC4649728.pdf
" Case Rep Gastroenterol 2015;9:311 –316  DOI: 10.1159/000441386   Published online: October 13, 2015  © 2015 The Author(s)   Published by S. Karger AG, Basel   1662‒0631/15/0093‒0311$39.50/0   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/c2/4e/crg-0009-0311.PMC4649729.pdf
" Case Rep Oncol  2015;8:466 –471  DOI: 10.1159/000441772   Published online: November 4, 2015  © 2015 The Author(s)   Published  by S. Karger AG, Basel   1662‒6575/15/0083‒0466$39.50/0   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/a6/a7/cro-0008-0466.PMC4649730.pdf
" Case Rep Neurol 2015;7:209 –212  DOI: 10.1159/000441489   Published online: October 21, 2015  © 2015 The Author(s)   Published by S. Karger AG, Basel   1662‒680X/15/0073‒0209$39.50/0   www.karger.com/crn   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/86/25/crn-0007-0209.PMC4649732.pdf
" Case Rep Gastroenterol 2015;9:341 –346  DOI: 10.1159/000441384   Published online: October 21, 2015  © 2015 The Author(s)   Published by S. Karger AG, Basel   1662‒0631/15/0093‒0341$39.50/0   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/9f/da/crg-0009-0341.PMC4649733.pdf
" Case Rep Gastroenterol  2015;9:317 –326  DOI: 10.1159/000441387   Published online: October 17, 2015  © 2015 The Author(s)   Published  by S. Karger AG, Basel   1662‒0631/15/0093‒0317$39.50/0   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/d9/33/crg-0009-0317.PMC4649734.pdf
" Case Rep Oncol  2015;8:451 –455  DOI: 10.1159/000441469   Published online: October 24, 2015  © 2015 The Author(s)   Published  by S. Karger AG, Basel   1662‒6575/15/0083‒0451$39.50/0   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/f7/69/cro-0008-0451.PMC4649735.pdf
" Case Rep Oncol  2015;8:432 –438  DOI: 10.1159/000440799   Published online: October 20, 2015  © 2015 The Author(s)   Published  by S. Karger AG, Basel   1662‒6575/15/0083‒0432$39.50/0   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/14/fa/cro-0008-0432.PMC4649736.pdf
"http://www.nccn.org/professionals/physician_gls/pdf/breast.pdf (accessed May  26, 2015 ).",Non-OADS,/arxiv_data1/oa_pdf/14/fa/cro-0008-0432.PMC4649736.pdf
"http://www.nccn.org/professionals/physician_gls/pdf/nhl.pdf (accessed May 26, 2015 ).",Non-OADS,/arxiv_data1/oa_pdf/14/fa/cro-0008-0432.PMC4649736.pdf
" Case Rep Oncol 2015;8:439 –446  DOI: 10.1159/000441468   Published online: October 21, 2015  © 2015 The Author(s)   Published by S. Karger AG, Basel   1662‒6575/15/0083‒0439$39.50/0   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/ca/b4/cro-0008-0439.PMC4649737.pdf
" Case Rep Oncol  2015;8:423 –425  DOI: 10.1159/000441122   Published online: October 14, 2015  © 2015 The Author(s)   Published  by S. Karger AG, Basel   1662‒6575/15/0083‒0423$39.50/0   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/11/fd/cro-0008-0423.PMC4649738.pdf
"Karger AG, Basel   1662‒680X/15/0073‒0213$39.50/0   www.karger.com/crn   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/52/28/crn-0007-0213.PMC4649740.pdf
" Case Rep Oncol 2015;8:456 –460  DOI: 10.1159/000441020   Published online: October 29, 2015  © 2015 The Author(s)   Published by S. Karger AG, Basel   1662‒6575/15/0083‒0456$39.50/0   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/d2/b0/cro-0008-0456.PMC4649744.pdf
" Case Rep Oncol 2015;8:461 –465  DOI: 10.1159/000441775   Published online: October 30, 2015  © 2015 The Author(s)   Published by S. Karger AG, Basel   1662‒6575/15/0083‒046 1$39.50/0   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/c9/1f/cro-0008-0461.PMC4649750.pdf
" Case Rep Oncol  2015;8:478 –481  DOI: 10.1159/000441836   Published online: November 4, 2015  © 2015 The Author(s)   Published  by S. Karger AG, Basel   1662‒6575/15/0083‒0478$39.50/0   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/bc/e3/cro-0008-0478.PMC4649752.pdf
" Case Rep Neurol 2015;7:227 –232  DOI: 10.1159/000441490   Published online: November 5, 2015  © 2015 The Author(s)   Published by S. Karger AG, Basel   1662‒680X/15/0073‒0227$39.50/0   www.karger.com/crn   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/3b/f2/crn-0007-0227.PMC4649754.pdf
" Case Rep Oncol 2015;8:4 26–431  DOI: 10.1159/000441415   Published online: October 16, 2015  © 2015 The Author(s)   Published by S. Karger AG, Basel   1662‒6575/15/0083‒0426$39.50/0   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/5e/83/cro-0008-0426.PMC4649755.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.",Non-OADS,/arxiv_data1/oa_pdf/18/7f/tmj.2014.0199.PMC4649761.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits anynoncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.JOURNAL OF WOMEN’S HEALTH Volume 24, Number 11, 2015DOI: 10.1089/jwh.2015.5220 867",Non-OADS,/arxiv_data1/oa_pdf/50/cc/jwh.2015.5220.PMC4649764.pdf
"Available at: http://us.milliman.com/insight/2014/ An-actuarial-analysis-of-breast-cancer-screening-and-follow- on-diagnostics-in-a-commercially-insured-population Ac- cessed March 5, 2014.",Non-OADS,/arxiv_data1/oa_pdf/50/cc/jwh.2015.5220.PMC4649764.pdf
"Available at: http://nordic.cochrane.org/sites/nordic.cochrane .org/ﬁles/uploads/images/mammography/mammography- leaﬂet.pdf Accessed February 22, 2014.",OADS,/arxiv_data1/oa_pdf/50/cc/jwh.2015.5220.PMC4649764.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.ANTIOXIDANTS & REDOX SIGNALING Volume 23, Number 13, 2015 DOI: 10.1089/ars.2015.6297 1001",Non-OADS,/arxiv_data1/oa_pdf/2e/67/ars.2015.6297.PMC4649766.pdf
The	protein	sequence	 was	examined	for	the	motifs	using	ExPASy	PROSITE	 (http://prosite.expasy.org/).,Non-OADS,/arxiv_data1/oa_pdf/e9/11/IJPhS-77-453.PMC4649777.pdf
"Thereafter,	 the	model	was	validated	using	PROCHECK, 	 ERRAT	and	VERIFY_3D	 present	at	Structural 	 Analysis	and	Verification	 server	(http://nihserver.mbi.",OADS,/arxiv_data1/oa_pdf/e9/11/IJPhS-77-453.PMC4649777.pdf
The	 active	site	prediction	in	the	CnsP2	protease	was	carried	 using	CASTp	Calculation	 web	tool	(http://sts-fw.bioengr.,OADS,/arxiv_data1/oa_pdf/e9/11/IJPhS-77-453.PMC4649777.pdf
Virtual screening of novel CnsP2 ligands and  structure retrieval: Novel	ligands	for	CnsP2	proteases	 were	screened	 from	PubChem 	(http://pubchem.ncbi.nlm.nih.,OADS,/arxiv_data1/oa_pdf/e9/11/IJPhS-77-453.PMC4649777.pdf
"Prior	to	docking,	the	protein	 structure	was	energy	minimized	 using	UCSF	Chimera	 for	500	steps	(http://www.cgl.ucsf.",Non-OADS,/arxiv_data1/oa_pdf/e9/11/IJPhS-77-453.PMC4649777.pdf
Available	from:	http://www.who.int/medicines/areas/quality_safety/safety_efficacy/Pharmacovigilance_B.,Non-OADS,/arxiv_data1/oa_pdf/db/f8/IJPhS-77-493.PMC4649779.pdf
Available	from:	http://www.ec.europa.eu/health/files/eudralex/ vol-1/dir_2001_83/2001_83_ec_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/db/f8/IJPhS-77-493.PMC4649779.pdf
The	clue	about	the	 amino	acids	involved	in	protein	catalysis	was	gained	 from	the	UniProt	Server	(http://www.uniprot.org/).Substrate selection: The	three-dimensional 	PDB	structures	 of	the	 phytochemicals	 present	in	the	aforesaid	 plants	and	 the	standard	FDA	approved	 drug	molecules	 were	 retrieved	from	KNApSAcK-3D	 (http://knapsack3d.,OADS,/arxiv_data1/oa_pdf/df/31/IJPhS-77-439.PMC4649782.pdf
sakura.ne.jp/)	 and	PubChem	(http://pubchem.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/df/31/IJPhS-77-439.PMC4649782.pdf
"Molecular property predictions: The	selected	phytochemicals	 were	examined 	for	 their	molecular	 properties,	 absorption,	 distribution, 	 metabolism	 and	excretion	 (ADME)		and	toxicity	 using	PreADMET 	(http://preadmet.bmdrc.org/).",OADS,/arxiv_data1/oa_pdf/df/31/IJPhS-77-439.PMC4649782.pdf
Available	 from:	 http://ayurveda-foryou.com/panchakarma/nasya.html.,Non-OADS,/arxiv_data1/oa_pdf/5b/21/IJPhS-77-367.PMC4649785.pdf
Available	from:	http://www.medicines.org.uk/emc/medicine/23962/SPC/ pecfent.,Non-OADS,/arxiv_data1/oa_pdf/5b/21/IJPhS-77-367.PMC4649785.pdf
Available from:  http://www.unodc.org/documents/wdr/WDR_2010/World_ Drug_Report_2010_lo-res.pdf [Last cited on 2015 Jan 20].,OADS,/arxiv_data1/oa_pdf/71/84/IJPsyM-37-330.PMC4649800.pdf
Available from: https://www.unodc.org/pdf/india/ publications/south_Asia_Regional_Profile_Sept_2005/10_ india.pdf.,Non-OADS,/arxiv_data1/oa_pdf/71/84/IJPsyM-37-330.PMC4649800.pdf
Available from: http://www.pubmedcentral.nih.gov/ articlerender.fcgi?artid=4041792&tool=pmcentrez&rende rtype=abstract [Last cited on 2015 Jan 20].,OADS,/arxiv_data1/oa_pdf/71/84/IJPsyM-37-330.PMC4649800.pdf
Available  from: http://www.who.int/substance_abuse/publications/ opioid_dependence_guidelines.pdf [Last cited 2015 Jan 20].,Non-OADS,/arxiv_data1/oa_pdf/71/84/IJPsyM-37-330.PMC4649800.pdf
Available from: http://www.who.int/ whr/2001/en/whr01_en.pdf [Last accessed on 2014 Nov 20] 2.,OADS,/arxiv_data1/oa_pdf/06/f1/IJPsyM-37-277.PMC4649809.pdf
Available from: http://ncrb.nic.in/ [Last accessed on 2011  Nov 20].,Non-OADS,/arxiv_data1/oa_pdf/06/f1/IJPsyM-37-277.PMC4649809.pdf
Available from: http://www.hindu.com/2008/01/31/ stories/2008013160930100.htm [Last accessed on 2011  Sept 16].,Non-OADS,/arxiv_data1/oa_pdf/06/f1/IJPsyM-37-277.PMC4649809.pdf
Available from: http://populationcommission.nic.in/facts1.,OADS,/arxiv_data1/oa_pdf/06/f1/IJPsyM-37-277.PMC4649809.pdf
Available from: http://ddp-ext.worldbank.,Non-OADS,/arxiv_data1/oa_pdf/06/f1/IJPsyM-37-277.PMC4649809.pdf
Available from: http://www.nlm.nic.in/lsi.htm [Last  accessed on 2011 Sept 16].,Non-OADS,/arxiv_data1/oa_pdf/06/f1/IJPsyM-37-277.PMC4649809.pdf
Available from: http://www.worldwide-tax.com/india/ ind_unemployment.asp [Last accessed on 2011 Sept 16].,Non-OADS,/arxiv_data1/oa_pdf/06/f1/IJPsyM-37-277.PMC4649809.pdf
Available from:  http://www.indexmundi.com/india/unemployment_rate.,Non-OADS,/arxiv_data1/oa_pdf/06/f1/IJPsyM-37-277.PMC4649809.pdf
Available from: http://economix.fr/ pdf/colloques/2006_India/Biswas_Sindzingre.pdf [Last  accessed on 2013 Nov 07].,Non-OADS,/arxiv_data1/oa_pdf/06/f1/IJPsyM-37-277.PMC4649809.pdf
World bank; 2001; Available  from: http://siteresources.worldbank.org/INTPOVERTY/ Resources/335642-1124115102975/1555199-1124115210798/ lanapp.pdf [Last accessed on 2013 Nov 07].,Non-OADS,/arxiv_data1/oa_pdf/06/f1/IJPsyM-37-277.PMC4649809.pdf
Warsaw 2005; Available from: http://www.tiger.edu.,Non-OADS,/arxiv_data1/oa_pdf/06/f1/IJPsyM-37-277.PMC4649809.pdf
Available from: http://rbidocs.rbi.org.in/rdocs/ Content/PDFs/2IGRDI050511.pdf [Last accessed on 2014  Mar 24].,OADS,/arxiv_data1/oa_pdf/06/f1/IJPsyM-37-277.PMC4649809.pdf
Available from: http://indiabudget.nic.in/es2001-02/ chapt2002/tab118.pdf [Last accessed on 2013 Nov 07].,Non-OADS,/arxiv_data1/oa_pdf/06/f1/IJPsyM-37-277.PMC4649809.pdf
Available from:  http://ncrb.nic.in/adsi2005/atable%202.2.pdf [Last accessed  on 2011 Sept 16].,OADS,/arxiv_data1/oa_pdf/06/f1/IJPsyM-37-277.PMC4649809.pdf
Available from: http://www.tn.gov.in/dear/tab06/a20.pdf  [Last accessed on 2009 Feb 01].,Non-OADS,/arxiv_data1/oa_pdf/06/f1/IJPsyM-37-277.PMC4649809.pdf
Available  from: http://dacnet.nic.in/eands/2.4%20(b)State-wise%20 Population%20Below%20%20Poverty%20Line%202004-05.,Non-OADS,/arxiv_data1/oa_pdf/06/f1/IJPsyM-37-277.PMC4649809.pdf
Available from: http://labourbureau.nic.in/cpa2tab.,Non-OADS,/arxiv_data1/oa_pdf/06/f1/IJPsyM-37-277.PMC4649809.pdf
Available  from: http://indiabudget.nic.in/es2006-07/chapt2007/tab94.,Non-OADS,/arxiv_data1/oa_pdf/06/f1/IJPsyM-37-277.PMC4649809.pdf
Available from: http://indiabudget.nic.in/es2006-07/ chapt2007/tab96.pdf [Last accessed on 2011 Sept 16].,Non-OADS,/arxiv_data1/oa_pdf/06/f1/IJPsyM-37-277.PMC4649809.pdf
Available from: http://www.indiabudget.nic.,Non-OADS,/arxiv_data1/oa_pdf/06/f1/IJPsyM-37-277.PMC4649809.pdf
Available from:  http://cwc.gov.in/Water_Data_Pocket_Book_2006/Table 2.05final.pdf [Last accessed on 2013 Nov 07].,OADS,/arxiv_data1/oa_pdf/06/f1/IJPsyM-37-277.PMC4649809.pdf
Available from:  http://www.iaes.org/conferences/past/charleston_50/ prelim_program/e60-2/jha.htm [Last accessed on 2008  Feb 14].,Non-OADS,/arxiv_data1/oa_pdf/06/f1/IJPsyM-37-277.PMC4649809.pdf
Available from:  http://blog.scopus.com/posts/the-nobel-laureates-in- scopus [Last cited on 2014 Dec 8].,Non-OADS,/arxiv_data1/oa_pdf/ad/5c/IJPsyM-37-376.PMC4649813.pdf
Available  from http://ajph.aphapublications.org/doi/pdf/10.2105/ AJPH.83.2.215 [Last accessed on 1 Nov 2014].,Non-OADS,/arxiv_data1/oa_pdf/da/3c/IJPsyM-37-299.PMC4649815.pdf
Available from: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/da/3c/IJPsyM-37-299.PMC4649815.pdf
Available from: http://www.aiims.,Non-OADS,/arxiv_data1/oa_pdf/84/91/IJPsyM-37-282.PMC4649816.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/6e/cd/IJPsyM-37-272.PMC4649817.pdf
Available from: http://www.pubchem.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/34/37/IJPsyM-37-345.PMC4649820.pdf
Available from: http://en.wikipedia.org/wiki/ Disaster [Last accessed on 2009 Nov 21].,Non-OADS,/arxiv_data1/oa_pdf/8b/28/IJPsyM-37-261.PMC4649821.pdf
"Available from: http://www.sphereproject.org/component/ option,com_docman/task,doc_download/gid,12/Itemid,26/ lang,English/.",OADS,/arxiv_data1/oa_pdf/8b/28/IJPsyM-37-261.PMC4649821.pdf
Available  from: http://www.searo.who.int/srilanka/documents/ psychological_first_aid_guide_for_field_workers.pdf  [Last accessed on 2014 Nov 2].,Non-OADS,/arxiv_data1/oa_pdf/8b/28/IJPsyM-37-261.PMC4649821.pdf
Available from: http://www.cdc.gov/ features/dsdev_disabilities/ [Last accessed on 2014 June 6].,OADS,/arxiv_data1/oa_pdf/4c/45/IJPsyM-37-311.PMC4649822.pdf
Available  from: http://timesofindia.indiatimes.com/city/hyderabad/ Backward-tribal-pockets-show-healthy-sex-ratio/ articleshow/19854175.cms [Last cited on 2014 June 6].,Non-OADS,/arxiv_data1/oa_pdf/4c/45/IJPsyM-37-311.PMC4649822.pdf
"Available  from: http://www.indiaonlinepages.com/population/ punjab-population.html [Last accessed on September 12,  2014].",Non-OADS,/arxiv_data1/oa_pdf/4c/45/IJPsyM-37-311.PMC4649822.pdf
Available from: http://www.fda.gov/Safety/MedWatch/ SafetyInformation/SafetyAlertsforHumanMedicalProducts/ ucm154914.htm.,Non-OADS,/arxiv_data1/oa_pdf/1d/e0/JFMPC-2-399.PMC4649867.pdf
Available from: http://www.who.int/mediacentre/ factsheets/fs317/en/index.html [Last accessed on Mar  2013].,OADS,/arxiv_data1/oa_pdf/64/1a/JFMPC-2-365.PMC4649869.pdf
Available from http://www.who.int/cardiovascular_ diseases/guidelines/PocketGL.ENGLISH.AFR-D-E.rev1.pdf  [Last accessed on Mar 2013].,Non-OADS,/arxiv_data1/oa_pdf/64/1a/JFMPC-2-365.PMC4649869.pdf
Available from: http://ish-world.com/ downloads/activities/colour_charts_24_Aug_07.pdf [Last  accessed Mar 2013].,Non-OADS,/arxiv_data1/oa_pdf/64/1a/JFMPC-2-365.PMC4649869.pdf
Available from: http://www.un.org/News/Press/docs//2011/wom1843.doc.htm [Last accessed on 2012 Dec 1].,Non-OADS,/arxiv_data1/oa_pdf/19/06/JFMPC-2-349.PMC4649870.pdf
Available from: http://www.censusindia.gov.,OADS,/arxiv_data1/oa_pdf/19/06/JFMPC-2-349.PMC4649870.pdf
"Source of Support:  None, Conflict of Interest:  None declaredfrom: http://censusindia.gov.in/vital_statistics/SRS_ Bulletins/Bulletins.aspx [Last accessed on 2012 Dec 1].",OADS,/arxiv_data1/oa_pdf/19/06/JFMPC-2-349.PMC4649870.pdf
Available from: http://www.fmpc2013.com/.,Non-OADS,/arxiv_data1/oa_pdf/46/d2/JFMPC-2-303.PMC4649875.pdf
Available from: http://www.nhsrcindia.,Non-OADS,/arxiv_data1/oa_pdf/46/d2/JFMPC-2-303.PMC4649875.pdf
Available from: http://nrhm-mis.nic.in/UI/RHS/RHS%20 2011/RHS%20-March%202011-%20Tables-%20Final%20 9.4.2012.pdf [Last accessed on 2013 Apr 9].,Non-OADS,/arxiv_data1/oa_pdf/c4/d0/JFMPC-2-326.PMC4649879.pdf
Available  from: http://www.knowledge.wharton.upenn.edu/india/ article.cfm?articleid=4719.,Non-OADS,/arxiv_data1/oa_pdf/30/f1/JFMPC-2-323.PMC4649882.pdf
Available from: http://www.ffpai.,Non-OADS,/arxiv_data1/oa_pdf/30/f1/JFMPC-2-323.PMC4649882.pdf
Available from: http://www.forbesindia.com/ article/breakpoint/reviving-the-family-doctor/33757/1.,Non-OADS,/arxiv_data1/oa_pdf/30/f1/JFMPC-2-323.PMC4649882.pdf
Ltd. 2012 Available from:  http://www.nationwidedocs.org/vision-mission-guiding-   principles/.,Non-OADS,/arxiv_data1/oa_pdf/30/f1/JFMPC-2-323.PMC4649882.pdf
Available from http://www.healthspring.in/home2/ vision/.,Non-OADS,/arxiv_data1/oa_pdf/30/f1/JFMPC-2-323.PMC4649882.pdf
Available from: http://www.afpionline.com/Pages/ CareerFamMed.aspx.,Non-OADS,/arxiv_data1/oa_pdf/30/f1/JFMPC-2-323.PMC4649882.pdf
"34, 1971. http://dc-siwan.bih.nic.in/mtp%20Act.pdf 2. WHO.",Non-OADS,/arxiv_data1/oa_pdf/3d/5a/JFMPC-2-376.PMC4649883.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/4.0/OPEN",Non-OADS,/arxiv_data1/oa_pdf/37/74/srep13510.PMC4649992.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.References 1.",Non-OADS,/arxiv_data1/oa_pdf/bf/7c/40801_2015_Article_32.PMC4650198.pdf
2001. http://www.stjames.ie/GPsHealthcareProfessionals/Newsletters/NMICBulletins/NMICBulletins2001/VOL7-3MEDICATION% 20ERRORS.pdf .,OADS,/arxiv_data1/oa_pdf/bf/7c/40801_2015_Article_32.PMC4650198.pdf
Geneva: WHO; 2004. http://apps.who.int/medicinedocs/ pdf/s6164e/s6164e.pdf .,OADS,/arxiv_data1/oa_pdf/bf/7c/40801_2015_Article_32.PMC4650198.pdf
2011.http://who-umc.org/Graphics/24729.pdf .,Non-OADS,/arxiv_data1/oa_pdf/bf/7c/40801_2015_Article_32.PMC4650198.pdf
2001. http://www.ismp-canada.org/download/ Medication%20Error%20Reporting%20Systems%20-% 20Problems%20and%20Solutions.pdf .,Non-OADS,/arxiv_data1/oa_pdf/bf/7c/40801_2015_Article_32.PMC4650198.pdf
"Geneva, Switzerland; 2014. p. 110. http://www.who.int/ medicines/areas/quality_safety/safety_efﬁcacy/emp_mes/en/ .",Non-OADS,/arxiv_data1/oa_pdf/bf/7c/40801_2015_Article_32.PMC4650198.pdf
2008. http://www.who-umc.org/graphics/ 24965.pdf .,Non-OADS,/arxiv_data1/oa_pdf/bf/7c/40801_2015_Article_32.PMC4650198.pdf
2015. http://who-umc.org/DynPage.aspx?id= 98082&mn1=7347&mn2=7252&mn3=7322&mn4=7326 .,OADS,/arxiv_data1/oa_pdf/bf/7c/40801_2015_Article_32.PMC4650198.pdf
2014.https://www.ismp.org/orderforms/reporterrortoismp.asp .,Non-OADS,/arxiv_data1/oa_pdf/bf/7c/40801_2015_Article_32.PMC4650198.pdf
2014. http://www.ema.europa.eu/ema/index.jsp?curl=pages/special_topics/general/general_content_000570.jsp .,Non-OADS,/arxiv_data1/oa_pdf/bf/7c/40801_2015_Article_32.PMC4650198.pdf
2011. http://apps.who.int/ medicinedocs/documents/s19152en/s19152en.pdf .,Non-OADS,/arxiv_data1/oa_pdf/bf/7c/40801_2015_Article_32.PMC4650198.pdf
"Make patient safety a pri- ority in Africa, patients urge 2011. http://www.who.int/ patientsafety/patients_for_patient/pfps_newsletter_july_2011_en.",Non-OADS,/arxiv_data1/oa_pdf/bf/7c/40801_2015_Article_32.PMC4650198.pdf
2004. https://www.healthdesign.org/sites/default/ ﬁles/Role%20Physical%20Environ%20in%20the%2021st%20Century%20Hospital_0.pdf .,OADS,/arxiv_data1/oa_pdf/bf/7c/40801_2015_Article_32.PMC4650198.pdf
"SUPPLEMENTARY MATERIAL is linked to the online version of the paper at http://www.nature.com/mi ACKNOWLEDGMENTS We thank Paresh Thakker for providing Il23afl/flmice, Miriam Merad for providing the AFS98 hybridoma cell line, Fanny Franchini for technical assistance, Philip Ahern for his comments and suggestions regarding the manuscript, Helen Ferry for flow cytometry cell sorting, and Richard Stillionfor histology.",Non-OADS,/arxiv_data1/oa_pdf/ce/40/mi201565a.PMC4650208.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)Wnt addiction treated by PORCN inhibition B Madan et al 2207 © 2016 Macmillan Publishers Limited Oncogene (2016) 2197 –2207",Non-OADS,/arxiv_data1/oa_pdf/9e/2f/onc2015280a.PMC4650263.pdf
"FH1–5^18 –20reduced glomerular C3 reactivity similar to full-length FH while also partially restoring plasmabasic research http://www.kidney-international.org © 2015 International Society of Nephrology Correspondence: Kevin J. Marchbank, Institute of Cellular and Genetic Medicine, School of Medicine, Newcastle University, 3rd Floor William Leech Building, Framlington Place, Newcastle upon Tyne NE2 4HH, UK.E-mail: Kevin.Marchbank@ncl.ac.uk 3These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/6a/71/ki2015233a.PMC4650264.pdf
Supplementary material is linked to the online version of the paper athttp://www.nature.com/ki REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/6a/71/ki2015233a.PMC4650264.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc- sa/4.0/ 1322 Kidney International (2015) 88, 1314 –1322basic research E-M Nichols et al.",Non-OADS,/arxiv_data1/oa_pdf/6a/71/ki2015233a.PMC4650264.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/GS Kaushal et al.",Non-OADS,/arxiv_data1/oa_pdf/0f/28/jid2015319a.PMC4650270.pdf
"To view a copy of this  license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/",Non-OADS,/arxiv_data1/oa_pdf/d6/01/cr2015120a.PMC4650423.pdf
Please read the full license for further details at - http://creativecommons.org/ licenses/by-nc-sa/4.0/,Non-OADS,/arxiv_data1/oa_pdf/b6/be/cr2015126a.PMC4650428.pdf
Available from: http://www.uroweb.org/guidelines/ online‑guidelines.,Non-OADS,/arxiv_data1/oa_pdf/ca/80/AJA-17-212.PMC4650459.pdf
Available from: http://www.fda.gov/downloads/AdvisoryCommittees/ CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ UCM412536.pdf.,Non-OADS,/arxiv_data1/oa_pdf/21/c7/AJA-17-201.PMC4650464.pdf
Available from: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/21/c7/AJA-17-201.PMC4650464.pdf
"The National Cholesterol Education Program under the auspices  of the National Heart, Lung and Blood Institute published the Adult  Treatment Panel  (ATP) III Clinical Identification of the MetS in  2001 ( Table  1) (http://www.nhlbi.nih.gov/files/docs/guidelines/ atp3xsum.pdf).",Non-OADS,/arxiv_data1/oa_pdf/50/1c/AJA-17-192.PMC4650473.pdf
The International Diabetes Federation (IDF) issued a consensus  statement in 2013 in which they further defined MetS and the criteria  for different races and ethnic groups ( Table  2) (http://www.idf.org/ metabolic syndrome).,Non-OADS,/arxiv_data1/oa_pdf/50/1c/AJA-17-192.PMC4650473.pdf
A risk assessment  calculator that uses information from the Framingham Heart Study  was developed to predict a person’s chance of having a heart attack in  the next 10 years (http://cvdrisk.nhlbi.nih.gov/calculator.asp).,Non-OADS,/arxiv_data1/oa_pdf/50/1c/AJA-17-192.PMC4650473.pdf
"In 2013, the American Heart Association and the American  College of Cardiology introduced a new ASCVD risk estimator  (http://tools.cardiosource.org/ASCVD-Risk-Estimator).",Non-OADS,/arxiv_data1/oa_pdf/50/1c/AJA-17-192.PMC4650473.pdf
"Men in the lowest  quartiles of serum TT, calculated free testosterone (cFT) and SHBG at  baseline had the highest odds ratios for developing the MetS or DM Table 1: ATP III clinical identification of the metabolic syndrome  (http://www.nhlbi.nih.gov/files/docs/guidelines/atp3xsum.pdf) Parameters Measurement Waist circumference Male >102 cm (>40 in) Female >88 cm (>35 in) Triglycerides ≥150 mg dl−1 HDL cholesterol Male <40 mg dl−1 Female <50 mg dl−1 BP ≥130/≥85 mmHg Fasting glucose ≥110 mg dl−1 Source: National Heart, Lung, and Blood Institute; National Institutes of Health;  US Department of Health and Human Services.",Non-OADS,/arxiv_data1/oa_pdf/50/1c/AJA-17-192.PMC4650473.pdf
"ATP: adult treatment panel; HDL: high  density lipoprotein; BP: blood pressure Table 2: International diabetes federation criteria for diagnosis of  metabolic syndrome (http://www.idf.org/metabolic syndrome) Central obesity (defined as waist circumference* with ethnicity specific values)  plus any two of the following four factors Raised  triglycerides≥150 mg dl−1 or Specific treatment for this lipid abnormality Reduced HDL  cholesterol<40 mg dl−1 in males <50 mg dl−1 in females or Specific treatment for this lipid abnormality Raised BP Systolic BP ≥130 or diastolic BP ≥85 mmHg or Treatment of previously diagnosed HTN Raised FPG FPG ≥100 mg dl−1 or Previously diagnosed type 2 DM If above 100 mg dl−1, OGTT is strongly recommended but is not  necessary to define presence of the syndrome Source: International Diabetes Federation.",Non-OADS,/arxiv_data1/oa_pdf/50/1c/AJA-17-192.PMC4650473.pdf
"TREATMENT OF THE METABOLIC SYNDROME Recommendations from the 2013 Consensus Conference held by  the IDF for management of the MetS include (http://www.idf.org/ metabolic syndrome): (1) patients should undergo a full cardiovascular  risk assessment (including smoking status) in conjunction with the  following: moderate calorie restriction (to achieve a 5%–10% loss of  body weight in the first year), moderate increase in physical activity,  change in dietary composition.",Non-OADS,/arxiv_data1/oa_pdf/50/1c/AJA-17-192.PMC4650473.pdf
"The  Food and Drug Administration in the United States has concluded that  the current evidence does not indicate significantly increased risk, but  trial data is needed (http://www.citizen.org/documents/2184_FDA%20 Denial%20of%20Petition_July%2016, %202014.pdf).",Non-OADS,/arxiv_data1/oa_pdf/50/1c/AJA-17-192.PMC4650473.pdf
Available  from: http://www.ipci2014.org/sites/ipci2014.org/files/icpd_eng.pdf.,OADS,/arxiv_data1/oa_pdf/f8/26/AJA-17-309.PMC4650475.pdf
Available from: http://www.cypalleles.ki.se/cyp3a4.htm.,Non-OADS,/arxiv_data1/oa_pdf/8c/e6/AJA-17-285.PMC4650481.pdf
"Available from: http://www.who.int/reproductivehealth/ publications/infertility/9789241547789/en.19 Quinn P, Barros C, Whittingham DG.",Non-OADS,/arxiv_data1/oa_pdf/fa/59/AJA-17-269.PMC4650482.pdf
Available from: http://www.census.gov/prod/cen2010/briefs/c2010br‑03.,OADS,/arxiv_data1/oa_pdf/1e/5e/AJA-17-206.PMC4650486.pdf
"The Korean Academy of Conservative Dentistry.255This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.The effect of different drinks on the color stability of different restorative materials after one month Objectives:  The aim of this study was to evaluate the effect of three different drinks  on the color parameters of four different restorative materials.",Non-OADS,/arxiv_data1/oa_pdf/7d/f1/rde-40-255.PMC4650520.pdf
"1Tekçe N; Serim ME, Department  of Restorative Dentistry, Faculty of Dentistry, University of Kocaeli, Kocaeli, Turkey  2Tuncer S; Demirci M, Department  of Conservative Dentistry, Faculty of Dentistry, Istanbul University, Istanbul, Turkey  3Baydemir C, Department  of Biostatistics and Medical Informatics, University of Kocaeli, Kocaeli, Turkey*Correspondence to Neslihan Tekçe, DDS, PhD.Assistant Professor, Department of Restorative Dentistry, Faculty of Dentistry, University of Kocaeli, Yuvacık, Basiskele, Kocaeli, TurkeyTEL, +0262 344 2111; FAX, +0262 344 2202; E-mail, neslihan_arslann@hotmail.comResearch article ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2015.40.4.255",Non-OADS,/arxiv_data1/oa_pdf/7d/f1/rde-40-255.PMC4650520.pdf
http://dx.doi.org/10.5395/rde.2015.40.4.255,Non-OADS,/arxiv_data1/oa_pdf/7d/f1/rde-40-255.PMC4650520.pdf
"Material type, composition and filler content of the materials used in the study  Material Type Content Filler content Dyract XP, Dentsply De Trey, Konstanz, GermanyPolyacid-modified composite resin(compomer)Urethane dimethacrylate (UDMA)Carboxylic acid modified dimethacrylate (TCB resin)Triethyleneglycol dimethacrylate (TEGDMA)Trimethacrylate resin (TMPTMA)Dimethacrylate resinsCamphorquinoneEthyl-4(dimethylamino)benzoateButylated hydroxy toluene (BHT)Strontium-alumino-sodium-fluoro-phosphor-silicate glassHighly dispersed silicon dioxideStrontium fluorideIron oxide pigments and titanium oxide pigmentsstrontium alimino-sodium-fluoro-silicate glass Strontium fluoride glass particles (0.8 µm)(47 wt%, 50 vol%) Filtek Ultimate  Universal,  Restorative (enamel)  3M ESPE, St. Paul,  MN, USANanofill composite NanoclusterBisphenol A-Glycidyl Methacrylate (Bis-GMA)Urethane dimethacrylate (UDMA) Triethylene glycol dimethacrylate (TEGDMA)  poly(ethylene glycol) dimethacrylate (PEGDMA)  ethoxylated bisphenol-A dimethacrylate (Bis-EMA)20 nm silica particuls,  4 - 11 nm zirkonyum  particuls  (78.5 wt% - 63.3 vol%) Filtek Ultimate  flowable, 3M ESPE,  St. Paul, MN, USANanofill composite(Low viscosity) Bisphenol A-Glycidyl Methacrylate (Bis-GMA)Urethane dimethacrylate (UDMA)Bis((methacryloxypropoxy)phenyl)propane (Bis-PMA)Triethylene glycol dimethacrylate (TEGDMA)Procrylat resins75 nm Silica nanofiller15 - 20 nm zirconia nanofillerytterbium trifluoride filler(65 wt% - 46 vol%) Filtek Silorane, 3M ESPE, St. Paul, MN, USASilorane composite(Low-shrink)Bis-3,4 Epoxy cyclohexylethyl phenyl methyl silane        (5 - 15 wt%)Epoxycyclohexylcyclopolymethyl siloxane, di- and epoxy-functional oligosiloxane trifluoride0.1 - 2 µm quartz particles(76 wt%, 55 vol%)The color stability of different restorative materials  http://dx.doi.org/10.5395/rde.2015.40.4.255",Non-OADS,/arxiv_data1/oa_pdf/7d/f1/rde-40-255.PMC4650520.pdf
http://dx.doi.org/10.5395/rde.2015.40.4.255,Non-OADS,/arxiv_data1/oa_pdf/7d/f1/rde-40-255.PMC4650520.pdf
reported The color stability of different restorative materials  http://dx.doi.org/10.5395/rde.2015.40.4.255,OADS,/arxiv_data1/oa_pdf/7d/f1/rde-40-255.PMC4650520.pdf
http://dx.doi.org/10.5395/rde.2015.40.4.255,Non-OADS,/arxiv_data1/oa_pdf/7d/f1/rde-40-255.PMC4650520.pdf
J Dent 2001;29:35-41.The color stability of different restorative materials  http://dx.doi.org/10.5395/rde.2015.40.4.255,Non-OADS,/arxiv_data1/oa_pdf/7d/f1/rde-40-255.PMC4650520.pdf
"The Korean Academy of Conservative Dentistry.262This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Comparison of mechanical properties of a new fiber reinforced composite and bulk filling composites Objectives:  The aim of this study was to evaluate the mechanical and physical  properties of a newly developed fiber reinforced dental composite.",Non-OADS,/arxiv_data1/oa_pdf/6d/d1/rde-40-262.PMC4650521.pdf
"1Abouelleil H; Pradelle N; Villat C; Attik  N; Colon P; Grosgogeat B, Laboratoire  des Multimatériaux et Interfaces, UMR CNRS 5615, Université Lyon1, Villeurbanne, France 2Pradelle N; Colon P, UFR D’odontologie,  Université Paris Diderot, APHP, Hôpital Rothschild, Service d’Odontologie, Paris, France 3Villat C; Grosgogeat B, UFR  Odontologie, Université Lyon1, Service de Consultations et de Traitements Dentaires, Hospices Civils de Lyon, Lyon, France *Correspondence to Hazem Abouelleil, DDS, MD.Dental practitioner and Lecturer, Laboratoire des Multimatériaux et Interfaces, UMR CNRS 5615, Université Lyon1, Villeurbanne, FranceTEL, +33(0)478778689; FAX, +33(0)478 778712; E-mail, hazem.abouelleil-sayed@univ-lyon1.frResearch article ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2015.40.4.262",Non-OADS,/arxiv_data1/oa_pdf/6d/d1/rde-40-262.PMC4650521.pdf
A modified flexural strength test was performed using bulk fill samples with 4 mm 2 cross  sectional areas polymerized only from the top side as done Mechanical properties of a fiber reinforced composite http://dx.doi.org/10.5395/rde.2015.40.4.262,Non-OADS,/arxiv_data1/oa_pdf/6d/d1/rde-40-262.PMC4650521.pdf
http://dx.doi.org/10.5395/rde.2015.40.4.262,OADS,/arxiv_data1/oa_pdf/6d/d1/rde-40-262.PMC4650521.pdf
"Scanning electron microscopy Scanning Electron microscope (S800-1, Hitachi Europe  Ltd., Whitebrook, Berkshire, UK) observations were  conducted under x80, x100, and x250 magnification to  http://dx.doi.org/10.5395/rde.2015.40.4.262",OADS,/arxiv_data1/oa_pdf/6d/d1/rde-40-262.PMC4650521.pdf
http://dx.doi.org/10.5395/rde.2015.40.4.262,OADS,/arxiv_data1/oa_pdf/6d/d1/rde-40-262.PMC4650521.pdf
"One interesting observation found from the fracture  toughness and the flexural strength test samples alike was that all fiber reinforced composite EXP samples remained attached, even after failure of the sample and formation of crack line, unlike the samples from other bulk fill brands  http://dx.doi.org/10.5395/rde.2015.40.4.262",Non-OADS,/arxiv_data1/oa_pdf/6d/d1/rde-40-262.PMC4650521.pdf
http://dx.doi.org/10.5395/rde.2015.40.4.262,OADS,/arxiv_data1/oa_pdf/6d/d1/rde-40-262.PMC4650521.pdf
Oper Dent 2001;26: 460-466. http://dx.doi.org/10.5395/rde.2015.40.4.262,OADS,/arxiv_data1/oa_pdf/6d/d1/rde-40-262.PMC4650521.pdf
"The Korean Academy of Conservative Dentistry.270This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Effect of immersion into solutions at various pH on the color stability of composite resins with different shades Objectives:  This study examined the color changes of a resin composite with different  shades upon exposure to water with different pH.",Non-OADS,/arxiv_data1/oa_pdf/96/00/rde-40-270.PMC4650522.pdf
"1Moon JD; Seon EM; Son SA;  Jung KH; Park JK, Department of Conservative Dentistry, School of Dentistry, Pusan National University, Yangsan, Korea 2Kwon YH, Department of Dental  Materials, School of Dentistry, Pusan National University, Yangsan, Korea*Correspondence to Jeong-Kil Park, DDS, MSD, PhD.Associate Professor, Department of Conservative Dentistry, School of Dentistry, Pusan National University, 20, Geumo-ro, Mulgeum-eup, Yangsan, 50612, KoreaTEL, +82-55-360-5221; FAX, +82-55-360-5214; E-mail, jeongkil@pusan.ac.krResearch article ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2015.40.4.270",Non-OADS,/arxiv_data1/oa_pdf/96/00/rde-40-270.PMC4650522.pdf
A post hoc  Tukey test was performed Color stability of composite at various pH solutions http://dx.doi.org/10.5395/rde.2015.40.4.270,Non-OADS,/arxiv_data1/oa_pdf/96/00/rde-40-270.PMC4650522.pdf
http://dx.doi.org/10.5395/rde.2015.40.4.270,Non-OADS,/arxiv_data1/oa_pdf/96/00/rde-40-270.PMC4650522.pdf
http://dx.doi.org/10.5395/rde.2015.40.4.270,Non-OADS,/arxiv_data1/oa_pdf/96/00/rde-40-270.PMC4650522.pdf
http://dx.doi.org/10.5395/rde.2015.40.4.270,Non-OADS,/arxiv_data1/oa_pdf/96/00/rde-40-270.PMC4650522.pdf
Dent Mater 2004;20:530- 534. http://dx.doi.org/10.5395/rde.2015.40.4.270,Non-OADS,/arxiv_data1/oa_pdf/96/00/rde-40-270.PMC4650522.pdf
"The Korean Academy of Conservative Dentistry.276This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and radiographical evaluation of mineral trioxide aggregate, biodentine and propolis as pulpotomy medicaments in primary teeth Objectives:  The purpose of this study was to evaluate the efficacy of mineral trioxide  aggregate (MTA), Biodentine and Propolis as pulpotomy medicaments in primary dentition, both clinically and radiographically.",Non-OADS,/arxiv_data1/oa_pdf/c4/42/rde-40-276.PMC4650523.pdf
"1Kusum B, Department of  Pedodontics and Preventive Dentistry, Maulana Azad Institute of Dental Sciences, MAMC complex,  BSZ Marg, New Delhi, India 2Rakesh K; Richa K, Department of  Pediatric and Preventive Dentistry,  Faculty of Dental Sciences, King George Medical University, Lucknow, India*Correspondence to Bharti Kusum, MDS.Senior Resident, Department of Pedodontics and Preventive Dentistry, Maulana Azad Institute of Dental Sciences, MAMC complex, BSZ Marg, New Delhi, 110002, India  TEL, +91-094-50361835; FAX, +91-011-23217081; E-mail, kusumbharti1984@gmail.comResearch article ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2015.40.4.276",Non-OADS,/arxiv_data1/oa_pdf/c4/42/rde-40-276.PMC4650523.pdf
"Group II Biodentine (Septodont, Saint-Maur-des-Fossés, France)  paste was obtained by mixing premeasured unit dose Pulpotomy medicaments in primary teeth http://dx.doi.org/10.5395/rde.2015.40.4.276",Non-OADS,/arxiv_data1/oa_pdf/c4/42/rde-40-276.PMC4650523.pdf
(a) (b) (c)Preoperative 3 Mon 6 Mon 9 Mon http://dx.doi.org/10.5395/rde.2015.40.4.276,Non-OADS,/arxiv_data1/oa_pdf/c4/42/rde-40-276.PMC4650523.pdf
"Clinical and radiographic scoring criteria Criteria for clinical and radiographic scoring Clinical score Clinical symptom Definition 1 asymptomatic•Pathology: absent  •Normal functioning  •Mobility (physiological) ≤ 1 mm  2 slight discomfort, short-lived•Pathology: questionable  •Percussion sensitivity  •Gingival inflammation (due to poor oral hygiene) •Mobility (physiological) > 1 mm, but < 2 mm  3 minor discomfort, short-lived•Pathology: initial changes present  •Gingival swelling (not due to poor oral hygiene)  •Mobility > 2 mm, but < 3 mm  4major discomfort, long-livedExtract immediately•Pathology: late changes present  •Spontaneous pain  •Gingival swelling (not due to poor oral hygiene)  •Periodontal pocket formation (exudate)  •Sinus tract present •Mobility ≥ 3 mm  •Premature tooth loss, due to pathology  Radiographic score Radiographic finding Definition 1no changes present at 6 mon  follow-up*•Internal root canal form tapering from chamber to the apex •Periodontal ligament (PDL)/periapical regions; normal width and  trabeculation 2pathological changes of  questionable clinical significance at 3 mon follow-up*•External changes are not allowed (widened PDL) widening, abnormal  inter-radicular trabeculation or variation in radiodensity  •Internal resorption acceptable (not perforated) •Calcific metamorphosis is acceptable and defined as: uniformly thin  root canal; shape (non-tapering); variation in radiodensity from canal to canal (one cloudier than the other) 3pathological changes present at 1 mon follow-up*•External changes are present, but not large  •Mildly widened PDL  •Minor inter-radicular radiolucency with trabeculation still present  •Minor external root resorption; internal resorption changes are  acceptable, but not if external change is also present (perforated form)  4pathological changes present Extract immediately•Frank osseous radiolucency present *time period from the beginning of the treatment to the assigned follow-up  http://dx.doi.org/10.5395/rde.2015.40.4.276",Non-OADS,/arxiv_data1/oa_pdf/c4/42/rde-40-276.PMC4650523.pdf
http://dx.doi.org/10.5395/rde.2015.40.4.276,Non-OADS,/arxiv_data1/oa_pdf/c4/42/rde-40-276.PMC4650523.pdf
Comparison of radiographic success rates in all the three groups over different follow-up periods.Success rate - Radiographic sign scores 100.0 100.0 100.0 100.0 96.0 96.092.0 92.0 88.0 80.0 72.0 72.0 0 Mon 3 Mon 6 Mon 9 Mon Follow-up periodFrequency (%)100.0 90.0 80.0 70.0 60.050.040.0 30.0 20.010.0 0.0Group I Group II Group III http://dx.doi.org/10.5395/rde.2015.40.4.276,Non-OADS,/arxiv_data1/oa_pdf/c4/42/rde-40-276.PMC4650523.pdf
8 Some researchers  http://dx.doi.org/10.5395/rde.2015.40.4.276,Non-OADS,/arxiv_data1/oa_pdf/c4/42/rde-40-276.PMC4650523.pdf
Pediatr Dent 2001;23:15- http://dx.doi.org/10.5395/rde.2015.40.4.276,Non-OADS,/arxiv_data1/oa_pdf/c4/42/rde-40-276.PMC4650523.pdf
"Fuks AB, Holan G, Davis JM, Eidelman E. Ferric sulfate  http://dx.doi.org/10.5395/rde.2015.40.4.276",OADS,/arxiv_data1/oa_pdf/c4/42/rde-40-276.PMC4650523.pdf
Available from: http://scielo.sld.cu/scielo.php?script=sci_abstract&pid=S0034-75072007000300006&lng=en&nrm=iso&tlng=en (updated 2015 Sep 3).,OADS,/arxiv_data1/oa_pdf/c4/42/rde-40-276.PMC4650523.pdf
Br Dent J 2000;188:417. http://dx.doi.org/10.5395/rde.2015.40.4.276,OADS,/arxiv_data1/oa_pdf/c4/42/rde-40-276.PMC4650523.pdf
"The Korean Academy of Conservative Dentistry.286This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Influence of a glide path on the dentinal crack formation of ProTaper Next system Objectives:  The aim was to evaluate dentinal crack formation after root canal  preparation with ProTaper Next system (PTN) with and without a glide path.",Non-OADS,/arxiv_data1/oa_pdf/70/4b/rde-40-286.PMC4650524.pdf
"Assistant Professor, Department of Endodontics, Faculty of Dentistry, Bülent Ecevit University, Kozlu 67600, Zonguldak, TurkeyTEL, +03722613639; FAX, +03722613400; E-mail, sevincaktemur@hotmail.comResearch article ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2015.40.4.286",Non-OADS,/arxiv_data1/oa_pdf/70/4b/rde-40-286.PMC4650524.pdf
(a)  (b)  (c)Effect of glide path on dentinal crack http://dx.doi.org/10.5395/rde.2015.40.4.286,Non-OADS,/arxiv_data1/oa_pdf/70/4b/rde-40-286.PMC4650524.pdf
http://dx.doi.org/10.5395/rde.2015.40.4.286,Non-OADS,/arxiv_data1/oa_pdf/70/4b/rde-40-286.PMC4650524.pdf
Scanning 2015;37:49-53. http://dx.doi.org/10.5395/rde.2015.40.4.286,Non-OADS,/arxiv_data1/oa_pdf/70/4b/rde-40-286.PMC4650524.pdf
"The Korean Academy of Conservative Dentistry.290This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Effect of dentin treatment on proliferation and differentiation of human dental pulp stem cells   Objectives:  Sodium hypochlorite (NaOCl) is an excellent bactericidal agent, but it is  detrimental to stem cell survival, whereas intracanal medicaments such as calcium hydroxide (Ca[OH] 2) promote the survival and proliferation of stem cells.",Non-OADS,/arxiv_data1/oa_pdf/84/45/rde-40-290.PMC4650525.pdf
"1Park M; Jung IY, Department of  Conservative Dentistry, Yonsei University College of Dentistry, Seoul, Korea 2Pang NS, Department of Advanced  General Dentistry, Oral Science Research Center, Yonsei University College of Dentistry, Seoul, Korea*Correspondence to Il-Young Jung, DDS, MSD, PhD.Professor, Department of Conservative Dentistry, Yonsei University College of Dentistry, 50 Yonsei-ro, Seodaemun-gu, Seoul, Korea 03722TEL, +82-2-2228-3151; FAX, +82-2-313-7575; E-mail, juen@yuhs.acResearch article ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2015.40.4.290 †Minjeong Park and Nan-Sim Pang contributed equally to this article.",Non-OADS,/arxiv_data1/oa_pdf/84/45/rde-40-290.PMC4650525.pdf
"In Group 4, 5.25% NaOCl and 1 mg/mL Ca(OH) 2 treatments were followed by Effect of dentin treatment in regenerative endodontics http://dx.doi.org/10.5395/rde.2015.40.4.290",Non-OADS,/arxiv_data1/oa_pdf/84/45/rde-40-290.PMC4650525.pdf
http://dx.doi.org/10.5395/rde.2015.40.4.290,Non-OADS,/arxiv_data1/oa_pdf/84/45/rde-40-290.PMC4650525.pdf
Growth characteristics and immunophenotypic characterization of established cell lines  Cell lineDoubling  time (hr)Growth  characteristicCD146 Stro-1 CD90 CD105 CD34 CD45 1 28.2 adherent 85.6 11.7 92.3 93.3 0.5 1.8 2 32.1 adherent 78.2 15.3 96.2 92.2 0.9 2.0 3 25.3 adherent 82.2 15.8 97.1 96.1 1.2 2.4 4 26.2 adherent 89.5 14.9 91.8 94.7 1.5 1.5 5 29.3 adherent 80.5 10.2 90.6 95.6 0.9 1.4 6 30.1 adherent 95.1 11.9 93.2 89.3 1.3 1.9 7 28.5 adherent 88.1 10.1 95.2 90.2 1.2 2.0 8 30.5 adherent 87.2 17.2 95.1 95.5 1.4 2.1 9 29.4 adherent 83.1 13.3 95.6 92.2 0.9 2.1 10 30.2 adherent 77.1 17.1 97.2 93.1 1.0 1.8 11 27.6 adherent 95.3 10.9 96.6 95.2 1.6 1.7 Total 28.8 ± 1.9 85.6 ± 6.2 13.4 ± 2.7 94.6 ± 2.2 93.4 ± 2.2 1.1 ± 0.3 1.9 ± 0.3 (%) http://dx.doi.org/10.5395/rde.2015.40.4.290,Non-OADS,/arxiv_data1/oa_pdf/84/45/rde-40-290.PMC4650525.pdf
http://dx.doi.org/10.5395/rde.2015.40.4.290,Non-OADS,/arxiv_data1/oa_pdf/84/45/rde-40-290.PMC4650525.pdf
3 2 1 0Fold change of DMP-1 expression Control          G2              G3            G4             G5(a) 32 1 0Fold change of DSPP-1 expression Control          G2              G3            G4             G5(b) http://dx.doi.org/10.5395/rde.2015.40.4.290,Non-OADS,/arxiv_data1/oa_pdf/84/45/rde-40-290.PMC4650525.pdf
http://dx.doi.org/10.5395/rde.2015.40.4.290,Non-OADS,/arxiv_data1/oa_pdf/84/45/rde-40-290.PMC4650525.pdf
Effect of dentin  http://dx.doi.org/10.5395/rde.2015.40.4.290,Non-OADS,/arxiv_data1/oa_pdf/84/45/rde-40-290.PMC4650525.pdf
http://dx.doi.org/10.5395/rde.2015.40.4.290,Non-OADS,/arxiv_data1/oa_pdf/84/45/rde-40-290.PMC4650525.pdf
"The Korean Academy of Conservative Dentistry.299This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.The effect of saliva decontamination procedures on dentin bond strength after universal adhesive curing Objectives:  The purpose of this study was to investigate the effectiveness of multiple  decontamination procedures for salivary contamination after curing of a universal adhesive on dentin bond strength according to its etch modes.",Non-OADS,/arxiv_data1/oa_pdf/e7/59/rde-40-299.PMC4650526.pdf
"Associate Professor, Department of Conservative Dentistry, Wonkwang University School of Dentistry and Oral Science Research Center, 460 Iksandae-ro, Iksan, Korea 54538TEL, +82-63-850-6629; FAX, +82-63-859-6932; E-mail, conspsj@wku.ac.krResearch article ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2015.40.4.299",Non-OADS,/arxiv_data1/oa_pdf/e7/59/rde-40-299.PMC4650526.pdf
http://dx.doi.org/10.5395/rde.2015.40.4.299,Non-OADS,/arxiv_data1/oa_pdf/e7/59/rde-40-299.PMC4650526.pdf
http://dx.doi.org/10.5395/rde.2015.40.4.299,Non-OADS,/arxiv_data1/oa_pdf/e7/59/rde-40-299.PMC4650526.pdf
http://dx.doi.org/10.5395/rde.2015.40.4.299,Non-OADS,/arxiv_data1/oa_pdf/e7/59/rde-40-299.PMC4650526.pdf
"Orcid numberSujung Park, 0000-0003-3457-1242Saliva decontamination for universal adhesive http://dx.doi.org/10.5395/rde.2015.40.4.299",Non-OADS,/arxiv_data1/oa_pdf/e7/59/rde-40-299.PMC4650526.pdf
http://dx.doi.org/10.5395/rde.2015.40.4.299,Non-OADS,/arxiv_data1/oa_pdf/e7/59/rde-40-299.PMC4650526.pdf
Saliva decontamination for universal adhesive http://dx.doi.org/10.5395/rde.2015.40.4.299,Non-OADS,/arxiv_data1/oa_pdf/e7/59/rde-40-299.PMC4650526.pdf
"The Korean Academy of Conservative Dentistry.306This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Identification of Enterococcus faecalis antigens specifically expressed in vivo Objectives:  Molecular mechanism of the pathogenicity of Enterococcus faecalis ( E.  faecalis), a suspected endodontic pathogen, has not yet been adequately elucidated due to limited information on its virulence factors.",Non-OADS,/arxiv_data1/oa_pdf/86/44/rde-40-306.PMC4650527.pdf
"1,2Lee SW, Department of Dental  Education, Department of Periodontology, Dental Science Research Institute and BK21 Project, School of Dentistry, Chonnam National University, Gwangju, Korea 3Shet UK, Department of Maxillofacial  Surgery, Dental Science Research Institute and BK21 Project, School of Dentistry, Chonnam National University, Gwangju, Korea 4Park SW; Lim HP; Yun KD, Department of  Prosthodontics, Dental Science Research Institute and BK21 Project, School of Dentistry, Chonnam National University, Gwangju, Korea 5Kang SS; Kim SE, Department of  Veterinary Medicine, Chonnam National University, Gwangju, Korea*Correspondence to Seok-Woo Lee, DDS, MS, PhD.Professor, Departments of Dental Education and Department of Periodontology, School of Dentistry, Chonnam National University, 77 Yongbong-ro, Buk-gu, Gwangju, Korea 61186TEL, +82-62-530-5820; FAX, +82-62-530-5810; E-mail, swlee@jnu.ac.krResearch article ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2015.40.4.306",Non-OADS,/arxiv_data1/oa_pdf/86/44/rde-40-306.PMC4650527.pdf
"Additional local anesthesia of 2% lidocaine hydrochloride with 1:100,000 epinephrine was In vivo induced antigens of E. faecalis http://dx.doi.org/10.5395/rde.2015.40.4.306",Non-OADS,/arxiv_data1/oa_pdf/86/44/rde-40-306.PMC4650527.pdf
http://dx.doi.org/10.5395/rde.2015.40.4.306,Non-OADS,/arxiv_data1/oa_pdf/86/44/rde-40-306.PMC4650527.pdf
"Identified gene sequences were compared to DNA and protein databases using a BLAST program (http://www.ncbi.nlm.nih.gov) and analyzed by Vector NTI Software (Invitrogen, Carlsbad, CA, USA).",OADS,/arxiv_data1/oa_pdf/86/44/rde-40-306.PMC4650527.pdf
Optical dentistry (450 nm) 0.2000  0.1000  0.0500  0.0250  0.0125  0.0063  0.0031  0.0016  0.0008  0.0004  0.0002  0.00010.6 0.5 0.4 0.30.2 0.1 0Adsorbed serum Non-adsorbed serum Serum dilution http://dx.doi.org/10.5395/rde.2015.40.4.306,Non-OADS,/arxiv_data1/oa_pdf/86/44/rde-40-306.PMC4650527.pdf
"E. faecalis protein antigens identified by CMAT GenBank Protein ID Protein name Function AFA92809.1 Deoxyribose-phosphate aldolase Energy metabolism AEA94635.1 Selenide, water dikinase Energy metabolism ADX80204.1 Beta-glucosidase Energy metabolism AA079953.1 Oxidoreductase Energy metabolism PF08503.3 Tetrahydrodipicolinate N-acetyltransferase Energy metabolism ADX80368.1 3-ketoacyl-(acyl-carrier-protein) reductase Energy metabolism AEA93036.1 Diaminopimelate epimerase Energy metabolism AEA92693.1 DNA topoisomerase subunit A Transcription EF62_0348 rRNA-23S ribosomal RNA Transcription AEA93730.1 Translation initiation factor IF2 Transcription ADX79467.1 Alanine racemase Amino acid biosynthesis AEA95149.1 Response regulator sensor histidine kinase Cellular process ACF94631.1 Copper resistance protein Energy metabolism AA080103.1 Putative membrane protein Outer membrane protein ADX79209.1 Conserved hypothetical protein Unknown ADX81283 Conserved hypothetical protein Unknown http://dx.doi.org/10.5395/rde.2015.40.4.306",Non-OADS,/arxiv_data1/oa_pdf/86/44/rde-40-306.PMC4650527.pdf
http://dx.doi.org/10.5395/rde.2015.40.4.306,Non-OADS,/arxiv_data1/oa_pdf/86/44/rde-40-306.PMC4650527.pdf
http://dx.doi.org/10.5395/rde.2015.40.4.306,Non-OADS,/arxiv_data1/oa_pdf/86/44/rde-40-306.PMC4650527.pdf
Microbiology 2008;154:1161-1169. http://dx.doi.org/10.5395/rde.2015.40.4.306,Non-OADS,/arxiv_data1/oa_pdf/86/44/rde-40-306.PMC4650527.pdf
"The Korean Academy of Conservative Dentistry.314This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Management of apicomarginal defect in esthetic region associated with a tooth with anomalies  Tooth related factors such as palatoradicular groove can be one of the causes for localized periodontal destruction.",Non-OADS,/arxiv_data1/oa_pdf/a2/f0/rde-40-314.PMC4650528.pdf
"1Meharwade VV; Mali PP, Department  of Periodontology, Sinhgad Dental College and Hospital, Pune, Maharashtra State, India 2Shah DY; Meharwade VV,  Department of Conservative Dentistry, Sinhgad Dental College and Hospital, Pune, Maharashtra State, India*Correspondence to Vinayak Venkoosa Meharwade, BDS, MDS.Assistant Professor, Department of Periodontology, Sinhgad Dental College and Hospital Pune, 4/A, Anant Jyoti Society, Sahakarnagar No-1, Pune, Maharashtra State, IndiaTEL, +910224223208; FAX, +910224351308; E-mail, drmvinayak@gmail.comCase report ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2015.40.4.314",Non-OADS,/arxiv_data1/oa_pdf/a2/f0/rde-40-314.PMC4650528.pdf
Preoperative intraoral periapical radiograph.Apicomarginal defect in esthetic region http://dx.doi.org/10.5395/rde.2015.40.4.314,Non-OADS,/arxiv_data1/oa_pdf/a2/f0/rde-40-314.PMC4650528.pdf
http://dx.doi.org/10.5395/rde.2015.40.4.314,Non-OADS,/arxiv_data1/oa_pdf/a2/f0/rde-40-314.PMC4650528.pdf
http://dx.doi.org/10.5395/rde.2015.40.4.314,Non-OADS,/arxiv_data1/oa_pdf/a2/f0/rde-40-314.PMC4650528.pdf
http://dx.doi.org/10.5395/rde.2015.40.4.314,Non-OADS,/arxiv_data1/oa_pdf/a2/f0/rde-40-314.PMC4650528.pdf
http://dx.doi.org/10.5395/rde.2015.40.4.314,Non-OADS,/arxiv_data1/oa_pdf/a2/f0/rde-40-314.PMC4650528.pdf
"Naik M, de Ataide Ide N, Fernandes M, Lambor R. Treatment of combined endodontic: periodontic lesion  http://dx.doi.org/10.5395/rde.2015.40.4.314",Non-OADS,/arxiv_data1/oa_pdf/a2/f0/rde-40-314.PMC4650528.pdf
Indian J Dent Res 2012;23:415-418. http://dx.doi.org/10.5395/rde.2015.40.4.314,Non-OADS,/arxiv_data1/oa_pdf/a2/f0/rde-40-314.PMC4650528.pdf
"The Korean Academy of Conservative Dentistry.322This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Treatment of non-vital immature teeth with amoxicillin-containing triple antibiotic paste resulting in apexification A recent treatment option for non-vital immature teeth in young patients is revascularization with triple antibiotic paste (TAP).",Non-OADS,/arxiv_data1/oa_pdf/34/13/rde-40-322.PMC4650529.pdf
ac.krCase report ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2015.40.4.322,Non-OADS,/arxiv_data1/oa_pdf/34/13/rde-40-322.PMC4650529.pdf
(a) (b) (c) (d) (e)Amoxicillin-containing triple antibiotic treatment of immature teeth  http://dx.doi.org/10.5395/rde.2015.40.4.322,Non-OADS,/arxiv_data1/oa_pdf/34/13/rde-40-322.PMC4650529.pdf
(a) (b) (c) (d) http://dx.doi.org/10.5395/rde.2015.40.4.322,Non-OADS,/arxiv_data1/oa_pdf/34/13/rde-40-322.PMC4650529.pdf
http://dx.doi.org/10.5395/rde.2015.40.4.322,Non-OADS,/arxiv_data1/oa_pdf/34/13/rde-40-322.PMC4650529.pdf
http://dx.doi.org/10.5395/rde.2015.40.4.322,Non-OADS,/arxiv_data1/oa_pdf/34/13/rde-40-322.PMC4650529.pdf
J Endod 2004;30:196-200. http://dx.doi.org/10.5395/rde.2015.40.4.322,OADS,/arxiv_data1/oa_pdf/34/13/rde-40-322.PMC4650529.pdf
"The Korean Academy of Conservative Dentistry.328This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Statistical notes for clinical researchers: effect sizeOpen lecture on statistics ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2015.40.4.328 In most clinical studies, p  value is the final result of data analysis.",Non-OADS,/arxiv_data1/oa_pdf/55/70/rde-40-328.PMC4650530.pdf
"n t value p value Effect size Characteristics 1 145 142 100 3 1000.3 0.3820.03Trivial effect &  insignificant 2 145 142 100 3 10,0003 0.0010.03Trivial effect &  significant 3 145 115 100 30 1003 0.0010.30Substantial effect &  significant *SD, standard deviation.=       3    100/√100=   3    100 =       3    100/√10,000=   3    100 =       3    100/√100=  30    100 http://dx.doi.org/10.5395/rde.2015.40.4.328",Non-OADS,/arxiv_data1/oa_pdf/55/70/rde-40-328.PMC4650530.pdf
10    0.2 http://dx.doi.org/10.5395/rde.2015.40.4.328,Non-OADS,/arxiv_data1/oa_pdf/55/70/rde-40-328.PMC4650530.pdf
Available from: http://www.leeds.ac.uk/educol/documents/00002182.htm  (updated  2015 Sep 6) .,Non-OADS,/arxiv_data1/oa_pdf/55/70/rde-40-328.PMC4650530.pdf
Available from: http://www2.jura.uni-hamburg.de/instkrim/kriminologie/Mitarbeiter/Enzmann/Lehre/StatIIKrim/EffectSizeBecker.pdf  (updated 2015 Sep 6) .Table 4.,Non-OADS,/arxiv_data1/oa_pdf/55/70/rde-40-328.PMC4650530.pdf
"Conversion from various statistics to Perason r correlation coefficient  association measures3  Statistic Conversion formula Comment χ2df = 1 r =A single degree of freedom chi-square value divided by the number of cases t r = From t value to r correlation coefficient  F r = From F value with single freedom numerator to r  Cohen’s d r = From Cohen’s d to rχ 2df = 1       N√    t2 t2 + df√    d2 d2 + 4√   F(df = 1,_) F(df = 1,_) + df(error) √ http://dx.doi.org/10.5395/rde.2015.40.4.328",Non-OADS,/arxiv_data1/oa_pdf/55/70/rde-40-328.PMC4650530.pdf
"The Korean Academy of Conservative Dentistry.332This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Simple methods to enhance bond strength of self-adhesive resin cementsReaders' forum ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2015.40.4.332 How can we improve the bond strength between resin cements and the tooth substrate when cementing indirect  restorations with self-adhesive resin cements?Q The use of self-adhesive resin cements is accomplished by a simple clinical step, in which the simultaneous  demineralization/infiltration of the bonding substrate takes place.",Non-OADS,/arxiv_data1/oa_pdf/bf/b6/rde-40-332.PMC4650531.pdf
Dent Mater J 2012;31:980-987. http://dx.doi.org/10.5395/rde.2015.40.4.332,Non-OADS,/arxiv_data1/oa_pdf/bf/b6/rde-40-332.PMC4650531.pdf
"The Korean Academy of Conservative Dentistry.334This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Working width, a deserted aspect of Endodontics Understanding the complexity of the root canal system and the aim to provide  successful endodontic treatment has led to the development of newer techniques, instruments, and materials.",Non-OADS,/arxiv_data1/oa_pdf/26/a3/rde-40-334.PMC4650532.pdf
"10,13 ISSN 2234-7658 (print) / ISSN 2234-7666 (online) http://dx.doi.org/10.5395/rde.2015.40.4.334 Letter to editor Denzil Albuquerque1,  Jojo Kottoor2* 1Private Practice, Dental Expert,  Mumbai, Maharashtra, India 2Department of Conservative Dentistry  and Endodontics, Mar Baselios Dental College, Kochi, Kerala, India  Received August 4, 2015; Accepted September 6, 2015.",Non-OADS,/arxiv_data1/oa_pdf/26/a3/rde-40-334.PMC4650532.pdf
Available from: http://www.fkg.ch/products/endodontics/root-canal-preparation-and-retreatment/xp-endo-finisher (updated 2015 Sep 8).,Non-OADS,/arxiv_data1/oa_pdf/26/a3/rde-40-334.PMC4650532.pdf
Dent Clin North Am 2008;52:707-730. http://dx.doi.org/10.5395/rde.2015.40.4.334,Non-OADS,/arxiv_data1/oa_pdf/26/a3/rde-40-334.PMC4650532.pdf
The additional files and  information are available at: http://www.regulatoryrna.org/pub/ miwi_cleave/index.html.,OADS,/arxiv_data1/oa_pdf/29/fd/cr20154a.PMC4650574.pdf
Please read the full license for further details at - http://creativecommons.org/ licenses/by-nc-sa/4.0/,Non-OADS,/arxiv_data1/oa_pdf/b3/62/cr2015109a.PMC4650626.pdf
"To view a copy of this  license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/",Non-OADS,/arxiv_data1/oa_pdf/4e/dd/cr2015110a.PMC4650627.pdf
"To view a copy of this  license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/",Non-OADS,/arxiv_data1/oa_pdf/13/f3/cr201596a.PMC4650630.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2015  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseApril 2015 |  98  | e51524 | Page 1 of 8Video Article Behavioral Phenotyping of Murine Disease Models with the Integrated Behavioral Station (INBEST) Boris Sakic1, Marcella P. A. Cooper2, Sarah E. Taylor2, Milica Stojanovic2, Bosa Zagorac2, Minesh Kapadia3 1Department of Psychiatry and Behavioral Neurosciences, McMaster University 2Department of Psychology, Neuroscience & Behaviour, McMaster University 3Neuroscience Program, McMaster University Correspondence to: Boris Sakic at sakic@mcmaster.ca URL: http://www.jove.com/video/51524 DOI: doi:10.3791/51524 Keywords: Behavior, Issue 98, behavioral phenotyping, Integrated Behavioral Station, disease models, home-cage monitoring, computerized tracking, chronic studies, mice Date Published: 4/23/2015 Citation: Sakic, B., Cooper, M.P.A., Taylor, S.E., Stojanovic, M., Zagorac, B., Kapadia, M. Behavioral Phenotyping of Murine Disease Models with the Integrated Behavioral Station (INBEST).",Non-OADS,/arxiv_data1/oa_pdf/7e/25/jove-98-51524.PMC4650674.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/51524/ Introduction Rapid advancements in genetic engineering over the past few decades have led to an unprecedented proliferation of animal models of human diseases.,Non-OADS,/arxiv_data1/oa_pdf/7e/25/jove-98-51524.PMC4650674.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8424 | DOI: 10.1038/srep08424 5",Non-OADS,/arxiv_data1/oa_pdf/47/f3/srep08424.PMC4650823.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/66/d4/srep07572.PMC4650828.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7572 | DOI: 10.1038/srep07572 9",Non-OADS,/arxiv_data1/oa_pdf/66/d4/srep07572.PMC4650828.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/4.0/OPEN",Non-OADS,/arxiv_data1/oa_pdf/a6/d5/srep15932.PMC4650830.pdf
Open AccessL Burback Aripiprazole for microprolactinomaID: 15-0100; November 2015 DOI: 10.1530/EDM-15-0100 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0Unported License .q2015 The authors http://www.edmcasereports.com Published by Bioscientiﬁca Ltd,Non-OADS,/arxiv_data1/oa_pdf/cb/ae/edmcr-2015-150100.PMC4650831.pdf
L Burback Aripiprazole for microprolactinomaID: 15-0100; November 2015 DOI: 10.1530/EDM-15-0100 http://www.edmcasereports.com 2,Non-OADS,/arxiv_data1/oa_pdf/cb/ae/edmcr-2015-150100.PMC4650831.pdf
L Burback Aripiprazole for microprolactinomaID: 15-0100; November 2015 DOI: 10.1530/EDM-15-0100 http://www.edmcasereports.com 3,Non-OADS,/arxiv_data1/oa_pdf/cb/ae/edmcr-2015-150100.PMC4650831.pdf
Trials utilized aripiprazole in doses ranging from 2 L Burback Aripiprazole for microprolactinomaID: 15-0100; November 2015 DOI: 10.1530/EDM-15-0100 http://www.edmcasereports.com 4,Non-OADS,/arxiv_data1/oa_pdf/cb/ae/edmcr-2015-150100.PMC4650831.pdf
L Burback Aripiprazole for microprolactinomaID: 15-0100; November 2015 DOI: 10.1530/EDM-15-0100 http://www.edmcasereports.com 5,Non-OADS,/arxiv_data1/oa_pdf/cb/ae/edmcr-2015-150100.PMC4650831.pdf
(doi:10.1007/s00213-013-3154-1 ) Received in ﬁnal form 26 September 2015 Accepted 6 October 2015 L Burback Aripiprazole for microprolactinomaID: 15-0100; November 2015 DOI: 10.1530/EDM-15-0100 http://www.edmcasereports.com 6,Non-OADS,/arxiv_data1/oa_pdf/cb/ae/edmcr-2015-150100.PMC4650831.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2f/f4/pcv139.PMC4650865.pdf
"The molar fraction of atmospheric CO 2(XCO 2) was obtained from NOAA (http://esrl.noaa.gov) (ppm), and pH2O5water vapor pressure ( matm) was obtained from Reference 38.",OADS,/arxiv_data1/oa_pdf/52/6c/srep06164.PMC4650900.pdf
"Determination CONAMA Nu357,http://www.mma.gov.br/port/conama .",OADS,/arxiv_data1/oa_pdf/52/6c/srep06164.PMC4650900.pdf
"ANA-Brazilian National Water Agency ,http://www.ana.gov.br .",Non-OADS,/arxiv_data1/oa_pdf/52/6c/srep06164.PMC4650900.pdf
"IBGE-Brazilian Institute of Geography and Statistics ,http://www.ibge.gov.br .",Non-OADS,/arxiv_data1/oa_pdf/52/6c/srep06164.PMC4650900.pdf
"A6 , (eds U.S. Geological Survey), 1–45 (available online at ,http://pubs.water.usgs.gov/ twri9A ., 2012, data of access: 01/10/2013).",OADS,/arxiv_data1/oa_pdf/52/6c/srep06164.PMC4650900.pdf
"17(available online at ,http://pubs.usgs.gov/of/2010/1280 ., 2010, data of access: 05/10/2013).",OADS,/arxiv_data1/oa_pdf/52/6c/srep06164.PMC4650900.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/52/6c/srep06164.PMC4650900.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a9/31/srep05006.PMC4650901.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5006 | DOI: 10.1038/srep05006 12",Non-OADS,/arxiv_data1/oa_pdf/a9/31/srep05006.PMC4650901.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/12/c9/bmjgast-2015-000050.PMC4650904.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/2d/bb/bmjgast-2015-000057.PMC4650907.pdf
Secondary hepatitis C key facts April 2014. http://www.who.int/mediacentre/factsheets/fs164/en/ 3.,Non-OADS,/arxiv_data1/oa_pdf/2d/bb/bmjgast-2015-000057.PMC4650907.pdf
2013. http://www.stata.com/support/faqs/statistics/meta-analysis/ 11.,OADS,/arxiv_data1/oa_pdf/2d/bb/bmjgast-2015-000057.PMC4650907.pdf
"Recommendations for testing, managing, and treating hepatitis C. Secondary recommendations for testing,managing, and treating hepatitis C. 2015. http://www.hcvguidelines.org http://dx.doi.org/10.1002/hep.27950 18.",Non-OADS,/arxiv_data1/oa_pdf/2d/bb/bmjgast-2015-000057.PMC4650907.pdf
"For more information, visithttp://light.ece.uiuc.edu/.Author contributions B.B.",Non-OADS,/arxiv_data1/oa_pdf/96/19/srep06211.PMC4650916.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: G.P.,Non-OADS,/arxiv_data1/oa_pdf/96/19/srep06211.PMC4650916.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5641 | DOI: 10.1038/srep05641 6",Non-OADS,/arxiv_data1/oa_pdf/40/88/srep05641.PMC4650917.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/4.0/Serum exosomal miRNAs in hepatocellular carcinoma WS o h n et al 8 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/7e/30/emm201568a.PMC4650928.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/4.0/RKIP signaling in cancers AA Farooqi et al 7 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/8d/25/emm201570a.PMC4650930.pdf
"To view a copy of this license, visit http://creativecommons.org/li censes/by-nc-sa/4.0/ Supplementary Information accompanies the paper on Experime ntal & Molecular Medicine website (http://www.nature.com/emm)Effective Vaccination by using EVs of K. pneumonia W-H Lee et al 9 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/8d/03/emm201559a.PMC4650931.pdf
"To view a copy of this license, visit http://creativecommons.org/li censes/by-nc-sa/4.0/ Supplementary Information accompanies the paper on Experime ntal & Molecular Medicine website (http://www.nature.com/emm)Neovascularization by proangiogenic cells Y-E Choi et al 11 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/05/ed/emm201560a.PMC4650932.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6448 | DOI: 10.1038/srep06448 5",Non-OADS,/arxiv_data1/oa_pdf/f8/14/srep06448.PMC4650933.pdf
"analyzed the data, and wrote the paperwith assistance from D.W. Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.",Non-OADS,/arxiv_data1/oa_pdf/63/63/srep07296.PMC4650936.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7296 | DOI: 10.1038/srep07296 8",Non-OADS,/arxiv_data1/oa_pdf/63/63/srep07296.PMC4650936.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any mediu m, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/72/d8/aev371.PMC4650961.pdf
"The websites of the American Society of Anesthesiologists ( http://www.asahq.org ), Australian and New Zealand College of Anaesthetists ( http://www.anzca.edu.au ), European Society of Anesthesiologists ’(http://www.esahq.org/ euroanaesthesia ), Canadian Anesthesiologists ’Society ( http:// www.cas.ca ), and the Scandinavian Society of Anesthesiology and Intensive Care Medicine ( http://ssai.info/guidelines/ )w e r e also searched for airway guidelines.",Non-OADS,/arxiv_data1/oa_pdf/72/d8/aev371.PMC4650961.pdf
Available from http://vortexapproach.com/Vortex_Approach/Vortex.,OADS,/arxiv_data1/oa_pdf/72/d8/aev371.PMC4650961.pdf
Available from http://www.anzca.,Non-OADS,/arxiv_data1/oa_pdf/72/d8/aev371.PMC4650961.pdf
Available from http://www.anzca.edu.au/fellows/continuing-professional-development/pdfs/emergency-r esponse-activity-cico.pdf (accessed 22nd February 2015) 17.,Non-OADS,/arxiv_data1/oa_pdf/72/d8/aev371.PMC4650961.pdf
Available from https://www.health.qld.840 |Frerk et al.,OADS,/arxiv_data1/oa_pdf/72/d8/aev371.PMC4650961.pdf
Avail- able from http://www.nrls.npsa.nhs.uk/resources/?entry id45=59860 (accessed 30 May 2015) 25.,Non-OADS,/arxiv_data1/oa_pdf/72/d8/aev371.PMC4650961.pdf
Available from http://www.airwaycam.,Non-OADS,/arxiv_data1/oa_pdf/72/d8/aev371.PMC4650961.pdf
Available from http://www.das.uk.com/ guidelines/other/ ﬁbreoptic-guided-tracheal-intubation- through-sad-using-aintree-intubation-catheter (accessed 27 July 2015) 255.,Non-OADS,/arxiv_data1/oa_pdf/72/d8/aev371.PMC4650961.pdf
Available from http://www.chfg.org/resources/07_qrt04/Anonymous_ Report_Verdict_and_Corrected_Timeline_Oct07.pdf (ac- cessed 12 April 2015) 263.,Non-OADS,/arxiv_data1/oa_pdf/72/d8/aev371.PMC4650961.pdf
Available from https://www.smash words.com/books/view/377530 (accessed 5 January 2014) 269.,Non-OADS,/arxiv_data1/oa_pdf/72/d8/aev371.PMC4650961.pdf
Available from https://www.smashwords.,Non-OADS,/arxiv_data1/oa_pdf/72/d8/aev371.PMC4650961.pdf
Available from http://www.das.uk.com/guidelines/airwayalert.html (accessed 4 August 2015) 306.,Non-OADS,/arxiv_data1/oa_pdf/72/d8/aev371.PMC4650961.pdf
Available from https://www.medicalert.org.,Non-OADS,/arxiv_data1/oa_pdf/72/d8/aev371.PMC4650961.pdf
Available from http://www.rcoa.ac.uk/document-store/cpd-matrix (accessed 4 August 2015) Handling editor: R. P. Mahajan848 |Frerk et al.,OADS,/arxiv_data1/oa_pdf/72/d8/aev371.PMC4650961.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseMarch 2014 |  85  | e51444 | Page 1 of 7Video Article Mizoroki-Heck Cross-coupling Reactions Catalyzed by Dichloro{bis[1,1',1''- (phosphinetriyl)tripiperidine]}palladium Under Mild Reaction Conditions Miriam Oberholzer1, Christian M. Frech2 1Institute of Inorganic Chemistry, University of Zürich 2Institute of Chemistry & Biological Chemistry, Zürich University of Applied Sciences Correspondence to: Christian M. Frech at christian.frech@zhaw.ch URL: http://www.jove.com/video/51444 DOI: doi:10.3791/51444 Keywords: Chemistry, Issue 85, Heck reaction, C-C cross-coupling, Catalysis, Catalysts, green chemistry, Palladium, Aminophosphines, Palladium nanoparticles, Reaction mechanism, water-induced ligand degradation Date Published: 3/20/2014 Citation: Oberholzer, M., Frech, C.M.",Non-OADS,/arxiv_data1/oa_pdf/f3/dd/jove-85-51444.PMC4650967.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/51444/ Introduction Palladium-catalyzed C-C cross-coupling reactions, which were acknowledged by the award of the Nobel Prize in chemistry in December 2010, nowadays belong to an indispensable tool for the target oriented synthesis of complex organic molecules across all research fields and industrial segments.",OADS,/arxiv_data1/oa_pdf/f3/dd/jove-85-51444.PMC4650967.pdf
bioRxiv 2015; doi: http://dx.doi.org/ 10.1101/014498.,Non-OADS,/arxiv_data1/oa_pdf/10/73/coped-27-685.PMC4650984.pdf
" Case Rep Dermatol  2015;7:322 –327  DOI: 10.1159/000441601   Published online: October 30, 2015  © 2015 The Author(s)   Published  by S. Karger AG, Basel   1662‒6567/15/0073‒0322$39.50/0   www.karger.com/cde   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/15/64/cde-0007-0322.PMC4650989.pdf
" Case Rep Dermatol  2015;7:306 –310  DOI: 10.1159/000441602   Published online: October 28, 2015  © 2015 The Author(s)   Published  by S. Karger AG, Basel   1662‒6567/15/0073‒0306$39.50/0   www.karger.com/cde   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/63/3e/cde-0007-0306.PMC4650990.pdf
" Case Rep Dermatol  2015;7:316 –321  DOI: 10.1159/000441412   Published online: October 29, 2015  © 2015 The Author(s)   Published  by S. Karger AG, Basel   1662‒6567/15/0073‒0316$39.50/0   www.karger.com/cde   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/7c/c6/cde-0007-0316.PMC4650991.pdf
" Case Rep Dermatol  2015;7:292 –297  DOI: 10.1159/000441347   Published online: October 10, 2015  © 2015 The Author(s)   Published  by S. Karger AG, Basel   1662‒6567/15/0073‒0292$39.50/0   www.karger.com/cde   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/a8/5d/cde-0007-0292.PMC4650992.pdf
" Case Rep Dermatol  2015;7:298 –302  DOI: 10.1159/000441249   Published online: October 10, 2015  © 2015 The Author(s)   Published  by S. Karger AG, Basel   1662‒6567/15/0073‒0298$39.50/0   www.karger.com/cde   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/f3/70/cde-0007-0298.PMC4650993.pdf
" Case Rep Dermatol 2015;7:311 –315  DOI: 10.1159/000441467   Published online: October 29, 2015  © 2015 The Author(s)   Published by S. Karger AG, Basel   1662‒6567/15/0073‒0311$39.50/0   www.karger.com/cde   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/75/ad/cde-0007-0311.PMC4650994.pdf
" Case Rep Dermatol 2015;7:303 –305  DOI: 10.1159/ 000441248   Published online: October 16, 2015  © 2015 The Author(s)   Published by S. Karger AG, Basel   1662‒6567/15/0073‒0303$39.50/0   www.karger.com/cde   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/fb/d3/cde-0007-0303.PMC4650995.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-sa/4.0/",Non-OADS,/arxiv_data1/oa_pdf/e6/42/mtm201544.PMC4650997.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License ( <http://creativecommons.org/licenses/by-nc/4.0/ >) which permits any non- commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.AIDS RESEARCH AND HUMAN RETROVIRUSES Volume 31, Number 11, 2015DOI: 10.1089/aid.2015.0034 1178",Non-OADS,/arxiv_data1/oa_pdf/7d/ae/aid.2015.0034.PMC4651018.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License ( <http://creativecommons.org/licenses/by-nc/4.0/ >) which permits any non- commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.AIDS RESEARCH AND HUMAN RETROVIRUSES Volume 31, Number 11, 2015DOI: 10.1089/aid.2015.0151 1170",Non-OADS,/arxiv_data1/oa_pdf/6a/51/aid.2015.0151.PMC4651022.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use, distribution, and re-production in any medium, provided the original author(s) and the source are credited.",Non-OADS,/arxiv_data1/oa_pdf/e7/67/wound.2015.0645.PMC4651054.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use, d is- tribution, and reproduction in any medium, provided the original author(s) and the source are credited.JOURNAL OF NEUROTRAUMA 32:1805–1814 (November 15, 2015) DOI: 10.1089/neu.2014.3736 1805",Non-OADS,/arxiv_data1/oa_pdf/4a/4e/neu.2014.3736.PMC4651056.pdf
Peptide mass data were used to query the National Center for Biotechnology Information protein sequence database accessed through the ProteinProspector MS-Fit search engine (http://prospector.ucsf.edu/prospector/mshome .htm).,OADS,/arxiv_data1/oa_pdf/4a/4e/neu.2014.3736.PMC4651056.pdf
"KeckBiotechnology Resource Laboratory, Yale University (http://keck.med.yale.edu/index.aspx).",OADS,/arxiv_data1/oa_pdf/4a/4e/neu.2014.3736.PMC4651056.pdf
and N.D. contributed equally to this work.Supplemental material for this article may be found at http://dx.doi.org/10.1128 /AEM.01573-15 .,Non-OADS,/arxiv_data1/oa_pdf/68/5b/zam8164.PMC4651090.pdf
Science 344: 1246843. http://dx.doi.org/10.1126/science.1246843 .,Non-OADS,/arxiv_data1/oa_pdf/68/5b/zam8164.PMC4651090.pdf
http://www.pnl.gov/main/publications /external/technical_reports/PNNL-16983.pdf .,Non-OADS,/arxiv_data1/oa_pdf/68/5b/zam8164.PMC4651090.pdf
http://dx.doi.org/10.1111/j.1469-8137 .2010.03327.x .,Non-OADS,/arxiv_data1/oa_pdf/68/5b/zam8164.PMC4651090.pdf
Nat Prod Rep 28:1883– 1896. http://dx.doi.org/10.1039/c1np00042j .,OADS,/arxiv_data1/oa_pdf/68/5b/zam8164.PMC4651090.pdf
http://dx.doi.org/10.1271 /bbb.60437 .,Non-OADS,/arxiv_data1/oa_pdf/68/5b/zam8164.PMC4651090.pdf
http://dx.doi.org/10.1002/1521-4028(200107)41:3/4 /H11021185::AID-JOBM1 85/H110223.0.CO;2-T .,Non-OADS,/arxiv_data1/oa_pdf/68/5b/zam8164.PMC4651090.pdf
http://dx.doi.org/10.1021/cb300383y .,Non-OADS,/arxiv_data1/oa_pdf/68/5b/zam8164.PMC4651090.pdf
Biochemistry 53:4047– 4058. http://dx.doi.org/10.1021/bi500285t .,Non-OADS,/arxiv_data1/oa_pdf/68/5b/zam8164.PMC4651090.pdf
http://dx.doi.org/10.1021 /bi101892z .,Non-OADS,/arxiv_data1/oa_pdf/68/5b/zam8164.PMC4651090.pdf
Curr OpinBiotechnol 22:394 – 400. http://dx.doi.org/10.1016/j.copbio.2010.10.009 .,OADS,/arxiv_data1/oa_pdf/68/5b/zam8164.PMC4651090.pdf
http://dx.doi.org/10.1016/j.cbpa.2013.11 .015.,OADS,/arxiv_data1/oa_pdf/68/5b/zam8164.PMC4651090.pdf
http://dx.doi.org/10.1016/j.biortech.2013.04.033 .,OADS,/arxiv_data1/oa_pdf/68/5b/zam8164.PMC4651090.pdf
http://dx.doi.org/10.1128/AEM.00223-14 .,Non-OADS,/arxiv_data1/oa_pdf/68/5b/zam8164.PMC4651090.pdf
http://dx.doi.org/10 .1007/s00253-013-5166-5 .,Non-OADS,/arxiv_data1/oa_pdf/68/5b/zam8164.PMC4651090.pdf
Characterization and genomic analysis of kraft lignin biodegradation by the beta-proteobacterium Cupriavidus basilensis B-8.Biotechnol Biofuels 6:1. http://dx.doi.org/10.1186/1754-6834-6-1 .,Non-OADS,/arxiv_data1/oa_pdf/68/5b/zam8164.PMC4651090.pdf
http://dx.doi.org/10 .1021/cb300608x .,Non-OADS,/arxiv_data1/oa_pdf/68/5b/zam8164.PMC4651090.pdf
Enzyme Microb Technol 10:646 – 655. http://dx.doi.org/10.1016/0141-0229(88)90055-5 .,OADS,/arxiv_data1/oa_pdf/68/5b/zam8164.PMC4651090.pdf
http://dx.doi.org/10.1016/0168-1656(90)90098-V .,OADS,/arxiv_data1/oa_pdf/68/5b/zam8164.PMC4651090.pdf
http://dx.doi.org/10.1016/S0300-9084(85)80292-3 .,OADS,/arxiv_data1/oa_pdf/68/5b/zam8164.PMC4651090.pdf
http://dx.doi.org/10.1016/0923-2508(92)90025-J .,OADS,/arxiv_data1/oa_pdf/68/5b/zam8164.PMC4651090.pdf
http://dx.doi.org/10.1271/bbb1961.52.3073 .,Non-OADS,/arxiv_data1/oa_pdf/68/5b/zam8164.PMC4651090.pdf
http://dx.doi.org/10.1128 /AEM.00880-09 .,Non-OADS,/arxiv_data1/oa_pdf/68/5b/zam8164.PMC4651090.pdf
http://dx.doi.org/10.1128 /JB.185.6.1768-1775.2003 .,Non-OADS,/arxiv_data1/oa_pdf/68/5b/zam8164.PMC4651090.pdf
http://dx.doi.org/10.1271/bbb .110525 .,Non-OADS,/arxiv_data1/oa_pdf/68/5b/zam8164.PMC4651090.pdf
J Biol Chem 289: 8656 – 8667. http://dx.doi.org/10.1074/jbc.M113.536250 .,OADS,/arxiv_data1/oa_pdf/68/5b/zam8164.PMC4651090.pdf
http://dx.doi.org/10.1021/es503886d .,Non-OADS,/arxiv_data1/oa_pdf/68/5b/zam8164.PMC4651090.pdf
http://dx.doi.org/10.1002/bit.24833 .,OADS,/arxiv_data1/oa_pdf/68/5b/zam8164.PMC4651090.pdf
http://dx.doi.org/10.1002/jobm .3620370309 .,Non-OADS,/arxiv_data1/oa_pdf/68/5b/zam8164.PMC4651090.pdf
Tetrahedron Lett 53:842– 845. http://dx.doi.org/10.1016/j.tetlet.2011.12.016 .,Non-OADS,/arxiv_data1/oa_pdf/68/5b/zam8164.PMC4651090.pdf
http://dx.doi.org/10 .1016/0014-5793(89)80656-8 .,OADS,/arxiv_data1/oa_pdf/68/5b/zam8164.PMC4651090.pdf
J Comput Biol 19:455– 477. http://dx.doi.org/10.1089 /cmb.2012.0021 .,OADS,/arxiv_data1/oa_pdf/68/5b/zam8164.PMC4651090.pdf
http://dx.doi.org/10 .1093/bioinformatics/btq224 .,OADS,/arxiv_data1/oa_pdf/68/5b/zam8164.PMC4651090.pdf
http://dx.doi.org/10 .1093/molbev/msu300 .,Non-OADS,/arxiv_data1/oa_pdf/68/5b/zam8164.PMC4651090.pdf
http://dx.doi .org/10.1093/molbev/mst024 .,Non-OADS,/arxiv_data1/oa_pdf/68/5b/zam8164.PMC4651090.pdf
http://dx.doi.org/10.1016/j.fgb.2014.03.007 .,OADS,/arxiv_data1/oa_pdf/68/5b/zam8164.PMC4651090.pdf
http://dx.doi.org/10 .1007/s10532-014-9695-0 .,Non-OADS,/arxiv_data1/oa_pdf/68/5b/zam8164.PMC4651090.pdf
Biotechnol Biofuels 6:14. http://dx.doi .org/10.1186/1754-6834-6-14 .,Non-OADS,/arxiv_data1/oa_pdf/68/5b/zam8164.PMC4651090.pdf
"http://dx.doi.org/10 .1021/cb400505a .53.Kunjapur AM, Tarasova Y, Prather KLJ.",OADS,/arxiv_data1/oa_pdf/68/5b/zam8164.PMC4651090.pdf
http://dx.doi.org/10.1021/ja506664a .,OADS,/arxiv_data1/oa_pdf/68/5b/zam8164.PMC4651090.pdf
http://dx.doi.org/10.1128/JB.187.6.2030-2037 .2005 .,Non-OADS,/arxiv_data1/oa_pdf/68/5b/zam8164.PMC4651090.pdf
http://dx.doi.org/10.1126/science.1257570 .Palamuru et al.,OADS,/arxiv_data1/oa_pdf/68/5b/zam8164.PMC4651090.pdf
"Availabe at http://www.apho.org.uk/resource/item.aspx?RID=111280, (last accessed 23 March 2012).",Non-OADS,/arxiv_data1/oa_pdf/f3/1c/bjc2015311a.PMC4651121.pdf
type: Online Source http://www.cancerresearchuk.org/cancer-info/cancerstats/types/breast/.,Non-OADS,/arxiv_data1/oa_pdf/bc/03/bjc2015287a.PMC4651125.pdf
A description of the real-time PCR assay and the list of human miRNAs included in the panel can be found on the manufacturer’s website (http://www.appliedbiosystems.com).,Non-OADS,/arxiv_data1/oa_pdf/d7/48/bjc2015300a.PMC4651127.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)miR-221/222 as tumour suppressors in CRPC signature BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.300 1065,Non-OADS,/arxiv_data1/oa_pdf/d7/48/bjc2015300a.PMC4651127.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Breast density and subtypes of breast cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.315 1113,Non-OADS,/arxiv_data1/oa_pdf/e8/69/bjc2015315a.PMC4651128.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Discrepant mitotic index and Ki67 in breast cancer: prognosis 1002 www.bjcancer.com | DOI:10.1038/bjc.2015.239,Non-OADS,/arxiv_data1/oa_pdf/60/1f/bjc2015239a.PMC4651130.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER The roles of tumour-associated LECs in gastric cancer 1054 www.bjcancer.com | DOI:10.1038/bjc.2015.282,Non-OADS,/arxiv_data1/oa_pdf/f8/6f/bjc2015282a.PMC4651131.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)DII and BrCa study in Swedish women BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.304 1103,Non-OADS,/arxiv_data1/oa_pdf/5d/a3/bjc2015304a.PMC4651132.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Second-line gemcitabine plus Nab-paclitaxel BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.328 995,Non-OADS,/arxiv_data1/oa_pdf/f7/c0/bjc2015328a.PMC4651133.pdf
"With 1541 incident pancreatic cancers, the NIH-AARP Diet and Health Study (http://dietandhealth.cancer.gov/) includes more than two times the number of cases as compared with the largest single prospective study to date (Bhoo-Pathy et al, 2013), and allows for further investigation of potential differences in risk between caffeinated and decaffeinated coffee.",Non-OADS,/arxiv_data1/oa_pdf/0f/93/bjc2015235a.PMC4651134.pdf
"The NIH-AARP Diet and Health Study, detailed elsewhere (http://dietandhealth.cancer.gov/) (Schatzkin et al, 2001), included 566 398 participants who responded to the mailed study questionnaire, which collected data on demographics,health-related behaviours, and diet.",Non-OADS,/arxiv_data1/oa_pdf/0f/93/bjc2015235a.PMC4651134.pdf
"National Cancer Institute: Bethesda, MD, USA, Available at http://seer.cancer.gov/csr/1975_2012/(based on November 2014 SEERdata submission, posted to the SEER website, April 2015).",Non-OADS,/arxiv_data1/oa_pdf/0f/93/bjc2015235a.PMC4651134.pdf
Available athttp://www.dietandcancerreport.org (last accessed 15 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/0f/93/bjc2015235a.PMC4651134.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Coffee intake and risk of pancreatic cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.235 1085,Non-OADS,/arxiv_data1/oa_pdf/0f/93/bjc2015235a.PMC4651134.pdf
For the statistical analyses of the generated array data BRB Array tools Version 4.2.1 (https:// linus.nci.nih.gov/BRB-ArrayTools.html) and R statistical software Version 2.14.2 (https://cran.r-project.org/bin/windows/base/old/ 2.14.2/) were used.,OADS,/arxiv_data1/oa_pdf/e3/c7/bjc2015303a.PMC4651135.pdf
Available from http://worldwide.espacenet.com/ publicationDetails/biblio?DB=worldwide.espacenet.com&II=1&ND=3&adjacent=true&locale=en_EP&FT=D&date=20150625&CC=WO&NR=2015091979A2&KC=A2.,Non-OADS,/arxiv_data1/oa_pdf/e3/c7/bjc2015303a.PMC4651135.pdf
Available from: http://worldwide.espacenet.com/publicationDetails/biblio?DB=worldwide.espacenet.com&II=4&ND=3&adjacent=true&locale=en_EP&FT=D&date=20111124&CC=US&NR=2011287968A1&KC=A1.,Non-OADS,/arxiv_data1/oa_pdf/e3/c7/bjc2015303a.PMC4651135.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)DNA methylation in rectal cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.303 1045,Non-OADS,/arxiv_data1/oa_pdf/e3/c7/bjc2015303a.PMC4651135.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Biomarker data for aflibercept in first-line mCRC 1034 www.bjcancer.com | DOI:10.1038/bjc.2015.329,Non-OADS,/arxiv_data1/oa_pdf/86/9c/bjc2015329a.PMC4651136.pdf
"http://informahealthcare.com/drt ISSN: 1061-186X (print), 1029-2330 (electronic) J Drug Target, 2014; 22(5): 460–467 !2014 Informa UK Ltd. DOI: 10.3109/1061186X.2014.888070 ORIGINAL ARTICLE Glutathione PEGylated liposomes: pharmacokinetics and delivery of cargo across the blood–brain barrier in rats Jaap Rip1, Linda Chen1, Robin Hartman2, Angelique van den Heuvel1, Arie Reijerkerk1, Joan van Kregten1, Burt van der Boom1, Chantal Appeldoorn1, Marco de Boer1, David Maussang1, Elizabeth C. M. de Lange2, and Pieter J. Gaillard1 1to-BBB technologies BV, Leiden, The Netherlands and2Division of Pharmacology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands Abstract Partly due to poor blood–brain barrier drug penetration the treatment options for many brain diseases are limited.",Non-OADS,/arxiv_data1/oa_pdf/ae/3d/DRT-22-460.PMC4651142.pdf
"http://informahealthcare.com/ada ISSN: 0095-2990 (print), 1097-9891 (electronic) Am J Drug Alcohol Abuse, 2014; 40(1): 82 !2014 Informa Healthcare USA, Inc. DOI: 10.3109/00952990.2013.867966 ERRATUM Correction to: The advent of a new pseudoephedrine product to combat methamphetamine abuse The publisher and authors would like to draw the reader’s attention to two errors in the following article: Brzeczko AW, Leech R, Stark JG.",Non-OADS,/arxiv_data1/oa_pdf/5a/5d/ADA-40-82.PMC4651157.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/4f/94/msv164.PMC4651229.pdf
"Brieﬂy, the sRNA data were quality-ﬁltered, trimmed of adaptors, and collapsed and counted according to nonredundant sequences; thenthe distinct sRNA sequences were mapped to the P. abies genome (Pabies 1.0; http://congenie.org/, last accessed August 8, 2015) with no mismatches allowed.",OADS,/arxiv_data1/oa_pdf/4f/94/msv164.PMC4651229.pdf
2009 ) was optimized to analyze the PARE data in collaboration with Targetﬁnder 1.6 ( https://github.com/ carringtonlab/TargetFinder?,Non-OADS,/arxiv_data1/oa_pdf/4f/94/msv164.PMC4651229.pdf
"The model gene ﬁle (Pabies1.0_ HC_cds.fna), which contains well-annotated genes of high conﬁdence, and the gene homolog annotation ﬁle (pabies_poplar.txt), were obtained from the ConGenIE (http://congenie.org/, last a ccessed August 8, 2015).",OADS,/arxiv_data1/oa_pdf/4f/94/msv164.PMC4651229.pdf
"2007 ).PHAS loci of coding potential /C01<CP<0 were then retrieved for comparison by BLAST against the public protein data set UniRef90 (http://www.uniprot.o rg/help/uniref, last accessed August 8, 2015).",OADS,/arxiv_data1/oa_pdf/4f/94/msv164.PMC4651229.pdf
"Accession Numbers All the sRNA data for 44 libraries can be found in the ENA database (http://www.ebi.ac.uk /ena/, last accessed August 8, 2015), project number ERP002476 ( Nystedt et al.",OADS,/arxiv_data1/oa_pdf/4f/94/msv164.PMC4651229.pdf
"Sequence data for the four PARE libraries are deposited in the Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/ geo/, last accessed August 8, 2015) under the accession number of GSE65248.Supplementary Material Supplementary ﬁles S1 and S2,tables S1–S11 ,a n d ﬁgures S1–S3 are available at Molecular Biology and Evolution online (http://www.mbe.o xfordjournals.org/).",OADS,/arxiv_data1/oa_pdf/4f/94/msv164.PMC4651229.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/5e/d2/msv168.PMC4651232.pdf
"Ninety-nine per- cent binomial conﬁdence intervals were calculated in theMSTATv.6.1.1 statistical package ( http://mcardle.wisc.edu/ mstat/ ) to establish the statistical difference in the quantity of synonymous changes between the S. eubayanus and S. cerevisiae subgenomes of the lager-brewing yeasts ( supple- mentary table S4 ,Supplementary Material online) and to construct error bars in ﬁgure 5 .M S T A Tw a sa l s ou s e dt o perform Wilcoxon rank-sum tests on the data in ﬁgure 6 .",OADS,/arxiv_data1/oa_pdf/5e/d2/msv168.PMC4651232.pdf
"The percent identity between gene sequences, either amino acid or nucleotide as applicable, was calculated from MUSCLEalignments using Clustal2.1 accessed from the MUSCLE server ( http://www.ebi.ac.uk/Tools/msa/muscle/ ).",OADS,/arxiv_data1/oa_pdf/5e/d2/msv168.PMC4651232.pdf
Gene trees were made in MEGA 6.06 ( http://www.megasoftware.net/ ) (Tamura et al.,OADS,/arxiv_data1/oa_pdf/5e/d2/msv168.PMC4651232.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/01/54/msv156.PMC4651234.pdf
Williams 82 genome database version 1.1 ( http://www.phytozome.,OADS,/arxiv_data1/oa_pdf/01/54/msv156.PMC4651234.pdf
Supplementary Material Supplementary ﬁgures S1–S6 and tables S1–S4 are available at Molecular Biology and Evolution online ( http://www.mbe.,Non-OADS,/arxiv_data1/oa_pdf/01/54/msv156.PMC4651234.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/e3/82/msv160.PMC4651237.pdf
"2006 ), which was downloaded from the NCBI ftp server ( ftp://ftp.ncbi.nih.gov/genomes/Bacteria/ Pseudomonas_aeruginosa_ UCBPP_PA14_uid57977, last accessed July 28, 2015).",OADS,/arxiv_data1/oa_pdf/e3/82/msv160.PMC4651237.pdf
"Variant Detection To reliably call SNPs and SV, duplicate reads were removed using MarDuplicates in Picardtools ( http://picard.source- forge.net , last accessed July 28, 2015).",OADS,/arxiv_data1/oa_pdf/e3/82/msv160.PMC4651237.pdf
"Functional Term Analysis The ﬁnal list of genes for each sample was collated for each treatment group and for each time point and the gene lists were subjected to gene enrichment analysis using DAVID 6.7 (http://david.abcc.ncifcrf.gov/ , last accessed July 28, 2015) (Huang et al.",OADS,/arxiv_data1/oa_pdf/e3/82/msv160.PMC4651237.pdf
"We also used EASE, the free, stand-alone software package from DAVID bioinformatics resources ( http://david.abcc.",OADS,/arxiv_data1/oa_pdf/e3/82/msv160.PMC4651237.pdf
Supplementary Material Supplementary ﬁgure S1 and tables S1–S4 a r ea v a i l a b l ea t Molecular Biology and Evolution online ( http://www.mbe.,Non-OADS,/arxiv_data1/oa_pdf/e3/82/msv160.PMC4651237.pdf
Genomic data are stored atthe European Nucleotide Archive (SRA) under accessionnumber PRJEB7071 ( http://www.ebi.ac.uk/ena/data/view/ PRJEB7071 ).,OADS,/arxiv_data1/oa_pdf/e3/82/msv160.PMC4651237.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/83/0a/msv165.PMC4651238.pdf
"We combined results from ﬁve independent runs (totaling 2 billion post–burn-in genera- tions) and visualized the resulting topology and divergencetimes using FigTreev1.4.0 ( http://tree.bio.ed.ac.uk/software/ ﬁgtree/ , last accessed August 9, 2015).",OADS,/arxiv_data1/oa_pdf/83/0a/msv165.PMC4651238.pdf
Supplementary Material Supplementary ﬁgures S1–S14 and tables S1–S7 are available atMolecular Biology and Evolution online ( http://www.mbe.,Non-OADS,/arxiv_data1/oa_pdf/83/0a/msv165.PMC4651238.pdf
Available from: http://www.bioconductor.,OADS,/arxiv_data1/oa_pdf/83/0a/msv165.PMC4651238.pdf
"Published by the British Institute of Radiology under the terms of the Creative Commons Attribution –NonCommercial 4.0 Unported License http://creativecommons.org/licenses/by-nc/4.0/ , which permits unrestricted non-commercial reuse, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/f8/c7/bjr.20140526.PMC4651256.pdf
Available from: https://www.gov.uk/drug-safety-update/ gadolinium-containing-contrast-agents-new-advice-to-minimise-the-risk-of-nephrogenic-systemic- ﬁbrosis 10.,Non-OADS,/arxiv_data1/oa_pdf/f8/c7/bjr.20140526.PMC4651256.pdf
Available from: https://www.medicines.org.,Non-OADS,/arxiv_data1/oa_pdf/f8/c7/bjr.20140526.PMC4651256.pdf
Available from: https://www.medicines.org.uk/emc/medicine/15927 19.,Non-OADS,/arxiv_data1/oa_pdf/f8/c7/bjr.20140526.PMC4651256.pdf
Available from:http://www.acr.org/quality-safety/resources/ ;/media/37D84428BF1D4E1B9A3A2918- DA9E27A3.pdf 69.,Non-OADS,/arxiv_data1/oa_pdf/f8/c7/bjr.20140526.PMC4651256.pdf
Available from: http://www.ranzcr.edu.au/ documents-download/doc_download/553-revised-college-guidelines-for-gadolinium- containing-mri-contrast-agents.pdfBJR MA Kirchin et al 10 of 10 birpublications.org/bjr Br J Radiol;88:20140526,Non-OADS,/arxiv_data1/oa_pdf/f8/c7/bjr.20140526.PMC4651256.pdf
"2, 2015 http://dx.doi.org/10.15283/ijsc.2015.8.2.128 REVIEW ARTICLE 128Accepted for publication July 22, 2015, Published online November 30, 2015 Correspondence to Hamid Tebyanian Applied Biotechnology Research Center, Baqiyatallah University of  Medical Sciences, Tehran 1435944711, IranTel: +989198045743, Fax: +982-21-886-22356 E-mail: Tebyan.hamid@yahoo.com  This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/4.0/), which permits unrestricted non-commercial use, dis-tribution, and reproduction in any medium, provided the original work is properly cited.Planarians: an In Vivo Model for Regenerative Medicine Ali Karami, Hamid Tebyanian, Vahabodin Goodarzi, Sajad Shiri  Applied Biotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran The emergence of regenerative medicine has raised the hope of treating an extraordinary range of disease and serious  injuries.",Non-OADS,/arxiv_data1/oa_pdf/a6/7f/ijsc-08-128.PMC4651277.pdf
"2, 2015 http://dx.doi.org/10.15283/ijsc.2015.8.2.134 ORIGINAL ARTICLE 134Accepted for publication October 2, 2015, Published online November 30, 2015 Correspondence to Davood Mehrabani Stem Cell and Transgenic Technology Research Center, Shiraz  University of Medical Sciences, Shiraz 71348-74478, IranTel/Fax: +98-71-3234-1025 E-mail: mehrabad@sums.ac.ir  This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/4.0/), which permits unrestricted non-commercial use, dis-tribution, and reproduction in any medium, provided the original work is properly cited.Induction of Spermatogenesis by Bone Marrow-derived  Mesenchymal Stem Cells in Busulfan-induced  Azoospermia in Hamster Amin Tamadon1, Davood Mehrabani1, Farhad Rahmanifar2, Alireza Raayat Jahromi3,  Mohadeseh Panahi4, Shahrokh Zare1, Zahra Khodabandeh1, Iman Razeghian Jahromi1,  Nader Tanideh1,5, Mehdi Dianatpour1,6, Mani Ramzi7, Omid Koohi-Hoseinabadi8 1Stem Cell and Transgenic Technology Research Center, Shiraz University of Medical Sciences, Departments of 2Basic Sciences,  3Clinical Sciences, 4DVM graduated, School of Veterinary Medicine, Shiraz University, Departments of 5Pharmacology, 6Human  G e n e t i c ,  S c h o o l  o f  M e d i c i n e ,  S h i r a z  U n i v e r s i t y  o f  M e d i c a l  S c i e n c e s ,  7Hematology and Bone Marrow Transplant Research Center,  8Laboratory Animal Center, Shiraz University of Medical Sciences, Shiraz, Iran Background:  Bone marrow-derived mesenchymal stem cells (BM-MSCs) have potential of differentiation and they se- crete anti-inflammatory cytokines and growth factors which make them appropriate for cell therapy.",Non-OADS,/arxiv_data1/oa_pdf/ed/33/ijsc-08-134.PMC4651278.pdf
"2, 2015 http://dx.doi.org/10.15283/ijsc.2015.8.2.146 ORIGINAL ARTICLE 146Accepted for publication August 31, 2015, Published online November 30, 2015 Correspondence to Ahmed M. Elbana Department of ORL-H&N Surgery, Faculty of Medicine, University  of Alexandria, Egypt.",Non-OADS,/arxiv_data1/oa_pdf/78/c7/ijsc-08-146.PMC4651279.pdf
"King Fahd Military Medical Complex  P.O.Box.No-946 Dhahran-31932 Kingdom of Saudi ArabiaTel: +966504875923, Fax: +966138405555 E-mail: ahmedelbanna@yahoo.com  This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/4.0/), which permits unrestricted non-commercial use, dis-tribution, and reproduction in any medium, provided the original work is properly cited.Role of Endogenous Bone Marrow Stem Cells  Mobilization in Repair of Damaged Inner Ear in Rats Ahmed M. Elbana1, Seddik Abdel-Salam1, Ghada M. Morad2, Ahmed A. Omran1 Departments of 1ORL-H&N Surgery, 2Histology, Faculty of Medicine, Univer sity of Alexandria, Alexandria, Egypt Background and Objectives: The utilization of the stem cells is widely used in the last few years in different fields  of medicine, either by external transplantation or endogenous mobilization, most of these studies still experimental  o n  a n i m a l s ;  f e w  w e r e  t r i e d  o n  h u m a n  a s  i n  t h e  s p i n a l  c o r d  i n j u r y  o r  m y o c a r d i a l  i n f a r c t i o n .",Non-OADS,/arxiv_data1/oa_pdf/78/c7/ijsc-08-146.PMC4651279.pdf
"2, 2015 http://dx.doi.org/10.15283/ijsc.2015.8.2.155 ORIGINAL ARTICLE 155Accepted for publication August 21, 2015, Published online November 30, 2015 Correspondence to Gyu-Jin Rho Department of Vet OBS/Theriogenology and Biotechnology, College of Veterinary Medicine, Gyeongsang National University, 501, Ji nju-daero,  Jinju 52828, Korea Tel: +82-55-772-2347, Fax: +82-55-772-2349E-mail: jinrho@gnu.ac.kr Co-Correspondence to Bong-Wook Park Department of Oral & Maxillofacial Surgery, School of Medicine, Gyeongsang National University, Gangnam-ro 79, Jinju 52828, Kor ea Tel: +82-55-750-8264, Fax: +82-55-761-7024 E-mail: parkbw@gnu.ac.kr   This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/ li- censes/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the o riginal work is properly cited.Cryopreservation of Human Wharton’s Jelly-derived  Mesenchymal Stem Cells Following Controlled Rate Freezing  Protocol Using Different Cryoprotectants; A Comparative Study Sharath Belame Shivakumar1, Dinesh Bharti1, Si-Jung Jang1, Sun-Chul Hwang2, Ji-Kwon Park3,  Jeong-Kyu Shin3, June-Ho Byun4, Bong-Wook Park4, Gyu-Jin Rho1,5 Departments of 1Vet OBS/Theriogenology and Biotechnology, 2Orthopaedic Surgery, School of Medicine,  3Obstetrics and Gynaecology, School of Medicine, 4Oral and Maxillofacial Surgery, School of Medicine,  5Research Institute of Life Sciences, Gyeongsang National University, Jinju, Korea Objectives:  To compare the effect of three different cryoprotectants on basic stem cell characteristics for the possibility  of using well defined, dimethyl sulfoxide (DMSO) and serum free freezing solutions to cryopreserve human Wharton’s  jelly-derived mesenchymal stem cells (WJMSCs) following controlled rate freezing protocol.",Non-OADS,/arxiv_data1/oa_pdf/2c/3b/ijsc-08-155.PMC4651280.pdf
"2, 2015 http://dx.doi.org/10.15283/ijsc.2015.8.2.181 ORIGINAL ARTICLE 181Accepted for publication July 8, 2015, Published online November 30, 2015 Correspondence to Maha Baligh Zickri Departments of Histology, Faculty of Medicine, Cairo University,  Cairo, EgyptaTel: +201223955078, Fax: +20235381183/+20235381760 E-mail: maha_kaah@yahoo.com  This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/4.0/), which permits unrestricted non-commercial use, dis-tribution, and reproduction in any medium, provided the original work is properly cited.Comparative Histological Study on the Therapeutic Effect of  Green Tea and Stem Cells in Alzheimer’s Disease Complicating  Experimentally Induced Diabetes Hend Shafik Bassiony1, Maha Baligh Zickri1, Hala Gabr Metwally2, Hala Ahmed Elsherif1,  Sarah Mohammed Alghandour1, Wael Sakr3 Departments of 1Histology, 2Clinical Pathology, Faculty of Medicine, Cairo University, Cairo,  3Department of General Surgery, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt Background and Objectives:  Alzheimer’s disease (AD) is a devastating neurodegenerative disorder.",Non-OADS,/arxiv_data1/oa_pdf/02/0f/ijsc-08-181.PMC4651282.pdf
"2, 2015 http://dx.doi.org/10.15283/ijsc.2015.8.2.191 ORIGINAL ARTICLE 191Accepted for publication May 29, 2015, Published online November 30, 2015 Correspondence to Seyed Mojtaba Hosseini Student Research Committee, Zand Blvd, Shiraz 7174776179, IranTel: +989178033070, Fax: +987132122970 E-mail: hoseini2010m@gmail.com  This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/4.0/), which permits unrestricted non-commercial use, dis-tribution, and reproduction in any medium, provided the original work is properly cited.A Novel Cell Therapy Method for Recovering after  Brain Stroke in Rats Seyed Mojtaba Hosseini1,2,3, Mohammad Farahmandnia1,2, Sepehr Kazemi1,2,  Benafshe Shakibajahromi1,2, Fatemeh Sabet Sarvestani1,2, Zahra Khodabande4 1Student Research Committee, 2Cell & Molecular Medicine Student Research Group, Medical School, 3Stem Cell Laboratory,  Department of Anatomy, 4Trangenic Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran Background:  Nowadays, stroke leads to a significant part of the adult mortality and morbidity and also it could result  in some neurological deficits in the patients’ lives.",Non-OADS,/arxiv_data1/oa_pdf/1a/48/ijsc-08-191.PMC4651283.pdf
"2, 2015 http://dx.doi.org/10.15283/ijsc.2015.8.2.200 ORIGINAL ARTICLE 200Accepted for publication May 19, 2015, Published online November 30, 2015 Correspondence to Samraa H Abdel-Kawi Department of Histology, Faculty of Medicine1, Beni-Suef University,  Mohammed Hassan street, Faculty of Medicine, Beni-suef 62511,  EgyptTel: +201001916480, Fax: +20822321352 E-mail: samraahussein@yahoo.com  This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/4.0/), which permits unrestricted non-commercial use, dis-tribution, and reproduction in any medium, provided the original work is properly cited.Possible Therapeutic Effect of Stem Cell in Atherosclerosis in  Albino Rats.",Non-OADS,/arxiv_data1/oa_pdf/0f/9f/ijsc-08-200.PMC4651284.pdf
"2, 2015 http://dx.doi.org/10.15283/ijsc.2015.8.2.209 ORIGINAL ARTICLE 209Accepted for publication September 25, 2015, Published online November 30, 2015 Correspondence to Shereen A. Saleh Department of Internal Medicine, Faculty of Medicine, Gastroen- terology and Hepatology Unit, Ain Shams University, Lotfy El  Sayed St., Abasseya Square, Cairo 11827, EgyptTel: +20-02-26131342, +20-02-24821485, Fax: +6837673-94070 E-mail: shereen_saleh2014@hotmail.com  This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/4.0/), which permits unrestricted non-commercial use, dis-tribution, and reproduction in any medium, provided the original work is properly cited.Autologous Stem Cells Transplantation in Egyptian Patients  with Liver Cirrhosis on Top of Hepatitis C Virus Hoda Al Tayeb1, Ahmed El Dorry2, Nehad Amer1, Nadia Mowafy3,  Maha Zimaity1, Essam Bayoumy1, Shereen A.Saleh1 Departments of 1Internal Medicine, 2Diagnostic and Interventional Radiology, and 3Clinical Pathology,  Faculty of Medicine, Ain Shams University, Cairo, Egypt Background and Objectives:  Use of pluripotent stem cells is an ideal solution for liver insufficiencies.",Non-OADS,/arxiv_data1/oa_pdf/49/f2/ijsc-08-209.PMC4651285.pdf
"2, 2015 http://dx.doi.org/10.15283/ijsc.2015.8.2.219 ORIGINAL ARTICLE 219Accepted for publication May 9, 2015, Published online November 30, 2015 Correspondence to Mahdieh Ghiasi Stem Cell laboratory, The Academic Center for Education, Culture  and Research, Qom Branch, Qom 3713189934, IranTel: +98-25-32700155, Fax: +98-25-32700154 E-mail: m.ghiasi@acecr.ac.ir  This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/4.0/), which permits unrestricted non-commercial use, dis-tribution, and reproduction in any medium, provided the original work is properly cited.Fibrin Scaffolds Designing in order to Human Adipose-derived  Mesenchymal Stem Cells Differentiation to Chondrocytes  in the Presence of TGF- β3  Mohsen Sheykhhasan, Reza Tabatabaei Qomi, Mahdieh Ghiasi Stem Cell laboratory, The Academic Center for Education, Culture and Research, Qom Branch, Qom, Iran Background and Objectives:  One of the most cellular source used for cartilage tissue engineering are mesenchymal  s t e m  c e l l s  ( M S C s ) .",Non-OADS,/arxiv_data1/oa_pdf/9d/81/ijsc-08-219.PMC4651286.pdf
"2, 2015 http://dx.doi.org/10.15283/ijsc.2015.8.2.228 BRIEF REPORT 228Accepted for publication August 12, 2015, Published online November 30, 2015 Correspondence to Chang-Hwan Park Lab.",Non-OADS,/arxiv_data1/oa_pdf/04/83/ijsc-08-228.PMC4651287.pdf
"of Neural Stem Cell Biology, Graduate School of Biomedical Science & Engineering and Department of Microbiology, College  of Medicine, Hanyang University, 222 Wangsimni-ro, Seongdong-gu, Seoul 04763, KoreaTel: ＋82-2-2220-0646, Fax: ＋82-2-2220-2422 E-mail: chshpark@hanyang.ac.kr  This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/4.0/), which permits unrestricted non-commercial use, dis-tribution, and reproduction in any medium, provided the original work is properly cited.FGF8 is Essential for Functionality of Induced Neural  Precursor Cell-derived Dopaminergic Neurons Mi-Sun Lim1,2, Soo Young Lee3, Chang-Hwan Park1,2,3 1Graduate School of Biomedical Science and Engineering, 2Hanyang Biomedical Research Institute,  3Department of Microbiology, College of Medicine, Hanyang University, Seoul, Korea Induced neural precursor cells (iNPCs) are one source of transplantable dopaminergic neurons used in cell therapy  for Parkinson’s disease.",Non-OADS,/arxiv_data1/oa_pdf/04/83/ijsc-08-228.PMC4651287.pdf
"2, 2015 http://dx.doi.org/10.15283/ijsc.2015.8.2.235 BRIEF REPORT 235Accepted for publication September 25, 2015, Published online November 30, 2015 Correspondence to KL Vandana Department of Periodontics, College Of Dental Sciences, MCC 'B'  Block, Bapuji Hospital rd., Karanataka 577004, Davangere Tel: + 91-08192-231285, 231029, Fax: +91-8192-236493 E-mail: vanrajs@gmail.com  This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/4.0/), which permits unrestricted non-commercial use, dis-tribution, and reproduction in any medium, provided the original work is properly cited.Autologous Stem Cell Application in Periodontal  Regeneration Technique (SAI-PRT) Using PDLSCs  D i r e c t l y  F r o m  a n  E x t r a c t e d  T o o t h …An Insight KL Vandana1, Rajendra Desai3, Priyanka Jairaj Dalvi2 Department of 1Periodontics and 2Periodontics and 3Oral and Maxillofacial Surgery, College of Dental Sciences, Davangere Periodontal regeneration represents the ultimate goal of periodontal therapy.",Non-OADS,/arxiv_data1/oa_pdf/99/21/ijsc-08-235.PMC4651288.pdf
"Surgical Neurology International OPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Unique Case Observations, a supplement to  Surgical Neurology International Editor: S. A. Enam,  MD  Aga Kahn University; Karachi,  Sindh, Pakistan © 2015 Surgical Neurology International | Published by Wolters Kluwer - MedknowS448Abstract Background:  “Headbanging” is the slang term used to denote violent shaking of  one’s head in time with the music.",Non-OADS,/arxiv_data1/oa_pdf/5f/87/SNI-6-448.PMC4651337.pdf
"http://surgicalneurologyint.com/Recurrent-subdural-hematoma-secondary-to- headbanging:-A-case-report/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/5f/87/SNI-6-448.PMC4651337.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/aa/d0/dddt-9-6001.PMC4651359.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 6001–6008Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6001Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8325 9Use of letrozole and clomiphene citrate combined  with gonadotropins in clomiphene-resistant  infertile women with polycystic ovary syndrome:   a prospective study Wenyan Xi1 shankun liu2 hui Mao1 Y ongkang Yang1 Xiang Xue1 Xiaoning lu1 1The second affiliated hospital of  Xi’an Jiaotong University, Xi’an city,   shaanxi, 2Taian city central hospital,   shandong, Taian, People’s republic  of chinaBackground:  Gonadotropin has been used to stimulate ovulation in clomiphene-resistant  infertile women with polycystic ovary syndrome (PCOS), but it is associated with overstimu - lated cycles with the development of many follicles.",Non-OADS,/arxiv_data1/oa_pdf/aa/d0/dddt-9-6001.PMC4651359.pdf
"Approximately 25% of  women with PCOS will not respond at all to CC and are considered to be “clomiphene  resistant”.2 In addition, CC may have an antiestrogenic effect on endometrial develop - ment and cervical mucus production, which have been implicated in a low pregnancy  rate despite a relatively high ovulation rate with the use of this drug.3,4correspondence: Xiang Xue The Second Affiliated Hospital of Xi’an  Jiaotong University, no 157, Xiwu road,  Xi’an city, shaanxi Province 710004,  People’s republic of china Tel +86 130 7290 6155 email xwyanzi@126.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Xi et al Running head recto: Letrozole co-treatment with HMG for ovarian induction  DOI: http://dx.doi.org/10.2147/DDDT.S83259",Non-OADS,/arxiv_data1/oa_pdf/aa/d0/dddt-9-6001.PMC4651359.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/aa/d0/dddt-9-6001.PMC4651359.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/aa/d0/dddt-9-6001.PMC4651359.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/91/46/dddt-9-6035.PMC4651361.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 6035–6042Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6035Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S7322 4Profile of suvorexant in the management of   insomnia eliza L Sutton Department of Medicine, University  of Washington, Seattle, WA, USAAbstract:  Suvorexant, approved in late 2014 in the United States and Japan for the treat - ment of insomnia characterized by difficulty achieving and/or maintaining sleep, is a dual  orexin receptor antagonist and the first drug in its class to reach the market.",Non-OADS,/arxiv_data1/oa_pdf/91/46/dddt-9-6035.PMC4651361.pdf
"Insomnia, defined in the  International Classification of Sleep Disorders4 as: Correspondence: eliza L Sutton Department of Medicine, University of  Washington Box 354765, 1959 NE Pacific  Street, Seattle, WA 98195, USA email esutton@u.washington.ed u Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Sutton Running head recto: Suvorexant for insomnia DOI: http://dx.doi.org/10.2147/DDDT.S73224",Non-OADS,/arxiv_data1/oa_pdf/91/46/dddt-9-6035.PMC4651361.pdf
"Available from:  http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ ucm409950.ht m. Accessed March 17, 2015.",Non-OADS,/arxiv_data1/oa_pdf/91/46/dddt-9-6035.PMC4651361.pdf
